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ABSTRACT
This study aimed to investigate the genetic basis of chicken colonisation potential 
variations in virulence between two Campylobacter jejuni strains. Genomic subtractive 
hybridisation was developed for C  jejuni and to compare the genetic complement of a 
poor coloniser, strain NCTC11168, and a good coloniser, strain 81116.. Twenty-three 
DNA fragments were identified that were specific for strain 81116 and absent in strain 
NCTCl 1168. Five of these DNA fragments, inserts 31, 50, 183, 186 and 188, were 
identified as a putative arsenite export gene {arsE), di- and tri-peptide transporter gene 
(dtpT), transfer gene (traG), arsenate reductase gene {arsC) and a gene encoding a 
putative integral membrane protein with an unknown function (Cj0033B), respectively. 
Obtention of this information significantly benefited from the known genome sequence of 
NCTCl 1168 (Parkhill et al, 2000). The recent, albeit preliminary, sequence from 
C. jejuni strain RM1221 (http://www.tigr.org/) was used to compare the genomic 
locations of these inserts in strain 81116, as well as hypothesise mechanisms for their 
absence in strain NCTCl 1168. The results suggest that the tRNA loci and the occurrence 
of direct repeats in C. jejuni play key roles in the generation of genetic diversity, and 
therefore, the evolution of this species. Two of the 81116-specific DNA fragments, inserts 
50 and 236, identified as part of a di- and tri-peptide transporter (dtpT) gene and y- 
glutamyl transpeptidase (ggt) gene, respectively, were further investigated for potential 
involvement in chicken colonisation. Mutants were generated in strain 81116 for each of 
these genes and characterised by a number of in vitro and in vivo methods. Using a 
chicken colonisation model, results suggested that DtpT was required for optimal 
bacterial colonisation of chicken caeca. This DtpT protein appears to be important in the 
acquisition of intestinal di- and tripeptides as energy sources, and thus contributing to the 
survival of the organism in the host gut. GOT was also required for persistent chicken 
colonisation. Inactivating GGT in strain 81116 appeared to cause a reduction in bacterial 
intracellular glutathione over time. Once glutathione levels had been significantly 
reduced, the mutant became sensitive to the toxic metabolites including those seen during 
host inflammatory responses. Thus, the reduction in colonisation may have been due to 
depleted intracellular glutathione levels. Overall, this study has confirmed the value of 
subtractive hybridisation in identifying genetic diversity in C. jejuni. The generation of 
such genetic variants of C. jejuni may enable adaptation to different environments or as 
illustrated by phenotypic variation, including in colonisation potential.
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CHAPTER ONE
Introduction
C hapter 1. In troduction
1. Introduction
1.1 Historical background
Campylobacters were first described in 1913 as ‘vibrios’ associated with ovine and 
bovine abortions (McFadyean & Stockman, 1913). Five years later these spiral 
bacteria were reassigned as Vibrio fetus (Smith, 1918). In 1959 Florent identified two 
similar vibrios, one of which resulted in infertility of cows, and the second of which 
caused sporadic abortion in cattle and sheep (Florent, 1959). These organisms were 
named Vibrio fetus subsp. verierealis and Vibrio fetus subsp. intestinalis respectively.
Another group of Vibrio-\\kQ organisms were probably first identified in calves with 
enteritis in 1931 (Jones et al., 1931) and in humans with diarrhoea in a 1938 outbreak 
(Levy, 1946). In 1957 King was the first to study human strains in depth. She 
recognised that while some conformed to classic types, others formed a similar but 
distinct group characterised by an unusually high optimum growth temperature. The 
most prominent symptom in patients caused by these ‘vibrio-related’ bacteria was 
diarrhoea and these were then known as Vibrio jejuni (King, 1957). Moreover 
organisms from the faeces of pigs with diarrhoea identified yet another distinct vibrio- 
like bacteria which was then classified as Vibrio coli (Doyle, 1944; Doyle 1948).
The identification of the low DNA base composition, microaerobic growth 
requirements and their non-fermentative metabolism resulted in the assignment of this 
bacteria to a new genus namely Campylobacter (Sebald & Veron, 1963), to reflect the 
fundamental differences from Vibrios. Campylo and bacter literally are the Greek 
words for curved and rod. It was not until 1972 that the Campylobacter organisms 
were first selectively isolated using a filtration method from the stools of patients with 
acute enteritis (Dekeyser et al., 1972). Previous studies had cultured Campylobacters 
from blood and attempts to culture from faeces failed owing to overgrowth of 
coliforms. In 1977 the development of selective media overcame the major 
difficulties in the Camylobacter isolation procedure (Skirrow, 1977). These isolates 
were most likely what we refer to today as Campylobacter jejuni or C. coli. Although 
they were derived from an initial association with enteric disease in animals (Jones et
C hapter 1. In troduction
ah, 1931; Doyle, 1948), these two species are the most important human pathogens in 
this genus.
In the mid-late 1990’s, a study was carried out to identify the agents responsible for 
causing infectious intestinal diseases (IID) in England (Tompkins et al., 1999). The 
prevalence of Campylobacter species in diarrhoeic stools (12 %) far exceeded that of 
other well known bacterial enteric pathogens including Salmonella species (5 %), E. 
coli 0157 (0.1 %) and Shigella species (0 %). Presently C. jejuni is the greatest cause 
of human bacterial enteritis world-wide. In 2001, for example, over 56, 000 cases 
were reported to the Communicable Disease Surveillance Centre (CDSC) in England 
and Wales alone (Anon., 2002). In the UK, for example, which has sophisticated 
epidemiological systems, it has been established that for every case reported, 7.6 
cases occur unreported within the community (Wheeler et al, 1999). In light of these 
figures, and considering that the average cost per case presenting to general 
practitioner is £315 (Roberts et al, 2003), the socio-economic impact of 
Campylobacter infection is considerable.
1.2 Campylobacter biology
Campylobacters are Gram-negative, spiral-shaped rods, generally 0.5-5.0pm long and 
0.2-0.8pm wide (Figure 1.1). They display a typical darting motility, which is due to 
the possession of one or two polar flagella perhaps aided by cell shape. However, 
some species are non-motile (C. gracilis) or have multiple flagella (C. showae). 
Campylobacters are mostly microaerobic, requiring an atmosphere of 3-15% O2 and 
3-5% CO2 . They are partly differentiated on the basis of optimal growth 
temperatures. C. jejuni, C. coli and C. lari are referred to as thermophilic due to the 
optimum growth temperature of 42°C. The majority of other Campylobacter species 
grow at temperatures ranging from 25 to 37°C. Campylobacters are unable to ferment, 
or oxidise carbohydrates and instead utilise pyruvate, amino acids and serine or 
tricarboxylic acid cycle intermediates, for energy metabolism (Griffiths and Park, 
1990^
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Figure 1.1 Transmission Electron Micrograph of Campylobacter jejuni strain 81116
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Under certain conditions, such as exposure to oxygen, nutrient deprived conditions 
(such as aquatic systems) or during the stationary phase of growth, C  jejuni can 
become spherical and unculturable. Such organisms have been termed viable non- 
culturable (VNC). The reasons for this VNC state is unclear. Some controversy exists 
regarding the capacity of VNCs to colonise animals. Medema and colleagues were 
unable to recover VNC organisms from chick or embryonated-egg models (Medema 
et al., 1992). In contrast. Stem and colleagues reported a small number of chicks were 
colonised with some VNC isolates (Stem et al., 1994) and Cappelier and colleagues 
managed to resuscitate VNC cells following chick or murine passage (Cappelier et al., 
1999a). Furthermore these authors managed to culture VNC organisms following egg 
passage by injecting into the vitelline cavity, which has more favourable conditions 
for cell growth than the allantoic cavity (Cappelier et al., 1999b). Importantly these 
resuscitated VNC organisms were able to retain their capacity to adhere to HeLa cells 
in vitro, suggesting they could be enteropathogenic. In contrast, inoculation of VNC 
forms from four C. jejuni strains into one-day-old chicks resulted in no colonisation, 
even using 10 times the numbers of viable culturable organisms required for 100 % 
colonisation (Feamley et al, 1996). The reasons why C. jejuni produce VNC 
organisms is unclear.
1.3 Taxonomy and biotyping
The taxonomy of the genus Campylobacter has undergone considerable revision since 
its inception in 1963 (Sebald & Veron, 1963). The number of Campylobacter species 
recognised in the genus is constantly rising, with new ones frequently being 
identified. Campylobactericeae belong to the rRNA superfamily VI of the 
Proteobacteria (Vandamme & Goossens, 1992). Comparison of 16S rRNA gene 
sequences between strains of Campylobacter, Arcobacter, Helicobacter, 
Sulfurospirillum, Wolinella and Bacteroides ureolyticus has placed the rRNA 
superfamily VI organisms in distinct groups (Table 1.1). In group I Campylobacter 
and B. ureolyticus form a phylogenetically-related cluster, group II comprised all four 
species of Arcobacter, and group III encompassed Helicobacter species and Wolinella 
succinogenes, which is the only member species in this genus (On, 2001). Finally, the 
genus Sulfurospirillium and Dehalospirillum multivorans were also found to belong
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to the rRNA superfamily VI but do not fit in any of the already mentioned groups thus 
forming a fourth related cluster (On, 2001).
An organism that causes a gastric, hepatic, reproductive, systemic or any other 
disorder needs to be routinely identified and prevalence established. As well as 
disease symptoms, the host or ecological niche may sometimes aid towards 
categorisation. Culture media made selective by the addition of antibiotics (see 
Section 2.1.5) enables the isolation of Campylobacters from faeces (Skirrow, 1977). 
The identification of Campylobacters is normally performed using biochemical tests. 
Since they do not ferment or oxidise carbohydrates, chemical tests that are routinely 
used for Enterobacteriaceae cannot be used. Most biotyping schemes are focused on 
differentiating Campylobacter.^ according to the production of catalase, growth at 42°C 
or 25°C and resistance to nalidixic acid or cephalothin. Only one phenotypic test, the 
ability to hydrolyse hippuric acid, distinguishes C. jejuni from C. coli (Harvey, 1980). 
This test is unreliable, as some C. coli strains occasionally test positive and some 
strains (1.6 %) of C. jejuni are hippurate-negative (Totten et al, 1987). The tolerance 
of C. fetus to glycine and the ability to produce hydrogen sulphide distinguishes this 
organism from the rest of the taxa. All C. hyointestinalis strains grow 
microaerobically in the presence of hydrogen when grown on blood agar media. Other 
biochemical tests routinely used for discriminating Campylobacter species are their 
abilities to produce urease, hydrolyse indoyle acetate and reduce nitrate. Additional 
tests also used involve growth on media containing one of the following additional 
components; 1.5% glycine, 1.5 or 3 % sodium chloride and cefoperazone (64 pg/ml).
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Table 1.1
Superfamily VI of Proteobacteria phylogenetic clusters arranged into four groups as 
inferred by comparison of 16S rRNA gene sequences of each strain (On, 2001).
GrouD I GrouD III
Campylobacter mucosali Helicobacter bovis
Campylobacter hyointestinalis subsp. hyointestinalis Helicobacter heilmanni Type 1
Campylobacter fetus subsp. fetus Helicobacter suis
Campylobacter fetus subsp. Venerealis Helicobacter heilmanni Type 2
Campylobacter hyointestinalis subsp. lawsonii Helicobacter felis
Campylobacter lanienae Helicobacter sallomonis
Campylobacter concisus Helicobacter bizzozeronii
Campylobacter curvus Helicobacter acinonychis
Campylobacter showae Helicobacter nemestrinae
Campylobacter rectus Helicobacter pylori
Campylobacter sputorum bv sputorum Helicobacter pullorum
Campylobacter sputorum bv paraureolyticus Helicobacter pometenis
Campylobacter hominis Helicobacter cholecystus
Campylobacter gracilis Helicobacter rodentium
Campylobacter upsaliensis Helicobacter fennelliae
Campylobacter helveticus Helicobacter trogontum
Campylobacter coli Helicobacter muridarum
Campylobacter lari Helicobacter hepaticus
Campylobacter coli var. hyoilei Helicobacter bilis
Campylobacter jejuni subsp. doylei Helicobacter canis
Campylobacter jejuni subsp. jejuni Helicobacter cinaedi
Campylobacter ureolyticus Helicobacter rappini
Bacteroides ureolyticus Helicobacter mustelae 
Helicobacter typhlonicus 
Helicobacter suncus 
Wolinella succinogenes
GrouD II GrouD IV
Arcobacter nitrofigilis Sulfurospirillum deleyianum
Arcobacter butzleri Sulfurospirillum arcachonense
Arcobacter skirrowi Sulfurospirillum bamesii
Arcobacter cryaerophilus Dehalospirillum multivorans 
Sulfurospirillum arsenophilum
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1.4 Typing schemes
1.4.1 Serotyping
C. jejuni and C. coli are the Campylobacter species routinely classified to strain level. 
There are three main serotyping methods that have been developed, the Tenner, Lior 
and LET schemes. Tenner serotyping is based on the soluble heat stable (HS) antigens 
in a passive haemagglutination test (Tenner & Hennessy, 1980). Forty-two 
serostrains for C. jejuni and 18 for C  coli are commonly used for typing (Tenner et 
al, 1983; Mills et al, 1991; Mills et al, 1992). There has been much debate about 
whether the HS antigens are composed of lipopolysaccharide (LTS) or 
lipooligosaccharide (LOS) (Rietschel et al, 1990; Moran, 1995) and this may be 
strain dependent (Moran et al, 1996; Treston et al, 1996). Recently, the outer 
membrane components of C. jejuni have been re-examined. The results indicate that 
Campylobacter contains two classes of surface-located glycolipid (Tenner & Aspinall,
1997). The first class resembles the typical enterobacterial LTS consisting of 
complete LTS molecules with O chains. The second class, because of a low M r and 
serotypic diversity, resembles the lipooligosaccharide (LOS) molecules identified in 
Neisseria species (Mandrell & Apicella, 1993), which have short or no O chains. 
Recently a polysaccharide capsule surrounding the surface of the cell has been 
demonstrated by electron microscopy (Karlyshev et ah, 2001). Studies have shown 
that it is the capsule, rather than LTS or LOS, that is the main component detected by 
the Tenner serotyping system (Oza et al, 2002). The main downfalls of this scheme is 
reproducibility and problems can occur as a result of variation in the source, age, 
concentration and condition of red blood cells (Flicker et al, 1987).
The Lior serotyping scheme is an agglutination test based on heat labile antigens (Lior 
et al, 1982). Uncharacterised bacterial surface antigens and flagella are the 
serodeterminants for this serotyping system. Currently there are 108 Lior serotypes 
(Tatton & Wachsmuth, 1992) differentiating C. jejuni, C. coli and C. lari strains. This 
scheme is rarely used today.
The most recently developed scheme was the LET (Laboratory of Enteric Tathogens) 
scheme at the Central Tublic Health Laboratory, Colindale, London (Frost et al.
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1998). It was developed in order to address the problems faced with the Fermer 
system. The scheme uses the same strains for antiserum production as the Fermer 
scheme, however the test involves direct agglutination rather than passive 
haemagglutination. Reproducibility is addressed by absorbing the sera and as a 
consequence reduces cross-reactions between different antiseras (Jacobs-Reitsma et 
al, 1995). The antigenic components detected by the system have been shown to be 
LPS and LOS as well as capsular polysaccharide (Oza et al, 2002). Unfortunately 
the scheme has not proved to be any better than the Fenner scheme, with cross­
reacting isolates still a problem (Oza et al, 2002). The scheme has also been shown 
to be unsuitable for the typing of veterinary isolates, due to the large number (40 %) 
of untypable strains (Newell et al, 2000). This is not surprising given that the 
original Fenner type strains are largely representative of Campylobacters isolated 
from Canada in the early 1980s.
1.4.2 Phage typing
Further typing is frequently required for Campylobacter epidemiological studies. This 
is because, for example, in the LEP scheme, 53 % of C. jejuni isolates tested belonged 
to the ten most prevalent serotypes and 19 % were untypable (Frost et al, 1998). 
Therefore phage typing is used by the Public Health Laboratory Service in 
conjunction with serotyping greater discrimination in typing C. jejuni and C. coli 
strains (Khakhria & Lior, 1992). This scheme is composed of 19 phages that can 
identify 46 different phage types. The combined usage of LEP serotyping and phage 
typing has identified between 6 and 29 subtypes within each predominant HS type 
and therefore has allowed a more detailed characterisation of strains (Frost et al,
1999).
1.4.3 Genotyping
Alternative schemes based on the genetic content (genotyping) have been shown to be 
more discriminatory (Wassenaar & Newell, 2000). Pulse field gel electrophoresis 
(PFGE) is a technique routinely used to genotype C. jejuni strains. Initially, the 
bacterial cells are embedded in chromosomal-grade agarose and lysed in situ to 
prevent DNA shearing. Then the use of a rare cutting restriction endonuclease 
enzyme, typically Smal, Sail or Kpnl is used to cut the genomic DNA. This normally
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results in 8-16 fragments that are resolved by gel electrophoresis using a ramped 
puiser (Yan et al, 1991). Even though the discriminatory potential of PFGE profiling 
is excellent (Owen et al, 1997; Fitzgerald et al, 2001; Michaud et al, 2001), 
disadvantages of the technique are the lengthy genomic DNA preparation process and 
its dependence on expensive specialised electrophoresis equipment. Furthermore, the 
enzymes commonly used for PFGE do not digest the genomic DNA from all 
Campylobacter strains (A. M. Ridley, personal communication).
Amplified fragment length polymorphism (AFLP) is another technique that has been 
recently applied to genotype Campylobacters. Here, one or two enzymes, generally 
Hhal and Hinjl, are used to digest the chromosomal DNA. Then adapters are ligated 
to both ends of each fragment to create a template sequence for subsequent PGR 
amplification. Two rounds of PGR are performed to select a subset of these 
fragments. The second PGR also has one of its primers labelled with a fluorescent 
marker. The final amplified subset is separated on a polyacrylamide sequencing gel to 
give a banding profile (Duim et a l, 1999). AFLP has been found to be equally as 
discriminatory as PFGE but far less labour intensive (Ghampion et al, 2002). 
Moreover, AFLP has been a valuable tool for concurrent identification of 
Campylobacters at the species, subspecies and strain levels (Duim et al., 2001). 
Interestingly, AFLP profiling has found C. lari to be a heterogeneous species that may 
comprise multiple taxa.
A further technique developed for sub-typing, but this time focusing on one or both of 
the C. jejuni flagellin (fla) gene rather than the entire genome is y7ûf-typing. This 
method is based on the restriction fragment length polymorphism (RFLP) analysis of 
the PGR product obtained for the flaA and/or flaB  genes (Ayling et a l, 1996). These 
two genes are tandemly (head-to-tail) oriented and separated by an intervening DNA 
segment of approximately 200 bp. Not only are these genes highly conserved, there is 
over 90 % DNA identity between flaA and flaB  genes in individual isolates. This sub­
typing scheme is based upon the fact that the fla  genes significantly vary between 
different isolates (Aim et al, 1993). However, strong evidence was found supporting 
intragenomic recombination between flaA  genes from different strains and 
intergenomic recombination between the two tandem genes (Harrington et al, 1997).
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This may benefit the organism through generating increased antigenic variation to 
help escape the immunological responses of the host. Therefore, the recombination 
that occurs between fla  genes, whilst leaving the strain genotypically unaltered, makes 
this typing scheme unstable for long term monitoring of strains (Harrington et al,
1997). On top of this, a number of investigators have produced yZar-typing schemes 
using different primer sets and different restriction enzymes and this has made strain 
comparisons between different groups impossible (Aim et al 1993; Nachamkin et al, 
1993; Owen et al, 1994; Ayling et al, 1996).
Multi locus sequence typing (MLST) is a recently developed method based on the 
DNA sequence comparison of selected house keeping genes to help identify bacterial 
strain association with disease (Maiden et al, 1998). The genes are carefully chosen 
on the basis of chromosome location, suitability for primer design, and sequence 
diversity. For each locus, alleles are assigned an arbitrary number. The allele number 
for all the genes are then combined and given a unique sequence type (ST) number. 
MLST for C. jejuni has shown this organism to be genetically diverse and weakly 
clonal (Dingle et al, 2001). Nevertheless, associations have been observed between 
animal and human strains from MLST data (Schouls et al, 2003). The overwhelming 
advantages of this technique over other typing methods are the lack of ambiguity of 
the sequence data and it’s portability between laboratories.
Finally, DNA chip array is an emerging technology for genotyping (Schena et al, 
1995; Shalon et al, 1996; Dorrell et al, 2001; Dalma-Weiszhausz et al, 2002; 
Pearson et al, 2003). Briefly, a fully sequenced genome is divided into overlapping 
gene fragments. Each fragment is spotted onto a treated glass slide or ‘chip’. Every 
gene has a known location on the microarray, and thousands of genes can be arrayed 
per chip. The DNA spots then act as hybridisation targets that will bind 
complementary sequences labelled with appropriate fluorescent tags. Whole genomes 
can be hybridised against the chip and comparisons made. The main downfall of this 
technology is that it is dependent on the number of genomes/genes already identified 
and sequenced. On top of this, DNA chip array technology is extremely expensive. 
Nevertheless, the genomes of C. jejuni strains from diverse sources have been 
compared with the completely sequenced strain, NCTC11168 (Parkhill et el, 2000;
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Dorell et al, 2001; Pearson et al, 2003). These studies have revealed extensive 
genetic diversity between C jejuni strains especially within the flagella, lipo­
oligosaccharide and capsule regions. Furthermore, seven hypervarible plasticity 
regions were identified in the genome, which encompassed 50 % of the variable 
C. jejuni gene pool.
1.5 H abitat
Campylobacters are ubiquitous in the environment and have been isolated from many 
water sources including rivers, wells, domestic water supplies contaminated with 
sewage effluent, as well as surface water from farms (Engberg et al, 1998; Moore et 
al, 2001; Rosef et al, 2001; Schaffter and Parriaux, 2002; Trachoo et al, 2002). For 
this reason some campylobacteriosis outbreaks have been due to drinking untreated 
water or accidental contamination (Stehr-Green et al, 1991; Godoy et al, 2002 
Holme, 2003). On the other hand, these organisms need the conditions found in the 
intestines of birds and mammals to successfully grow. Campylobacters have been 
isolated from most animal species investigated, ranging from birds, farm livestock, 
dogs and cats, rodents to primates (Seguin et al, 1986; Wokatsch and Bockemuhl, 
1988; Misawa et a l, 2000; Sandberg et al, 2002). Even reptiles and shell fish have 
been found to harbour Campylobacters (Endtz et al, 1997; Tu et al, 2001). 
However, Campylobacter carriage in the intestines of wild and domestic animals 
rarely results in disease. Nevertheless, infected animal faeces released into the 
environment contaminate water sources and infected new hosts consuming this water. 
This ongoing cycle is not surprising when considering that Campylobacters have been 
shown to survive for substantial periods of time in water and faeces (Blaser et al, 
1980).
Although, Campylobacters are carried by a wide-range of animals, there appears to be 
a dominance of species types colonising particular hosts. C. jejuni are found in a large 
range of animals but predominantly in poultry, domestic and wild birds (Stanley and 
Jones, 1998; Petersen et al, 2001). C. coli are commonly found in pigs and birds (van 
Looveren et a l, 2001), C. lari in birds (Waldenstrom et al, 2002), C. upsaliensis in 
dogs and cats (Moser et al, 2001), C. hyointestinalis in pigs, cattle and simians 
(Guscetti et al, 1994; Busato et a l, 1999; Misawa et al, 2000), and C. mucosalis in
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pigs (van der Walt et al., 1988). Other Campylobacter species may be isolated from 
the genital tracts of domestic animals, such as C. fetus from cattle. (Eaglesome et al, 
1995). These are only some examples of Campylobacter-host reservoirs and it would 
not be unsurprising to find other animal reservoirs.
1.6 Clinical symptoms
The infectious dose for C. jejuni can be as little as 500 organisms (Robinson, 1981; 
Black et al, 1988). In comparison, it is much more infectious than Vibrio cholerae, 
Enteropathogenic E. coli (EPEC) and S. typhi, for which the infective doses are 10  ^
c.f.u., 10^-10  ^ c.f.u. and 10^-10  ^ c.f.u., respectively (Blaser and Newman, 1982; 
Donnenberg et al, 1993; de Castillo et a l, 1997). On the contrary, C. jejuni is not as 
infectious as other enteric pathogens such as Shigella and Enterohemorrhagic E. coli 
(EHEC) in which as few as 10-100 microrganisms can cause infection (DuPont et al, 
1989; Geera/., 2002).
Clinical symptoms generally appear two to ten days after infection. Initially there may 
be fever with confusion or delirium, followed by severe abdominal pain and profuse 
diarrhoea. Nausea is common and vomiting may sometimes occur. Diarrhoea is 
extremely watery and in some cases may contain blood and mucus. Diarrhoea can be 
gradual or explosive and tends to last two to seven days (Wood et al, 1992; Skirrow 
and Blaser 2000). Illness can last from a few days to three weeks (Skirrow, 1977). 
The disease, even its severe form, tends to be self-limiting, despite the fact that 
organisms may be isolated for several weeks after resolution of symptoms. The main 
symptom that causes distress amongst patients is the persistent abdominal pain. Not 
surprisingly, severe campylobacteriosis can sometimes be mistaken for appendicitis 
especially if diarrhoea was not a prominent feature. However, occasionally 
Campylobacters can cause genuine appendicitis (Megraud et al, 1982). Colonic 
biopsies have shown an acute inflammation of the mucosa with oedema, infiltration 
by polymorphonuclear leukocytes, and crypt abscess formation (Shalygina et al, 
1994). Furthermore, the epithelium and lamina propria were infiltrated with an 
increased number of immunoglobulin A (IgA) secreting plasma cells (van Spreeuwel 
et al, 1985). In spite of this, systemic infection is uncommon, detectable in less than 
1 % of all cases of campylobacteriosis (Blaser et al, 1985; Skirrow and Blaser, 2000).
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In extremely rare cases complications can occur from Campylobacter enteritis such 
that the colon becomes greatly dilated and more worryingly colonic perforation can 
occur. This condition is known as Toxic Megacolon (Kummer and Meyenberger, 
1998; Schneider et al, 2000).
Many species of Campylobacter associated with gut colonisation have been isolated 
from humans. In most cases C. jejuni shbsp. jejuni and C  coli are the most frequently 
isolated strains (Lindblom et ah, 1990). However, isolation techniques may not be 
optimised for other Campylobacters and consequently, data is possibly biased towards 
these two species (Goossens et al, 1990). Nevertheless, studies have isolated C. lari 
and C. upsaliensis from human diarrhoeic samples (Prasad et al, 2001). C. fetus, C. 
hyointestinalis and C  concisus have also been found to cause gastroenteritis but 
generally in immunocompromised patients (Minet et al, 1988; Anstead et al, 2001; 
Aabenhus et al, 2002).
Campylobacter species may also be responsible for periodontal diseases. Reports 
have implicated C. rectus, C. concisus and C. showdae for oral colonisation (Tanner 
et al, 1987; Noiri et al, 1997; Haffajee et al, 2001). Furthermore meningitis has 
been associated with C  fetus (Dronda et a l, 1998), C. jejuni (Goossens et al, 1986; 
Ruef et al, 1988) and C  coli (Marzo Sola et al, 2000). Campylobacters have also 
been shown to be the cause of abscesses throughout the body, including brain (La 
Scola et al, 1998), lungs (Targan et al, 1977), liver (Brmbolic, 1995) and ovaries 
(Kanagawa et al, 2000).
Guillain Barré Syndome (GBS) is a rare complication commonly associated with a 
previous C. jejuni infection. GBS is considered to be an autoimmune-mediated 
disorder targeting the myelin sheath of peripheral nerves (Yuki et al, 1993; Ang et 
al, 2002). Infection with Campylobacters of Fenner serotypes 0:19, 0:23 and 0:36 is 
particularly associated with the development of GBS (Fenner & Aspinall, 1997). This 
association has implicated a relationship between anti-glycolipid auto-antibodies 
present in acute-phase sera of GBS patients and the LFS fraction of the 
Campylobacter (Willison and Yuki, 2002). Similarly, animal models have elicited 
antiganglioside responses to the LFS from C. jejuni (Ang et al, 2002; Bowes et al.
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2002). Confusingly, Penner serotyping has been suggested to be directed towards the 
capsule rather than LPS or LOS (Karlyshev et al, 2001; Oza et al, 2002) and 
therefore the C. jejuni component associated with this syndrome, whether it is 
LPS/LOS or capsule has yet to be firmly established. Other infectious pathogens, 
including Cytomegalovirus (Yuki, 2001), Haemophilus influenzae (Mori et al, 2000) 
and Mycoplasma pneumoniae (Pfausler et al, 2002), are also considered to trigger 
this condition. GBS is clinically heterologous and is associated with the rapid 
development of limb weakness, weakness of the respiratory muscles, and areflexia 
(loss of reflexes). Paralysis occurs three weeks following infection and full recovery 
can take from weeks to months (Mishu and Blaser, 1993; Hughes et al, 1999; Okuma 
et al, 1999).
A less common clinical variant of GBS is Miller-Fisher Syndrome (MFS) which is 
also associated with C. jejuni (Fisher, 1956; Zielinska et al, 2000). MFS is 
characterised by acute onset of unsteadiness of gait (ataxia), areflexia and an inability 
to move the eyes, usually associated with non-reactive pupils (ophthalmoplegia) (Ang 
et al, 2002). Other sequelae of Campylobacter infections are the development of 
reactive arthritis and Reiter’s syndrome (Peterson, 1994; Hannu et al, 2002). Even 
though rare, this rheumatic manifestation commonly affects the knee joints. Other 
pathogens, such as Chlamydia trachomatis and enteric bacteria including Salmonella, 
Shigella and Yersinia have also been implicated (Fendler, 2001).
Campylobacter infections are now recognised as a serious risk to individuals with a 
serious underlying illness. Liver cirrhosis, neoplasia, immunosuppressive therapy, and 
human immunodeficiency virus (HIV) infection are all associated with increased 
morbidity and mortality related to campylobacteriosis (Pigrau et a l, 1997). Infections 
can be chronic and recurrent with added complications such as bacteraemia (Johnson 
et al, 1984; Puri et al, 1992; Woo et al, 2002). Immunocompromised hosts often 
tend to have relapsing illnesses, suggesting that the host’s acquired immunity has a 
central role in terminating the infection. Interestingly, pregnant women have a 
tendency to become bacteraemic sometimes leading to abortions (Smith, 2002) and 
thus avoiding bacterial pathogens may be particularly important in these individuals. 
This is because pregnant women become immunosuppressed, presumably to reduce
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the chances of rejecting tissues of their own offspring (Flaxman and Sherman, 2000). 
Thus Campylobacters are emerging to be a added problem to individuals with 
impaired immune systems and more care is required to prevent infection.
1.7 Sources and transmission routes
1.7.1 Developed nations
Campylobacters are the main foodbome bacterial pathogens causing illness in humans 
in England and Wales. In terms of disease burden, other important pathogens include 
Salmonellas, Clostridium perfringens, verocytotoxin producing Escherichia coli 
(VTEC) 0157, and Listeria monocytogenes (Adak et al, 2002). A study that 
identified microorganisms present in loose stool specimens revealed that 
Campylobacters (12.2 % of stools tested), rotavirus group A (7.7 %) and small round 
structured virus (SRSV) (6.5 %) as the most common pathogens in these samples 
(Tompkins et al, 1999). Salmonellas were also found (5 %) but less frequently. 
Patients from developed nations, irrespective of age, tend to have more severe 
symptoms (bloody diarrhoea) than developing nations (milder watery diarrhoea) when 
infected with Campylobacter (Ronveaux et a l, 2000; de Wit et a l, 2001). In addition, 
patients from industrialised countries are generally infected with only one 
Campylobacter serotype and are rarely reinfected, unlike developing nations where 
patients tend to be infected with mixed serotypes and frequently reinfected 
asymptomatically with new, different serotypes (Sjogren et al, 1989). Fatality rates 
from developed nations are low, with most Campylobacter-xolàXQà deaths occurring 
among infants, the elderly, or the immunosuppressed (Guandalini, 1989; Pigrau et al, 
1997; Smith, 1998; Brann, 2001).
The main Campylobacter species identified to cause enteritis in humans are C. jejuni 
(88 %) and C. coli (9%) (Tompkins et al, 1999). Cross contamination of foods and 
surfaces, through raw poultry preparation in domestic kitchens and consumption of 
undercooked poultry, are thought to be the main sources for campylobacteriosis. 
Evidence for this is derived from a comparison of C. jejuni clinical isolates with 
isolates from chickens sold in retail shops during the same time period. Most of the
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predominant genotypes were common to both, suggesting that chickens are a major 
vehicle for disease (Hanninen et al., 2000). Further evidence was provided by an 
analysis of the distribution of human clinical isolates and chickens isolates, where a 
large proportion of serotypes overlapped (Nielsen et al., 1997). This is not surprising 
since surveys have shown that 30-100% of poultry harbour C. jejuni as part of the 
normal gut flora, predominantly in the caeca, and with poultry being food for humans 
(O'Sullivan et al., 2000). Contamination therefore is very likely to occur during 
poultry processing. The number of C. jejuni organisms residing in the avian gut varies 
between 10"^  and 10  ^ c.f.u. (Sayal et al, 1984; Stem et a l, 1995). Transport and 
factory processing of chickens contributes to increase the numbers of organisms on 
carcasses and these range from 10^  to 10  ^c.f.u. (Hood et al, 1988; Stem et a l, 1995). 
Furthermore, poultry flocks that are Campylohacter-nQgàtiwQ before reaching the 
abattoir, are rapidly contaminated during processing (Newell et al, 2001). Moreover, 
these organisms have been shown to survive on chicken carcasses at low temperatures 
and aerobic conditions (Svedhem., et al, 1981; Chynoweth et a l, 1998; Lee et al,
1998). Poultry therefore should be considered as a major risk factor for 
campylobacteriosis in developed countries. Campylobacters are killed after treatment 
at 60CC for at least 15 minutes and cooking food thoroughly may help reduce 
infection in humans. (Svedhem et a l, 1981)
Other vehicles of transmission that have been identified include contaminated water, 
untreated milk, bird-pecked milk and contact with pets (Torre and Tello, 1993; Cogan 
et a l, 1999; Shane, 2000; Sopworth et al, 2003). Children under three years old seem 
to be particularly at risk from Campylobacter infection from household pets (Tenkate 
and Stafford, 2001). However, the vast majority of illnesses appear to be sporadic 
cases (Rodrigues et al, 2001; Sopworth et a l, 2003) and it is highly likely that the 
sources and vehicles of human infection are numerous. Generally, the frequency of 
campylobacteriosis is higher in infants and young adults (Johnson and Nolan, 1985). 
Incidences are also higher in summer and autumn, possibly because of the inadequate 
cooking of meat, especially chicken, on barbecues (Ikram et a l, 1994). Furthermore, 
the seasonal peaks for poultry contamination with C. jejuni partly matches human 
infections (Refregier-Petton et al, 2001) implicating poultry as the main vehicle for 
human infection. Interestingly, there also appears to be a slight male dominance in
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younger adults for campylobacteriosis, presumably caused by unfamiliarity with 
hygienic food handling practices or eating undercooked meals more readily (Deming 
et al, 1987; Skirrow, 1987). Lastly, foreign travel is also a predisposing factor 
especially amongst adults in their twenties (Kapperud and Aesen, 1992; Stafford et 
al, 1996). These travellers tended to present the same symptoms as if they had 
acquired the infection domestically, even though local inhabitants have much milder 
illnesses, which suggested that tourists to undeveloped countries did not have the 
acquired immunity that the locals tended to have.
1.7.2 Non-developed nations
Patients in developing nations appear to have different clinical symptoms to those in 
industrialised nations. This phenomenon possibly reflects the differences in exposure 
rates and the development of protective immunity. Acquired immunity in developing 
countries has shown to be age dependent. Most patients with gastroenteritis in 
developing countries are children under the age of five (Lin et al, 1998; Prasad et al, 
2001; Coker et al, 2002). Symptoms, irrespective of age, on average are less severe 
than in industrialised countries, possibly because of increased exposure and high 
infection rates early in life, which in turn induce high levels of immunity (Sjogren et 
a/., 1989). There is also a higher asymptomatic carriage of this organism. Individuals 
in poorer nations tend to be infected with multiple Campylobacter serotypes and are 
frequently reinfected asymptomatically with new serotypes. Whilst symptoms are 
generally less severe than in industrialised countries, watery stools, fever, abdominal 
pain, vomiting, dehydration and the presence of faecal leukocytes are common 
features amongst patients who are under weight and malnourished (Coker et a l, 1985; 
Rao et al, 2001). Death can also occur in infected children debilitated by malnutrition 
(Black et al, 1984). Incidences of enteritis in under fives was over one hundred times 
higher than in developed countries. After five years of age there is a rapid decline in 
the incidences of infection (Oberhelman and Taylor, 2000). Nevertheless, mothers 
breast-feeding milk to infants is thought to provide some protection against infectious 
diarrhoea (Ruiz-Palacios et al, 1990; Torres and Cruz, 1993), and milk secretory IgA 
antibodies against Campylobacter surface antigens may play an important role in 
protecting children under six months of age (Newburg, 1999). There seems to be no 
seasonal preference for Campylobacter enteritis in developing nations. The lack of
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seasonality may be due to the more temperate climate all year round, as well a lack of 
efficient surveillance programs in third world countries. Drinking water, cross 
contamination from flies, poor hygiene and sanitation and close proximity to animals 
are all thought to contribute to the frequent nature of Campylobacter infection in third 
world countries (Khalil et al, 1994; Saidi et al, 1997).
C. jejuni and C. coli are the two main species isolated from developing countries, and 
the former was found to comprise a majority of the isolates and this is a similar 
situation to that seen in developed countries. Other species, including C  lari and 
C. upsaliensis may also be important (Lin et al, 1998; Prasad et al, 2001), but the 
lack of diagnostic capacities in developing nations has made the exact distribution of 
each species difficult to determine. The differences in disease symptoms between 
non-developed and developed countries may also be due to strain/species variation 
or/and host factors. Indeed, in Tanzania and Thailand C. coli strains are thought to be 
significantly less enterotoxigenic than C. jejuni for patients with diarrhoea (Taylor et 
al, 1988; Lindblom et al, 1995). Strains isolated from the developing world can be 
successfully typed but by predominantly using typing antisera derived from a subset 
of strains endemic to that country (Taylor et al, 1988; Sjogren et al, 1989). However 
there is little evidence that the serotype differences account for the different clinical 
symptoms and epidemiological patterns, since travellers from developed countries 
who become infected during visits to developing nations exhibited the same spectrum 
of illness as if they were at home (Kapperud and Aesen, 1992; Stafford et al, 1996).
1.8 Host response to infection with Campylobacter jejuni
1.8.1 Host colonisation
As humans typically acquire Campylobacters via the oral route, the stomach’s gastric 
acid barrier provides the first line of defence against infection. Indeed, the higher 
prevalence of campylobacteriosis in individuals ingesting C. jejuni with sodium 
bicarbonate is a reflection of this (Black et al, 1988). Following passage through the 
stomach, the organisms colonise the ileum and colon (Colgan et al, 1980). The high 
concentration of bile salts in the small intestine and colon is normally toxic to micro­
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organisms, as it can disrupt cell membranes (Sung et al, 1992). However, 
Campylobacter strains are resistant to the activity of bile salts (Lin et al, 2002; Lin et 
al, 2003). These organisms overcome gut peristalsis and colonise the mucin barrier or 
attach to eukaryotic cell surfaces. Motility, spiral-cell shape and chemotaxis appear to 
be important for mucous colonisation and subsequent attachment (Yao et al, 1994; 
Shigematsu et al, 1998; Allen and Griffiths, 2001). The results fi*om intestinal 
biopsies of patients, infected primates and other experimental animal models have 
demonstrated that gut cell invasion by Campylobacter spp can occur in vivo and 
supports the theory that bacterial invasiveness is a major virulence factor (Newell and 
Pearson, 1984; Sanyal., et al, 1984; van Spreeuwel et al, 1985 Russell et al, 1993).
1.8.2 Iron
Iron is essential for all microorganisms. Iron binding proteins such as transferrin, 
ferritin and lactoferrin are a human defence mechanism to withhold iron from 
microorganisms. Receptors for extracellular lactoferrin have been identified in the 
human intestinal brush border, which in turn may play a role in iron absorption from 
the gut (Kawakami and Lonnerdal, 1991). Furthermore, phagocytes also have a 
receptor for lactoferrin, which is involved in the transfer of iron to intercellular ferritin 
inorder to reduce the amount of extracellular free iron (Kijlstra, 1990). Moreover, 
ferritin synthesis has been found to increase under the influence of IL-1 and TNF. 
Limiting the availability of iron in response to infiammation by phagocytes, as well as 
by intestinal absorption, may contribute to growth inhibitory on C. jejuni and other 
microorganisms (Jurado, 1997).
1.8.3 Complement
Studies on the role of complement from patients recovering from Campylobacter 
infection indicated that the classical pathway was activated by antibody in the serum. 
The specificity of this bactericidal activity was found to be restricted to the infecting 
Penner serotype, and activity could also be neutralised by purified homologous LPS 
derived from another strain (Jones et al, 1985). Campylobacters may also directly 
activate complement in normal human serum, which is most likely due to the 
alternative pathway (Fanandez et a l, 1995). In summary, serum develops a more
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potent and specific bactericidal effect during C  jejuni enteritis, and this may be an 
important factor in host defence against this organism (Pennie et al, 1986).
1.8.4 Defensins
Mammalian defensins are endogenous cysteine-rich peptide antimicrobials that are 
produced by epithelial cells, macrophages and neutrophils and their production is 
augmented by infection or infiammation (Zhang et al, 1999; Bals, 2000). Defensins 
have been found to kill bacteria by permeabilising microbial membranes (Ganz and 
Weiss, 1997). Human alpha defensins (hAD) are stored in Paneth cells (secretory 
epithelial cells found in the crypts of small intestine) (Ghosh et al, 2002), and human 
beta defensins (hBD) are located in epithelial cells of the gut, skin, respiratory and 
urogenital tracts (Hao et al, 2001). Bacterial adhesion, LPS and fiagellins from 
Gram-negative bacteria, as well as host proinfiammatory cytokines, TNF-alpha and 
IL-1 beta, are known to trigger a signalling pathway that allows the nuclear- 
transcription factor, NF-kappaB to translocate from the cytoplasm to the nucleus 
(Eaves-Pyles Qt al, 1999; Carlo et al, 2000; Ogushi et al, 2001; McDermott et al,
2003). In response, NF-kappaB induces proinfiammatory cytokine production, which 
includes IL-1, TNFa, IL-6 and IL-12 and is essential for Thl (CTL) responses. As a 
consequence, IL-1 and TNFa stimulates hBD-2 expression by host cells (McDermott 
et al, 2003; Tsutsumi-Ishii et al, 2003). In contrast, the expression of hBD-1 in 
human colon epithelial cells HT-29 and Caco-2 cells were constitutively expressed 
(O’Neil et al, 1999; Kaiser and Diamond, 2000). The constitutive expression of hBD- 
1 may play a frontline role in monitoring bacteria on mucosal surfaces. On the other 
hand, modulation of hBD-2 expression by pathogenic bacterial infection and/or 
proinfiammatory cytokines has placed these antimicrobials in the front line of innate 
host defence (Kim et al, 2004).
C. jejuni has been shown to cause activation NF-kappaB upon infection of intestinal 
cells in vitro (Mellits et al, 2002). Moreover, persistent colonisation of NF-kappaB- 
deficient mice is associated with significantly impaired IgG humoral responses, which 
is consistent with an innate or adaptive immune system defect(s) (Fox et al, 2004). 
This suggests that the mechanism of clearance of C. jejuni is NF-kappaB dependent, 
and, as well as in the ability of C. jejuni to escape immune surveillance. In C. jejuni.
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the surface lipoprotein known as JlpA is thought to mediate adherence of the 
bacterium to epithelial cells (Jin et al, 2001). Further studies have shown JlpA to 
interact with the HEp-2 cell surface heat shock protein (Hsp) 90a, a major molecular 
chaperone that, initiates signalling pathways, which lead to the activation of NF- 
kappaB (Jin et al, 2003). However, the exact role defensins play in limiting 
campylobacteriosis has not been established, nevertheless the nature and location of 
bacterial defensins imply they may be an important innate response during 
campylobacteriosis.
1.8.5 Antibodies
Secretory immunoglobulin A (sIgA) response at the intestinal mucosa is considered 
the primary defence against enteric organisms. Campylobacter antigens such as, 
flagellin, outer membrane proteins and LPS elicit sIgA responses (Windsor et al, 
1986; Black et a/., 1988; McSweegan et a/., 1987; Lee et al, 1999; Cawthraw et al, 
2002). Specific sIgA immobilises bacteria in the mucin and causes the organisms to 
aggregate. More specifically, the antibody binds to bacterial surface proteins that 
mediate adherence and block bacterial adherence to mucosal cells by steric hindrance. 
Therefore sIgA may be important for preventing the immediate spread of 
Campylobacter infection as well as preventing infection (Wallis, 1994). In 
Campylobacter-mfQcXodi patients, the specific IgA antibody responses are induced 
during the convalescent phase and detected for several weeks. In contrast, the main 
antibody associated with the blood and tissue, IgG can be detected up to a year post­
infection (Cawthraw et al, 2002). IgG responses are also directed towards flagellin, 
outer membrane proteins and LPS (Nachamkin and Hart, 1985; Chart et al, 1996; 
Cawthraw et al, 2000; Cawthraw et al, 2002; Prendergast et al, 2004). The role of 
systemic antibodies in ecati-Campylobacter immunity is not known. However, the 
importance of a specific humoral immune response to C. jejuni has been highlighted 
in a patient with IgA and IgM deficiency (Johnson et al, 1984), who suffered from a 
relapsing C  jejuni bacteremia and enteritis over several months. This individual only 
became clear of the organism once detectable IgG antibodies against C  jejuni had 
developed.
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IgM is the first antibody produced by primer B-cells prior to isotype switching. IgM 
is critical for infections caused by encapsulated bacterial pathogens (Horwitz and 
Silverstein, 1980; Gigliotti and Insel, 1982; Jarvis and Vedros, 1987). The bacterial 
binding sites of IgM are less specific than IgG and combined with the superior ability 
of IgM to activate complement may help contribute to partial protection of the host 
while the IgG responses are maturing. IgM seems to be targeted mainly against the 
LPS of the infecting Campylobacter serotype and if  s antibacterial effects are 
dependent on the classical complement pathway (Sugita et al, 1994; Prendergast et 
al, 1999). Interestingly, a commercial IgM-containing preparation has been used 
successfully to cure hypogammaglobulinémie patients with persistent C. jejuni 
infections, presumably by inducing bactericidal activity (Borleffs et al, 1993).
Antibodies may play a central role in limiting invasion but not colonisation by 
C. jejuni, since patients who are immunocompromised tend to become bacteraemic. 
Protective immunity from prior disease was found when human volunteers were 
rechallenged with the homologous strain but not with an heterologous strain (Black et 
al, 1988). In addition, there appears to be a correlation between disease severity and 
protection from subsequent infection, as well as resulting illness. This suggests that in 
immune individuals, the antibodies from the primary infection may provide an 
effective memory response against the secondary infection. Therefore, immune 
patients are more likely to have reduced C  jejuni colonisation. The severity of disease 
may not only be due to the individual’s immune response but also to specific genetic 
factors that can vary between C. jejuni strains (Klipstein et al, 1986; Pang et a l, 
1987; Black et a l, 1988; Gorelov et a l, 1990).
1.8.6 Bacterial invasion
In some cases infection of the gut epithelium leads to a systemic infection and 
bacteremia. Campylobacters can be recovered from spleen, gall bladder and liver 
(Fitzgeorge et al, 1981; Ampelas et al, 1982; Sanyal et al, 1984; Brmbolic, 1995). 
Animal model studies have implicated bacterial penetration of the intestinal epithelial 
cell barrier by invasion and M cell translocation as facilitators for the spread of 
intestinal Campylobacter to blood (Newell and Pearson, 1984; Walker et al, 1988). In 
vitro experiments have confirmed that C. jejuni can penetrate into host epithelial cells
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and into endosomal vacuoles of Caco-2 cells (Grant et al, 1993). In addition, 
transcellular, rather than paracellular epithelial translocation has been implicated as 
the mechanism whereby C  jejuni crosses the host intestinal epithelium (Bras and 
Ketley, 1999).
Systemic infection is most prevalent and severe in malnourished individuals (Murga 
et al, 1995). In the developed world severe systemic infection is invariably only seen 
in immunocompromised individuals and can be fatal (Font et a l, 1997). There is also 
evidence in animal models that clearance of C. jejuni from the bloodstream by the 
liver represents an important defence mechanism during systemic infections. Virulent 
strains of Campylobacter may persist in the liver for up to 30 days (Bar et al, 1989). 
The hepatic macrophages (Kupffer’s cells) are responsible for removal of 
Campylobacters from the bloodstream, so severe liver damage is associated with 
enhanced disease severity (Pigrau et al, 1997).
The host appears to have developed several mechanisms to prevent systemic disease 
by invading organisms. Polymorphonuclear leukocytes (PMNs, neutrophils) are 
usually the first phagocytic cells to encounter bacterial invaders and are frequently 
observed in Campylobacter diarrhoeic stools, along with blood and mucus (Black et 
al, 1988). This is not surprising since PMNs are dispersed throughout the body, being 
most abundant in blood and many tissues. Microscopic examination of rectal biopsy 
specimens in campylobacteriosis has shown PMNs in the crypts, and lymphocytes and 
plasma cells in the muscularis mucosa. Monocytes moving through the bloodstream, 
before differentiation into macrophages, are quickly recruited to the site where 
bacterial invasion occurs (Rot et al, 1986). In most cases, macrophages kill 
phagocytosed C. jejuni cells, however in 10 % of patients the macrophages are unable 
to destroy phagocytosed organisms efficiently (Wassenaar et al, 1997). Listeria 
monocytogenes is able to survive macrophage phagocytosis, by escaping from the 
phagosome into the cytoplasm and inducing apoptotic death of the host macrophage 
(Campbell, 1994; Ebe et al, 1999). On the other hand. Salmonella remains 
intravacuolar, subverts phagosome fusion with lysosomes, and eventually induces 
apoptosis (Monack et al, 1996; Rathman et al, 1996). Generally, macrophages 
present bacterial peptides, complexed with the major histocompatibility complex class
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II (MHC II) on their surface, once the bacteria has been killed by the host cell. This is 
then presented to T-helper cells (CD4" )^, which provide B-cell help in producing anti­
bacterial antibody responses. However, if the bacteria is not killed and escapes the 
phagosome, the host cell then displays bacterial peptides on MHC class I. This in turn 
stimulates cytotoxic T cells (CD8^) to become primed and kills any host cells 
intracellularly infected with bacteria. This may contribute to some of the damage 
observed amongst patients infected with Campylobacter. However, since neutrophils 
induce a greater immunopathological response than cytotoxic T-cells, it seems likely 
that they are mainly responsible for ulceration of the gut lining seen during human 
campylobacteriosis.
Professional phagocytes (PMNs and macrophages) engulf bacteria by endocytosis. 
The bacteria become enclosed in a membrane-encased vacuole called a phagosome. 
Normally the pH decreases rapidly inside the phagosome to reduce bacterial survival. 
However in Salmonella, ‘spacious phagosomes’ are formed and are understood to 
have delayed acidification which contributes to bacterial survival within these 
phagosomes (Alpuche-Aranda et al, 1992). Conversely, in Shigella and Listeria, the 
bacterium manages to escape from the phagosome to the host cell cytoplasm 
(Zychlinsky et al, 1992; Campbell, 1994). Nevertheless, phagosomes containing 
bacteria normally fuse with lysosomes (also known as granules) to form a 
phagolysosome. Lysosomes release lysozyme, proteases and defensins, as well as 
peroxides, superoxide hypochlorous acid and nitric oxide (Rosen et al, 1995). All 
these substances contribute to the death of an invading bacterium. The major downfall 
of this host defence system is the inflammatory tissue damage induced by the 
microbiocidal activity of phagocytes, particularly reactive oxygen species (McCord 
and Wong, 1978).
1.8.7 Inflammatory responses
Mammalian toll-like receptor (TLR) proteins, found on epithelial cells, macrophages 
and dendritic cells, represent a conserved family of innate immune pattern recognition 
receptors (Means et al, 2000). These receptors are coupled to a signaling pathway 
that is conserved in mammals, insects, and plants enabling the activation of genes that
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mediate innate immune defenses. TLRs uniquely recognise bacterial products. LPS is 
recognised by TLR4; lipoprotein, proteoglycan (from Gram-positive bacteria) and 
LOS by TLR2; flagellin by TLR5; and unmethylated CpG (cytosine phosphate 
guanosine) -oligodeoxynucleotide by TLR9. TLR9 recognises bacteria because 
bacterial DNA is not methylated as heavily as eukaryotic DNA. Pathogen recognition 
triggers the toll-like receptor (TLR) signalling cascade, resulting in nuclear 
localisation of NF-kB and induction of proinfiammatory cytokines, including tumour 
necrosis factor-alpha (TNF-a), interleukin-I (IL-1, IL-6, lL-8 and IL-12). Briefly, the 
induction of the acute phase (innate response) proteins (that stimulate prostaglandins, 
defensins, lactoferrin and increases complement) is triggered by IL-1. Neutrophils are 
stimulated by IL-8. Macrophage and Dendritic cell maturation is triggered by TNF-a. 
Finally, B-cells are activated by IL-6 and cytoxicity in natural killer (NK) cells are 
stimulated by IL-12.
Host cells secrete IL-1 in response to C. Jejuni infection and activate and induce 
cytokine synthesis in macrophages, as well as stimulating activated B-cells to 
proliferate and synthesise antibodies (Birkholz et al., 1993; Pancorbo et al, 1999; 
Jones et al, 2003). Furthermore, IL-1 induces fever (apparently by stimulating 
prostaglandins in the temperature regulatory region of the brain), increases the 
numbers of PMNs mobilised to the site of infection, and increases lactoferrin levels to 
reduce the amount of available iron for the bacteria. As a result, IL-1 causes nausea 
and lethargy in humans infected with C. jejuni.
IL-8 recruits and activates PMNs or neutrophils to the site of infection. In vitro 
studies have demonstrated that host cells secrete IL-8 in the presence of C. jejuni 
(Hicky et al, 1999; Hickey et al, 2000; Jones et al, 2003). The most adhesive and 
invasive strains appear to induce the highest levels of IL-8 secretion (Hickey et al.,
1999). Furthermore, the cecum and colon become infiltrated with neutrophils 
following oral inoculation of gnotobiotic pigs (Boosinger and Powe, 1988). IL-8 
suggests that the intestinal epithelial layer has been breached and stimulates the 
production of vasoactive compounds, such as prostaglandins and leukotrienes 
(Everest et al, 1993). The dilation of blood vessels enables PMNs to move out of the 
blood vessels and into the surrounding tissue to combat the infection. The migration
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and degranulation of PMNs may therefore contribute to further intestinal damage 
during Campylobacter infection (Hickey et al, 1999).
TNF-a is produced by macrophages and lymphocytes and causes activation of 
macrophages and dendritic cells so that they can prime T-cell responses. TNF-a is 
produced immediately after mice have been challenged with viable Campylobacter 
(Abram et al, 2000). These results suggest that in human campylobacteriosis, TNF-a 
would contribute to fever, wasting and intestinal haemorrhaging.
Surprisingly IL-6 has not been observed in mouse in vivo studies (Abram et al, 
2000). Normally, during systemic bacterial infections IL-6 plays an important role in 
enhancing antibody responses by B-cells. Nevertheless, human monocytic cells 
release IL-6 in the presence of C. jejuni cells whether these are dead or alive 
(Birkholz et al., 1993; Jones et al, 2003). Such differences in cytokine responses 
observed between humans and mice may reflect the differences seen in disease 
outcome.
IL-12 is essential for the development of CD8^ cells and it also stimulates the 
cytotoxity of natural killer (NK) cells destroying infected cells in a non-MHC 
dependent manner. This process has been shown to participate in intestinal 
inflammation in mice. To date no studies have been conducted to see whether C. 
jejuni or its components stimulate host cells to release IL-12. Nevertheless, interferon- 
gamma (IFN-y) is an IL-12 inducible cytokine that that has been shown to be induced 
by INT407 cells following exposure to live C  jejuni cells (Chikano et al, 2000; Al- 
Salloom et al, 2003).
In conclusion, it appears that a combination of Thl responses, which activate antigen- 
presenting cells to kill phagocytosed bacteria, and Th2 responses, which stimulate 
antibody production mechanisms are stimulated by the host to act against C. jejuni 
infection. All in all, the lack of a suitable animal model for human campylobacteriosis 
has severely limited our understanding for human immune responses to 
Campylobacter infection. Nevertheless, the severity and persistence of
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Campylobacter infections in immunocompromised individuals has suggested that the 
host immune response plays an important role in limiting disease (Johnson et al, 
1984; Puri et al, 1992; Woo et al, 2002).
1.9 Genetic content
C. jejuni has a low G+C content (averaging 30.6 %) and a relatively small genome 
size (1.6-1.7Mbp) (Taylor, 1992). The C. jejuni strain NCTC11168 has been 
completely sequenced (Parkhill et ah, 2000). The organism has a 1,641,481 bp 
circular chromosome and which has been predicted to contain 1,654 open reading 
frames. Ninety four percent of the genome codes for proteins, which makes this the 
densest bacterial genome sequenced to date. The genome is unusual in that it does not 
contain insertion sequence elements, transposons or prophages and contains very few 
repetitive DNA sequences. There seems to be little organisation of genes into clusters 
or opérons, however, there are a few exceptions, these include the genes for ribosomal 
RNA, extracellular polysaccharide biosynthesis, flagella modification and 
lipopolysaccharide synthesis. It is interesting to note that only three sigma factors 
(a^^, and cj^ )^ and very few two-component transcriptional regulators have been 
predicted from the genome and this poses questions about how the organism regulates 
gene expression in response to environmental change. For example, in comparison 
with other organisms. Bacillus subtilis has 14 sigma factors, E. coli has 7 sigma 
factors and Streptomyces coelicolor has 50 sigma factors (Wosten et al, 1998; 
Helmann, 2002), and therefore the three sigma factors for C. jejuni suggests that 
certain pathways may be co-ordinately regulated. The factor is responsible for 
expression of the house-keeping genes, whereas and appear to be mainly 
responsible for the regulation of the flagellin genes (see Section 1.10).
The genome contains the genes for only one known and previously characterised 
toxin, the cytolethal distending toxin (CDT), even though other toxin activities have 
been described (Wassenaar, 1997). Furthermore, no pilin subunit gene has been 
identified even though under certain conditions pilus-like appendages have been 
observed in C. jejuni strain 81-176 (Doig et ah, 1996). In a later study, these were 
shown to be an artefact of the growth medium, which is consistent with the absence of
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a candidate pilin monomer in protein gel analyses as well as the dearth of pilin 
biosynthesis genes in the C. jejuni genome (Parkhill et al, 2000; Gaynor et al, 2001). 
Analysis of the genome also suggests that a significant proportion of the total gene 
content encodes for membrane, periplasmic and lipoproteins (Karlyshev et al, 1998). 
Approximately 54 % of genes identified in NOTCH 168 have orthologues in the 
closely related pathogen Helicobacter pylori. However, some of the important 
virulence-related genes present in H. pylori, including the vaculating toxin (vacA) and 
the cag pathogenic island (Censini et ah, 1996; Aim & Trust, 1999), are absent in 
C. jejuni. Evidence from phenotyping and genotyping schemes have, however, shown 
a huge diversity amongst C. jejuni strains and although the sequencing of one 
C. jejuni genome has been useful, the genes already identified may not reflect all the 
possible genes found in this species. In summary, C. jejuni still requires much more 
genetic analysis to identify new genes and their functions and this may further our 
understanding on Campylobacter pathogenesis.
One of the most exciting features of the C. jejuni genome sequence was the 
identification of at least 24 hypervariable regions mainly found in genes encoding for 
surface structures. These were mainly short tracts of single nucleotides (primarily 
guanine and cytosine) which varied in length by one or more bases, known as 
homopolymorphic tracts. Most of the homopolymorphic tracts were grouped in three 
regions, LOS/LPS, flagellar and capsular biosynthesis clusters. Such tracts are 
common in the genomes of Neisseria meningitidis (Saunders et al, 2000), N. 
gonorrhoeae (Jonnson et al, 1991; Shafer et al, 2002) and Helicobacter pylori 
(Tomb et al, 1997). In N. gonorrhoeae phase variation of three LOS modification 
genes in the igtABCDE operon enables reversible and rapid changes in LOS (Shafer et 
al, 2002). The phase variable synthesis of IgtC and IgtD produces elongated LOS 
alpha-chains, and the presence of this LOS species confers serum-antibody and 
complement sensitivity. As the LOS/LPS, flagellin and the capsular polysaccharide of 
C  jejuni are all antigenic, the homopolymeric tracts may also provide mechanisms for 
immune evasion in this organism.
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1.10 Flagellum
Campylobacters swim by virtue of rotating flagella located on one or both polar ends. 
The flagellum itself consists of a filament, hook, and a rod. The basal body anchors 
the flagellum to the cell envelope. The basal body is a complex structure composed of 
several rings that spans both membranes and mounted on the rod. This is what forms 
the motor, which is driven by the movement of protons through multiple force- 
generating units belonging to the rings of the cytoplasmic membrane. The hook forms 
the connection between the filament and motor and positions the filament at an angle 
to the cell. This angle causes the filament, when it is rotates, to act as a propeller.
The unsheathed flagellum is the best-characterised virulence factor of the 
Campylobacter species to date. The filament is predominantly composed of the 
protein flagellin. FlaA is the major protein component of the flagellum and FlaB is the 
minor one. The flagellin genes are found in tandem on the chromosome and are 
separated by approximately 170 bp. The flaA and flaB  genes are around 95% 
homologous at the nucleotide level. Sequence variations between FlaA and FlaB are 
clustered at the N and C termini and a small region in the middle (Nuijten et al., 
1992). The two genes are independently transcribed, as flaA  is regulated by the sigma 
factor (fUA), and flaB  by (rpoN). The former is expressed at much higher 
levels than the latter. The expression offlaB  can be modulated by changes in the level 
of nitrogen and divalent cations, pH, and growth phase (Aim et al, 1993). 
Furthermore, the transcription of the a^^-dependent transcription of flagellar genes in 
C. jejuni is associated with the formation of the flagellar secretory apparatus 
(Hendrixson and DeRita, 2003). The sensor kinase FlgS and its cognate response 
regulator FlgR form a two component system (Wosten et al, 2004). The interaction of 
a distinct environmental stimulus (that remains to be elucidated) with FlgS, leads to 
the activation of the kinase activity. As a result FlgS autophosphorylates and 
subsequently transfers its phosphate to FlgR. FlgR stimulates the production of g^^  
and activates the transcription of genes necessary for the assembly of the hook-basal 
body filament complex (see Figure 1.2).
Several of the well-characterised genes involved in the regulation of the flagellar 
transcription cascade paradigm from S. Typhimurium are absent. Briefly, in
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Figure 1.2 Model of the regulation of C. jejuni flagellum as proposed by Wosten et al, 
2004.
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Salmonella, the flagellar genes can be divided into three classes based on their order 
of transcription (Kutsukake et al, 1990; Karlinsey et al, 2000). Class 1 includes the 
major transcription regulators,yZ/zDC that are required for expression of the remaining 
flagellar genes. Class 2 includes genes encoding the flagellar secretory apparatus, the 
flagellar basal body and hook structures and Class 3 genes, transcription of which 
requires include those encoding the flagellin subunits that are incorporated last in 
the growing flagellum. Feedback loops are incorporated into the regulatory cascade to 
ensure that the flagellar genes are transcribed in the appropriate order, starting from 
the cell envelope and extending extracellulary to the tip of the flagellum (Gillen and 
Hughes, 1991).
The flhDC  transcriptional regulators are absent in C. jejuni However, the 
dependent transcription of flagellar genes (flagellar hook, basal body and flagellin 
genes) has been suggested to be also linked to the formation of the flagellar secretory 
apparatus (Wu et al, 1995). The fUK gene that is required for hook assembly 
termination and initial filament assembly is not present in C. jejuni The anti­
sigma factor (flgM) has been identified as Cjl464. Hendrixson and DeRita have 
suggested that flgM  does not appear to play a major role in the net levels of flaA 
expression, which is unlike that seen with cj^^-dependent transcription of the major 
flagellin in other bacteria (Hendrixson and DeRita, 2003). However, Wosten and 
colleagues have disputed these results and suggested that FlgM reduces the activation 
offlaA transcription (Wosten et ah, 2004). The basis for these contradictory results is 
not known. Studies have shown that flagellin synthesis can be switched on and off in 
C. coli by phase variation caused by a frame-shift vaflhA. The precise function of 
FlhA is unknown but it belongs to a family of proteins involved in the regulation or 
secretion of surface extracellular proteins (Park et a l, 2000). Recently, it has been 
shown that inactivation of flhA  in a virulent strain results in a genome-transcription 
pattern similar to a strain variant that is attenuated in virulence (Carrillo et al, 2004). 
These findings indicate that the flagellar regulatory system may play an important role 
in Campylobacter pathogenesis and that the flhA  regulator is a key element involved 
in the coordinate regulation of late flagellar genes and of virulence factors in C. jejuni: 
Overall, the conservation of the tight and complex regulation of the flagella 
biosynthesis in C  jejuni can be explained by the requirement for highly motile
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bacteria for efficient colonisation of hosts (Wassenaar et al, 1993; Wosten et al,
2004).
In C. jejuni the inactivation of flaA  results in non-motile organisms, which only 
express a truncated flagellum. The flaA  mutants have been shown to be less adhesive 
to, and invasive for epithelial cells in vitro (Wassenaar et a l, 1991), indicating that 
motility is an important pathogenicity determinant. Also, mutants with inactivated 
flaA  genes are less able to colonise the chicken caecum compared to the wild-type. In 
comparison, a poorly motile variant with flagella composed of FlaA was found to 
colonise better than the wild-type. In contrast inactivation of the flaB  gene results in 
normal full length flagellum comprised completely of FlaA and only a slight 
reduction in motility, but the corresponding mutant had a caecal colonisation potential 
a thousand-fold greater than the wild-type (Wassenaar et a l, 1993). This was not 
reflected by the in vitro invasion assay where the flaB  mutants had indistinguishable 
adhesive and invasive properties when compared to the wild type. Although the 
reason for enhanced colonisation in flaB  mutants could not be explained, it does 
suggest that the presence of FlaA, rather than motility, was essential for optimal 
bacterial colonisation of chicken caeca. Furthermore, while both flagellins are not 
necessary for motility, both products are required for a fully active flagellar filament 
(Wassenaar al, 1993; Yao et al, 1994).
The in vivo observations obtained for C. jejuni can be partly explained by the results 
from in vitro experiments. Studies on INT-407 cells have shown that flagellated 
strains have a higher adherent capacity than non-flagellated strains (McSweegan and 
Walker, 1986). Moreover, purified flagellum demonstrates specific binding to 
epithelial cells. On the contrary. Grant and colleagues rejected the hypothesis that 
flagella were involved in adherence, and instead suggested that they play a role in 
internalisation of polarised Caco-2 cells (Grant et al, 1993). Similarly, invasion of 
INT407 cells requires fully functional flagella (Yao et al, 1994). In summary, these 
studies suggest that normal motile flagella is required by C. jejuni for colonising and 
penetrating the host intestinal epithelium. The C. jejuni flagella export apparatus may 
be also involved in secreting virulence-associated factors dependent on bacterial-host 
interactions by a type III secretion mechanism similar to that described for Yersinia
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enterocoUtica (Young et al., 1999). Protection against C. jejuni infection in mice and 
rabbits can be conferred by anti-flagellar antibodies, but only against challenge with 
homologous Lior serotypes (Pavlovskis et al, 1991; Lee et a l, 1999).
Evidence suggests that flaA intragenomic and flaA and flaB  intergenomic 
recombination, as well as deletion and duplication, can occur when the bacterium is 
in the natural host (Nuijen et al, 2000). Indeed intestinal co-colonisation of C. jejuni 
strains in chickens, appears to allow the generation of recombinant-flagellin genes in 
those strains (Hanninen et al, 1999). This may be a mechanism for increasing 
antigenic diversity of Campylobacters, in order to escape the host’s immunological 
responses, or to enable adaptation to environmental stresses (Wassenaar et a l, 1995; 
Harrington cf a/., 1997).
Interestingly, two of the flagellar biosynthesis and modification region genes, mafl 
and maf5 contain homopolymeric G tracts (Karlyshev et al, 2002). Mutation in the 
ma/5 gene results in aflagellate organisms which, however, after prolonged incubation 
become partially motile. Inactivation of both mafl and maf5 results in permanently 
non-motile organisms (Karlyshev et al, 2002). This suggests that the restoration of 
motility in the maf5 mutant is the result of activation of the mafl gene via a presumed 
slipped-strand mispairing mechanism.
Mass spectrometry experiments on the purified flagellin proteins of C. jejuni have 
indicated a molecular mass approximately 10% higher (a 6000 Da shift) from the 
predicted protein (Thibault et al, 2001). This is probably due to post-translational 
modification of the flagellin protein. Glycosylation of bacterial proteins is relatively 
uncommon, and until recently there has been scepticism about the existence of 
glycoproteins in many bacteria. It is now well established that the flagellins, as well 
as a number of other as yet uncharacterised proteins of C. jejuni, are glycosylated 
(Doig et a l, 1996; Guerry et a l, 1996; Szymanski et a l, 1999). Two glycosylation 
systems have been identified in C. jejuni. Firstly, a general protein glycosylation (pgl) 
system involved in the modification of soluble and membrane associated proteins 
(Szymanski et a l, 1999). Secondly, a flagellin and LOS glycosylation system.
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involving neuBl, neuB2, neuBS and ptm  genes (Guerry et a l, 1996; Linton et a l,
2000). There appears to be considerable strain-to-strain variation in the presence of 
genes involved in flagellar modification (Logan et al, 2002). As yet, the role of 
prokaryotic protein glycosylation is unclear, but one possible function may be in 
immune evasion.
1.11 Campylobacter surface structures
1.11.1 LPS/LOS
The lipopolysaccharide (LPS) is a major virulence factor of most Gram-negative 
bacteria. LPS is often described as an endotoxin and can cause septic shock in patients 
(Calandra, 2001). It has been suggested that C. jejuni produces one of two forms of 
LPS, the low molecular weight (MW) lipo-oligosaccharide (LOS) or the high MW 
LPS (Moran, 1996). Both the LPS and LOS consist of a membrane-anchoring lipid A 
portion attached to a core polysaccharide. The lipid A portion is the part responsible 
for much of the pathological damage associated with disease. The LPS contains an 
additional component connected to the core polysaccharide. This is an external 
surface-exposed polysaccharide composed of repeating oligosaccharide units (O- 
antigen). Interestingly, in C. jejuni a convincing case has been made against the LPS 
form, in that the high molecular weight, protease-stable 0-antigen observed was 
actually a capsular polysaccharide (Karlyshev et al, 2000). As a consequence, the 
literature is confusing about whether an LPS or LOS structure is being referred to. 
Therefore, the term cited by each author has been preserved below even though it may 
be incorrect.
The chemical composition of LOS may be associated with the induction of GBS 
(Penner and Aspinall, 1997; Wassenaar and Blaser, 1999). Sialylation of LOS has 
been shown to bestow increased resistance to the bactericidal effects of human serum 
and enhances evasion of the host immune response (Guerry et al, 2000; Linton et al.,
2000) as seen in N. gonnorhoeae (Wetzler et al, 1992). Indeed, in Salmonella 
differences in the 0-antigenic side chain of their LPS has been shown to influence 
resistance to phagocytosis (Liang-Takasaki et al, 1982). In C. jejuni the inactivation
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of galE, a gene important for the biosynthesis of LPS, resulted in organisms with a 
reduced potential to invade epithelial cells in vitro (Fry et al., 2000). A similar 
situation was observed in N. gonorrhoeae, where LOS was implicated as a ligand for 
human receptors (Preston et al, 1996). Thus, LPS or LOS may be crucial virulence 
factors in the pathogenesis of bacteria that express them.
Interruption of glycosylation of LOS, by inactivating the wlaN gene, results in a 
mutant incapable of binding cholera toxin, which has a high affinity for terminal 
oligosaccharide region of ganglioside GMi (Linton et a l, 2000). This result indicates 
that the structural alteration in the mutant is located in the outer core region and WlaN 
is involved in the addition of one or more of the outer core sugar residues of a GMp 
like oligosaccharide. In addition, homopolymeric tracts found within the wlaN gene 
have been shown to render the expression of a functional gene product phase variable, 
which may explain why not all patients develop GBS when infected with a potentially 
neuropathic serotype (Nishimura et a l, 1997). Interestingly, strain NOTCH 168 
(Parkhill et al, 2000) had only one copy of a gene encoding sialyltransferase, whilst a 
GBS-associated strain had two gene copies (Gilbert et al, 2000). As anticipated, the 
former had a much lower sialyltransferase activity suggesting a link between the 
number of sialyltransferase gene copies in the C  jejuni genome and the development 
of GBS.
1.11.2 Capsule
Relatively recent investigations of the heat stable antigens involved in Penner 
serotyping suggested the antigen to be capsular rather than long-chained LPS (Chart 
et al, 1996). However, it was not until the year 2000, that the first genetic and 
biochemical evidence of a C. jejuni capsular polysaccharide emerged (Karlyshev et 
al, 2000; Parkhill et al, 2000; Karlyshev et al, 2001; Oldfield et al, 2002), and also 
that the HMW oligossacharide was not attached to core LOS. In the genome of strain 
NOTCH 168, two gene clusters containing kps orthologues were identified, and the 
genetic regions in between the groups consisted of different polysaccharide synthesis 
genes, some of which were implicated in capsule biosynthesis. The C. jejuni kps 
cluster of genes has significant sequence similarity, and overall organisation to 
capsular polysaccharide genes from E. coli K1 (Bliss and Silver, 1996). The capsule
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in E. coli confers resistance to the bactericidal activity of serum, as well as phagocytic 
uptake, and may also contribute to intraphagocytic survival of the organism (Allen et 
al, 1987). Indeed, loss of the C. jejuni capsule through inactivation of kpsM  in C. 
jejuni resulted in organisms which were more sensitive to complement and which 
displayed reduced virulence in the ferret model (Bacon et al, 2001).
1.11.3 S layer
A paracrystalline lattice called the S-layer, composed of highly antigenic, acidic high 
molecular weight proteins (SapA proteins; 97-149 kDa), on the outer membrane has 
been observed in C. fetus (Blaser et al, 1988). C. fetus possesses multiple 
homologues of the sap A gene on a 6.2 kb segment of DNA (Dworkin and Blaser,
1997). Antigenic variation of the S-layer proteins is well recognised and is controlled 
by a DNA inversion system. Here a single promoter can be alternately connected or 
disconnected from any one of the multiple sapA homologues so that any homologue 
may be expressed but only any one at one time. Inversion events involve homologous 
recombination between conserved 600 bp regions at the 5’ ends of the sapA 
homologues and are dependent on RecA (Dworkin et a l, 1997). Mutants lacking 
these proteins were found to be more susceptible to the bactericidal effects of 
antibody and complement, as well as phagocytosis by PMNs and shown to be less 
virulent in the mouse model (Blaser and Pei, 1993). The S-layer proteins of 
Aeromonsa salmonicida and Bacillus cereus, have also been shown to have a 
significant role in the adhesion of non-phagocytic host cells (Garduno et al, 2000; 
Kotiranta et al, 2000). Conversely, in C. fetus, the S-layer do not appear to have a 
role in mediating adhesion to HEp-2 cells (Graham and MacDonald, 1998). However, 
they are essential for colonisation and/or translocation across the placenta, which is 
necessary for C. yêtw5-associated abortions in ewes (Grogono-Thomas et a l, 2003). 
The development of a possible synthetic vaccine candidate for C. fetus associated 
ovine abortions, could potentially involve the conserved antigenic regions of the S- 
layer proteins that would induce a protective immune response (Grogono-Thomas et 
aA,2003^
C rectus has also been reported to contain a S-layer protein (150-166 kDa) but 
appears to contain a single copy of the gene {crs), with no evidence for variable
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expression, as observed for C  fetus (Wang et al, 1998). In this case, the product of 
crs may be involved in down regulating inflammatory cytokines (Wang et al, 2000) 
To date, no S-layer like proteins have been described in C. jejuni and C. coli, or any 
other species of Campylobacter besides C. fetus and C  rectus.
1.12 Toxins
Several groups have reported the presence of either cytotoxins, enterotoxins, or both, 
in Campylobacter (Wassenaar, 1997). The mechanism of action of these toxins and 
their importance in disease, however, remains unclear. The occurrence of watery 
diarrhoea has led to the hypothesis that an enterotoxin may be involved in some 
aspects of the disease, whereas cytotoxin may be responsible for bloody diarrhoea. 
However, the existence of four potential toxins has been indicated by the publication 
of the genome sequence. The genome sequence of C. jejuni strain NCTC11168, for 
example contains the cdtABC genes encoding cytolethal distending toxin, two genes 
that encode proteins with haemolysin domains, and a gene encoding phospholipase 
which causes haemolytic activity in C. coli (Grant et a l, 1997). However, due to the 
the genotypic and phenotypic variation observed amongst C. jejuni strains, it is not 
surprising that one strain does not contain all the possible Campylobacter toxins 
(Dorrell et al, 2001; Pearson et al, 2003).
1.12.1 Cytotoxins
The most convincing cytotoxin described to date is the cytolethal distending toxin 
(CDT) first reported by Johnson and Lior (1988). Studies have shown that the 
majority of C. jejuni strains produced this toxin, although to varying levels (over a 3- 
log range). This is in contrast to C. coli, where although all strains possessed the cdt 
genes, very few produced CDT, or CDT production was very low (Pickett et a l, 
1996; Eyigor et a l, 1999). Other species of Campylobacter also produce CDT, 
including C. fetus, C. lari, C. hyointestinalis and C. upsaliensis (Pickett et a l, 1996; 
Mooney et a l, 2001). CHO, Vero, HeLa and Hep-2 cells are all sensitive to the 
action of this toxin, which causes eukaryotic cell elongation over a two to four day 
period, after which the cells disintegrate (Johnson and Lior 1988).
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The cloning and sequencing of the cdt genes from C  jejuni has revealed three 
adjacent genes {cdtA, cdtB, cdtC) that slightly overlap with each other and are all 
required for CDT activity (Pickett et a l, 1996). Additional analysis of the cdt genes 
from C. jejuni and C. coli has shown that they are species-specific, while the 
sequences of the genes within one species are highly homologous (Eyigor et al, 
1999). It has been established that in C. jejuni CDT is a tripartite AB toxin in which 
CdtB is the active 'A' subunit and is critical for CDT activity (Lara-Tejero et al, 2001; 
Lara-Tejero et al, 2002). CdtA and CdtC constitute the heterodimeric 'B' subunit 
required for the delivery of CdtB, since conserved regions of CdtA and CdtC were 
shown to bind HeLa cells (Lee et al, 2003). The deoxyribonuclease (DNase) I-like 
activity of CdtB is essential for CDT toxicity (Lara-Tejero et al, 2000). The DNA 
damage triggers a series of carefully controlled processes that stop cell cycle 
progression to ensure that cell division will not proceed to the next phase until the 
DNA damage has been repaired. Furthermore, CdtB activity in vitro is directed to 
single-stranded DNA, which is only present in the S phase of the cell cycle, which 
immediately precedes 0%. This correlates to the activity of the CDT holotoxin, which 
has been shown to cause sensitive cells to become blocked in the Gi phase of their 
cell cycle (Whitehouse et al, 1998). CDT has also been demonstrated to induce 
interleukin-8 (IL-8) release in INT407 cells (Hickey et al, 2000). Furthermore, CDT- 
negative C  jejuni mutants caused less severe diarrhoea and proximal duodenitis than 
the wild-type strain in mice deficient in NF-kB, suggesting that CDT may have 
proinflammatory activity in vivo (Fox et al, 2004). In addition, CDT may play a 
direct role in diarrhoea by disturbing the survival or maturation of crypt cells into 
functional villus epithelial cells. This causes temporary erosion of the villus, and 
subsequently, loss of absorptive functions. Overall, further study is required to define 
the role(s) of CDT in C. jejuni pathogenesis.
Reports on the production of other cytotoxins are still conflicting due to the use of 
different cell lines, bacterial culture conditions and the C. jejuni strains. The existing 
data has been compared (Wassenaar, 1997) and the existence of five other cytotoxins 
besides CDT has been suggested: (1) a 70-kDa cytotoxin active on HeLa, CHO and 
other cells but inactive on Vero cells (2) a cytotoxin active on Vero and HeLa cells (3)
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a cytotoxin neutralised by Shiga-like toxin (4) a cytotoxin displaying haemolytic 
activity and (5) a hepatotoxin.
A cytotoxic porin-LPS complex has been identified and characterised in C. jejuni and 
shown to be toxic to Hep-2 cells (Bacon et al, 1999). It is also heat labile at 70°C and 
resistant to inactivation by trypsin. The porin is the major outer membrane protein 
(MOMP) of C. jejuni and the most highly expressed protein in this organism, and is 
antigenic and has a molecular mass ranging from 41 to 46 kDa (Newell et al, 1984). 
Even though MOMP is believed to be a porin, surprisingly it has little similarity to 
porins of other Gram-negative bacteria. Still, there is evidence that this protein exists 
as a trimeric arrangement of porin monomers, which forms a cation selective, small 
and voltage sensitive pore (De et al, 2000). The homotrimeric MOMP may also be 
important for attachment to host cells and fibronectin (extracellular matrix protein), as 
well as transport functions across the outer membrane (Moser et al, 1997). 
Furthermore, MOMP porin expression increases at 42°C, as compared to 31°C, which 
suggests that it may have a physiologically different effect in chickens as opposed to 
humans (Dedieu et al, 2002), and therefore may have a role in adapting the organism 
to different host environments. MOMP has also been suggested to play a role in the 
general resistance of C. jejuni to many hydrophilic antibiotics (Page et al, 1989). 
Porins from other bacteria are also toxic. For example, in Neisseria the PorB porin- 
containing blebs that are released from the bacterial outer membrane may fuse with 
the host cell (Bjerknes et al, 1995) inhibiting phagosome degranulation, down 
regulating both actin polymerisation and opsonin receptor expression, and, 
consequently reducing the level of bacterial phagocytosis. Furthermore, the PorB 
channels inserted in the host cell may allow an influx of Ca^ "^ , which, combined with 
other signals, induces apoptotic death by Ca^^-dependent proteases (Muller et al,
1999). However, since the cytotoxic preparation of MOMP-LPS contains LPS, it is 
difficult to determine the actual component responsible for the observed cytotoxicity 
(Bacon et al, 1999). Thus, the contribution of MOMP to the pathogenesis of 
Campylobacter remains unclear.
Few studies have investigated the role of cytotoxin production in the presentation of 
clinical symptoms. Some of these studies have demonstrated a link between the two
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(Florin and Antillon, 1992; Klipstein et al, 1985; Everest et al, 1993), while others 
have failed (Perez-Perez et al, 1989; Ruiz-Palacious et al, 1992). As with other 
bacterial pathogens, the possible nature of toxin production in Campylobacter spp 
may be complex and may involve a range of different toxins expressed under a variety 
of different conditions.
1.12.2 Enterotoxin
There is conflicting evidence as to whether Campylobacters secrete a cholera-like 
enterotoxin (CLT). A cell product has been identified that elongates CHO cells, can 
be detected with a GMI-based ELISA, produces fluid accumulation in intestinal 
loops, and cross-reacts immunologically with both V. cholerae cholera toxin (CT) and 
E. coli heat-labile toxin (LT) (Ruiz-Palacious et al, 1983; McCardell et al, 1984; 
Johnson and Lior, 1986). To the contrary, the genome sequenced strain did not appear 
to encode for genes with similarities to CT or LT. Furthermore, not all patients with 
CLT-positive infections had the expected watery diarrhoea symptoms (Mathan et al, 
1984; Everest et al, 1992). Nevertheless, some strains of C. jejuni have been shown 
to be enterotoxigenic in vivo, through a mechanism that increases intracellular cAMP 
levels in intestinal cells and alters electrolyte exchange (Fernandez and Toro, 1998). 
Without standardisation of the bacterial growth conditions, cell lines and bacterial 
strains as well as the identification of a candidate gene, the existence of CLT remains 
controversial (Wassenaar, 1997).
1.13 Chemotaxis
Chemotaxis is required for effective colonisation of the thick mucus of the 
gastrointestinal tract. C. jejuni has been shown to be attracted to the components of 
mucin, such as L-serine and L-fructose, and certain organic acids, for example 
pyruvate and succinate, whereas bile salts are repellents (Hugdahl et al, 1988). 
Initially, attractants bind to a specific chemoreceptor on bacterial cell surfaces. CheW 
has been shown to be a coupling protein in E. coli and binds the aspartate 
chemoreceptor. Tar, to CheA (Boukhvalova et al, 2002). Tar is one of many bacterial 
tranducers known as methyl-accepting chemotaxis proteins (MCPs) involved in 
transmembrane signalling. There are ten putative genes, designated Tip for
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transducer-like protein, containing MCP domains (Cjl506, Cj0144, Cjl564, Q0262, 
Cj0246, Cj0448, Cj0951/0952, C jlllO , C jll90 and Cj0019, designated Tlpl-10, 
respectively) in the genome of strain NCTC11168 (Parkhill et al, 2000; Marchant et 
al, 2002), as well as one MCP-like protein published for C  coli (Gonzalez et al, 
1998). Interestingly, a DNA probe comprising the highly conserved domain (HCD) of 
TlpA from C. coli can be used in Southern hybridisation-based assays, to enable the 
discrimination of individual strains of C. coli and C. jejuni indicating considerable 
diversity in this genetic region. Lastly, CheV is also present in strain NCTC11168 
and contains a CheW-like domain which may have similar structural scaffolding 
functions as CheW
The insertional inactivation of the cheY, a gene thought to have a role in chemotaxis, 
results in a more adherent and invasive phenotype compared to the wild type in vitro. 
Inactivation of this gene also results in a non-motile phenotype in the chemotaxis 
assay. To the contrary, duplication of cheY results in attenuation of virulence in the 
ferret model and reduces colonisation in the mouse model (Yao et a l, 1997). All these 
observations suggest cheY to be a repressor of adherence and invasion.
In E. coli, CheA is a protein histidine kinase which becomes autophosphorylated, and 
transfers the phosphate group to CheY, in response to receiving a signal from the 
chemoreceptor (Zhu et al, 1997). In C. jejuni, a reduction in an attractant has been 
proposed to increase autophosphorylation of CheA, as observed for other bacteria 
(Marchant et al, 2002). Phosphorylated CheY binds to the switch protein FliM on the 
flagellum motor. This results in a switch of flagellar rotation from counter clockwise 
to clockwise. Incidentally, CheZ is an autophosphatase (Zhu et al, 1997) which 
dephosphorylates phosphorylated-CheY and was surprisingly not present in the 
genome of strain NCTC11168 since it is frequently associated with other bacterial 
chemotaxis systems (Parkhill et al 2000). However, both CheV and CheA contain a 
response regulator domain and it has been speculated that these domains may enable 
phosphate groups to be removed from CheY (Marchant et al, 2002). In Bacillus 
subtillis, CheC and CheD have been shown to regulate the méthylation of MCPs 
(Rosario and Ordal, 1996) but these proteins have not been identified in C. jejuni. 
Nevertheless, the methylesterase CheB is present in the C. jejuni genome sequenced
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strain (Marchant et al, 2002). In E. coli this enzyme has been shown to be a response 
regulator protein which modulates the level of méthylation in transmembrane 
chemoreceptors, and indirectly controls the direction of flagellar rotation (Saxl et al.,
2001). The methyltransferase CheR has a similar function to CheB. The counter 
clockwise flagellar rotation causes the bacteria to swim smoothly, whereas clockwise 
rotation causes a tumbling effect. Overall, the genome of strain NCTCl 1168 contains 
orthologues of the chemotaxis genes cheW (Cj0283c), cheA (Cj0284c) and cheV 
(Cj0285c) located together, whilst cheR (Cj0923c) and cheB (Cj0924c) are adjacent to 
each other, and cheY (C jlll8c) is located distally. Chemotaxis in C. jejuni has been 
demonstrated to play an important role in colonisation of the intestinal tract of mice 
and chicks (Takata et al, 1992; Hendrixson et al, 2004). The ability to detect a 
chemical gradient, and the movement of an organism up or down that gradient is an 
important step for intestinal colonisation by C  jejuni and an essential prerequisite to 
pathogenesis in human disease.
1.14 Adhesion and invasion
Upon infection and crossing the mucus layer, an important feature of Campylobacter 
pathogenesis is adhesion to the epithelial cell surface and subsequent toxin secretion 
or translocation across the intestinal epithelium. HeLa, INT407, Hep-2 and Caco-2- 
cells have all been used to demonstrate Campylobacter adhesion in vitro (Fauchere et 
al, 1989; de Melo and Pechere, 1990; Konkel et al, 1992; Moser et al, 1992; Kelle 
et al, 1998). Surface components including flagella, LPS and outer membrane 
proteins have been attributed to the ability of Campylobacter to adhere to cells. 
Invasion is also thought to be involved in triggering inflammation, as invasion of 
C. jejuni is required for the induction of IL-8, prostaglandins and leukotrienes 
(Everest et al, 1993; Hickey et al, 1999). Clinical C. jejuni isolates show varying 
degrees of invasiveness (Newell et a l, 1985; Schwartz et al., 1996) which may be 
related to disease symptoms (Everest et al., 1992). In general, clinical isolates are 
found to be more invasive than non-clinical strains (Konkel and Joens, 1989) 
however, this is debatable (Tay et a l, 1996).
Flagella appear to be involved in both adherence and invasion (Wassenaar et al, 
1991; Grant et al, 1993). C  jejuni mutants with paralysed flagella showed 30- to 40-
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fold reduced adherence and invasion in INT407 cells in vitro when compared to the 
wild-type. Moreover, these mutants internalised cells 6- to 7-fold better than 
aflagellate mutants (Yao et al, 1994). This strongly implicates motility with a major 
role in adherence, whilst flagella appears to have a major role in invasion.
The LPS also mediates binding of C  jejuni to host cells (McSweegan & Walker, 
1986). The LPS is a major antigenic component on the cell surface of C. jejuni and 
can bind to INT 407 cells and exert endotoxic properties on host cells. Purified LPS 
specifically binds to epithelial cells and subsequently inhibits adhesion (McSweegan 
and Walker, 1986). However, as large amounts of LPS tend to be used in these assays, 
overt toxity of the epithelial cells may prevent adhesion. Inactivation of galE, a gene 
involved in LPS synthesis, also causes a reduction in adhesion to, and invasion of 
INT407 cells, even though no effect on the level of chicken colonisation compared to 
wild-type is observable (Fry, et al., 2000). Analysis of the C. jejuni genome sequence 
and use of the DNA arrays has recently led to the identification of a number of genes 
involved in LPS biosynthesis. Such genes may vary from strain to strain (Parkhill et 
al, 2000; Dorell et al, 2001; Pearson et al, 2003). The differences in C. jejuni LPS 
moiety may play a role in the bacterium-host interaction as seen in other bacteria. For 
example, in H. influenzae the phosphorylcholine moiety is important for bronchial 
cell adherence and subsequent invasion (Swords et al, 2000). Also, in N. 
gonorrhoeae the complete deletion of the alpha-0S chain of LOS significantly 
impairs invasion of human conjuctival, endometrial and cervical cell lines (Minor et 
2000^
The PEBl protein is one of the most fully characterised adhesins in C. jejuni and 
C. coli (Pei & Blaser, 1993). It was one of four antigenic proteins, PEBl, PEB2, 
PEB3 and PEB4, identified by Pei, Elison and Blaser (Pei et al, 1991). These proteins 
possess molecular masses of 28, 29, 30, 31 kDa respectively. Only PEBl and PEB3 
are surface exposed as they are recognised by convalescent sera from C. jejuni and C. 
coli infected patients. PEBl has been shown to be a major adhesin for epithelial cells 
(Kervella et al, 1993), since disruption of the pehlA  gene results in significantly 
reduced adhesion as well as decreased invasion of HeLa cells in vitro, and 
significantly affects the ability of the organism to colonise the mouse model (Pei et
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al., 1998). In contrast, inactivation of pehlA  does not affect colonisation in the chick 
model (Meinersmann et al, 1996). PEBl has similarity to amino acid transporters, 
while PEB3 has similarity to the binding components of bacterial ABC transporter 
proteins. Both these antigens may be candidates for a human Campylobacter vaccine.
A 37 kDa outer membrane protein CadF is thought to have a role in facilitating the 
binding of C. jejuni to eukaryotic extracellular matrix proteins, specifically 
fibronectin. CadF is highly conserved in C. jejuni and C. coli (Konkel et a l 1999). 
Characterisation of CadF in C. jejuni suggests a role in colonisation, since the cadF 
mutant is unable to colonise the caeca of chickens (Ziprin et a l, 1999). Fibronectin is 
present at regions of cell to cell contact in the gastrointestinal epithelium, as well as 
being associated with microfilaments (Quaroni et al, 1978). This may provide a 
potential binding site for CadF and may be a key feature for promoting adhesion of 
C. jejuni to the appropriate receptors on host cells involved in uptake. Moreover, upon 
binding fibronectin, C. jejuni may stimulate host cell signalling events assoeiated with 
bacterial uptake, since the presence of the microfilament depolymerisation agents, 
Cytochalasin D and mycalolide B result in a significant reduction in C. jejuni INT407 
invasion (Monteville et al, 2003). The cadF gene is also present in the NCTCl 1168 
genome (Parkhill et al, 2000). Two further genes, Cj 1279c and Cj 1349c, are 
predicted to encode fibronectin binding domains but are yet to be fully characterised 
(Parkhill et al, 2000).
The P95 gene was isolated from C. jejuni using degenerate primers to a conserved 
region of a number of adhesins fi*om other Gram-negative bacteria (Kelle et al.,
1998). The corresponding protein, which is 869 amino acids in length, shows 
significant homology with the filamentous haemagglutinin of Bordella pertussis and 
with the high-molecular-weight surface exposed adhesins of Haemophilus influenzae 
which mediate bacterial adherence to epithelial cells (Kelle et al., 1998). The role of 
P95 in the adherence of C. jejuni has still to be determined.
JlpA is a surface exposed lipoprotein loosely associated with the cell surface. The jlpA  
gene encodes a 42.3 kDa acid polypeptide and contains a typical signal sequence and 
lipoprotein processing site at the N-terminus. The adherence of JlpA mutants to HEp-
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2 cells is reduced compared with the wild type (Jin et al, 2001). Recently, JlpA has 
been shown to interact with the heat shock protein (hsp) 90alpha in HEp-2 cells and to 
initiate signalling pathways leading to activation of NF-kappaB and p38 MAP kinase. 
The activation of these two molecules suggests that JlpA triggers 
inflammatory/immune responses in host cells following C. jejuni infection (Jin et al, 
2003^
The pili of Salmonella and Escherichia coli have been shown to have a role in 
mediating adherence (Dibb-Fuller et a l, 1999; La Ragione et a l, 2000). In addition, 
pilus expression is thought to be regulated by environmental factors (Goransson et al., 
1990). The analysis of the NCTCl 1168 genome sequence did not indicate any clear 
candidate pilus genes for C. jejuni. In the presence of bile salts, C. jejuni were thought 
to produce pilus-like appendages, 4-7nm in diameter and greater than 1pm in length, 
which formed flexible bundles (Doig, et a l, 1996). This is a property of certain type 
IV pili. The inactivation of a gene proposed to be involved in pilus biosynthesis, 
prepilin peptidase (pspA), apparently resulted in afimbrial mutants which had no 
effect on bacterial adherence in vitro or on ferret colonisation even though disease 
symptoms were reduced. Most recently, these pilus-like appendages have been shown 
to be an artefact due to the presence of bile salts in the media (Gaynor et al, 2001).
C. jejuni invasion is dependent both on de novo synthesis of C. jejuni proteins, and 
host cell signal transduction (Wooldridge and Ketley, 1997; Konkel et al, 1999). A 
recent study has identified a Campylobacter protein in the cytosol of INT407 cells 
(Konkel et a l, 1999). This protein, "Campylobacter invasion antigen B’ (CiaB) is 
required for invading INT407 cells but not for adherence (Konkel et al., 1999), and a 
role for this protein in internalisation has been postulated. However, the suggestion 
that CiaB may be a member of a type III secretion system, due to amino acid 
similarity to invasion-related proteins from other pathogenic bacteria (IpaB from 
Shigella flexneri, SipB fi*om Salmonella Typhimurium and YopB fi*om Yersinia 
pseudotuberculosis) has been challenged (Fallen et a l, 1999). Re-analysis of the 
protein sequences found no evidence to link CiaB to these proteins. Furthermore, 
although ciaB was present in NCTCl 1168 genome sequence (Cj0914c), ciaB was not 
present in all C. jejuni strains (Parkhill et al, 2000; Datta et al, 2003). Nevertheless,
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homologues of a type IV secretion system (comBl, comb2, comb3 and virBll), found 
on a C  jejuni plasmid, have been shown to be important in both INT407 cell adhesion 
and invasion, as well as contributing to virulence in the ferret model (Bacon et al, 
2000^
Molecular characterisation of invasive and non-invasive strains has also been 
attempted using the random, amplified polymorphic DNA (RAPD) technique 
(Carvalho et al, 2001). This study revealed a distinct 1.6 kb band, named iam for 
invasion associated marker, common to invasive strains. Whether this iam locus is 
actually involved in invasion, however, is highly debateable since it is also present in 
20 % of non-invasive strains.
Eukaryotic host signalling pathways that lead to cytoskeletal rearrangements have 
been implicated in C. jejuni internalisation since inhibition of host protein kinases, in 
particular tyrosine kinases, inhibits C. jejuni internalisation (Wooldridge et al, 1996). 
In particular caveolae (plasma membrane invaginations) appear to have a role in C. 
jejuni invasion (Wooldridge et al, 1996). The cytoskeleton of eukaryotic cells is 
predominantly composed of actin and tubulin, and is involved in bacterial invasion, 
cellular and subcellular bacterial movements and determination of host cell shape 
(Finlay & Falkow, 1997). C. jejuni strain 81-176 associate with these filamentous 
structures, which are composed of polymerised microtubule (MT) proteins, during the 
initial stages of the invasion process in INT 407 cells (Hu & Kopecko, 1999). 
Unfortunately, the C. jejuni genome sequence did not provide any clear candidates for 
invasion-related genes (Parkhill et al, 2000). Nevertheless, Cjl371 has some 
similarity to vacJ, which in Shigella flexneri encodes a protein involved in 
intracellular spread but not invasion or intracellular movement. More specifically, 
VacJ is required to move the bacteria, contained within a membranous protrusion, 
from the infected cell into the cytoplasm of the adjacent cell (Suzuki et al, 1994).
1.15 Iron acquisition
Successful C. jejuni colonisation of the intestine requires an effective mechanism for 
the uptake of iron. Iron is considered to be critical for virulence and survival.
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Campylobacters do not produce siderophores but are able to use high affinity iron 
chelators, ferrichrome and enterochelin produced by other organisms (Pickett et al, 
1992). Generally, bacteria are able to acquire iron by killing host cells, for example by 
releasing toxins to liberate the host’s iron stores. In C. jejuni, haemolysins have been 
identified (Hossain et al, 1993), including PldA which is a contact dependent 
haemolysin (Grant et al, 1997). Other organisms, such as Neisseria, Helicobacter, 
Haemophilus and Listeria, also use transferrin, lactoferrin, ferritin or hemin as a direct 
source for iron (Gray-Owen et al, 1995; Deneer et al, 1995; Dhaenens et al, 1997; 
Schryvers and Stojiljkovic, 1999).
Once the sideophore has complexed with iron, it is taken up by a specific receptor 
found on the bacterium’s outer membrane. As a consequence, the iron compound is 
transported through the outer membrane and into the periplasmic space. A periplasmic 
binding protein and an ABC transporter located on the inner membrane import the 
compound into the cytosol. C  coli acquires the sideophore enterochelin (also known 
as enterobactin), from other enteric bacteria, using the components of the periplasmic 
binding-protein-dependent transport system (ceuBCDE). However, this operon lacks a 
gene encoding the outer membrane receptor and as yet unidentified elsewhere in the 
genome. Nevertheless, C. coli mutants defective in this system were unable to utilise 
enterochelin (Richardson & Park, 1995). Interestingly, mutagenesis in ceuBCDE 
system did not affect the level of colonisation in chicks (Cawthraw et a l, 1996). This 
data suggests that other iron uptake systems operate during colonisation. Another 
system involved in iron acquisition has been identified and is called the 
haemin/haemoglobin uptake system (chuABCD) (Rock et al, 1999). Both ceu and chu 
systems are present in all C. jejuni strains tested to date and may be the predominant 
mechanisms in this organism for iron acquisition. However, other systems are also 
implicated in iron uptake, for example genes encoding the outer membrane receptor 
cfr gene is now known to be a enterobactin receptor associated with the ceuBCD 
system (Guerry et al, 1997; Palyada et al, 2004) and a ferrichrome uptake system 
(fliuABD) identified on the basis of the sequence alone, are found in certain strains 
(Galindo et al, 2001).
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Since the genome of strain NCTCl 1168 was sequenced (Parkhill et al, 2000), a 
number of putative iron acquisition genes have since been identified; for example the 
ABC iron transporter, FeoB protein. In Legionella, FeoB is important for extracellular 
and intracellular growth especially in iron-limited environments (Robey and 
Cianciotto, 2002). It also plays a role for Salmonella in intracellular survival and 
replication in macrophages (Boyer et al, 2002). Moreover, FeoB mutants in 
Helicobacter are unable to colonise the gastric mucosa of mice (Velayudan et al,
2000). However, characterisation of the putative FeoB in C  jejuni has suggested that 
it was not involved in iron uptake (Raphael et al, 2003).
Iron is also capable of generating oxygen radicals in the presence of oxygen. Such 
radicals can damage DNA, proteins and membranes. Therefore iron homeostasis has 
to be carefully balanced, and this is achieved by tightly controlling the uptake, 
metabolism, and storage of iron. The expression of iron-regulated systems in Gram- 
negative bacteria is generally controlled by the Fur (ferric uptake regulator) protein, 
which represses the transcription of iron-regulated promotors by using Fe^ "^  as a 
cofactor (Stojiljkovic et al, 1994; Hassett et al, 1996). It has been suggested that Fur 
binds to specific DNA sequences (Fur boxes) overlapping Fur-regulated promotors 
when the intracellular Fe^  ^concentration is high enough to allow the formation of a 
complex consisting of a Fur dimer and Fe^ .^ In C. jejuni, the promotor regions of both 
ahpC and katA genes have Fur box consensus sequences. Surprisingly, the expression 
of these genes are still iron repressed in the fur  mutant which suggests that Fur in C. 
jejuni is not involved in iron repression (van Vliet et al, 1998). Nevertheless, the 
expression of the C. jejuni fur  gene is controlled from two promotors, located in front 
of the first and second ORF upstream of fur, but neither is iron-regulated (van Vliet et 
al, 2000). A Fur homologue, named peroxide stress regulator (PerR), has been 
identified in C. jejuni and protein profiling of the PerR mutant identified this protein 
as a repressor of KatA and AhpC (van Vliet et al, 1999). Furthermore, quantitative 
analysis of KatA expression showed that the fu r  mutation also affected catalase 
activity suggesting additional non-iron-dependent regulation of KatA, and also that 
Fur co-regulates katA expression with PerR. Generally in Gram-negative bacteria, the 
OxyR (regulator in response to oxidative stress) protein is a transcription factor that 
senses oxidative stress through a change in protein conformation (due to disulphide
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bond formation) and is a regulator for KatA and AhpC expression (Christman et al, 
1989; Dhandayuthapani era/., 1997).
1.16 Oxidative stress
In C. jejuni the expression of genes associated with oxidative-stress resistance is 
required to protect the organism from reactive oxygen species produced during 
normal microaerobic metabolism, during exposure to air, and when in contact with the 
host defence system. The main superoxide defence mechanism is superoxide 
dismutase {sodB), which requires iron as a cofactor. The product of sodB, SOD 
catalyses the conversion of oxygen radicals to hydrogen peroxide and dioxygen. This 
reaction was identified as important for C. jejuni survival intracellularly in INT407 
cells (Pesci et al, 1994), and in air and in model food systems (Purdy et al, 1999). 
Moreover, SOD is important for the efficient colonisation of chicks (Purdy et a l,
1999X
The other main oxidative stress mechanism in C. jejuni is involved in peroxide 
defence. Catalase {katA) and alkyl hydroperoxide reductase {ahpC) are both repressed 
by iron and the peroxide stress regulator, PerR (see Section 1.15), and iron is required 
by PerR for the regulation of these genes (van Vliet et a l, 1999). Catalase converts 
hydrogen peroxide (a by product of SOD and other metabolic processes) to oxygen 
and water. Even though katA mutants are sensitive to hydrogen peroxide, they are not 
altered in their ability for aerobic growth or colonisation of chicks (Purdy et a l,
1999). Nevertheless, katA is important for intramacrophage, but not intraepithélial, 
survival (Day et ah, 2000). On the other hand, ahpC is important for aerobic survival 
(Bâillon et al, 1999). Alkyl hydroperoxide reductase reduces alkyl hydroperoxides to 
alcohols, and as a result becomes oxidised. The oxidised AhpC protein may be 
reduced by the ferredoxin protein, Fdx in order to recycle the reduced AhpC form 
(van Vliet et al, 2001). Recently, another protein. Dps, has been implicated in the 
peroxide defence. Dps is a DNA binding protein, which protects against hydrogen 
peroxide stress by sequestering intracellular free iron (Ishikawa et al, 2003). In E. 
coli. Dps is induced during starvation and complexes with DNA. Evidence suggests it 
confers resistance to hydrogen peroxides, as well as DNAses and acid stress (Almiron 
et al, 1992; Choi et al, 2000).
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Finally, the NCTCl 1168 genome sequence has revealed Cj0637c as encoding a 
putative methionine sulfoxide reductase (Msr). In E. coli and Mycobacterium 
tuberculosis, MsrA catalyses the reduction of methionine sulfoxide in proteins to 
methionine (St John et al, 2001). Mutants in this gene are hypersensitive to killing, 
not only by hydrogen peroxide, but also by the reactive nitrogen intermediates, nitrite 
and S-nitrosoglutathione. Both nitrite and S-nitrosoglutathione can give rise to nitric 
oxide (NO), which can react with superoxide to form peroxynitrite. Peroxynitrite can 
oxidise the methionine residue in proteins to methionine sulfoxide. However, the 
enzymatic activity of MsrA can reduce methionine sulfoxide back to methionine and 
prevent protein damage. Macrophages expressing inducible nitric oxide synthase 
(iNOS) release these reactive nitrogen intermediates, and this is an important feature 
of macrophage activity during phagocytosis, which contributes to bacterial death. 
Therefore, characterisation of MsrA in C. jejuni is required to establish whether it is a 
bacterial repair mechanism for peroxynitrite-mediated intracellular damage.
1.17 Secretion systems
Pathogenic bacteria synthesise a diverse range of virulence factors that need to be 
localised on the bacterial cell surface, secreted into surrounding fluids or injected 
directly into the cytoplasm of eukaryotic host cells. In Gram-negative bacteria this 
targeting requires the movement of proteins from the cytosol, across the inner 
membrane, through the periplasm and finally over the outer membrane. There are five 
main types of mechanisms for the secretion of proteins termed types I, II, III, IV and 
V.
1.17.1 The general secretory pathway
Types II and V are Sec-dependent secretion pathways. In other words these two 
systems require the same secretion machinery for translocation across the inner 
membrane. In the cytoplasm Sec A binds the signal sequence of the pre-protein to be 
translocated. SecB acts as a chaperone and binds to the mature portions of the pre­
protein maintaining them in an unfolded, export-competent state. SecB also binds to 
SecA. SecA directs this complex to the SecYEG translocation channel in the inner
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membrane. Once Sec A enters the membrane, following ATP binding, SecB is 
released into the cytoplasm and the pre-protein is partially translocated through 
SecYEG. As a consequence, the signal peptidase cleaves the signal peptide of the pre­
protein. SecD, SecF and YajC stabilises the membrane-bound form of SecA. The 
energy of ATP binding and hydrolysis promotes cycles of membrane insertion and de­
insertion of SecA and catalyses the progressive threading of the protein across the 
inner membrane. The NCTCl 1168 genome has been found to contain homologues of 
SecA (Cj0942c), SecY (Cjl688c), SecE (Cj0472), SecG (Cj0235c), SecD (Cjl093c) 
and SecF (Cj 1092c) but no SecB (Parkhill et al, 2000).
1.17.2 Type I
Type I or ABC transporter systems comprise three components; an ATP binding 
cassette (ABC) in the inner membrane, a membrane fusion protein or accessory 
factor, which is anchored in the inner membrane and spans the periplasmic space, and 
an outer membrane component (Tomii and Kanehisa 1998; Higgins, 2001). Type I 
systems secrete proteins and other substrates across both the inner and outer 
membranes in a single step. In the cytoplasm the ABC protein specifically recognises 
a carboxy-terminal signal on the protein to be exported. Substrate binding inhibits 
ATPase activity of the ABC protein and promotes interaction with the membrane 
fusion protein. This stimulates the interaction of the membrane fusion protein with the 
outer membrane component. The exact mechanism by which the protein is secreted 
into the environment is unclear but the three type I secretion proteins may form a 
channel through which the proteins pass in a single step.
In C. fetus the S-layer proteins appears to be secreted by a Sec-independent 
mechanism, using a type I mechanism analogous to that of E. coli haemolysin 
(Thompson et al, 1998). Initially, the SapA carboxy-terminal secretion signal is 
recognised by the SapD protein. The SapA-SapD complex then initiates the sequential 
assembly of SapE and SapF trimers, resulting in an contiguous pore through which 
the SapA is secreted. Once secreted the S-layer proteins attach non-covalently to the 
outer membrane via an interaction with EPS.
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In the genome sequence of strain NCTCl 1168, ^5M (C j 1448c) and kpsT (Cj 1487c) 
have been identified as homologues of ABC transporters involved in capsular 
polysaccharde transport across the inner membrane (Karlyshev et al, 2000; Parkhill 
et al, 2000). In E. coli, KpsM and KpsT form the integral membrane component and 
the peripheral ATP-binding component, respectively and constitute a system for 
transport of polysialic acid capsule (Pavelka et al, 1991). In addition KpsD (Cj 1444c) 
and kpsE (Cj 1445c) are believed to be involved in periplasmic translocation of the 
capsule (Russo et al, 1998; Wunder et al, 1994). On the whole, strain NCTCl 1168 
contains a large number of putative ABC transporters. A high proportion of these 
have homologies to proteins in other organisms. Although the remainder appear to 
have conserved ABC-component protein motifs, their overall sequences are unique to 
Campylobacter.
1.17.3 Type II
The type II system requires the presence of a signal peptide recognised by the Sec 
machinery. Once the protein is translocated through the inner membrane, the 
periplasmic protein (in its folded conformation) is guided to the outer membrane and 
subsequently transferred across the outer membrane. The process requires a 
machinery known as the secreton, which consists of around 12-15 proteins. Protein D 
is a member of the secretin family and is present in the outer membrane where it is 
believed to form a gated secretion pore. In Enterobacteriaceae the S protein assists 
outer membrane insertion of protein D. The remaining type II components appear to 
be associated with the cytoplasmic membrane, where a number of them have some 
interaction with the secretin. The proton motive force of the cytoplasmic membrane is 
required for outer membrane translocation. The exact mechanism for type II secretion 
is unknown but findings suggest that the type II secretion apparatus forms a multi 
protein complex that spans both membranes (Sandkvist, 2001). It has been proposed 
that four inner membrane proteins form a pilus like structure that could act as a piston 
to push proteins through the outer membrane pore (Sandkvist, 2001).
The C. jejuni genome contains genes predicted to encode type II system components 
(Parkhill et al, 2000). For example Cj 1470c, Cj 1471c and Cj 1474c genes encode 
putative type II protein secretion system components F, E and D, respectively.
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However, Cj 1470c is a pseudogene and many other necessary type II components 
have not been identified. One possible explanation may be that Campylobacters 
contain very different components from those already identified as type II secretion 
systems in other bacteria. Generally, proteins secreted by the type II pathway include 
proteases, cellulases, pectinases, phospholipases, lipases and toxins, all of which may 
contribute to host cell damage and disease. The Eps (extracellular protein secretion) 
type II transport system of V. cholerae for example, secretes cholera toxin into the 
surrounding milieu. Once the toxin is transported into the periplasmic space by the 
Sec machinery, the mature A and B subunits are rapidly assembled into the A:B$ 
holotoxin before being transported by the Eps system across the outer membrane 
(Sandkvist a/., 1995; Sandkvist ûf/., 2000).
1.17.4 Type III
The type III secretion system is a host contact dependent system that translocates 
proteins directly into eukaryotic host cells in a Sec-independent manner. In 
Salmonella, Shigella and Yersinia, protein and inositol phosphatases and protein 
kinases have been identified as the injected effectors. The effectors can influence 
pathogen survival, internalisation and replication by affecting host phosphorylation, 
which plays an important role in many host cell signal transduction pathways 
(DeVinney et al, 2000). Common effector targets includes the actin cytoskeleton 
(invasion or antiphagocytosis), apoptotic pathway, and endosomal trafficking 
pathways (establishment of a favourable intracellular niche). Secretion of effectors 
requires two stages, secretion out of the bacterium and translocation into the 
eukaryotic cell. More than 20 proteins are required in this process. Most of which are 
located in the inner membrane and interestingly these components are homologous to 
Fli/Flh proteins involved in flagellar biosynthesis (Hueck, 1998). The outer membrane 
protein is homologous to the secretin protein D from type II systems. The signal for 
secretion resides within the amino-terminal and is not subjected to amino terminal 
processing. The protein effector requires cytoplasmic chaperone proteins to prevent 
degradation in the bacterial cytoplasm, efficient recognition by type III secretion 
proteins, as well as protect it from premature interaction with the other type III 
components. It has been proposed that a transmembrane channel and an extracellular
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needle-like appendage may serve as a protein transport channel to the host cell 
(Hueck, 1998).
The Campylobacter 73 kDa CiaB protein (see Section 1.14) is found in the cytosol of 
infected INT407 cells (Konkel et al, 1999). It is one of eight proteins that are 
secreted upon contact with the host cell. A mutation in the ciaB gene results in 
significant reduction in C. jejuni internalisation, despite a lack of reduction in host 
cell binding (Konkel et al, 1999). Rivera-Amill and colleagues have shown that CiaB 
proteins are only induced in response to certain stimulatory signals such as foetal 
bovine serum, bile salts and eukaryotic host cell components (Rivera-Amill et al,
2001). However, recent comparisons of the sequences of CiaB and IpaB from Shigella 
flexneri, SipB from Salmonella and YobB from Yersinia pseudotuberculosis, have 
questioned the relatedness of these proteins (Fallen et al, 1999) and therefore the role 
of CiaB in secretion.
The assembly of the flagellum initially involves the synthesis of a dedicated protein 
export apparatus that subsequently transports other flagellar proteins by a type III 
mechanism from the cytoplasm to the outer surface of the cell. Flagellum biosynthesis 
is highly ordered such that the basal body-hook structure is assembled initially and it 
includes subunits that share a high degree of homology with subunits that form the 
secretion machinery of the contact-dependent type III secretion apparatus. In 
pathogenic bacteria such as Salmonella and Yersinia the flagellum export apparatus 
also functions as a secretion system for the transport of several extracellular proteins 
(Young et al, 1999; Aldridge and Hughes, 2002). In Y. enterocolitica, one of the 
proteins secreted is the virulence-associated phospholipase (YplA), which may 
influence bacterial-host interactions. This phospholipase appears to contribute to host 
tissue damage in a mouse model (Schmiel et al, 1998). The Campylobacter flagellar 
secretion apparatus (see Figure 1.2) may also play a role in secreting extracellular 
proteins associated with virulence, such as cytotoxicity, haemolysis, proteolysis, 
protein phosphorylation, and protein dephosphorylation (Wosten et al, 2004). The 
C. jejuni strain NCTCl 1168 genome (Parkhill et al, 2000) contains a phospholipase 
homologue (pldA) (Grant et al, 1997), but the mechanism of secretion has not been 
elucidated. Nevertheless a pldA mutant in a C. jejuni clinical strain F38011 has 
impaired cecum colonisation in chickens (Ziprin et al, 2001). Therefore it would not
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be too surprising to find that the flagellar export apparatus in C  jejuni may also 
transport non-flagellar proteins involved in bacterial-host interactions.
1.17.5 Type IV
Type IV secretion systems mediate secretion or direct cell to cell transfer of 
macromolecular virulence factors (Fischer et al. 2002). The subunits of this secretion 
system are evolutionarily related to those of conjugation transfer systems carrying tra 
genes for delivering effector molecules (DNA or protein) to eukaryotic host cells. The 
conjugation systems are distinct from the other four (types I, II, III and V) bacterial 
secretion pathways (Christie, 2001). The Sec-independent virB operon from the plant 
pathogen Agrobacterium tumefaciens is required for the transport of large, single 
stranded DNA, known as T-DNA. This is, to date, the best studied bacterial type IV 
secretion system and is the prototype for this family. Transport across both bacterial 
membranes and into plant cells results in integration of the T-DNA with the plant 
genome and this induces the formation of crown gall tumours (Zhu et al, 2000). The 
virB operon consists of 11 genes. The products (of virB2 to virB ll genes and the 
virD4 gene) build a core membrane spanning channel and a pilus extending across the 
outer membrane. The product of virBl has lytic glycosylase activity and appears to 
enhance the efficiency of T-DNA transfer but is not essential for secretion. At least 
three proteins, VirD2 relaxase, VirE2 and VirF are secreted into the recipient plant 
cell. VirD2 and VirE2 form a complex with T-DNA and VirE2 also forms a 
translocation pore in the membrane of the plant cell. Collectively, these protein 
substrates are required for protecting and guiding the T-DNA from the bacterial 
cytosol to the plant cell nucleus.
One other example of a type IV secretion system worth mentioning is the Ptl secretion 
system from Bordetella pertussis, which secretes an AB-type toxin known as the 
pertussis holotoxin (Rambow-Larsen and Weiss, 2002). The nine Ptl proteins are 
believed to form a macromolecular complex spanning both the inner and outer 
membranes and leading to the exterior of the cell. This huge complex most likely 
forms a channel to allow proteins to pass from the cytoplasm to the surface of the cell, 
as seen for the virB operon. However, the pertussis toxin secretion system is rather 
unusual among type IV secretion systems in that it secretes the toxin extracellularly
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rather than directly to the host cell. Furthermore, the toxin itself is the only known 
type IV secretion substrate, the subunits of which possess ^ec-dependent signal 
sequences.
In C. jejuni, homologues of a type IV secretion system have been identified in 
plasmids in strain 81-176 (Bacon et al, 2000; Bacon et al, 2002). The pVir plasmid 
(35 kb) has four putative genes, comBl, comB2, comB3 and virB 11, the products of 
which have significant levels of similarity to components of type IV secretion systems 
in other bacteria. Moreover, inactivation of comBS and virB 11 results in reduced 
adherence to and invasion of INT407 cells, and significantly reduces virulence in the 
ferret diarrhoeal model. However, when the pVir plasmid is transferred to a strain 
with a low level of invasion, the invasion ability does not increase, which suggests 
that genes present in the chromosome of strain 81-176 are also required for invasion. 
Interestingly, a mutation in the comB gene significantly impaired the natural 
transformation ability of C. jejuni strain 81-176. However, it appears that only 10 % 
of plasmids isolated from 58 fresh clinical isolates contain virB 11 homologues. A 
second 81-176 plasmid, pTet (35 kb), encodes an additional type IV secretion system, 
which appears to be dispensable to invasion. Nevertheless, some of the pTet 
components may be able to partially complement some pVir mutants. Overall, these 
results suggest that distinct mechanisms of virulence may exist amongst different 
strains of C  jejuni strains.
1.17.6 Type V
Type V systems are also known as autotransporters. The prototype for type V 
secretion systems was identified in N. gonorrhoeae as a secreted IgA protease protein, 
which was initially expressed in the cytoplasm as a large mutidomain 169 kDa protein 
(Pohlner et al, 1987). The immature protein consists of a Sec-dependent amino- 
terminal signal sequence, followed by the 106 kDa mature portion of the protein, a 30 
amino acid gamma protein, a 15 kDa secreted alpha protein, and a carboxy-terminal 
45 kDa beta protein. Firstly, the precursor is translocated through the inner membrane 
by the Sec machinery and the amino-terminal signal sequence is cleaved. In the 
periplasm, the beta domain is targeted to the outer membrane where it forms a beta 
barrel pore through which the rest of the protein can pass to the cell surface. The beta
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domain undergoes autoproteolysis and the remaining protein is released into the 
extracellular environment. Further autoproteolytic cleavages release the mature IgA 
protease, gamma and alpha proteins. The gamma and alpha proteins have unknown 
functions but may act as chaperones for the unfolded mature protein.
There are at least four autotransporters (Simon Park, personal communication) in the 
C. jejuni genome sequence (Parkhill et al, 2000). The characterisation of these genes 
and information regarding their role in pathogenesis in C  jejuni is awaited.
1.18 Comparative genomics
Gradually, complete genome sequences are becoming available for multiple strains of 
pathogenic bacterial species and comparative analysis is providing important insights 
into the evolution of bacterial virulence. The availability of two completed genome 
sequences from unrelated Helicobacter pylori strains (J99 and 26695) has revealed 
that, although the two chromosomes are organised differently in a number of discreet 
regions, the genome size and gene order of these isolates was highly similar (Aim and 
Trust, 1999). The regions of organisation difference are associated with insertion 
sequences (IS), restriction modification (R-M) genes, repeat sequences, or a 
combination of all of these. A whole genome DNA microarray specific for both 
genomes determined that 22% of genes, in 15 isolates, were strain-specific. These 
included R-M genes, transposases and genes encoding cell-surface proteins (Salama 
et al, 2000). The remaining 78% of core genes encode metabolic and cellular 
processes. Finally, frequent change of nucleotides in the third position of the triplet 
codons and various copies of insertion elements on the individual chromosomes 
appear to contribute to distinct polymorphic fingerprints among strains analysed by 
various genotyping methods (Ge et al, 1999). Thus, nucleotide variation, together 
with the organisational re-arrangements, has also contributed to the genetic diversity 
observed for H. pylori
Although the Salmonella genome (5 Mbp) sequences reveal extensive sequence 
conservation among the Salmonella serovars, horizontal gene transfer has provided 
each genome with between 10-12% of unique DNA (Edwards et al, 2002). The
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insertions (such as genetic islands, phage genomes and transposable elements) and 
deletions (relative to other serovars) are distributed throughout many sites on the 
chromosome, and are likely to be responsible for the different abilities of the serovars 
to infect a variety of hosts, cause a range of symptoms and survive a diversity of 
immune responses.
The population genetics for Mycobacterium tuberculosis strains by MLST has 
demonstrated a high conservation of gene sequences, but whole genome microarray 
analysis has identified numerous deleted chromosomal regions amongst isolates 
(Fitzgerald and Musser, 2001). Interestingly, the data indicates that the accumulation 
of deletions in the M. tuberculosis genome resulted in diminished virulence. These 
deletions are the consequence of recombinational or insertion sequence (IS)- mediated 
events and, therefore, an important source of genome variation in this organism.
These are a few examples of the outcomes of comparative genomic studies. Overall, 
therefore, within recent years, comparative genomics has contributed considerable 
insight into the evolution of pathogenic bacteria.
Campylobacters exhibit extensive intraspecies variation and appear to be quite diverse 
when compared to other enteropathogens. The phenotypic (Fenner and Hennessy, 
1980; Lior et al. 1982) and genotypic (Owen et al, 1997; Dingle et al, 2001; Schouls 
et al, 2003) typing schemes, as well DNA arrays (Dorell et al, 2001) have all 
identified substantial variation between strains. This may reflect both variation within 
a gene sequence, and the presence or absence of whole genes, or possibly clusters of 
genes. Genome sequencing of an individual bacterial strain will not identify all the 
genes relevant for that species. Although the sequencing of a large number of diverse 
strains may identify all the genes important for that species, in reality, this is not 
economically feasible at present and alternative approaches are, therefore, required.
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1.19 Problems faced in Campylobacter Research
Many different species of animals have been tested in an attempt to establish a model 
system that mimics human campylobacteriosis. The closest model to human infection 
is oral infection of non-human primates, especially Macaca nemestrima (Russell et 
al, 1989) but this is largely limited on ethical grounds. An oral ferret model, inducing 
mild diarrhoea, appears to be an extremely useful in vivo tool in the study of some 
virulence factors (Fox et a l, 1987; Doig et al, 1996; Yao et al, 1997), but is beyond 
the facilities of most research laboratories and may be poorly reproducible (Newell,
2001). Smaller animals such as newly hatched chicks, both adult and infant mice, 
piglets, hamsters and rabbits (Welkos, 1984; Humphrey et al, 1985; Burr et al, 1988; 
Abimiku et a l, 1989; Babakhani et al, 1993; Bemdtson et a l, 1994; Vuckovic et al,
1998) have also been used, but with limited success (see review by Newell, 2001). 
Oral challenge of C. jejuni in rodents normally results in colonisation, but rarely 
disease. Alternative routes of transmission, such as intra-nasal and intra-peritoneal 
challenge have been suggested, however the abnormal route, high doses and high 
mortality are a poor reflection of human disease symptoms. The most success with 
rabbits has been achieved with the removable intestinal tie adult rabbit diarrhoea 
(RITARD) model and the rabbit ileal loop test (RILT) (Caldwell et al, 1983; Everest 
et al, 1993). Both methods involve the surgical ligation of the caecum under 
anaesthesia, injection of bacteria into the lumen of the tied intestine, and the 
measurement of the host response. In the RITARD model, the tie is removed after a 
few hours and the pathological effects are observed in the following days. In the RILT 
model, fluid accumulation is primarily detected. As both of these rabbit models 
require considerable surgical skills and post-operative care they are consequently not 
widely used. Without a model to reflect the pathological events occurring in humans, 
clinical and epidemiological observations are our primary tools for studying the 
pathology of C. jejuni. Instead, acceptable models of colonisation have been 
developed, the most frequently used is the orally challenged one-day-old chick model 
(Wassenaar, et a l, 1993; Cawthraw et al, 1996). The main site of colonisation is the 
caecum, although organisms are recovered throughout the gastrointestinal tract as 
well as spleen and liver, indicating that some systemic infection occurs. This model 
has been particularly useful for detecting the compromised colonisation potentials of 
inactivated genes in C  jejuni. Some examples are mutants in flaA, flaB, cadF, galE
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and sod (Wassenaar et al., 1993; Purdy et al, 1999; Ziprin et al, 1999; Fry et al, 
2000).
The relative ease of culturing human intestinal epithelial cells has enabled studies on 
Campylobacter adhesion, invasion and toxin production. INT407, Caco-2 and Hep-2 
are the most frequently used cell lines in Campylobacter research and have 
contributed to the observation (Salama et al, 2000) of phenotypic differences 
between Campylobacter strains. However, the ability of a particular Campylobacter to 
adhere and invade may be dependent on the cell line and bacterial growth conditions 
used (Johnson and Lior, 1988; Konkel et a l, 1992; Konkel and Joens, 1989; 
Szymanski et ah, 1995; Fry, et a l, 2000; Pang et a l, 1987). Reviews have also 
revealed conflicting correlations between invasiveness and clinical symptoms (Ketley, 
1997).
Very few C.jejuni genes have been cloned and characterised compared to other 
enteric pathogens. The high A+T content, the lack of expression of certain genes and 
of the accessory factors required, and different méthylation patterns or codon usage 
are all factors implicated as causes of previous difficulties in cloning and expressing 
C. jejuni genes in E. coli (Ketley, 1997). Genomic instability, hypervariable 
sequences and the huge phenotypic and genotypic diversity further complicates 
research in Campylobacter genetics (Wassenaar and Blaser, 1999). Even with a 
complete genome sequence for one C. jejuni strain we are no nearer understanding 
Campylobacter genetics (Owen et al., 1997; Parkhill et al, 2000). Of the 1,654 
coding sequences predicted, 20% matched uncharacterised genes or were absent from 
the databases which suggests that they may be Campylobacter-spQciYic.
1.20 Aims of this study
Colonisation with C. jejuni can cause disease in humans but is always asymptomatic 
in chickens. Since a major vehicle of C. jejuni in human campylobacteriosis appears 
to be poultry, the identification of factors important in establishing and maintaining 
chicken colonisation may enable the reduction and possible eradication of C. jejuni in 
the food chain. A major characteristic of C. jejuni is the enormous diversity within the
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species as detected at the phenotypic and genotypic levels. The consequences of such 
diversity for properties like colonisation, disease induction and survival have yet to be 
determined. For example, genes found to be present in both chicken and human 
strains may contribute to our understanding of the population dynamics in C. jejuni 
colonising both humans and chickens. This, in turn may enable more accurate risk 
assessment of strains isolated from poultry. Genes predicted to encode for outer 
membrane proteins could be particularly important, since they would be the first 
proteins recognised by the host immune system and, therefore, might possess 
immunological properties important to control strategies such as vaccination. 
Variation in genes encoding outer membrane proteins, observed between different C. 
jejuni strains, may easily reflect differences in survival capacity and adaptation to 
specific ecological niches (Stintzi et al, 2003; Dorrell et al, 2001; Pearson et al, 
2003).
Therefore the overall aim of this study was to investigate the genetic basis of 
phenotypic differences in chicken colonisation between C. jejuni strains in order to 
identify potential chicken colonisation determinants.
The major objectives were to;
1. Use genomic subtractive hybridisation to identify DNA segments that are specific 
to a good colonising strain and absent in a poor colonising strain.
2. Perform similarity searches on selected identified DNA segments using public 
databases, characterising potential surface structures and conserved motifs to 
protein families.
3. Characterise the phenotypic properties of selected identified genes using defined 
mutants and a variety of assays to determine potential roles in 
colonisation/virulence and/or survival.
62
C hap ter 2. M ateria ls and m ethods
CHAPTER TWO
Materials and methods
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2.1 Bacteria, plasmids, oligonucleotides and media
2.1.1 Suppliers
All reagents and chemicals used were obtained from Sigma (Poole, Dorset) unless 
specified.
2.1.2 Bacterial strains
All bacterial strains used in this work are listed in Table 2.1 (a) and 2.1 (b).
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Table 2.1 (a) Campylobacter jejuni strains used in this study.
Source Strain Comment
Human NCTCl 1168
(laboratoiy adapted strain of the 
original 11168 isolated)
NCTC. Colindale. Isolated in 1977, then 
stored freeze dried. Isolated from patient 
with diarrhoea. Fully sequenced C jejuni 
genome (Parkhill, et al., 2000).
81116 (ST267) Isolated from patient with diarrhoea during a 
water-borne outbreak in a boarding school 
(Palmer, et al., 1983).
'
111680 Minimally passaged strain from patient with 
diarrhoea. Isolated in 1977, stored frozen 
ever since.
01/49, 01/50, 01/51 (ST626), 
01/53, 01/54, 01/55, 01/56
Kingston Hospital, London, UK. Patients 
with bloody-diarrhoea and vomiting.
99/339 (ST546), 99/340, 99/341, 
01/58, 01/80, 00/38 (ST490), 
00/43 (ST21), 00/48 (ST541), 
99/188 (ST21), 99/189 (ST41), 
99/388
Health Protection Agency, Collindale, UK 
Isolated from the faeces of patients with 
diarrhoea.
81-176 Patients with diarrhoea, associated with 
consumption of raw milk. Minnesota 
Department of Health, Atlanta,
Georgia, USA. (Korlath et al, 1985).
02/05, 02/06, 02/07, 02/08 Patients with diarrhoea. Smal refractory 
strains from Eva Olssen, Sweden.
99/97 (ST45),99/98, 99/99, 
99/100
Patients with diarrhoea.
Jaap Wagenar, Institute for Animal, Science 
and Health, Lelystad, Netherlands.
99/292, 99/293,99/294, 99/295 Patients with diarrhoea.
Al Lastovica, Red Cross Hospital, Cape 
Town, South Africa.
99/217 (ST21), 99/322 Patients with diarrhoea.
Morgen Madsen, Danish Veterinary Institute, 
Aarhus, Denmark.
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Poultry 94/194 Isolated from chicken faeces.
Chicken survey study, VLA, UK 
Coloniser in the 1-old-day chick model. 
(Cawthraw, personal communication).
00/14 (ST487), 00/15 (ST219), 
00/16 (ST540), 00/17 (ST488), 
00/18, 00/19, 00/20, 99/385, 
99/346, 99/423, 99/424, 99/425, 
99/426, 99/427,99/428,99/429, 
99/430, 00/37 (ST486), Chi 14 
(ST267), OF26 (ST353), Ch87 
(ST623), 99/197 (ST624), EX497 
(ST564), 99/325, 99/326, 99/327
Isolated from broiler houses and abattoirs 
Part of the cross-section and longitudinal 
study (Project number: OZOl 17), VLA, UK. 
OF denotes organic farm 
EX denotes. Public Health laboratory, 
Exeter, UK.
02/01, 02/02, 02/03 Isolated from chicken faeces. Smal 
refractoiy strains from Eva Olssen, Sweden.
99/23 (ST443) Isolated from chicken faeces.
Iva Steinhouserova, Czech Republic.
99/69 (ST499) Isolated from chicken faeces.
Jaap Wagnenaar, Institute for Animal, 
Science and Health, Lelystad, Netherlands.
Sheep SI, S3 (ST632), S4 (ST42), S7 
(ST639),S11 (ST19), S12 
(ST210, S14 (ST21), S22 
(ST636), S31 (ST634), S45 
(ST354), S58 (ST45), S63 
(ST61), S74 (ST271), S80 
(ST21), S98, SI00, S82 (ST61), 
S79 (ST206)
Isolated from sheep faeces.
Abbattoir survey 1999-2000, defra-fimded, 
VLA, UK.
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Cattle Cl (ST559), C9 (ST560),C18 
(ST619), C24 (ST49), C25 (ST55),
C34 (ST629), C2 (ST21), C17 (ST21), 
C20 (ST21), C44 (ST21), C50 (ST21), 
C6 (ST48), C15 (ST61), C21 (ST61), 
C23 (ST61), C47 (ST61), C31 
(ST206), C37 (ST219), C32 (ST262), 
99/312, 90/134 (ST21), 89/80 (376), 
88/312 (ST482), 88/238 (ST21), 
88/138 (ST501), 88/224 (21)
99/201 (ST48), 99/117 , 99/119, 
99/120, 99/121 (ST373)
99/202 (ST45)
Isolated from cow faeces.
Abbatoir survey 1999-2000, DEFRA 
funded, VLA, UK.
Isolated from cow faeces.
Jaap Wagnenaar, Institute for Animal, 
Science and Health, Lelystad, 
Netherlands
Isolated from cow faeces.
Morgen Madsen, Danish Veterinary 
Institute, Aarhus, Denmark
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Pig PS447, PS673.1 (ST630), PS741, 
PS714, PS703, PS835, PS841, 
PS585.2, PS857 (ST270), PS549.1 
(ST403), PS843 (ST403), PS849 
(403), PS484 (ST435), PS623 
(ST552), PS567 (554),
Isolated from pig faeces.
Abbatoir survey 1999-2000, DEFRA 
funded, VLA, UK.
Dog 02/04 Isolated from dog faeces. Smal 
refractory strains from Eva Olssen, 
Sweden.
99/368, 99/369 (ST548), 99/370, 
99/381, 99/382
Isolated from dog faeces. 
Collection at VLA, UK.
Ostrich 93/564 (ST481) Isolated from ostrich faeces. 
Collection at VLA
N/A EXl 14, EX2289 (ST498), 99/422 
(547), EX303 (ST206)
Environmental strains, isolated from 
puddles near poultry farms.
Public Health laboratory, Exeter, UK. 
Project number: B03003, VLA, UK.
The sequence type (ST) number from multi locus sequence typing (Dingle et al, 
2001; Manning, et al, 2003) has been given to each strain where possible.
N/A denotes non-applicable.
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Table 2.1 (b) E, coli strains used in this study
E, coli strain Information
TOPlOF’ F’{lacl‘^ Tni(? (jQ^)}mcrA A(mrr-IhsdIRMS-mcrBC) 
0  8 OllacZ AM 15 àJLA Cxi recA 1 deoRaroD (ara-leu) 
7697 galUgal¥irpsL(Str^)endAlnupG 
Invitrogen Life Technologies, Paisley, UK
HBlOl Derived from E. coli strain K-12. ATCC 33694 
Boyer and Roulland-Dussoix, (1969)
2.1.3 Plasmids used in this study 
Table 2.2
Plasmid Information
pCR*2.1-TOPO* Plasmid man shown at httn://www.invitroeen.com 
Invitrogen Life Technologies, Paisley, UK
pCR-Script™SK(+) httn://www.stratasene.com
Stratagene Europe, Amsterdam, The Netherlands
pBlueScript®SK(+/-) httn ://www. strataeene.com
Stratagene Europe, Amsterdam, The Netherlands
PGEM*T-Easy Plasmid man shown at httn:// www.nromeea.com 
Promega, Southampton, UK
pLA2917 Cosmid vector, Allen and Hanson, 1985
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2.1.4 Oligonucleotides used in this study
Table 2.3 (a) Oligonucleotides used in subtractive hybridisation procedure
Oligonucleotides DNA sequence
Adapter 1 5’ eta ata cga etc act ata ggg etc gag egg ccg ccc ggg cag gt 3’
3’ gg ccc gtc ca 5’
Adapter 2R 5’ eta ata cga etc act ata ggg cag cgt ggt cgc ggc cga ggt 3’
3' g ccg get cca 5’
PCR primer 1 5’ eta ata cga etc act ata ggg c 3’
Nested Primer 1 5’ teg age ggc cgc ccg ggc agg t 3’
Nested Primer 2 5’ age gtg gtc gcg gcc gag gt 3’
M13 Forward 5’ cgc cag ggt ttt ccc agt cac ga 3’
M13 Reverse 5’ tea cac agg aaa cag eta tga c 3’
16S rRNA Forward 5’ aat eta atg get taa cca tta 3’
16S rRNA Reverse 5’ gta act agt tta gta ttc egg 3’
Xf35 Forward 5’ caa tea ttc aga gca eta tgt 3’
If36 Reverse 5’ ctt eta age caa cet cet g 3’
KEY: Identical DNA sequence between adapter and the primers are shown in blue 
(5’- end of Adapter 1 and 2, complete sequence of PCR primer 1), red (3’- end of 
Adapter 1, complete sequence of nested primer 1) and green (3’- end of Adapter 2, 
complete sequence of nested primer 2). PCR primer 1 amplified tester-specific 
(81116) DNA prior to a preincubation step at 72 °C for 2 mins, which filled in the 
missing strands of the adapters intum creating the binding site for PCR Primer 1. The 
nested PCR primers were used to further reduce the background and enrich for tester- 
specific DNA.
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Table 2.3 (b) Primers used for amplification, sequencing, degenerate PCR and 
chromosomal walking. All the primers were purchased from Sigma Genosys 
Pampisford, UK. Tm denotes the melting temperature of the oligonucleotides (oligo).
Oligo Tm Sequence 5’ to 3’ Comment
If 35 
If 36
56.8
59.0
caa tea ttc aga gca eta tgt 
ctt eta age caa cet cet g
Ribosomal RNA fragment, 548 
bp PCR product
If 41 
If 42
62.1
62.5
gtc tat cat ccc att ttg gaa ac 
cag gtc ttg aaa aaa tea atg aag
Subtractive hybridisation clone 
30, 259 bp PCR product
If 43 
If 44
57.5
65.1
ggt aaa tea ggc ata gtttttag 
ggt etc ctt taa ttt gcg get
Subtractive hybridisation clone 
50, 124 bp PCR produet
If 45 
If 46
59.7
61.0
caa ggt ctt caa aaa gtt eta atg 
gtt gga acc act att tgt tat gc
Subtractive hybridisation clone 
65, 147 bp PCR produet
If47
If48
64.8
55.4
gca ggt ctg ctt ttc cac c 
eta tea tea tag gtt tgt ctt g
Subtractive hybridisation clone 
183, 195 bp PCR product
If 49 
If 50
54.9
53.7
gtc tct atg agt cca act ate a 
ggg taa ata aga agt tag aat tc
Subtractive hybridisation elone 
236,262 bp PCR product
If 51 
If 52
55.1
66.2
gaa atacta tea tea tgg agt g 
ccg ttt ttt cac ctt cgc ata c
Subtractive hybridisation clone 
243, 133 bp PCR produet
If 66 62.7 ggn ggn aay gen rtn gay gen Degenerate ggt primer, gave a 
1.6 kbp PCR product with If 50
If 67 
If 68
64.2
65.6
gaa gat etc ata tct tta get tct age atg 
gaa gat eta aga tgg cag cac tta taa aag
Inverse PCR ggt primers
If 69 63.4 ggc age act tat aaa age gg Sequencing ggt primer
If 70 63.1 cet ggt ttg att gaa aaa tea tc Sequencing ggt primer
If 71 69.9 cca aaa cca aaa tgc cqat ccg Chromosomal walking dtpT 
primer
If 72 69.9 egg atg gca ttt tgg ttt tgg Chromosomal walking dtpT 
primer
If 75 65.7 gtt ctg gca agg gca aga ata g Subtractive hybridisation clone 
30 sequencing primer
If 76 62.2 cag tta atg gca gca ata tct tg Subtractive hybridisation elone 
65 sequencing primer
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If 77 57.0 caa agt ata gga gtc caa age Subtractive hybridisation clone 
183 sequeneing primer
If 78 52.0 gaa caa atg taa tat ttc act c Subtractive hybridisation clone 
30 primer, used with If 41 gave 
a 0.8 kbp PCR product
If 79 60.1 gaa ttc gtc cct tgc ttt ac Subtractive hybridisation clone 
50 primer, used with If 44 gave 
a 0.6 kbp PCR produet
If 80 64.6 cag ctg cat caa cag cat tc Sequencing ggt primer
If 81 56.9 gtg atg taa atg eta tea tgg Sequencing ggt primer
If 82 59.7 gtt tcc aaa atg gga tga tag Sequencing subtractive 
hybridisation clone 30 primer
If 83 57.5 cat aac aaa tag tgg ttc caa c Sequencing subtractive 
hybridisation clone 65 primer
If 84 55.4 caa gac aaa cct atg atg ata g Sequencing subtractive 
hybridisation clone 183 primer
If 87 
If 88
68.7
71.8
gaa gat etc ttc agg ttt taa gtt cat tcc ac 
gaa gat ctg caa tta tgg gaa ttt ttg caa g
Inverse PCR ABC transporter 
primers
If 89 57.0 gat eta ata ttt ctt ttt tta tat ttg c Subtractive hybridisation clone 
50, used with If 43 gave a 0.8 
kbp PCR product
If 94 61.9 gcc ttt ate aag aac ttc ttg c Chromosomal walking ggt 
primer
If 95 58.5 ctt tgc eta ttt tat tgg eta g Sequencing ggt primer
If 98 
If 99
70.2
65.5
aca gca age gaa ccg gaa ttg 
ate atg cga aac gat cct ca
Cosmid primers for amplifying 
DNA insertion
If 100 66.3 ctt gat aaa ggc gga aat gcc Primer to replace ggt 
degenerate primer If 66
If 101 66.3 ggc att tcc gcc ttt ate aag Sequeneing ggt primer
If 102 
If 103
50.6
60.2
ctt eta agt tct aat act ctt tg 
gaa eta tgc gtg tct cct att g
Cj0653c and Cj0654c primers
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If 104 
If 105 
If 106 
If 107
55.3
48.8
61.0
62.0
cac caa agt tta aaa ttg ate 
gta aat act cat att ttc tcc
cac aat age tgc cgt tct c 
gcc taa tgc cca ttt tac aag
Transporter gene (dtpT) , 1.7 
kbp PCR product
TheûfraC and genes, 1.4 
kbp PCR product
If 108 71.0 gat gca eta cag cca aag cat aac eta ctg Sequencing ggt primer
If 109 67.2 gaa aaaatg ggc tat aaa ate aca aaa gaa c Sequencing ggt primer
If 110 
If 111
56.8
50.1
caa aga tag ccc tta tgg tac 
gta tea ttt eta egg aat ac
The 50 kbp island and Cj 101 Ic 
junction
If 112 
If 113
57.8
54.2
ctt acg age ata tgg gat tag 
gaa gaa ata aat aag cgt tat g
The 50 kbp island and Cj 1012c 
junction
If 114 
If 115
69.7
64.3
ctg cag cag caa ctt gtt gtt etc tag 
cac tcc tat tac ctt aat age cga taa tg
The 50kbp island, 15.1 kbp 
PCR product
If 116 
If 117
68.2
66.8
ctt att cct tgt tct get tct tga ttg c 
ccc tta ate aaa tcc aca aga ttg ate
The 50kbp island, 14.9 kbp 
PCR product
If 118 
If 119
61.3
68.7
gag tta aga tac tag ctt atg eta aag age 
ggt taa aag ttt gtt tga tac cgc agg t
The 50kbp island, 15.5 kbp 
PCR product
If 120 
If 121
67.9
60.5
cga age aaa aga ttc get aaa agg tac 
eta atg ata gtg tag ctt ctg ctt att c
The 50kbp island, 4.9 kbp 
PCR product
If 123 55.8 gaa gaa gag aag ctt agt taa aag The TraG gene, use with Jf47, 
1.5 kbp PCR product
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2.1.5 Bacterial culture methods
All strains were stored at -80°C in 1 % (w/v) proteose peptone water containing 10 % 
(v/v) glycerol until required. Strains were routinely grown from frozen on 10 % (v/v) 
blood agar plates containing Skirrow’s antibiotics {Vancomycin (10 pg/ml), 
Polymyxin B (2.5 i.u./ml) Trimethoprim (5 pg/ml)}and Actidione (250 pg/ml) 
(BASA) (Skirrow, 1977) at 42°C in a microaerobic atmosphere (85 % (v/v) Ni, 7.5 % 
(v/v) CO2, 7.5 % (v/v) O2). Escherichia coli strains were grown in atmospheric 
oxygen at 37°C in Luria-Bertani broth (LB), with shaking at 200 rpm or on LB agar 
plates.
2.1.6 Culture media
All culture media reagents were obtained from Oxoid (Basingstoke) unless specified 
and prepared using distilled water (dH20). Sterilisation was carried out by autoclaving 
at 121°C at 15 p.s.i. for 15 minutes. Blood and antibiotics were added to media after 
it had cooled to 52°C. Storage was at 4°C in the dark
10 % ( \/y ) Blood Agar (BA) Plates 
Blood agar base 40 g
Sheep blood (defibrinated) 100 ml
1 litre dH20
BA plates containing Skirrow’s supplement and Actidione tBASA)
As for blood agar plates with the addition of Skirrow’s antibiotic supplement 
(see also Section 2.1.5) and 5 ml Actidione (50 mg/ml).
BASAC plates containing
As for the BASA plates with the addition of Cefoperazone (30pg per ml) 
Biphasic Broth
25 ml of brain heart infusion agar with 1 % (w/v) yeast extract (BHI/YE) 
dispensed into 250 cm  ^tissue culture flasks laid flat to solidify, then overlaid 
with 30 ml of BHI/YE broth. Large biphasic broths contains 100 ml of
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BHI/YE dispensed in 1000 cm^ tissue culture flasks overlaid with 200 ml of 
BHI/YE broth.
BHI/YE Broth
Brain heart infusion broth 37g
Yeast extract 10 g
Made up to 1 litre with dHiO.
BHI/YE Agar
Brain heart infusion agar 47 g
Yeast extract 10 g
Made up to 1 litre with dHiO
Heart Infusion IHf) Broth tnH 7.41 
Beef heart infusion 500 g
Tryptose 10 g
NaCl 5 g
Made up to 1 litre with dH20
Luria-Bertani broth ILBl pH 7.5 
NaCl 10 g
Tryptone 10 g
Yeast extract 5 g
Made up to 1 litre with dH20.
LB Agar
As for LB broth with 1.5 % Bacto agar (Difco, Beckton Dickinson, Oxford, 
UK) added.
SSM Motilitv Agar 
(Goossens et al, 1989)
Mueller Hinton Broth with 0.4 % (w/v) agar, Cefoperazone (30 pg/ml) and 
Trimethoprim (50 pg/ml)
75
C hap ter 2. M ateria ls and m ethods
2.1.7 General buffers
All buffers were prepared using distilled water (dHiO) unless specified.
0.1 M Phosphate Buffered Saline (PBS) nH 7.2 
0.0234 M disodium hydrogen phosphate 
0.0066 M potassium dihydrogen orthophosphate 
0.07 MNaCl 
pH 7.2
50 X TAB
Tris base 242 g
Glacial acetic acid 57.1 ml
EDTA 37.2 g
Make up to 1 litre with dHiO.
Dilute with dHiO to give a 1 x TAB working solution of 
40 mM Tris-acetate 
2 mM EDTA, pH 8.5
6  X DNA Loading Buffer 
0.175 % xylene cyanole FF 
0.175 % orange G 
0.125 % bromophenol blue
10 % Ficoll® 400 
10 mM Tris HCl pH 7.5 
50 mM EDTA
Tris-EDTA (TE) buffer 
100 mM Tris HCl pH 8.0 
100 mM EDTA
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2.2 Routine techniques used in DNA cloning
2.2.1 Separation of DNA fragments by agarose gel electrophoresis
Analysis of large DNA fragments (greater than 1 kbp) was done in either 0.8 % (v/v) 
or 1 % (v/v) agarose in 1 x TAB buffer. For smaller DNA fragments (less than 1 kbp) 
a 2 % (v/v) agarose gel was prepared. A DNA molecular marker of established DNA 
band sizes was run alongside the DNA samples. Either a Lamda DNA/i7mdIII ladder 
o r a l  kbp DNA ladder (Invitrogen Life Technologies, Paisley, UK) were the DNA 
molecular markers used and 250 ng of marker was loaded on the gel. A 6 x DNA 
loading buffer (2 pi) was added to the sample (lOpl) before loading the agarose gel. 
The agarose gel was placed in a Sub-Cell tank (Bio-rad Laboratories Ltd, Hertford, 
UK) and submerged in 1 x TAB buffer and electophoresed at 100 V. The gel was 
incubated in ethidium bromide solution (1 mg/ml) for 30 min and DNA bands were 
visualised under ultra-violet light.
2.2.2 Restriction digests of DNA
Genomic, plasmid and DNA fragments were cut using restriction endonucleases 
obtained from Promega, Southampton, UK. Digestions were carried out according to 
the manufacturer’s instructions with the appropriate reaction buffer. Generally, 
genomic DNA was incubated overnight at 37°C, (for 3 hours for plasmid and DNA 
fragments) in 20-100 pi reaction volumes. Smal was the only restriction endonuclease 
used that required an incubation temperature of 25°C.
2.2.3 Filling-in reaction for blunt end formation of staggered ends
Immediately following plasmid DNA digestion (Section 2.2.2), 5 U of Klenow 
obtained from Roche Molecular Diagnostics and 200 pM of dNTPs (Promega, 
Southampton, UK) were added to the digest and incubated at room temperature for 15 
min. The blunt-ended DNA was cleaned up by either extracting the DNA with an 
equal volume of phenol/chloroform/isoamylalcohol (25:24:1) followed by ethanol 
precipitation (Section 2.2.5) of the aqueous phase or put through agarose gel 
electrophoresis and the DNA fragment of interest was cut out and extracted (Section 
2.2.6).
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2.2.4 Dephosphorylation of 5’ DNA ends
Calf intestinal phosphatase (CIP) was obtained from Roche Diagnostics Ltd, Lewes, 
UK. Immediately following plasmid DNA restriction digestion (Section 2.2.2), 18 U 
of CIP was added directly to the restriction digest and incubated at 37°C for 20 min. 
Another aliquot of CIP was added and incubated as before. The dephosphorylated 
DNA was then extracted with an equal volume of phenol/chloroform/isoamylalcohol 
(25:24:1) and the top aqueous phase was ethanol precipitated (Section 2.2.5). The 
final pellet was dissolved in 10- 20 pi of water.
2.2.5 Ethanol precipitation of DNA
DNA was precipitated by the addition of 0.1 x vol 3M sodium acetate (pH 4.6) and 
2 X vol absolute ethanol. Glycogen (20 pg) was added to the precipitation mixture 
only if the DNA concentration was less than 500 ng. The mixture was incubated at -  
20°C for 30 min, the centrifuged at 15115 ref, 4°C for 15 min. The pellet was washed 
with ice-cold 70 % (v/v) ethanol (500 pi), air dried at room temperature for 5-10 min 
and resuspended in 10-20 pi of water.
2.2.6 Extraction of DNA from agarose gels
Digested DNA (Section 2.2.2) was run on a 1 % (v/v) agarose gel and the DNA 
fragment of interest was excised and subjected to QIAEX II DNA extraction 
procedure (Qiagen, Crawley, UK ) Briefly, the gel slice was solubilised and the DNA 
adsorbed to silica particles. The bound DNA was washed a number of times and then 
eluted with water.
2.2.7 Ligation of DNA
T4 DNA ligase lU/pl was obtained from Roche Diagnostics Ltd, Lewes, UK and was 
supplied with a lOx dilution buffer (20 mM Tris-HCl, 1 mM EDTA, 5 mM 
dithiothreitol (DTT), 60 mM KCl, 50 % (v/v) glycerol, pH 7.5 (8°C ). Reactions were 
carried out according to manufacturer’s instructions; generally 120 ng of insert and 20 
ng of vector was used in a reaction volume of 10 pi and incubated overnight at room 
temperature, after which additional ligase (0.5 U) was added along with 100 pmol
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ATP (Roche Diagnostics Ltd, Lewes, UK). This mixture was incubated at room 
temperature for a further 5 hours before use in transformation experiments (Section
2.3.2). 
2.2.8 Cloning of PCR products 
2.2.8.1 Cloning into PCR®2.1-TOPO® vector
Cloning of PCR products were carried out using the TOPO TA cloning® kit 
(Invitrogen Life Technologies, Paisley, UK) according to the manufacturer’s 
instructions. Briefly this involved incubating the PCR product to be cloned (approx. 
50-400 ng) with the vector (PCR®2.1-T0P0®) for 5 min at room temperature. The 
cloned PCR product was added to thawed One Shot ® chemically-competent 
TOPO 1 OF’ E. coli cells (supplied with the kit) and incubated on ice for 30 minutes. 
The cells were heat shocked for 30 seconds at 42°C, before being recovered at room 
temperature with shaking (200 rpm) in 300 pi of LB. After recovery the cells were 
plated out onto LB agar plates containing kanamycin (50 pl/ml) and ampicillin (10 
pg/ml) at 37°C overnight to select for transformants. The following day, single
colonies were picked off and subcultured in LB broth containing kanamycin
)
(50 pl/ml) at 37°C.
2.2.5.2 Cloning into pGEM®T-Easy vector
An alternative vector for cloning PCR products was the pGEM®T-Easy Vector system 
obtained from Promega, Southampton, UK. Briefly, this involved incubating the 
pGEM®T-Easy vector with the PCR product to be cloned (50 ng) for 1 hour at room 
temperature. The cloned PCR product was transformed into TOPOlOF’ E. coli cells as 
already described. The important difference between pGEM®T-Easy and pCR®2.1- 
TOPO® was that transformants of the former were ampicillin (100 pg/ml) resistant 
only.
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2.3 Transformation of plasmid DNA
2.3.1 Preparation of B. coli competent cells
A small culture (5 ml) of E. coli cells were grown overnight at 37°C with shaking 
(200 rpm) from a single colony. In the morning, 1 ml of this freshly grown culture was 
used to inoculate 100 ml of LB supplemented with 5 mM glucose, 10 mM magnesium 
sulphate and 10 mM magnesium chloride. The E. coli cells were left to grow at 37°C, 
200 rpm until the ODggonm reached 0.4-0.5. The cells were immediately cooled on ice 
and spun at 1912 ref, 4°C for 10 min. The pellet was gently resuspended in 0.5 x vol 
of ice-cold 0.1 M magnesium chloride and spun as before. The pellet was resuspended 
in 0.05 X vol of ice-cold transformation solution (100 mM calcium chloride, 50 mM 
magnesium chloride, 50 mM manganese chloride, 50 mM rubidium chloride). The E  
.coli suspension was incubated on ice for one hour. Glycerol (10 % v/v) was added to 
the cell suspension and 100 pi aliquots were quickly frozen on dry ice. Finally the heat 
shock competent E. coli cells were stored at -80°C
2.3.2 Heat shock transformation of E, coli cells
Ten microlitres of plasmid DNA (10 ng) or ligation reaction (2.2.7) was added to 100 
pi of heat shock competent E. coli cells (Section 2.3.1), which had been slowly 
thawed on ice. These were incubated on ice for 20 min before being heat shocked at 
42°C for 30 s and then placed back on ice. LB (300 pi) was added to the shocked cells 
and the mixture incubated at 37°C, 200 rpm for one hour. Finally suitable volumes of 
cells were plated onto LB agar plates supplemented with the appropriate antibiotic. 
The plates were incubated at 37°C overnight for colonies to establish.
2.3.3 Electroporation of C. jejuni cells
Campylobacters were cultured for 17 hours at 42°C in a microaerobic atmosphere. 
The culture plates were placed at 4°C for 20 minutes to allow the agar to become firm. 
Campylobacters were harvested from the plates and re-suspended in ice-cold sucrose 
solution (272 mM sucrose in 5 % (v/v) glycerol). Cells were washed in sucrose 
solution three times by centrifugation at 2200 ref for 15 min at 4°C. Finally the 
pelleted cells were re-suspended in sucrose solution to give a density of approximately
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10  ^ c.f.u./ml. A 50 pi aliquot of the electrocompetent Campylobacters was mixed 
with 5 pi of DNA (0, 0.5 and 1 pg) in a chilled EppendorH^ tube (Sigma, Poole, UK) 
and incubated on ice for 10 min. The bacteria were transferred to a 0.2 mm cuvette 
(Bio-rad Laboratories Ltd , Hertford, UK) and pulsed at 2.48 KV, 25 pF, 600 ohms 
using a Biorad Gene Puiser™. The contents of the cuvette were flushed with pre­
warmed HI broth (42°C) and plated onto two pre-dried BA plates. Cells were 
recovered for 5 hours at 42°C in a microaerobic atmosphere and then harvested into 
800 pi of PBS. The bacteria were harvested from the recovery plates using pre­
warmed PBS (42°C) and plated onto four BA plates containing the appropriate 
antibiotic and incubated for 72 hours at 42°C. A 50 pi aliquot of cells was diluted in 
450 pi of PBS and 100 pi plated out on an antibiotic plate as above. Plates were 
examined for the presence of colonies at 24 hours intervals for up to 72 hours. 
Colonies were counted and then sub-cultured on the appropriate antibiotic containing 
media. Genomic DNA was extracted (Section 2.4.3) from either broth or plate 
cultures of the transformants and analysed by PCR (Section 2.6.1) and Southern 
blotting (2.9.1) for confirmation of mutant.
2.4 DNA extraction procedures
2.4.1 Mini DNA plasmid preparations from E. coli
Following transformation (Section 2.3.2), an E. coli colony was picked and a small 
culture was grown overnight at 37°C. The culture (1.5 ml) was used to extract plasmid 
DNA from the E. coli cells using QIAprep spin miniprep kit (Qiagen, Crawley, UK) 
as described by the manufacturer.
2.4.2 Midi DNA plasmid preparations from E, coli
For larger scale preparations of plasmid DNA from E. coli, 100ml of culture was 
grown overnight at 37°C, 200 rpm. The culture was put through Qiagen plasmid midi 
purification kit (Qiagen, Crawley, UK) as described by the manufacturer.
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2.4.3 Genomic DNA preparations from Campylobacter DNA
The method for genomic DNA preparation was adapted from Ausubel et al, (1994). 
Campylobacter strains were grown overnight under microaerobic conditions at 42°C. 
The growth was harvested into 1 ml of PBS and centrifuged at 15115 ref. The pellet 
was resuspended in 567 pi TE and the bacteria were lysed by the addition of 30 pi of 
10 % (w/v) sodium dodecyl sulphate (SDS) and 3 pi of proteinase K (20 mg/ml) with 
incubation for one hour at 37°C. One hundred microlitres of 5M NaCl was added and 
the tube contents mixed by inversion. The addition of 80 pi of CTAB/NaCl solution 
(10 % (w/v) hexadecyltrimethyammonium bromide, 0.7 M NaCl), with thorough 
mixing and incubation at 65°C for 10 min, resulted in the precipitation of cell wall 
debris, denatured protein and polysaccharides. This complex was removed by 
centrifugation. An equal volume of chloroform/isoamylalcohol (24:1) was added to 
the aqueous layer, mixed and centrifuged. An equal volume of 
phenol/chloroform/isoamylalcohol (25:24:1) was added, mixed and centrifuged. The 
aqueous layer was then DNA precipitated with the addition of 0.6 x volumes of 
isopropanol. The DNA was pelleted by centrifugation and washed with 70 % (v/v) 
ethanol. The pellet was air dried for 5-10 min and re-suspended in a 200 pi of water.
2.5 Quantification of DNA
2.5.1 Spectrophotometer method of DNA estimation
The DNA was diluted 1 in 100 with water and the OD260nm was taken. A reading of 
1.0 at this wavelength was equivalent to 50 pg/ml of double stranded DNA. The ratio 
of OD260nm to OD280nm defined the purity of the DNA preparation. The ratio of 1.8 
defined a pure preparation.
2.5.2 Lamda DNA/Ef/«dIII fragments molecular marker method of DNA 
estimation
An alternative method of DNA estimation was also used, especially for estimating 
concentration of small amounts of DNA. The DNA sample was run on a 1 % (w/v) 
agarose gel against Lamda DNA/E//«dIII fragments (40 kbp Lamda DNA digested
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with 7/zwdIII). This DNA molecular marker was obtained from Invitrogen Life 
Technologies, Paisley, UK and 250 ng was loaded on the gel. The sample band 
intensity following ethidium bromide (1 mg/ml) incubation (Section 2.2.1) was 
compared with the marker (Table 2.4) and the weight of the DNA sample estimated.
Table 2.4 The estimated DNA weight of each Lamda DNA/fl7wdIII marker band.
Band size Estimated DNA weight
23.1 kbp 119ng
9.4 kbp 48.5 ng
6.6 kbp 33.8 ng
4.3 kbp 22.5 ng
2.3 kbp 11.96 ng
2.0 kbp 10.4 ng
0.56 kbp 0.56 ng
2.6 Polymerase chain reaction (PCR)
2.6.1 Standard PCR
PCR reactions were generally carried out in 20 pi volumes with lO-lOOng of DNA 
template and 20 pmol of each primer. HotStarTaq Master mix kit was obtained from 
Qiagen (Qiagen, Crawley, UK) and used as according to the manufacturer’s 
guidelines. HotStarTaq was activated by a 15 min, 95°C incubation step, followed by 
25 cycles of 94°C for 45 s (dénaturation step); 50-68°C for 45 s (annealing step); 72°C 
for l-5min (polymerisation step). After all the cycles were completed a final 
incubation at 72°C for 5 min was performed and the PCR product visualised by gel 
electrophoresis (2.2.1).
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2.6.2 Proof reading PCR
The Advantage cDNA Polymerase Mix, obtained from BD Clonetech, Basingstoke, 
UK was used to accurately and efficiently amplify specific segments of DNA. 
Generally 50 pi reaction volume was set up using 50 pmol of each primer and 200 pM 
dNTPs (Promega, Southampton, UK), according to the manufacturer’s instructions.
2.6.3 Colony PCR
A loopfiil of freshly grown bacteria was suspended in 200 pi of water. One microlitre 
of the suspension was directly used as template in the HotStarTaq PCR (as already 
described in Section 2.6.1).
2.6.4 Degenerate PCR
Degenerate PCR primers were designed from aligning conserved protein motifs (10 
amino acids long) and translating them back to their DNA sequence. HotStarTaq 
Master mix (Qiagen, Crawley, UK) was used with 75 pmol of degenerate primer in a 
20 pi reaction volume and alternatively raised and lowered annealing temperature 
parameters as described by Sachadyn et al, (1998).
2.6.5 Chromosomal walking
Genomic DNA template (lOOng) was put through 3 separate 50 pi PCR reactions with 
HotStarTaq Master (kit) using one primer (50 pmol). Each PCR was identical with 
exception of the annealing temperatures. The parameters were 95°C for 15 min; 
45/55/60°C for 30 s; 72°C for 2 min; followed by 60 cycles of 95°C for 30 s; 
45/55/60°C for 30s and 72°C for 2 min. The three PCR samples were combined, 
cleaned via ethanol precipitation and the end pellet was dissolved in 10 pi water. 
Following confirmation of a PCR product on an agarose gel, the product was 
sequenced. The sequencing primer used was designed adjacent to a region of 
unknown sequence, and provided specificity when sequencing the products of single 
primer reactions. This method was based on a rapid method to achieve chromosomal 
walks (Screaton a/a/., 1993)
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2.7 Subtractive hybridisation of two C. jejuni genomes
2.7.1 Subtractive hybridisation
The DNA sequences of adapters and primers used in this study are shown in Table 
2.3a. Initially, genomic DNA preparations from C. jejuni 81116 (tester) and strain 
NCTC11168 (driver) were isolated using the genomic DNA preparation (Section
2.4.3). Each preparation (5 pg) was digested with vf M  (lOU) and Dral (lOU) in a total 
volume of 100 pi for 7 h at 37°C, according to the methods described in the PCR- 
Select Bacterial Subtraction kit (BD Clontech, Basingstoke, UK), to give a range of 
blunt-ended fragments of between 0.1 and 2.0 kbp, as determined by gel 
electrophoresis. The blunt-ended DNA fragments from C. jejuni 81116 were 
subdivided into two aliquots and each aliquot was ligated to a different adapter (1 or 
2R). This resulted in double-stranded DNA fragments with an extended, single­
stranded adapter sequence on the 5' end of each complementary strand. Both aliquots 
were denatured and combined with an excess of denatured driver DNA and the 
mixture was incubated at 63°C for 1.5 h (Figure 3.4, hybridisation one). In the second 
hybridisation (Fig. 3.4, hybridisation two) the two aliquots were combined and 
incubated at 63 °C overnight with more fresh denatured driver DNA. During this stage 
tester-specific DNA (ligated to adapter 1) annealed to tester-specific DNA (ligated to 
adapter 2R). The recessed ends of the adapters were filled and the primary PCR was 
carried out to exponentially amplify tester-specific DNA (type f  molecules). In the 
secondary PCR, nested primers to adapters 1 and 2R were used to further enrich the 
tester-specific DNA (type f  molecules). The first genomic subtraction was carried out 
with a hybridisation temperature of 63 °C, as recommended by the manufacturer. A 
second round of subtractive hybridisation was performed with 10 pi of the secondary 
PCR products, but this time a hybridisation temperature of 61°C was used.
2.7.2 Preparation of subtractive hybridisation library
The secondary PCR products obtained from subtractive hybridisation (Section 2.7.1) 
were ligated into pCR®2.1-T0P0® vector (Section 2.2.8) using the TOPO survival
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TA Cloning® kit (Invitrogen). The ligated products were transformed into TOPI OF 
competent E.coli cells as recommended and colonies, which were resistant to 
kanamycin and ampicillin, selected. Colony PCR (Section 2.6.3) was performed using 
the M l3 forward and reverse primers together with HotStartaq™ Master mix (Section 
2 .6 .1).
2.8 DNA sequencing and analysis
2.8.1 DNA Sequencing
Plasmid DNA (400 ng) and PCR product DNA (100 ng) were sequenced using the 
BigDye™Terminator v3.0 Cycle Sequencing Ready Reaction kit (Applied 
Biosystems. Foster City, USA). Briefly, the DNA was precipitated to remove salt. The 
appropriate amount of DNA, Terminator master mix and 3.2 pmol of primer in a 20 pi 
reaction volume were prepared in a 0.2 ml Micro®Amp PCR tube, as described by the 
manufacturer. Cycle sequencing was carried out in a GeneAmp PCR System 9600 
(Applied Biosystems. Foster City, USA) and the PCR parameters were 25 cycles of 
96°C for 10 s; 50°C for 5 s; 60°C for 2 min. As soon as the program was completed 
the sequenced product was ethanol precipitated and the pellet dried as recommended, 
and sent for sequencing (Oswel, Southampton, UK).
2.8.2 Analysis of DNA sequences
The sequences obtained were analysed and edited by Seqman (Lasergene DNAstar 
Inc., Madison USA). These sequences were saved in the EDITSEQ program 
(Lasergene DNAstar Inc., Madison USA) and similarity searches were performed the 
BLAST suite of programs using (Altschul et a l, 1997). Similarity searches were 
carried out using the NCTC11168 genome sequence found on 
http://www.sanger.ac.uk and the BLAST (Altschul et a l, 1997) programs through the 
e-mail servers at the National Centre for Biotechnology Information (NCBI) at 
http://www.ncbi.nlm.nih.gov website. Open reading frames were detected using the 
http://www.expasv.ch/tools/dna.html website. When possible, potential surface 
structures and conserved motifs to protein families were identified by Predict Protein
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through the website at http://dodo.cpmc.columbia.edu/predictorotein/submit def.html
2.9 DNA hybridisation techniques
2.9.1 Southern blotting
Genomic DNA (10 pg) from C. jejuni was digested with HindiSl restriction enzyme 
and separated by electrophoresis through a 1 % (w/v) agarose gel in 1 x TAB buffer at 
25V overnight, until the dye front was two centimetres from the end of the gel. The 
agarose gel was incubated in denaturing solution (1.5 M NaCl, 0.5 M NaOH) with 
gentle agitation for one hour. The DNA was neutralised by immersion of the gel in a 
neutralisation solution (1.5 M NaCl, 0.5 M Tris-HCL (pH 7.5)) for one hour. The 
DNA was Southern blotted onto nylon membrane (Hybond N^, Amersham Pharmacia, 
Little Chalford, UK) by capillary action. This was achieved by laying the nylon 
membrane, two sheets of blotting paper and a thick layer of absorbent paper on top of 
the gel and applying a heavy weight. The capillary action from the gel towards the 
membrane resulted in transfer of the DNA onto the membrane. After 18 hours the 
DNA was cross-linked to the membrane by exposure to UV light for 5 min
2.9.2 Dot blotting
For dot blot, DNA concentration of each PCR product was estimated on a 1 % (w/v) 
agarose gel against a marker of known concentration (Section 2.5.2) and 50ng of each 
PCR product was denatured by placing the DNA in a boiling water bath for 5 min and 
immediately placing onto ice for 5 min. The denatured DNA was dotted onto Hybond- 
N+ membrane (Amersham Pharmacia, Little Chalford, UK). DNA was cross-linked 
by UV light for 5 min.
2.9.3 Labelling, hybridisation and detection of DNA probes to Southern blots
DNA (digested genomic, linearised plasmid, PCR products and DNA fragments) to be 
labelled was cleaned and resuspended in water as already described. The AlkPhos 
Direct CDV-Star ™ kit (Amersham Pharmacia, Little Chalford, UK) was used for all 
subsequent stages: from the labelling of the DNA (100-200 ng) with a phosphatase 
enzyme, hybridisation of the probe to the Southern blot and the detection of the probe
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on the blot. The method was as described in the manufacturer’s instructions. A 
temperature of 55-65°C was used for the hybridisation of the probe to the Southern 
blot and also for the subsequent stringency washes. The membrane was placed next to 
an X-ray film to allow fogging. Determination of where the probes had bound to the 
blot was achieved by development of the X-ray film.
2.9.4 Stripping blots for reprobing
The blots which had been probed (Section 2.9.3) were stripped according to the 
AlkPhos guidelines (Amersham International, Little Chalford, UK). Briefly, the blots 
were incubated in 0.5 % (w/v) SDS at 60°C for 60 min and then rinsed for 5 min in 
lOOmM Tris pH 8.0 at room temperature. The blots were stored at 4°C until required 
and then put through the hybridisation procedure with a new DNA probe.
2.10 In vitro methods
2.10.1 Transmission electron microscopy (EM)
Bacterial cultures (25 ml) were centrifuged at 2100g for 15 minutes to pellet the cells. 
Bacterial pellets were re-suspended in 100-500 pi of O.IM phosphate buffer pH 7.4 to 
give a concentrated suspension of bacteria. A 50 pi droplet of this bacterial suspension 
was placed on a sheet of dental wax. Formvar ™ carbon coated grids were floated on 
the bacterial suspension for ten minutes. Grids were then blotted dry and placed onto 
a drop of 2 % (v/v) phosphotungstic acid negative stain for 15 seconds. Grids were 
carefully blotted dry and viewed using a Philips CM 10 transmission electron 
microscope.
2.10.2 Bacterial growth curve
Strains were grown overnight on BA plates and the cells were harvested for preparing 
the inoculum. One hundred microliters of bacterial suspension in 0.1 M PBS pH 7.2 
(approximately 10  ^ to 10  ^c.f.u. ml'^) was inoculated into a pre-warmed (37°C) large 
BHI/YE biphasic broth and left to grow at 42°C under microaerobic conditions. A
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viable count of the bacterial culture was taken, in triplicate, after 0, 4, 7, 22, 30 and 50 
hours of growth. The total number of viable bacteria was determined by serially 
diluting the bacterial culture with PBS and plating out 100 pi onto pre-dried BASA 
plates. The plates were incubated for 24 hours at 42°C under microaerobic conditions 
and the colonies counted.
2.10.3 Aerobic stress assay
Campylobacter cells were grown overnight in 200 ml of Mueller Hinton both at 42°C 
under microaerobic conditions with shaking at 150 rpm. The cultures (10^ to 10  ^c.f.u. 
ml'^) were then placed in atmospheric oxygen at 42°C, again with shaking at 150 rpm. 
Aliquots were removed and viable counts of the bacterial culture were taken, in 
triplicate, after 0, 1, 2, 3, 4 and 7 hours of survival in atmospheric oxygen conditions. 
The total number of viable bacteria was determined as above. The BASA plates used 
for the mutants was supplemented with kanamycin 50 pg m l'\
2.10.4 Hydrogen peroxide susceptibility assay
Bacterial culture was grown overnight in 50 ml of Mueller Hinton broth at 42°C under 
microaerobic conditions with shaking at 150 rpm. A final concentration of 0.5 mM 
hydrogen peroxide was added to the 50 ml of culture and left under microaerobic 
conditions at 42 °C. A viable count of the bacterial culture was taken, in triplicate, 
after 0, 20, 40, 60, 80, 100 and 120 min of survival in 0.5 mM hydrogen peroxide. The 
total number of viable bacteria was determined as above.
2.10.5 Methyl viologen sensitivity assay
Sensitivity to methyl viologen (Paraquat) was determined by disc-diffusion assays. 
Bacterial cells grown overnight on 10 % (w/v) BASA plates were resuspended in 0.1 
M PBS pH 7.2 at approximately 10  ^c.f.u. ml'^ and a 100 pi bacterial suspension was 
spread onto 10 % (w/v) BASA plates. Ten microlitres of methyl viologen diluted to a 
range of concentrations with water (0.25 to 15 mM) was added to blank antimicrobial 
susceptibility test discs (Oxoid, Basingstoke; 6 mm in diameter), which were
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subsequently applied to the surface of the plates. After a 24 hour incubation at 42°C in 
a microaerobic atmosphere, all plates were examined for zones of growth inhibition. 
The diameter of the clear zone next to the disc was measured in mm.
2.10.6 Culture of mammalian cell lines
INT407 cells (Human Caucasian embryonic intestine, epithelial. ECACC 85051004) 
were obtained from the European Collection of Animal Cell Cultures (ECACC, 
CAMR, Porton Down, Salisbury). The frozen ampoules were thawed quickly and 
added to 10 ml of pre-warmed complete media (see below). Cells were pelleted by 
centrifugation at 80g for 5 min. The supernatant was removed and the cells re­
suspended in 25 ml of complete media and added to a sterile 250 cm^ polypropylene 
tissue culture flask. The cells were incubated at 37°C in 5 % (v/v) CO2 until a 
confluent monolayer was present. Confluent monolayers were trypsinised with 0.05 
% (w/v) trypsin / 0.02 % (w/v) EDTA in PBS and split in the ratio of 1:3 to 1:6.
Complete Media
Foetal calf serum (FCS) 20 ml
L-glutamine (200 mM) 2 ml
Non-essential amino acids (NEAA) 2 ml 
Gentamicin (10 mg/ml) 1 ml
Made up to 200 mL with Eagles Minimal Essential Medium (EMEM).
2.10.7 The gentamicin protection invasion assay
A twenty-four-well tissue culture plate was seeded with INT407 cells at a 
concentration of 2 x 10  ^cells per well and incubated at 37°C with 5 % (v/v) CO2 for 
48 hours to establish confluent monolayers (approx. 5x 1 0 ^  cells per well). On the 
day of the assay the monolayers were washed twice, with 2 ml Hank’s Balanced Salt 
Solution (HBSS) per well, to remove any residual antibiotics. Finally 1 ml of 
maintenance medium per well was added.
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Maintenance media
L-glutamine (200 mM) 2 mL
NEAA 2 mL
Made up to a final volume of 200 mL with EMEM.
Bacteria were harvested from BASA plates after 24 hours incubation in a 
microaerobic atmosphere. A loopfiil of bacteria was inoculated into pre-warmed 
(37°C) BHI/YE biphasic broth and incubated for 20 hours at 42°C , microaerobically. 
The Campylobacters were harvested by centrifugation at 2100 ref, 22°C and 
suspended in PBS at a concentration of 1 x 10  ^ c.f.u. per m l . A volume of 0.1 ml of 
the bacterial suspension was added to the maintenance media covering the cell 
monolayers in triplicate wells to give a bacterial to cell ratio of 1:200 or multiplicity 
of infection (MOI) of 200. Tissue culture plates were centrifuged at 450 ref, 22°C for 
15 min to bring the bacteria into close association with the eukaryotic cells. 
Centrifugation was carried out to eliminate variations in motility between strains, 
which might influence the numbers of bacteria, which adhere and in turn become 
internalised. Infected monolayers were incubated at 37°C in 5 % (v/v) CO2 for three 
hours to allow the bacteria to invade the cells. The monolayers were washed three 
times with 2 ml HBSS. To remove any external bacteria that had not invaded, 2 ml of 
maintenance media containing gentamicin at 250 pg/ml was added to each well and 
incubated for a further two hours. Following incubation the monolayers were washed 
three times with HBSS as before and lysed with 1 ml of 1 % (v/v) Triton X-100 in 
PBS. A magnetic stirrer bar (10 x 5 mm) was placed in each well of the 24-well- 
plate. The plate was placed on a magnetic stirrer and the Triton X-100 solution stirred 
at approximately 100 rpm for ten minutes. The total number of viable bacteria per 
well was determined by serially diluting the Triton X-100 lysed monolayer solution 
with PBS (neat to 10'^) and plating out 100 pi onto pre-dried BASA plates. The plates 
were incubated for 24 hours at 42°C under microaerobic conditions and the colonies 
counted. Each colony was assumed to represent one bacterium that had become 
internalised. The invasion efficiency of each isolate was calculated using the formula 
below, where the number of bacteria internalised per well was expressed as a
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percentage of c.f.u. added to the well at the start of the experiment. The standard error 
of the mean (SEM) was calculated for the invasion efficiencies of each isolate tested 
in triplicate wells. Error bars were used to represent the SEM of invasion efficiencies.
Invasion = total number tc.f.u.l of intracellular bacteria x 100 
Efficiency total number (c.f.u.) of bacteria in inoculum
As evidence existed from previous assays that variation in inocula could affect the 
invasion levels measured (Hu and Kopecko, 1999), a dose response curve was 
produced for comparing C. jejuni strains, where the total number of bacteria 
internalised per well was measured against a wide range of MOIs.
2.10.8 Estimating the bacterial cell concentration
An prospective of the number of bacteria per ml was made by lysing 50 pi of the 
bacterial suspension in 950 pi of IM sodium hydroxide. The optical density (OD) of 
the released nucleic acid was measured at 260 nm. From a calibration curve (Newell, 
unpublished data) it was estimated that an OD260 = 1 is approximately equal to 1.5 x 
10^  ^ c.f.u./ml. The bacteria were diluted in PBS accordingly to obtain the doses 
required for inoculation onto the monolayer of INT407 cells. This method is very 
crude and doesn’t take into account the number of live and dead bacteria. The actual 
viable count was determined retrospectively by serial dilution of the bacterial inocula 
in PBS and plating onto BASA plates.
2.10.9 Statistical analysis
Statistical analysis of the data was carried out using GraphPad Prism^^ software 
version 2.01 (San Diego, CA, USA).
2.10.10 Testing the motility of C. jejuni strains
The motility of C. jejuni strains was determined as a measure of swarming on SSM 
motility media (Section 2.1.6). C. jejuni were grown overnight on BASA plates and 
resuspended in 0.1 M PBS pH 7.4 (10^ c.f.u ml'^). A blunt hypodermic needle was
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dipped in the suspension and then stabbed four times into a pre-dried agar plate. This 
was performed in duplicate per strain tested. Furthermore, one batch of SSM motility 
media was used per experiment, to overcome any inconsistencies between different 
batches, which may have affected bacterial swarming. The plates were incubated in 
microaerobic conditions at 42°C. After 19, 26 and 33 hours the diameter of the colony 
was measured in cm.
2.10.11 Whole cell protein estimation
Protein assay dye reagent (Bio-Rad Laboratories Ltd, Hertford, UK) was used as 
recommended by the manufacturer. Bovine serum albumin (BSA) in 1 M Tris pH 8.0 
standards were prepared to the following concentrations, 0, 2, 4, 6, 10, 15 and 20 pg 
in a total volume of 800 pi. Each of these BSA concentrations was mixed with 200 pi 
protein assay dye reagent. The standards and blank were assayed in duplicate. The 
absorbance of each standard was measured at 595 nm. A standard curve using the 
BSA concentrations (X axis) against the absorbance (Y axis) was generated by 
GraphPad Prism™ software version 2.01 (San Diego, CA, USA).
Bacterial cells, grown to either log phase or stationary phase (20 and 40 hours 
respectively, at 42 °C), resuspended in 1 M Tris pH 8.0 (approximately 10  ^ to 10^ ® 
c.f.u. ml'^) were subjected to fteeze-thawing to fractionate the cells. In triplicate 
samples, 1 pi of bacterial suspension was resuspended in water to give a final volume 
of 800 pi and mixed with 200pl of the protein assay dye reagent. The absorbances 
were measured at 595 nm and the average value was used to estimate the protein 
concentration of the bacterial sample from the BSA standard curve generated by 
GraphPad Prism™ software. The software performs the standard curve calculations 
for the BSA standard curve and uses the sample absorbance value to determine the 
concentration of the sample.
2.10.12 y-GIutamyltransferase (GGT) ThermoTrace assay
The ‘Gamma GT reagent’ (Alpha Laboratories Ltd, Eastleigh, UK) was used to 
spectrophotometrically determine the specific activity for GGT, as recommended by 
the manufacturer. In the presence of the catalytic activity of GGT, the glutamyl group
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from the donor substrate (L-y-glutamyl-3-carboxy-4-nitroanilide) is transferred to the 
acceptor (glycine-glycine) forming glutamyl-glycine-glycine and 5-amino-2- 
nitrobenzoate. Cleavage of the substrate as a result of GGT activity induces the 
appearance of a yellow colour. The rate of formation of 5 -amino-2-nitrobenzoate is 
proportional to the rate of activity of GGT present in the sample and is measured 
kinetically at 405nm.
Gamma GT Reagent
Tris buffer lOOmmol/L
Glycine-glycine lOOmmol/L
L-y-glutamyl-3-carboxy-4-nitroanilide 2.9mmol/L
Also contains non-reactive filters and stabilisers, pH 8.20 ±0.1 at 20 °C.
The reagent was reconstituted with 20 ml of deionised water. Fractionated whole
bacterial cells in 1 M Tris pH 8.0, of known protein concentration (Section 2.10.9), 
were diluted 1 in 10 with water and 50pl of this sample was mixed with 950pl of 
prewarmed reconstituted reagent. The spectrophotometer maintained at the 
appropriate constant temperature (32, 37, 42 and 47 °C) was blanked with water at 
405nm. The bacterial sample was placed in a 1cm cuvette and the change in 
absorbance (AAbs) per min was determined at 32, 37, 42 and 47 °C. Boiled bacterial 
sample (inactivated enzyme activity) was used as a control. The Abs/min value for the 
bacterial sample, minus the Abs/min value of the boiled sample, was used to 
determine the GGT specific activity.
Calculations
Activity in U/L = AAbs/min x Factor
Factor = TV x 1000
9.5 X SV X P
TV = Total reaction volume in ml
SV = Sample volume in ml
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9.5 = millimolar absorption coefficient of 5-amino-2-nitrobenzene at 405nm 
P = Cuvette pathlength in cm 
The final activity value was determined as U/ml/mg of whole bacterial cell protein. 
Where one unit was defined as the quantity of enzyme that released Ipmol of 5- 
amino-2-nitrobenzoate per min per mg of protein at the relevant temperature.
2.10.13 Chemotaxis assay
The method employed to test the chemotactic behaviour of C. jejuni was an adaptation 
of a hard-agar plug (HAP) procedure (Hugdahl et al, 1988). Initially, the test 
chemical was prepared at twice the final concentration in 0.1 M PBS pH 7.2 and an 
equal volume mixed with 4 ml of 4 % (w/v) Bacto-agar (Difco, Becton Dickinson, 
Oxford, UK) in O.IM PBS pH7.2 kept at 55°C, then poured into a small petri dish and 
left to set. By using a borer with a diameter of 8 mm, HAPs were cut out of the set test 
chemical in agar and were used for the chemotaxis assay. The chemicals tested were 
L-malate (monosodium), oxgall, porcine bile, bovine bile, lysine, L-serine, N- 
acetylneuraminic acid, N-acetyl-D-glucosamine, a-ketoglutarate (monosodium), D(+) 
galactose, D (+) glucose and N-acetyl-D-galactosamine.
The C. jejuni strain to be tested was grown overnight on BASA plates and a washed 
suspension of 5 x 10  ^c.f.u. ml'^ in 0.1 M PBS pH 7.4 was prepared. An equal volume 
of bacterial suspension was gently mixed with 15 ml of 0.8 % (w/v) Bacto-agar 
(Difco, Beckton Dickinson, Oxford, UK) in O.IM PBS pH7.2 kept at 55°C. This was 
poured into a petri dish containing the prepared chemical HAP and a 0.1 M PBS 
pH7.2 HAP (control). Once set, the plates were kept upright and placed under 
microaerobic conditions at 37°C. The plates were checked after 3 and 6 hours, as well 
as overnight. The presence of visible zones of dense bacterial accumulation around the 
chemical plugs indicated that the chemical used was a chemoattractant for the strain. 
All chemotactic assays were done in duplicate.
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2.11 In vivo methods
2.11.1 Chicken-colonisation model
A quantitative oral chick-colonisation assay was performed as previously described 
(Wassenaar et a l, 1993). Briefly, groups of approximately 10 specific pathogen-free 
chickens (SPAFAS, Charles River), housed in isolators, were dosed at day 1 of age by 
oral gavage. Doses ranged from 10  ^ to 10  ^ c.f.u. in 100 pi 0.1 M PBS pH 7.2 of C. 
jejuni NCTC11168, 81116 DtpT-deficient mutant or GGT-deficient mutant. Doses 
were prepared by harvesting bacteria, grown overnight on blood agar plates at 42 °C, 
into sterile PBS. At 5 days or 3 weeks post-inoculation, the chicks were killed, and the 
levels of colonisation in the caeca were determined by plating out dilutions of caecal 
contents onto BAS AC plates. Mutants were plated onto BAS AC supplemented with 
kanamycin 50 pg m l'\ The degree of chick colonisation was determined as c.f.u. per 
g of caecal contents, for individual birds. The minimum level of detection was 100 
c.f.u. (g caecal contents)”^ The dose response for the colonisation potential of C. 
jejuni 81116 has been previously described (Wassenaar et a l, 1993) and has been 
consistent in over 20 experiments. Statistical analysis of the data was carried out using 
GraphPad Prism™ software version 2.01 (San Diego, CA, USA). The data were 
analysed by using a nonparametric Mann-Whitney (two-tailed) test to assess statistical 
significance. A statistical P value of < 0.05 was statistically different.
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CHAPTER THREE
The use of genomic subtractive 
hybridisation to identify differences in the 
genome content of colonising and non­
colonising variants in C. jejuni
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3.1 Introduction
Identification of bacterial factors that make one strain more pathogenic than another is 
potentially very useful, yet is one of the biggest problems facing those who study bacterial 
pathogenicity. Even though genome sequencing has become relatively common, it is still 
not practical or economically feasible to sequence entire genomes from a large number of 
bacterial strains so that the comparative genomics can be done to obtain those all- 
important ‘pathogenicity’ sequences. Helicobacter pylori was the first bacterial species 
from which genome sequences from two different strains were obtained (Tomb et al, 
1997; Aim et al, 1999). Interestingly, between 6 and 7 % of the coding capacity of each 
H. pylori genome comprised genes that were absent from the other strain. However, 
theses two genomes have only given a small sample of the genetic variation observed in 
this bacterial species (Chanto et al, 2002; Salama et al, 2000).
The population genetic structure of the genus of Campylobacter remains inconclusive and 
pathogenic types have not been identified (Meinersmann et a l, 2002). Indeed, 
epidemiological studies on large numbers of C. jejuni isolates have shown a high degree 
of phenotypic and genotypic diversity (Owen et a l, 1997; Lindstedt et a l, 2000; Dingle et 
al, 2001; Wassenaar & Blaser, 1999). It seems likely that such diversity is reflected in 
phenotypic variation in the colonisation and disease-causing potentials of strains. 
Certainly strain variation in virulence properties has been observed using both in vitro 
(Gorelov et a l, 1990) and in vivo models, though such models may poorly reflect the 
spectrum of disease seen in humans (Pang et a l, 1987; Black et a l, 1988; Wassenaar & 
Blaser, 1999). Understanding the molecular basis and biological consequences of genetic 
diversity among strains is important for disease control. Much remains to be learnt, 
however, about the mechanisms that give rise to and maintain C. jejuni genetic diversity, 
and its importance, for example, in determining the specificity of colonisation, persistence 
or disease. To this end the recent genome sequencing of a C. jejuni strain (Parkhill et a l, 
2000) now enables, by DNA array technology (Lan & Reeves, 2000), the absence of 
genes in other C. jejuni strains to be detected. However, the identification of the presence 
of additional genes in other strains is not feasible using this approach.
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The technique of genomic subtraction was first reported in 1990, for the isolation of DNA 
absent from deletion mutants of yeast (Straus et al., 1990). In 1996, suppressive 
subtractive hybridisation in H. pylori was reported as an amendment of this technique and 
was used to identify DNA specific to a monkey colonising strain (J166) absent in an 
unrelated strain (26695) whose genome has been fully sequenced (Akopyants et al, 
1998). DNA present in virulent strains and absent in less virulent or avirulent strains has 
been identified using subtractive hybridisation in a number of studies using bacterial 
pathogens including Mycobacterium, E. coli and Shigella (McGarvey and Bermudez, 
2001; Miyazaki et al, 2002; Walker and Verma, 2002). Clearly, subtractive hybridisation 
has successfully contributed to the identification of pathogenic factors.
The work in this chapter was to develop genomic subtractive hybridisation for C. jejuni 
and use it to find DNA segments that are absent firom or substantially different from any 
DNA in the strain the genome of which has been fully sequenced, NCTCl 1168 (Parkhill 
et al, 2000). At the time of these experiments considerable information was available on 
the colonisation potential of strain 81116. This strain had a comparatively low 
colonisation potential to that of freshly isolated C. jejuni strains (those with minimal 
laboratory passage which maximally colonise [10^-10^^ c.f.u. (g caecal contents)"^] one- 
day-old chicks within 5 days with oral doses of 10^ -10"^  c.f.u. ml~ )^ (Cawthraw et a l, 
1996). In spite of this, the colonisation potential of strain 81116 (data kindly provided by 
Shaun Cawthraw, Veterinary Laboratories Agency, Weybridge, UK) could be upregulated 
by in vivo passage to a level similar to that of fi-eshly isolated strains (Figure 3.1). In 
contrast, strain NCTCl 1168 (obtained from Julian Ketley, Leicester University, UK) 
appears to be a very poor coloniser, and even in vivo passage would not upregulate its 
colonisation potential to that seen in freshly isolated strains (data kindly provided by 
Shaun Cawthraw) (Figure 3.1). These two strains would be ideal comparators for 
subtractive hybridisation as it seemed likely that the observed lower colonisation potential 
of C. jejuni NCTCl 1168, compared with strain 81116, would be a reflection of genetic 
difference(s). It was anticipated that identification of DNAs specific to strain 81116 
would identify and lead to a better understanding of chicken colonisation determinants.
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Figure 3.1
Caecal colonisation levels of chicks given a range of doses of C. jejuni strains 81116 ( = ), 
NCTCl 1168 (v) and chick passaged NCTCl 1168 (11168P) (♦). The broken lines represents the 
detection limit of the experiment. This work was done by Shawn Cawthraw (VLA, Weybridge).
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Potentially, this approach could ultimately lead to more targeted and effective control 
strategies, such as the development of non-pathogenic C  jejuni strains for vaccine 
development or competitive probiotic strains, especially since the consumption of C. 
jejuni contaminated poultry meat is considered to be a significant risk factor for human 
infection (Tauxe, 1992).
3.2 Results and discussion
3.2.1 Preparation of tester and driver DNA fragments
Strain 81116 and NCTCl 1168 genomic DNA were partially digested with Alu\ and Dral 
enzymes as described in Section 2.7.1. The partially digested genomic DNA yielded the 
correct 0.1-2 kbp range of fragments (Figure 3.2, and was used as either driver 
(NCTCl 1168) or tester (81116) DNA.
3.2.2 Preparation of adapter 1- and adapter 2R-ligated-tester DNA
Each adapter was ligated to an aliquot of tester DNA fragments as described in Section 
2.7.1. The efficiency of adapters ligated to the genomic DNA fragments was tested by 
PCR amplification. Primer 1 and the 16S rRNA forward primer produced a band of 200 
bp (Figure 3.3). This band was expected to be 896 bp in size. One possible reason for this 
result may be due to the partial digestion of 81116 genomic DNA giving a range of 16S 
rRNA fi-agment sizes. Subsequent adapter ligation and PCR may have preferentially 
amplified the 200 bp 16S rRNA fragment. The 16S rRNA forward and reverse primers 
produced an expected 852 bp band (Figure 3.3).
Thus, the successful ligation resulted in adapters ligated to the 5’ ends of the DNA 
fi*agments. These results were still indicative of the efficient ligation to the 5’ ends of the 
DNA fi-agments to only one strand of adapter sequences (Table 2.3a), since the adapters 
were double stranded at the 3’ ends only. In addition, the adapters were unphosphoiylated 
and this therefore prevented the adapters fi*om ligating to one another.
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Figure 3.2
Partial digests of genomic DNA generated, using restriction endonucleases Alu\ and Dral, with 
fragments ranging from -2.0-0.1 kbp. Samples were run on a 2 % (w/v) agarose gel. Lane 1; 
81116 genomic DNA. Lane 2: digested 81116 (tester) DNA. Lane 3: NCTCl 1168 genomic DNA. 
Lane 4: digested NCTCl 1168 (driver) DNA.
1 2  3 4
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Figure 3.3
Results of the efficiency ligation analysis on a 1 % (w/v) agarose gel. Lane 1 ; C. jejuni adapter- 
ligated-DNA PCR product (852 bp) using 16S RNA forward and reverse primers. Lane 2: C. 
jejuni adapter-ligated-DNA PCR product (200 bp) using 16S RNA forward primer and PCR 
primer 1. Lane 3: Control E. coli adapter-ligated-DNA PCR product (572 bp) using 23 S RNA 
forward and PCR primer 1. Lane 4: Contol E. coli adapter-ligated-DNA PCR product (374 bp) 
using 23 S RNA forward and reverse primers.
E. coli controlL. jejuni
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3.2.3 Subtractive hybridisation
Figure 3.4 shows a schematic diagram of the subtractive hybridisation method used for 
C. jejuni strains 81116 (tester) and NCTCl 1168 (driver). Briefly, 1- and 2R-adapter tester 
DNA aliquots were denatured and combined with excess denatured driver DNA (which 
does not have adapters ligated). The homologous tester and driver DNA were left to 
anneal during the first 63°C hybridisation step. In the second 63°C hybridisation step, the 
aliquots were mixed together and fresh denatured driver DNA was added. At this stage 
any remaining homologous tester and driver DNA armealed and, more importantly, tester- 
specific DNA ligated to adapter 1 annealed to tester-specific DNA ligated to adapter 2R. 
All the possible molecules generated during the second hybridisation step are shown in 
Figure 3.4. Homologous tester DNA annealed to driver DNA (molecule c) and tester- 
specific DNA annealed to complementary tester-specific sequence (molecules b & 
Likewise, driver-specific DNA armealed to complementary driver-specific DNA 
(molecule e) was also produced. The remaining population of molecules consisted of 
single stranded tester and driver DNA (molecules a & d).
3.2.4 Selective PCR
Figure 3.4 also shows the molecules amplified during selective PCR. During the primary 
amplification, the adapter(s) on the 5’ ends of the double stranded (ds) DNA was copied 
onto the opposite strand at the 3’ end of the tester DNA. Primer 1, which has a common 
sequence to adapters 1 and 2R (Table 2.3a), was used to exponentially amplify tester 
dsDNA with adapters 1 and 2R at either end (molecule f). None of the driver DNA was 
amplified due to the absence of ligated adapters (molecules d and e). There was some 
linear amplification of tester dsDNA with an adapter on one end only (molecule c). 
Amplification of tester dsDNA with one type of adapter on both ends was suppressed by 
annealing of the complementary adapter sequence (molecule b). This prevented PCR 
primer 1 from annealing and suppression of non-specific DNA fragments (Siebert et a/., 
1995). In the secondary amplification, nested primers 1 and 2 were used to selectively 
amplify molecule f, since each primer is specific to the unique DNA sequence located on
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Figure 3.4
The strategy adopted for subtractive hybridisation. Digested tester DNA (81116) were subdivided 
into two portions and the 5’ends were ligated to an adapter. Each aliquot wass denatured and 
hybridised to excess denatured driver DNA (NCTCl 1168). In the second hybridisation, the 
aliquots were combined and excess denatured DNA was again added. Amplification with PCR 
primer 1 exponentially concentrated the type f  molecules, which represent DNA present in the 
tester but absent in the driver. A second PCR with nested primers 1 and 2R further enriched tester- 
specific DNA (molecule f).
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each adapter (Table 2.3a). Thus the secondary PCR products were enriched for tester- 
specific DNA.
3.2.5 Subtractive hybridisation efficiency
Products from the subtracted and unsubtracted C. jejuni DNA were separated on a 2 % 
(w/v) agarose gel, along with subtracted and unsubtracted E. coli controls (data not 
shown). The subtracted control E. coli produced a faint ladder-banding pattern, 
corresponding to the ^XllAIHaeUl DNA, where the unsubtracted E. coli produced a 
smear. This result demonstrated that the subtractive hybridisation procedure, for 
identifying homologous DNA between tester and driver, was effective for the E. coli 
DNA. However, the subtracted and unsubtracted C. jejuni DNA produced identical 
smears. This result indicated that the conditions were not optimal for hybridisation of 
homologous tester and driver C. jejuni DNA.
One microlitre of subtracted and unsubtracted C. jejuni DNA was further tested by PCR, 
to determine the relative abundance of the conserved C. jejuni 16S rRNA gene. The E. 
coli subtracted and unsubtracted DNA was similarly tested using the conserved E. coli 
23 S rRNA gene. A PCR product was clearly visible following 18 cycles of PCR with the 
unsubtracted E. coli DNA (Figure 3.5). However, the same band was not visible in the 
subtracted E. cu/z DNA until 21 cycles (Figure 3.5) indicating that the conserved 23S 
rRNA gene had been reduced in concentration for the subtracted control E. coli DNA. 
This result again indicated a successful reduction in tester and driver homologous DNA 
after subtractive hybridisation for E. coli DNA. Conversely, there was no such difference 
between subtracted and unsubtracted C. jejuni DNA in the number of cycles required to 
produce a 16S rRNA gene specific PCR band (Figure 3.5). Again this result suggested 
that DNA homologous between tester and driver had not been efficiently removed after 
subtractive hybridisation with C. jejuni DNA. Despite the apparent low efficiency of 
subtractive hybridisation the secondaiy PCR products were cloned into either pBluescript 
or pCRscript using blunt end or TA cloning respectively. Following transformation into 
DH5a E. coli cells, only four colonies were found to contain inserts and none of these
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Figure 3.5
Reduction of C. jejuni 16S rRNA and E. coli 23 S rRNA gene abundance by PCR-Select 
subtraction, following the first round of subtractive hybridisation at 63 °C. PCR was performed on 
subtracted (Lanes 1-4) or unsubtracted (Lanes 5-8) (a) C. jejuni and (b) E.coli secondary PCR 
products, using primers for 16S rRNA and 23 S rRNA, respectively. Samples were run on a 2 % 
(w/v) agarose gel. Lanes 1 & 5: 18 cycles. Lanes 2 & 6: 21 cycles. Lanes 3 & 7: 24 cycles. Lanes 4 
& 8: 27 cycles. However, only the control E. coli 23S rRNA gene was reduced which indicated 
successful subtraction of E. coli genomic DNA fragments.
(a) 1 2 3 4 5 6 7
C. jejuni
(b)
E. coli control
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four were found to be unique to 81116 when checked against the NCTCl 1168 genome 
sequence (data not shown).
3.2.6 Second round of subtractive hybridisation on C. jejuni DNA
To enhance the C. jejuni subtractive hybridisation, lOpil of the secondary PCR product 
was denatured and re-hybridised to denatured NCTCl 1168 driver DNA. However, this 
time the annealing temperature was reduced to 61°C for both hybridisation steps. The 
subtractive hybridisation primary and secondaiy PCRs were carried out as before and the 
products separated on a 2 % (w/v) agarose gel (data not shown). Some distinct bands 
were visible in the subtracted DNA but not in the unsubtracted.
These secondaiy PCR products were used as template to amplify a PCR product using the 
16S rRNA primers, following 18, 21, 24 or 27 cycles. A faint band was seen in the 
unsubtracted DNA following 21 cycles (lane 5, Figure 3.6) whilst this band was absent 
after the same number of cycles with the subtracted DNA (lane 1, Figure 3.6). In addition, 
the bands at 24 and 27 cycles appeared brighter with the unsubtracted DNA as compared 
to the subtracted. This suggested that the concentration of the conserved 16S rRNA gene 
had been reduced in the subtracted C. jejuni DNA. These results indicated that the second 
round of subtractive hybridisation at the lower hybridisation temperature greatly enhanced 
the efficiency for reducing homologous tester and driver DNA.
3.2.7 Selection of 81116-specific inserts from subtractive hybridisation library
Blunt end ligation and transformation of the secondaiy PCR products was again found to 
yield a low number of transformants. To increase the cloning efficiency, the secondary
PCR products were ligated into pCR 2.1-TOPO using the TOPO TA cloning kit
(Invitrogen). This technique yielded 255 colonies, of which 167 contained inserts. Inserts 
were detected by colony PCR using the M I3 forward and reverse primers (Figure 3.7). A 
clone without an insert produced a 200 bp PCR product. All 255 PCR products, from 
colony PCR, were then dot blotted onto Hybond N+ membranes. Alkaline-phosphatase 
(AP) was directly conjugated separately to partial digests of 81116 or NCTCl 1168 DNA,
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Figure 3.6
Reduction of C. jejuni 16S rRNA gene abundance by PCR-Select subtraction, following the 
second round of subtractive hybridisation at 61 °C. Samples were run on a 2 % (w/v) agarose gel. 
PCR was performed on subtracted (Lanes 1-4) or unsubtracted (Lanes 5-8) C. jejuni secondary 
PCR products using 16S rRNA forward and reverse primers. Lanes 1 & 5; 18 cycles. Lanes 2 & 6: 
21 cycles. Lanes 3 & 7: 24 cycles. Lanes 4 & 8: 27 cycles. The reduction in C. jejuni 16S rRNA 
gene indicated successful subtraction of C. jejun genomic DNA fragments.
1 2  3 4 5 6 7
C. jejuni
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Figure 3.7
The secondary PCR products were cloned into pCR®2.1-TOPO® vector. DNA inserts were 
detected by colony PCR using the Ml 3 forward and reverse primers. A selection o f the PCR 
products from colony PCR, run on a 2 % (w/v) agarose gel, are shown. A 200 bp PCR product 
indicated no DNA insert (Lanes 3, 4, 5, 10, 11, 13, 14, 16, 21 & 22). A PCR product larger 
than 200 bp indicated the presence o f a DNA insert (Lanes 1, 2, 6, 7, 8, 9, 12, 15, 17, 18, 19, 
20 & 23).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Composite photograph
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following dénaturation. The AP-conjugated DNA from 81116 or NCTCl 1168 was used 
to probe the dot blots. The clones without inserts (200 bp PCR products) acted as 
negative controls. Forty PCR products gave a strong signal with the 81116 probe and 
reacted weakly, or not at all, with the NCTCl 1168 probe (Figure 3.8). These forty-two 
samples were selected for DNA sequencing.
3.2.8 DNA similarities
DNA sequencing revealed that 24 of these 42 clones contained inserts that were absent in 
strain NCTCl 1168 (Table 3.1), of which one DNA sequence was represented twice 
(inserts 126 and 136; insert 136 has been included in the remaining analysis). The 
remaining 18 DNA inserts (43 %) were false positives, i.e. analysis using the bl a st  suite 
of programs revealed high sequence similarities in strain NCTCl 1168 and also predicted 
similarities of 75-100 % at the amino acid level when each DNA sequence was translated 
in all six reading frames. Most of these false-positive inserts were present in the cloning 
plasmid as chimeras (13 inserts), in which two different inserts had ligated into one vector 
joined by adapter sequences. Five inserts (46, 141, 149, 209 and 212) had weaker, but 
significant, similarities (40-61 % identity at the amino acid level) with genes present in 
strain NCTCl 1168. Twelve sequences had no similarity to any gene in the NCTCl 1168 
genome sequence, but they did have significant similarity to genes of other organisms. 
The remaining six sequences (inserts 30, 50, 65, 117, 121 and 243) had no significant 
similarity with any sequence present in the NCBl databases searched.
The 23 strain-8 111 6-unique DNA fragments (mean size of 272 bp; range 124-644 bp) 
were further analysed for the presence of potential surface structures and conserved 
motifs in protein families by PREDICT PROTEIN.
3.2.9 Southern-blot analysis
The prevalence of these 23 unique sequences, among a diverse range of other C. jejuni 
strains, was determined by Southem-blot analysis. The chromosomal DNA of each strain, 
digested with either Hindlll or HinQ., was run on a 1 % (w/v) agarose gel and blotted onto
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Figure 3.8
Representative dot-blot hybridisation of products from the subtractive hybridisation. The 
subtractive hybridisation products were cloned and PCR, using the M l3 forward and reverse 
primers, was used to amplify the inserts. Each PCR product was spotted onto a Hybond-N+ 
membrane and probed with (a) AP-labelled strain 81116 genomic DNA fragments and (b) AP- 
labelled strain NCTCl 1168 genomic DNA fragments. PCR products that hybridised strongly to 
strain 81116 DNA and weakly or not at all with strain NCTCl 1168 DNA were chosen for 
sequencing. An example of a strain 81116-specific insert has been circled.
" *
(b) * •
O
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Table 3.1
Summary of the sequence analysis for inserts specific to C. jejuni strain 81116 and absent 
fi*om strain NCTCl 1168.
Insert 1 Size 
(bp)
I  Predicted protein similarty/species j Predicted 
amino acid 
i  identity (%)
1 Blast 
j  score
Accession
no.
30 259 1 No similarity*
!
AJ315005
j Arsenite export protein (arsB) *  
1 Sinorhizobium  sp. As4
64 "1ÂJ3Î5Ô06'''
46 384 j  Putative oxidoreductase chain (Cj0415) 
j  Campylobacter jejuni
61 le-38
!
AJ315007
50 124 j No similarity * - AJ315008
60
'"65
170 j  Type I R-M protein {hsd^  subunit) 
! Haemophilus influenzae Rd ^  
j  No similarity *
51
:_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
2e-10
:_ _ _ _ _ _ _ _ _ _ _ _
AJ315009 
"  Âj3Î5ÔiÔ"
" # 3 " Type I R-M protein QisdM  subunit) 
Salmonella enterica
32 1^06"" A J S l s o T T "
117 280 No similarity
’
- AJ315012
121 321 No similarity AJ315013
135 644 Sty SPI Type I R-M (fisdM  subunit) * 
Salmonella enterica
32 2e-06 ÀJ315014
136
_ _
149
308
301
"2Ô8"
Putative type I R-M protein 
{hsdS> subunit)
Streptococcus thermophilus 
Putative ^ycosyltransferase (Cj 1135) 
Campylobacter jejuni 
Hypothetical protein (Cj 1337) 
Campylobacter jejuni
39
40
2e-10
2e-0k
AJ315015
"ÂJ13Î36ÔT
"lAJ3Î5dh6"
183 195 Hypothetical protein (Rv0235c) * 
Mycobacterium tuberculosis
62 0.033 AJ315017
186 196 Arsenate reductase {arsC) 
Aquifex aeolicus
35 8e-06 AJ315018
188 163 Cytochrome c oxidase 111* 
Trypanosoma brucei
38 3.4 AJ315019
202 309 Type II R-M protein 
Helicobacter pylori  J99
68 5e-32 AJ315020
205 313 dTDP-glucose 4,6-dehydratase {rmlB) 
Legionella pneumophila
51 7e-25 AJ131360.1
209 
212 
236 "
248 Hypothetical protein (CJ1333) 
Campylobacter jejuni 
Probable membrane protein (Cj 1560) * 
Campylobacter jejuni 
Gamma-glutamyl transpeptidase 
Helicobacter pylori  26695
48
....
2e-ll 
"  5e:l4"" 
5e-40
AJ315021 
AJ315022 
AJ315023 '
243 150 No similarity * ^
1
AJ315024
246 297 Abortive phage resistence protein 
Lactococcus lactis *
34 0.033 1 AJ315055
* Predicted membrane-spanning domain 
^DNA for inserts 60, 243 and 246 were identified as part of a 7.3 kbp Type 1 R-M operon in strain 81116, 
where insert 243 is an abortive phage resistance gene fragment (W. G. Miller, personal communication)
113
C hapter 3. C. jejuni genom ic subtractive hybridisation
a nitro-cellulose membrane. The membrane was probed with each of the 23 strain-81116- 
specific DNA inserts. The results confirmed the presence of all 23 sequences in strain 
81116 and their absence from strain NCTCl 1168 DNA and the original isolate, 111680. 
Only one of the 23 inserts (insert 121) was unique to strain 81116 (Figure 3.9a). In 
contrast, only insert 50 hybridised to all other strains tested, with the exception of strain 
NCTCl 1168 (Fig. 3.9b). The remaining 21 sequences gave variable distributions and 
banding patterns, of which eight examples are shown (Figure 3.9c, d, e, f, g, h, i & j, 
insert 246, 135, 141, 205, 236, 136, 31, 186, respectively). The results are summarised in 
Table 3.2. Insert 46 is an example of a chimeric insert, in which two DNA fragments 
(excinuclease ABC subunit A and putative oxidoreductase) were ligated together (Figure 
3.10a). Southern blot hybridisation using insert 46 as a probe, resulted in the excinuclease 
part hybridising to all strains (2 kbp band for HindjSl profile. Fig. 3.10b), and the 
oxidoreductase part hybridised to a 1.1 kbp band in strains 99/385, 81116, 99/388 and 
99/346, and a 2.4 kbp band for strain EX114. Generation of a new AP-labelled probe 
containing only the putative oxidoreductase sequence, resulted in a similar Southern 
pattern but without the 2.0 kbp bands (data not shown). For the other chimeric inserts, the 
individual strain-8 111 6-specific sequences were also amplified by PCR from strain 81116 
genomic DNA and then used to probe the Southern blots.
3.2.10 Analysis and characterisation of strain 81116-specific DNA
In these experiments a total of only 23 DNA sequences present in strain 81116 and absent 
from strain NCTCl 1168 were identified, confirming previous observations that intra­
species genetic variation exists between strains of C. jejuni (Dorrell et ah, 2001). These 
results imply that we have, to date, found only a portion of the total gene pool existing 
within the C. jejuni species. Of the 23 strain-8 111 6-specific DNA inserts identified six 
sequences had no significant similarities to any entiy in the databases searched suggesting 
that they are C. jejuni-spQcific or strain-specific sequences. In several cases, two or more 
of the strain-81116-specific inserts appeared to have been derived from the same genomic 
location, as indicated by Southern blotting, suggesting that such strain-specific genes may 
be clustered; for example, the Ffwfl profiles of inserts 60, 243 and 246 were identical
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Figure 3.9
The presence of DNA, from a selection of inserts, among a range of C. jejuni strains, as 
demonstrated by Southern blot analysis. Two random isolates of strain 11168 were tested. 
Southern hybridisation of //mcfllll-digested genomic DNA from each strain was carried out with 
AP-labelled subtractive-hybridisation-DNA inserts as probes, (a) Insert 121 hybridised to strain 
81116 only, (b) Insert 50 hybridised to all strains tested except strain 11168. (c) Insert 246 
hybridised to strains 99/189, 99/385, 81116, 99/388 & 99/346. (d) Insert 135 hybridised to strains 
99/189, 99/322, 99/312, 99/385, 81116, 99/388 & 99/346. (e) Insert 141 hybridised to strains 
81116, 99/385, 99/189, 99/388 & 99/346. (f) Insert 205 hybridised to strains 81116, 99/385, 
99/189, 99/388 & 99/346. (g) Insert 236 hybridised to strains 81116, 99/385, 99/189, 99/388, 
99/346 & 81-176. (h) Insert 136 hybridised to strains 81116, 99/385, 99/388, 99/346 & EXl 14. 
(i) Insert 31 hybridised to strains 81116, 99/385, 99/189 & EXl 14. (j) Insert 186 hybridised to 
strains 81116, 99/385, 99/189, EXl 14.
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Figure 3.10
An example of a chimeric clone, insert 46. (a) The product o f the DNA sequence between position 
426 bp and 16 bp has an amino acid identity of 61 % to a putative oxidoreductase in C. jejuni 
strain NCTC 11168; the sequences between 431 bp and 595 bp has 98 % amino acid identity to 
excinuclease ABC subunit A from NCTCl 1168. The amino acid concensus is shown in between 
the amino acid sequence for insert 46 and the putative oxidoreductase or excinuclease ABC unit 
A; conservative substitutions are indicated by +. (b) Southern blot hybridisation using insert 46 as 
a probe. The oxidoreductase part of chimeric insert 46 was shown to hybridise to strains 99/385, 
81116, 99/388 and 99/346 (1.1 kbp) and to EXl 14 (2.4 kbp) in a separate experiment (data not 
shown). The excinuclease part of insert 46 was shown to hybridise to all strains, including strain 
NCTCl 1168, as shown by the band in all the lanes at 2 kbp.
(a) 1 Insert 46
POS '  ABC
Putative oxidoreductase subunit (POS)
Insert 4 6 : 426 SIPYIGNYLSLDPTYKDAYGLPLIRVTYNFTKQDKNLyNFMLPKLKSXMQEM-GAQNIYT 250
consensus S+P+ NYLSLDPTYKDA+G+PL+R+TYNFT QD+ L+ F+ K + + M G ++I
POS : 428 SLPHKNNYLSLDPTYKDAFGMPLLRLTYNHTDQDRALHKFITDKTAEVAKRMQGVKSIKK 487
Insert 4 6 : 24 9 SPKLGDYGWSNGWYTSTHIAGGTIMGTDKSTSWNPYLQHWDVNNLFWGAGNFPHNPG 7 0 
consensus L DY W  Y STH GGT MG D+ T S W N  YLQHWD +NLFWGAGNF HN G
POS : 488 GAYLKDYSWP YQSTHNTGGTTMGADRETSWNTYLQHWDADNLFWGAGNFQHNSG 544
Insert 46 : 69 YNPTLTLNALAYRASEDL 16 
consensus YNPT T+ ALAYR +E +
POS : 545 YNPTDTVGALAYRCAEGI 562
Excinuclease ABC subunit A (ABC)
Insert 46: 595 RSQIDGVLVRLDEEIELAKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLQESSG 4 31 
consensus R+QIDGVLVRLDEEIELAKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLQES G
ABC : 177 RAQIDGVLVRLDEEIELAKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLQESFG 231
V"/ o \ ( ? \ b L l c r \ o o i 3 \ o o o \  kbp
-  10.0 
-5.0
-4.0
-3.0
-2.5
- 2.0
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Table 3.2
Southem-blot analysis of each insert against selected chosen C. jejuni strains.
Insert Hybridisation with C. jejuni strains* Total
81116 99/385 99/189 99/388 99/346 Exll4 81176 99/322 99/312 94/194 11168^
50 + + + + + + + + + + - 10
183 + + + + + + + - - - - 7
68 + + + + + - - + + - - 7
135 + + + + + - - + + - - 7
65 + + + + + - + - - - - 6
236 + . + + + + - + - - - - 6
141 + + + + + - - - - - - 5
205 + + + + + - - - - - - 5
246 + + + + + - - - - - - 5
60 + + + + + - - - - - - 5
243 + + + + + - - - - - - 5
30 + + - + + + - - - - - 5
46 + + - + + + - - - - - 5
136 + + - + 4- + - - - - - 5
31 + + + - - + - - - - - 4
186 + + + - - + - - - - - 4
212 + + + - - + - - - - - 4
202 + - + - - - - + + - - 4
188 + - + - + - - - - - - 3
149 + - - + - - + - - - - 3
209 + - - + - - + - - - - 3
117 + - + - - - - - - - - 2
121 + - - - - - - - - - - 1
Total 23 17 17 16 15 8 6 4 4 1 0
* + , Indicates a positive hybridisation; -, indicates a negative reaction (total absence of 
bands).
 ^Both NCTCl 1168 and strain variant, 11168 gave identical profiles.
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(data not shown). The low percentage of genuine strain-8 111 6-specific sequences, 
obtained from the initial subtractive-hybridisation experiment, may have been due to the 
inadequate annealing of homologous DNA sequences from strain NCTCl 1168 to 81116. 
Decreasing the temperature from 63 °C (optimal for bacteria with a GC ratio of 40-51 
mol %) to 61 °C improved this efficiency by allowing the preferential amplification of 
81116-specific sequences. Improved optimisation might be achieved by decreasing the 
hybridisation temperature further. The presence of a number of chimeric clones also 
confounded the overall efficiency, as these were detected as positive clones.
The sequences identified as present in 81116 and different or absent from NCTCl 1168 
will be discussed within the genetic groups in which they are represented. It should, 
however, be noted that the sequences identified in this study are only fragments (ranging 
from 124 to 644 bp) of much larger genes and that expression of the corresponding genes 
has yet to be proven.
3.2.10.1 Flagellar modification region
Inserts 209 and 149 had homology to Cjl333 and Cjl337 respectively, yet the homology 
was low enough to suggest that they are not the same genes. In NCTCl 1168, Cj 1333 and 
Cjl337 were found amongst seven hypothetical paralogous genes in the flagellar 
biosynthesis and modification region. These genes were designated as the motility 
accessory factor (jnaf) family (Figure 3.11) (Bleumink-Pluym et al, 1999; Karlyshev et 
al, 2002). It has been reported that sequences within the flagellar modification region 
vary between strains (Dorrell et al, 2001). In particular, it has been suggested that a 
region between Cjl318 and Cj 1336 of the flagella modification locus has been lost from 
strain 81116 (Dorrell et a l, 2001). Interestingly, two genes, mafl and maf4 were identical 
at the DNA level and that both genes contain homopolymeric tracts suggests that 
duplication may have occurred in strain NCTCl 1168 (Karlyshev et al, 2002). For strain 
81116, homologous recombination may have also occurred between the m af genes 
resulting in a modification locus different to NCTCl 1168. In my study, subtractive 
hybridisation identified insert 209 to encode a peptide with 48 % identity to Cjl333 
{mafl). One explanation for this anomaly would be a genetic rearrangement in
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Figure 3.11
This study has identified the products o f inserts 149 and 209 to have similarities to Cjl337 
(mqfS) and CJ1333 (maf2), respectively. There are seven maf family associated genes in the 
genome of strain NCTCl 1168 (Parhill et a l, 2000) and they are located in a large 37 kbp gene 
cluster. The maf genes are shown in red. The arrows denote the direction of transcription.
KEY
I I /Maf family genes H  flagella biosynthesis genes
H  genes involved in flagellin | | genes related to sugar biosynthesis, transport
glycosylation and processing o f glycoproteins
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Strain 81116, so that mqf2 was no longer located where expected relative to strain 
NCTCl 1168. Nevertheless, the identification of a second insert (149) encoding a peptide 
with 47 % identity to Cj 1337 {maf5), and the identical Southem-blot profiles using inserts 
149 and 209 as probes, suggests that these two DNA fragments were in close proximity 
on the 81116 genome. These data contradict the DNA array analysis on strains 
NCTC 11168 and 81116 between the Cj 1318 and Cj 1336 region (Dorell at al, 2001). For 
strain NCTCl 1168, the product of the maf genes had significant amino acid similarities to 
each other, ranging from 32 to 100 % (Karlyshev et al, 2002). One hypothetical 
mechanism to explain the observations for strain 81116 could be that adjacent maf genes 
have undergone homologous recombination and this has led to the formation of maf gene 
variants represented by inserts 149 and 209.
Over 40 genes are involved in fiagellar biogenesis of E. coli etnà Salmonella (Macnab and 
Parkinson, 1991; Macnab, 2003). The exact role for the Maf proteins in flagellar 
biosynthesis remains an enigma. Nevertheless, their genetic position and partial overlap 
with neuB and ptmA indicates a possible role in flagellin modification. Indeed, mafS has 
been demonstrated to be involved in the formation of flagella (Karlyshev et al, 2002). 
Moreover, mafl can partially restore motility, following mafS inactivation, by activating 
the mafl gene by phase variation (Karlyshev et al, 2002). Variation of Maf proteins in 
the natural C. jejuni population may dictate the post-translational modification of the 
flagellin subunit and flagellum biosynthesis. This may be a mechanism for increasing the 
antigenic diversity, in order to escape the host’s immunological responses or otherwise 
adapt to the environment. As an adhesin, the motility of the glycosylated flagellum might 
be required for initial attachment to host cells and, as an invasin, the penetration of 
intestinal epithelial cells (Wassenaar et al, 1991; Grant et al, 1993; Yao et al, 1994). 
However, flagella may no longer be advantageous, possibly even disadvantageous, once 
bacteria become internalised into epithelial cells and their formation may be switched off 
through maf phase variation. In addition to this, the reversible expression of maf will 
enable flagellum formation and allow C. jejuni to move to a new colonisation site when 
the nutrients at the infection site becomes limiting. The presence of a complex
1 2 2
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mechanism for flagella expression may provide C. jejuni with a selective advantage in the 
ecological niches it occupies.
3.2.10.2 LOS
Although subtractive hybridisation was developed to screen for the presence or absence 
of DNA, it can also detect polymorphisms between two strains. This was apparent for 
inserts 205 and 141. These inserts have similarities to dTDP-glucose 4,6-dehydratase 
(rmlE) from Legionella pneumophila, an enzyme involved in the glycosylation of the cell 
wall of pathogenic bacteria (Allard et ah, 2000), and a putative glycosyltransferase from 
C jejuni NCTCl 1168, respectively. Both inserts had identical Hinfi Southem-blot 
profiles and one was not found without the other in any of the C. jejuni strains that tested 
positive. This may suggest that the functions of these two genes, involved in 
polysaccharide biosynthesis, may be co-ordinated. Insert 141 does not hybridise to strain 
NCTCl 1168 DNA, despite encoding a product with 40 % amino acid identity to a 
putative glycosyltransferase (Cjll35), demonstrating that polymorphic genes can be 
detected by genomic subtractive hybridisation. These results confirm DNA microarray 
observations indicating that strain 81116 differs from strain NCTCl 1168 within this 
genetic region (Dorrell et a l, 2001). Moreover, the inner core/lipid A genes, galE, wlaX, 
waaC, wlaNA, wlaNB, rmlA, rmlB genes have also been identified in C. jejuni strain 
81116 previously (Fiy et al, accession number: AJ131360.1). From this gene cluster only 
galE and waaC were present in the genome of strain NCTCl 1168 (Parkhill et a l, 2000). 
This has validated genomic subtractive hybridisation as a technique to identify DNA 
fragments from one C. jejuni strain that is absent or substantially different from another 
strain. A majority of the DNA fragments identified will represent parts of genes since
94.3 % of the C. jejuni genome codes for proteins (Parkhill et al, 2000). Thus, 
subtractive hybridisation not only complements DNA microarray technology but also 
provides the additional benefit of detecting novel fragments of gene sequences in test 
strains.
Insert 141 was identified as wlaNB from strain 81116, the product of this gene has 
similarity to a family of glycosyltransferases involved in the biosynthesis of
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polysaccharides, more specifically, to (3-1, 4-glucosyltransferase (LgtF) from Aquifex 
aeolicus (56 % amino acid similarity, blast score 2e-33) and Haemophilus ducreyi (55 % 
amino acid similarity, blast score 3e-32). In C. jejuni strain NCTCl 1168, this product has 
40 % similarity to CJ1135, a putative two domain glycosytransferase (Parkhill et al,
2000). In N. meningitidis the IgtABCDE operon encodes the sugar transferases required 
for the biosynthesis of the a  chain of meningococcal LOS (Kahler et al, 1996). However, 
IgtF, forms part of a second glycosyltransferase operon known as ice (inner-core 
extension). The ice operon genes, IgtF and rfaK are flanked by direct repeats (DR) which 
have 92 % DNA identity to the DRs of a known insertion sequence (IS), thus suggesting 
that the ice operon was introduced into the N. meningitidis genome by an IS. 
Interestingly, both of the ice and Igt opérons are similar in that they are preceded by genes 
involved in tRNA synthesis, an arrangement which may result in co-ordinated regulation 
and expression. In summary, the ice operon was necessary for the completion of the 
neisserial LOS inner core and the addition of the a  chain, and the IgtABCDE operon is 
necessary for LOS a  chain biosynthesis which proceeds after the inner core is completed.
In S. Typhimurium, RmlB is the second of four enzymes (RmlA-D) involved in the 
dTDP-L-rhamnose pathway and catalyses the dehydration of dTDP-D-glucose to dTDP- 
4-keto-6-deoxy-D-glucose. The ultimate product of the pathway, dTDP-L-rhamnose, is 
the precursor of L-rhamnose, which is a key component of the cell wall of many 
pathogenic bacteria (Allard et al, 2000). This pathway does not exist in humans, making 
enzymes of this pathway very attractive targets for therapeutic intervention (Giraud and 
Naismith, 2000). In Pseudomonas aeruginosa the rml locus is composed of four ORFs, 
designated rmlB, rmlD, rmlA and rmlC (Rhaim et al, 2000). These genes are contiguous 
and transcribed in the same direction and arranged in the same manner as those of E. coli 
(Liu & Reeves, 1994; Stevenson g/ a l, 1994), Shigella species (Macpherson et a l, 1994; 
Rajakumar et a l, 1994; Klena & Schnaitman, 1993; Sturm et a l, 1986) and Salmonella 
enterica (Jiang et a l, 1991), suggesting that these rml biosynthetic loci evolved from a 
similar origin. In P. aeruginosa the L-rhamnose sugar appears to function as the linkage 
site for the O antigen (Rhaim et al, 2000) and the outer-core region of P. aeruginosa LPS 
has been shown to mediate the uptake of this organism by host epithelial cells (Pier et al.
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1996). Although, the C. jejuni genome sequenced strain, NCTCl 1168, does not contain 
any similarities to any of the four rml genes (Parkhill et al, 2000), the identification of 
DNA with similarity to rmlB and rmlA in strain 81116 may either indicate the existence 
of a rml operon in some C. jejuni strains or that the genetic pathway for L-rhamnose is 
different. The use of C  jejuni genetically defined mutants with known defects in the core 
LPS structure may help elucidate specific host-bacterium interactions and broaden our 
knowledge with respect to the mechanisms involved in the pathogenesis of this organism.
To date, two opérons containing similarities to glycosyltransferases have been identified 
in strain 81116 (Fry et al, 1998; Fiy et al, accession number: AJ131360.1). In the 
genome sequenced strain NCTCl 1168, many of the genes for lipid A biosynthesis are 
scattered throughout the genome, while genes involved in the inner and outer core LOS 
synthesis and assembly form an operon as described for strain 81116 (Fry et al, 1998). 
Conserved structures in C. jejuni are limited essentially to the lipid A and inner regions 
of the core polysaccharide, whilst the outer regions of the core polysaccharide and O 
antigen have been found to be highly diverse (Penner and Aspinall, 1997). Sugars that are 
unusual and generally rare in biological materials may be found in the core 
polysaccharide. Terminal sialic residues appear to be common in core polysaccharides 
and, along with structural mimiciy of human gangliosides, may be an important feature 
for the pathogenesis of Guillain-Barré and Miller-Fisher syndromes.
In C. jejuni, the strain to strain variation in these LPS genes may reflect a number of the 
phenotypic differences observed within this species (Wassenaar and Blaser., 1999). 
Alteration of the LPS may enhance serum resistance as observed for other bacteria 
(Demarco de Hormaeche et a l, 1991; Hood et a l, 2001). The different modifications 
made to the LPS may confer the degree of resistance to host antimicrobial factors, 
avoidance of immune system recognition, and the bacterium’s ability to internalise and 
survive within host cells (Evans et al, 2002; Lozniewski et a l, 2003). In C. jejuni, 
inactivation of galE resulted in a mutant, which expressed a lipid A core molecule of 
reduced molecular weight (due to the loss of galactose-containing units), that did not react
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with antisemm raised against the parental strain, and showed a reduction in its ability to 
adhere to, and invade INT407 cells (Fiy et al, 2000). However, the galE mutant was able 
to colonise chickens as efficiently as the parental strain, and the serum resistance and 
haemolytic ability was unchanged. Nevertheless, the ability of the mutant to take up 
DNA and integrate it into the genome was reduced 20-fold suggesting that LPS may play 
a role in DNA uptake as a receptor or indirectly by forming complexes with receptors. It 
is yet to be fully determined why extensive diversity exists in the C. jejuni LOS/LPS and 
the relationship this diversity has to the virulence of this pathogen. The understanding of 
the composition and arrangement of all the genes responsible for LPS biosynthesis and 
exactly what role (if any) each of these genes play in colonisation, invasion or 
inflammation needs to be determined. This may facilitate the design of strategies for the 
prevention of food-home campylobacteriosis.
3.2.10.3 Restriction modification and abortive phage-resistance genes
Prokaryotic restriction-modification (R-M) systems provide a specific kind of bacterial 
resistance and involve destmction of double-stranded DNA (Murray, 2000). It is widely 
believed that R-M systems have been maintained by bacteria as defensive tools against 
infection by viral, plasmid and other foreign DNAs. The enzymes that destroy foreign 
DNA are called restriction endonucleases or, more commonly, restriction enzymes. 
Restriction enzymes are highly specific, attacking only certain DNA sequences (generally 
four or six base pairs). For such a system to be effective, the bacterium needs a 
mechanism for protecting its own DNA from the restriction enzyme. Modification of 
bacterial DNA, at the sites where the restriction enzymes act, is such a mechanism and, is 
brought about by méthylation of purine or pyrimidine bases on each strand. Thus, once 
the DNA is modified by the methyltransferase the sequence is no longer a substrate for 
the restriction enzyme. There are various types of R-M systems. Type I R-M systems (R- 
M I) comprise of three genes, hsdS for sequence recognition, hsdM for méthylation, and 
hsdR for restriction. The acronym hsd was chosen at a time when R-M systems were 
referred to as specificity systems and hsd denotes ‘host specificity of DNA’. A typical R- 
M II system, such as EcoFl, contains one gene R for sequence recognition and restriction
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and one gene, M, for méthylation. A type III R-M system, also comprises two genes, one 
for sequence recognition and méthylation (M), and one for restriction (R).
In this study, a number of DNA inserts were found to have similarities to R-M genes. 
Similarities to both type I and II R-M systems from other bacteria were identified in 
inserts 60, 68, 135, 136 (all type I) and 202 (type II) (Table 3.1). Southem-blot profiles of 
inserts 68 and 135 were identical with both i/zwdlll and HinQ., suggesting that they are 
closely located in all strains tested. Analysis of these two inserts revealed a substantial 
amount of overlapping DNA sequence, suggesting that they might be part of the same R - 
M gene. It is quite rare to find more than one R-M system of a specific type in an 
organism, however there is increasing evidence for the existence of multiple R-M 
systems in C. jejuni (W. G. Miller, personal communication).
A complete 7.3 kbp hsd locus has already been identified in strain 81116 (W. G. Miller, 
personal communication). This R-M system is part of a diverse C. jejuni type I family, 
classified as IB. In contrast, strains NCTCI1168 and 81-176 contain genes belonging to a 
highly conserved family of type I R-M systems, designated as ID. The DNA sequences for 
inserts 246, 243 and 60 were found within this R-M system (Figure 3.12). The hsd operon 
was disrupted by two genes involved in abortive phage resistance (rloA and rloB). 
Interestingly, earlier Southem-blot analysis indicated that these inserts were in the same 
genomic location for C. jejuni strains 81116, 99/385, 99/189, 99/388 and 99/346 (Table 
3.2; Figure 3.9c). To date, the screening of C. jejuni strains using primers derived from 
the conserved regions of each family type, have identified type I R-M systems from IB, IC 
and ID families, and the results also suggested that only one family may exist per strain 
(W. G. Miller, personal communication). In addition to this, a number of C. jejuni strains 
were found to lack all previously characterised family types, suggesting that either an 
uncharacterised R-M system exists within these strains or that they were completely 
absent of any R-M system.
Insert 135 has similarity to a hsdMgene, belonging to the LA family. However, the full
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Figure 3.12
The 7.3 kbp hsd locus belonging to the IB family identified in strain 81116 by W. G. Miller. 
This /25'û? operon is disrupted by two genes, rloA and rloB, which are involved in abortive phage 
resistance. The positions o f inserts 246,243 and 60 are shown relative to the 7.3 kbp operon.
y
I I
Insert Insert Insert
246 243 60
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128
C hapter 3. C. jejuni genom ic subtractive hybridisation
identification of this putative R-M system and further sequence analysis is required to 
confirm whether it belongs to the lA family in C. jejuni. Nevertheless, this suggests that, 
not only type lA families exist in C  jejuni, but also that more that one type may exist 
within a strain. Insert 136 has similarities to the hsdS subunit and may be an example of a 
solitary hsdS gene as observed in other bacterial genomes (O'Sullivan et ah, 2000). This 
solitary hsdS may contribute to the formation of new chimeric hsdS subunits after 
homologous recombination with a hsdS gene belonging to a R-M system. Such events 
would generate the potential for new restriction specificities by genetic recombination 
between hsdS genes and may be an evolutionary response to counteract foreign DNAs. 
For example, the hsdS genes may serve as a reservoir for novel phage resistance, 
particularly when the bacterium is trying to become established in a habitat populated by 
phage (O'Sullivan et ah, 2000). Finally, insert 202 was identified as part of the 
methytransferase (M) gene from a type II R-M system. It is yet to be established whether 
this hsdM is paired with a hsdR gene. Nevertheless, solo methyltransferases have been 
identified in bacterial genomes and may defend the genome from incoming foreign R-M 
complexes that have the capacity to damage the genome (Kobayashi et ah, 1999).
One might speculate that the reason for so many R-M genes present in C. jejuni is related 
to the niche it occupies. In the intestinal tract, C. jejuni cells might uptake bacterial DNAs 
from foods eaten by the host and from the bacteria present as commensals in the large 
bowel/colon. Therefore, a good defence against foreign DNA is required to limit the 
acquisition of novel genes by horizontal transfer systems, (plasmids, bacteriophages, 
transposons or gene cassettes) (Brunder and Karch, 2000). R-M systems have undergone 
extensive horizontal transfer between genomes, as inferred from their sequence 
homology, codon usage bias and GC content differences (Kobayashi, 2001). However, 
analysis of the GC content of each insert, predicted to be part of a R-M gene, suggested 
them to be indigenous to C. jejuni.
Along with R-M systems, the identification of insert 246, which has a predicted protein 
similarity to an abortive phage-resistance protein from L. lactis, may indicate another
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potential mechanism to enhance C.jejunfs resistance to phage infection. In L  lactis, two 
distinct phage resistance mechanisms have been identified, a R-M system and an abortive 
infection (Abi) mechanism which impedes prophage proliferation and cell death 
(Twomey et al., 2000). The L. lactis Abi systems can be located chromosomally or on 
native lactococcal plasmids, and the majority of Abi systems are encoded by a single gene 
whist the remainder are encoded by two genes. Once intact phage DNA has entered the 
host cell, these Abi systems encompass a diverse variety of mechanisms, which may act 
to prevent phage DNA replication, transcription, translation, processing, or assembly or 
lysis of the cell, thus preventing phage proliferation. However, strain 81116 has been 
shown to be susceptible to phage lysis (Ridley and Newell, 2002). Phages specific to C 
jejuni and C. coli have been classified as members of the Myoviridae family. Typical 
features of these phages include an icosahedral head and rigid contractile head (Sails et 
al, 1998; Atterbury et al, 2003). Interestingly, restriction endonuclease analysis 
demonstrated that DNA fi*om the these phages was relfactoiy to digestion by a number of 
restriction enzymes (Sails et al, 1998). One hypothesis for the presence of the phage 
resistance gene in C. jejuni could be that the gene prevents certain phage species from 
lysing C. jejuni cells, as observed for Lactococci (Anba et al, 1995). Therefore, phage 
species that are unable to lyse C. jejuni cells need to be identified, and the abortive phage 
resistance gene within the strain needs to be inactivated and then tested for phage 
susceptibility.
C. jejuni strain 81116 is genetically stable (Manning et a l, 2001) in contrast to the 
general perception that C. jejuni strains are genetically unstable (Wassenaar and Blaser, 
1999). Whether this stability is due to R-M systems has yet to be established in this 
organism. C. jejuni is naturally competent and prone to uptake of DNA from the 
environment (Miller et al, 1988; Wassenaar et al, 1995; Wilson et al, 2003). R-M 
systems are particularly frequent in the genomes of naturally transformable bacteria 
(Kobayashi, 2001). This correlates with the C. jejuni genomic subtractive hybridisation 
findings where a fifth of the inserts identified were predicted to be parts of R-M systems. 
Whole DNA array comparisons of 11 C. jejuni strains of diverse origin also identified a
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high proportion of putative R-M genes in strain NCTCI 1168 to be either absent or highly 
divergent in these isolates (Dorell et al, 2001). Earlier work on the genetic transformation 
of C. jejuni identified plasmid DNA extracted from C. jejuni was significantly more 
efficient in obtaining transformants than plasmid DNA extracted from E. coli (Miller et 
al, 1988.). This suggested the presence of R-M systems in C. jejuni capable of restricting 
heterologous DNA and modifying endogenous DNA.
It has been suggested that the genome of C. jejuni undergoes genomic rearrangement 
(Wassenaar et al, 1998; Haninnen et al, 1999; Wassenaar et al, 2000). The acquisition 
or loss of a R-M system may be involved in such genomic rearrangements. The 
mechanism suggested involves the interaction between short homologous DNA 
sequences and illegitimate linkage of double strand DNA breaks, caused by residual 
restriction enzyme, with non complementary ends (Kusano et al, 1997; Sekizaki et al,
2001). The bacterial Rec enzymes involved in homologous recombination and 
recombinational repair of DNA damage may defend the host-bacteria against attack by R- 
M systems by repairing the restricted chromosomes (Handa et al, 2000) and these Rec 
enzymes may be present in C. jejuni (Parkhill et al, 2000).
The presence of partial or inactive R-M systems in bacterial genomes may serve as a new 
class of ‘contingency loci’ that can be reactivated upon recombination with a functional 
allele and may be a general paradigm for gene regulation (Aras et al, 2002). It seems that 
a R-M gene complex on the bacterial chromosome cannot be easily replaced by a 
homologous stretch of DNA, and resistance depends on cell death through restriction 
breakage in the genome that occurs after loss of the R-M system (Handa and Kobayashi,
1999). With this in mind, the combined conservation and sequence variation of R-M 
genes amongst C. jejuni strains may be useful for population genetic analysis in the 
future.
Sma\ Reftactorv C. ieiuni strains
Interestingly, the chromosomal DNA of strain 81116 does not cut with Smal
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(G. Manning, personal communication). Whether this is due to the absence of Smal sites 
in strain 81116 was unknown. Strain NCTCI 1168 DNA contains 15 Smal sites (Parkhill 
et ah, 2000) (Figure 3.13a) and is cut with this restriction enzyme. Nine of these Smal 
sites are found amongst the conserved 16S, 23S and 5S rRNA genes. Primers If35 and 
Jf36 were derived to amplify a 547 bp 23 S rRNA region containing a known Smal site. 
Not surprisingly, strain 81116 contained this region (Figure 3.13b). The unmethylated 
81116 PCR product was cut into two fragments (312 bp and 235 bp) following Smal 
restriction, as predicted for strain NCTCI 1168. This confirmed the presence of a Smal 
site in the genome of strain 81116 and suggested that restriction digestion in DNA from 
81116 was prevented by méthylation of this site. It is, therefore, tempting to speculate that 
the R-M genes (inserts 60, 68, 135, 136 and 202) detected, may have a role in this 
enzyme restriction.
An additional twelve C. jejuni strains, that also do not cut with Smal, were screened for 
the presence of each of the previously identified inserts encoding products with similarity 
to R-M genes, by Southern blot analysis (Figure 3.14) and the results are summarised in 
Table 3.3. Inserts 243 (no similarity in the database) and 246 (putative abortive phage 
resistance gene) were identified as part of the 7.3 kbp operon, which contained the R-M 
DNA for insert 60 (W. G. Miller, personal communication), therefore any one of these 
fragments could be used as a probe. None of these inserts were found to hybridise to all of 
the Smal refractory strains, suggesting that the R-M gene complex containing the insert 
DNA, is unlikely to be involved in Smal restriction. Because it seems likely that not all 
the R-M genes present in strain 81116 were identified by this subtractive hybridisation, it 
would be interesting to see if there are any more R-M genes in this strain and whether any 
of these have a role in Smal refraction.
3.2.10.4 Arsenic genes
Two more inserts (31 and 186), which were absent from the NCTCI 1168 genome, have 
similarities with genes involved in arsenic resistance in several bacteria. The product of 
insert 31 has 64 % amino acid identity to ArsB from Sinorhizohium sp. As4, an integral
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Figure 3.13
(a) The genome of NCTCI 1168 was used to derive primers (If35 and If36) to amplify a 547 bp 
23S rRNA region containing a known Smal site at position 42342 (shown in red), (b) These 
primers were used to amplify the same region in strain 81116 and the subsequent PCR product 
was subjected to Smal restriction. The samples were run on a 2 % (w/v) agarose gel. Lane 1: 
81116 rRNA PCR product. Lane 2: Two 81116-ffagments (312 bp and 235 bp) were observed 
following Smal restriction of the rRNA PCR product. This confirmed the presence of a Smal site 
in the genome of strain 81116.
Smal
(position 42342)
\Smal 
I  SmalSmal
Smal
mal
Smal
[Smal
SmalNCTCI 1168 
1641481 bp
Smali
SmaX
(b)
1 2
kbp
1 . 0 -
M
0 . 5 -
0 . 3 -
0.1 -
133
C hapter 3. C. jejuni genomic subtractive hybrid isation
Figure 3.14
Southern blot analysis of Smal refractory C jejuni strains using the different R-M systems 
identified from subtractive hybridisation. NCTCI 1168 was used as a negative control. A 
representative DNA insert was chosen for each different R-M system to probe the strains, (a) 
Insert 136; (b) insert 243; (c) insert 135; (d) insert 202. The weaker bands may represent closely 
related R-M DNA. The results are summarised in Table 3.3.
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Table 3.3
Southern blot analysis o f Smal refractory strains using the different R-M systems identified 
from subtractive hybridisation. Strain NCTCI 1168 was used as a negative control. One R-M 
system/gene is represented by (a) inserts 135 & 68, (b) insert 202, (c) insert 136, and (d) inserts 
246,243 & 60.
Strain 135^/68
Inserts*
202'' 136" 246/243" /60
81116 ++ ++ ++ ++
02/01 -H- - -H- 4-4-
02/02 - - - -f
02/03 ++ ++ -H- 4-4-
02/04 - - 44- -
02/05 - - - -
02/06 ++ - -H- 4-
02/07 ++ + 44- 4-k
02/08 ++ - 4-t- 4-
02/09 ++ + 4-4- 44-
02/10 ++ -H- 4-4- 4-4-
02/11 ++ + 44- 44-
02/12 - - - 4-
11168 - - - -
++ Indicates a strong positive hybridisation 
+ Indicates a weak positive hybridisation
Indicates a negative reaction (total absence o f bands)
 ^ Probe used to represent the R-M system/gene.
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membrane protein needed for the extrusion of arsenite. The product of insert 186 has 35% 
amino acid identity to ArsC from Aquifex aeolicus. The arsC gene encodes arsenate 
reductase, which reduces intracellular arsenate to arsenite. The different banding patterns 
observed for the Southem-blot profiles of arsB and arsC (data not shown), suggested that 
these two genes did not form part of an operon. However, arsC did have a identical 
HindAR and Hinfi profiles (data not shown) to those of insert 212, which has similarity to 
Cjl560 (a putative unknown membrane protein). This suggests that arsC and Cjl560 are 
co-located in the genome of all strains tested. Interestingly, the product of Cjl561 in 
strain NCTCI 1168 is predicted to have similarity to an arsenic transcriptional regulator 
(ArsR). Furthermore, both arsB and arsC were always both found within a positive C. 
jejuni strain, suggesting that one cannot be present in a genome without the other, and 
that maybe, a HindRl and Hinfi site exists between these two genes, which would explain 
the different Southern profiles. These results suggest the existence of an arsRCB operon 
in strain 81116. Sequencing outside of the Cj 1560 region is required for confirmation of 
this putative operon.
Arsenate is a molecular analogue of phosphate and inhibits oxidative phosphorylation, 
short circuiting life’s main energy-generation system (Oremland and Stolz, 2003). 
Arsenate’s usual mode of entry is through phosphate transporters. In contrast, arsenite is 
more broadly toxic because it binds to sulfhydryl groups, impairing the function of many 
proteins. Therefore, bacteria have evolved mechanisms of arsenic detoxification and 
resistance. For example. Staphylococcus aureus contains an arsRBC operon where ArsB 
is an integral membrane subunit that forms a translocation channel and intracellular 
arsenate (As (V)) is enzymatically reduced to the more toxic arsenite (As (III)) by ArsC in 
the cytosol (Ji et al, 1992). Arsenite is subsequently extmded from the cell by an energy 
dependent efflux process, which appears to be driven by the membrane potential (Broer et 
aC 199^1
The observation of arsenite-metabolising genes in strain 81116 and not in strain 
NCTCI 1168 is interesting especially since phenylarsonic compounds have been used, in
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the past, in poultry feed for controlling caecal coccidiosis and to promote growth 
(Pergantis et a l, 1997). The use of such compounds may have led to the contamination of 
some agricultural lands on which poultry litter has been used as manure (Gupta & 
Charles, 1999). The ars operon is widespread among the Enterobacteriaceae and 
exposure to arsenite or arsenate has also been shown to induce the synthesis of heat-shock 
proteins, indicative of the stress response triggered due to exposure to this toxic chemical 
(Chang et a l, 1989). The biological impact of the arsenic resistance genes in survival and 
subsequent colonisation of chickens by Campylobacters requires further investigation.
3.2.10.5 X-Glutamyl transpeptidase
Insert 236 has 72 % amino acid identity to the H. pylori y-glutamyl transpeptidase (GOT) 
polypeptide. Southem-blot analysis of ggt revealed an identical HinR, but a different 
HindRl pattern, to that of insert 65, for which no significant protein similarities could be 
identified. This suggests that these inserts are located in close proximity in the genome of 
strain 81116 and that they may be linked.
In mammalian tissues, GGT is a membrane-bound enzyme that catalyses the transfer of 
the y-glutamyl moiety from y-glutamyl compounds, such as the ubiquitous glutathione (L- 
y-glutamyl-L-cysteineglycine), to amino acids, as well as peptides and glutathione itself 
(Tate and Meister, 1981). The y-glutamyl amino acids are taken up by cells and the 
transported amino acid is released. The y-glutamyl molecule is subsequently used to 
regenerate glutathione. Thus GGT plays a role in the degradation and synthesis of 
glutathione. Collectively, these reactions give rise to a y-glutamyl cycle (refer to Chapter 
6 for more details).
In eukaryotic cells, glutathione is an antioxidant molecule and provides vital cellular 
protection against reactive oxygen species (ROS) generated by mitochondria, particularly 
hydrogen peroxide and certain organic hydroperoxides (O’Donovan and Fernandes,
2000). Evidence has shown that eukaiyotic GGT-dependent breakdown of extracellular 
glutathione, for subsequent intracellular resynthesis, helps to maintain cellular glutathione
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levels and increased cellular resistance to hydrogen peroxide-induced injury (Shi et al, 
1993; Sweiiy et al, 1995; Potdar et al, 1997; Chikhi et al, 1999). Therefore GGT has an 
important physiological role in oxidative stress. However, few bacterial GGTs have been 
characterised at the biochemical and molecular levels (Suzuki et al, 1989; Ishiye et ah, 
1993; Xu and Strauch, 1996; Chevalier et a l, 1999). The generation of ggt mutants has 
shown that GGT is not required for bacterial growth in vitro. Nevertheless, in E. coli, the 
utilisation of exogenous y-glutamyl peptides by cells was dependent upon the production 
of a catalytically active GGT by the cells. GGT has been found to be crucial for 
glutathione metabolism and hydrogen sulphide (H2S) production for the peridontal 
bacterial pathogen. Treponema denticola, where the H2S molecule is required by the 
pathogen to induce injury or death of gingival fibroblasts and epithelial cells (Chu et al, 
2002; Chu et al, 2003). In H. pylori, GGT appears to have a role in the colonisation of 
the gastric mucosa of mice (Chevalier et a l, 1999; McGovern et a l, 2001). It was 
suggested that GGT activity may play a part in the de novo synthesis of essential amino 
acids and, therefore, the reduced H. pylori colonisation observed in ggt mutants was due 
to poor survival in vivo. Whether C. jejuni GGT has a similar role in colonisation of the 
chicken intestinal tract, utilises glutathione for H2S production or combats oxidative 
stress will obviously require further investigation.
3.2.10.6 Cytochrome c oxidase
The product of insert 188 is predicted to have a membrane spanning domain and has 38 
% amino acid similarity to cytochrome c oxidase III from the protozoan Trypanosoma 
brucei. This similarity may not be too surprising considering that the cytochromes, found 
within the mitochondria of T. brucei, are believed to have prokaryotic ancestry (Whatley 
et al, 1979; Feagin et al, 1988). Prokaryotic cytochrome oxidases are water soluble 
redox proteins in the periplasm or anchored to the cytoplasmic membrane with the haem- 
containing globular domains exposed to the periplasm. This haemoprotein participates in 
electron transfer reactions involving the alternate oxidation and reduction of the haem 
iron and as a consequence transfers electrons to molecular oxygen, reducing it to water. 
Previous work has suggested that the genomic diversity, in genes important in the
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utilisation of alternative electron acceptors for respiration, may confer a selective 
advantage to strains in restricted oxygen environments (Pearson et al, 2003). From this it 
may be hypothesised that the existence of multiple and diverse types of cytochrome 
oxidase in the genome of C. jejuni isolates may be required to increase the organism’s 
affinity for oxygen within its microaerobic niche, and adapt its oxygen affinity according 
to the available oxygen.
3.2.10.7 Miscellaneous DNA sequences with similarities in the database
The product of insert 46 has 61 % amino acid similarity to Cj0415, a putative 
oxidoreductase in strain NCTCI 1168. The product of insert 212 has 56 % amino acid 
similarity to CJ1560, a probable membrane protein in strain NCTCI 1168. Each of these 
inserts hybridised to five and four C. jejuni strains, respectively (including strain 81116) 
(Table 3.2). The conservation of these DNAs amongst C. jejuni strains may suggest that 
they are part of a functional gene which provides some advantage to these particular 
C. jejuni isolates. However, it is difficult to determine the exact function, for either 
Cj0415 or Cjl560 without characterisation by genetic mutational analysis and subsequent 
identification of a phenotype.
The product of insert 183 has 62 % similarity to a hypothetical membrane protein in 
Mycobacterium tuberculosis (Table 3.2), and interestingly, the next best protein match 
has 46 % amino acid similarity to a transfer protein, TraG fi*om Neisseria gonorrhoeae. 
TraG forms part of the transfer machinery on conjugative plasmids and is involved in 
Type rv  secretion systems (Winans et al,\996). TraG is specifically necessary for 
mating-pair stability and may be part of the conjugative channel. However, this is all 
speculation, especially considering the fact that the blast scores for insert 183 were not 
very significant with either the putative hypothetical membranal protein from M. 
tuberculosis (0.033) or TraG firom N. gonorrhoeae (0.41). Nevertheless, insert 183 was 
the second most prevalent 81116-specific DNA amongst the randomly chosen C. jejuni 
strains (Table 3.2) and identification of the full gene sequence would give insights to the 
true function of this predominantly conserved region of DNA.
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3.2.10.8 DNA sequences with no DNA similarities in the database
Of the 81116-specific inserts that were identified 21.7 % (6/23 sequences) had no 
significant homologies to anything else in the databases searched. This is consistent with 
data from the NCTCI 1168 genome sequence in which there is no functional information 
for 22.2 % of the 1,654 predicted coding regions (Parkhill, et ah, 2000). Therefore, it 
would not be surprising for other C. jejuni strains also to encode novel genes that are 
unique to this species or indeed strain!
Of these six C. jejuni inserts, insert 50 is the most intriguing; not only because it is 
predicted to be a membranal protein but it was also found to hybridise to all the C. jejuni 
strains tested, except strain NCTCI 1168 (Table 3.2). Identification of the full gene 
sequence for insert 50 may give clues about its function. Moreover, the generation and 
characterisation of a mutant will confirm whether the gene for insert 50 has a role in 
chicken colonisation.
3.2.10.9 Relationships between strains using the southern blot data
One final interesting observation from the Southern blot analysis was the identical 
banding profiles observed for C. jejuni strains 99/312 and strain 99/322. This suggested 
that the genomic arrangement, of inserts 50, 68, 135 and 202, may be identical in these 
two strains, and consequently the two strains might be genetically related. Interestingly 
strain 99/312 was from the faeces of a cow whereas strain 99/322 came from human 
faeces. This suggests that cows are a general reservoir of human infections. Both AFLP 
and MLST data indicate an overlap in these two populations (Manning et al., 2003; 
Schouls et al., 2003), however, more analysis is required between the two isolates to 
determine whether there is significant genetic similarity. The genomic DNA from the 
remaining nine strains gave different hybridisation patterns when probed with the 23 
81116-specific DNA fragments. This further confirmed the genomic diversity observed 
within the C. jejuni species as indicated by many other methods including DNA arrays, 
PFGE and AFLP (Owen et al, 1997; Dorrell et al, 2001; Schouls et al, 2003).
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3.2.11 Conclusions
Genomic subtractive hybridisation has successfully identified DNAs present in the 
efficient colonising strain 81116, that were absent or substantially different in the poorer 
colonising strain NCTCI 1168. All of these 81116-specific DNA fragments were screened 
against the genome contigs of a second C. jejuni strain, RM 1221 rhttn://www.tigr.org/), 
to identify the full gene sequence, indication of genomic location of the gene and 
potential mechanism for its absence in strain NCTCI 1168 (Chapter 4). Furthermore, the 
81116-specific DNAs known as inserts 50 (Chapter 5) and 236 (Chapter 6) were 
hypothesised to be putative chicken colonisation factors and therefore further 
characterised.
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CHAPTER FOUR
Comparative genomics in C. jejuni : 
an insight into the mechanisms 
of genomic diversity
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4.1 Introduction
Epidemiological studies on large numbers of C. jejuni isolates have shown a high 
degree of phenotypic and genotypic diversity (Owen et al, 1997; Wassenaar and 
Blaser, 1999; Lindstedt et al, 2000; Dingle et al, 2001). It seems likely that such 
diversity is reflected in phenotypic variation in the colonisation and disease-causing 
potentials of different strains. Strain NCTCI 1168 genome microarray comparisons 
with other C. jejuni strains have revealed that a substantial amount of the genome 
(-80%) contains the core set of essential genes that determine the characteristics of all 
members of the species (Dorrell., et al, 2001). However, the remaining 20% of genes 
were either different or absent. Along with sequence variations, genes or entire gene 
clusters can be absent from different strains of C. jejuni (Dorrell et al, 2001; 
Harrington et al, 1997; Zhang et al, 2000). Hence it is likely that the genome 
sequenced strain of C. jejuni, NCTCI 1168 (Parkhill et al, 2000), only partially 
reflects the genetic diversity found vyithin the C. jejuni species.
The earlier subtractive hybridisation study (Chapter 3) between strains NCTCI 1168 
and 81116 not only revealed sequence divergence between these 2 strains but also 
identified potential genes present in 81116 which are not present in NCTCI 1168. 
Recently the availability of a second C. jejuni genome sequence, for strain RM 1221 
(preliminary data in the form of 19 contigs, kindly provided by The Institute of 
Genomic Research (TIGR), http://www.tigr.org/, and accomplished with support from 
United States Department of Agriculture), although not complete, has allowed further 
comparisons and analysis of these 81116-specific DNA fragments. Five of the 81116- 
specific DNA fragments showed identity to DNA in strain RM 1221. The information 
from strain RM1221 was used to further characterise each of the inserts, their possible 
location in the genome and potential mechanisms for their absence in strain 
NCTCI 1168.
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4.2 Results and discussion
Previously, subtractive hybridisation between C. jejuni strains NCTCI 1168 and 
81116 revealed 23 DNA fragments which were 81116-specific and not present in 
NCTCI 1168 (Chapter 3). Sequence comparisons revealed five of the 81116-specific 
DNA fragments, insert 31 (232 bp), insert 50 (124 bp), insert 183 (195 bp), insert 186 
(196 bp) and insert 188 (163 bp) to also be present in strain RM 1221. Insert 31 was 
found to be part of a heavy metal efflux gene predicted to be involved in arsenite 
export {arsB) (1050 bp); insert 186 was part of an arsenate reductase gene {arsC) (420 
bp); insert 50 had similarity to a di- and tri-peptide transporter gene (dtpT) (1551 bp); 
insert 188 was part of a gene with similarity to CJ0033 from C  jejuni strain 
NCTCI 1168 (CJ0033B) (2454 bp); and insert 183 was part of a transfer gene (jraG) 
(1602 bp) located within a 50 kbp genetic island. The findings are summarised in 
Table 4.1a. The genome organisation of each of these genes in strain RM1221 was 
compared to that in the genome of strain NCTCI 1168 and the results were 
extrapolated to the genome of strain 81116. This has provided insight into a potential 
mechanism that C. jejuni may exploit for generating genomic diversity.
4.2.1 Arsenic operon
The heavy metal efflux protein predicted to be involved in arsenite export (ArsB) 
from strain RM 1221 had 47 % amino acid identity to ArsB from Listeria innocua. 
The arsenate reductase (ArsC) from RM 1221 had 46 % amino acid identity to ArsC 
from Clostridium acetobutylicum. PCR using primers derived from the RM1221 
genome confirmed the same sizes of products and suggested that the arrangement in 
strain 81116 was the same (Figure 4.1). The arsB and arsC genes had a 4 bp overlap, 
were in different reading frames and had an average G+C ratio of 32 %. Each gene in 
the arsRBC operon had its own rbs predicted just upstream (approximately -5) of 
their start codon. A promoter sequence upstream of arsR and a transcriptional 
terminator downstream of arsB were also predicted. The putative arsRBC operon in 
the genome of strain RM 1221 contained an additional hypothetical 50 amino acid 
peptide, Cjl562, but its role in arsenic resistance has yet to be established. Strain 
NCTCI 1168 contains arsR and Cjl562 in the same genomic location as in strain 
RM1221. However, arsBC were absent from the genome of strain NCTCI 1168. 
Furthermore, there was a 7 bp direct repeat sequence (DR) (5’- aaa tga a -3’) flanking
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Table 4.1 (a) Summaiy of the genes identified in strain RM1221 that were originally 
identified in strain 81116.
Clone Locus* Size Amino Acid Identity Closest Homology Blast Score
Number (bp) (Similarity) in Database
31 . 800621-
801670
1050 47 % (65 %) arsB
L. innocua 
NP_569192.1
le-78
186 801658-
802077
420 46 % (67 %) arsC C. acetobutylicum 
NP_149268.1
2e-26
50
1606471-
1608021
1551 34 % (50 %) (ApT B. subtilis 
NP_388249.1
8e-69
188 604529-
606982
2454 32 % (50 %) Q0033 C. jejuni 
NP_281255.1
le-27
183 1271251-
1272852
1602 21 % (41 %) traG
N. gonorrhoeae 
AF374415_2
3e-14
* Note that the RM1221 genome sequence data (received May 2003) may contain errors or be 
incomplete and therefore should be regarded as preliminary.
(b) Genes identified within the 50 kbp island in strain RM 1221,
1277018- 699 31%(51%)xgrC C. jejuni 3e-20
1277716 (Cj0863c) NP_282024.1
1257443 - 1152 29 % (48 %) traC
S. typhimurium
le-37
1258594 BAA77998.1
1239217- 1254 26%(49%)vgrG P. aeruginosa 3e-14
1240470 NP_248785.1
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Figure 4.1
(a) The products of PCR primers suggested that the arsB and arsC arrangement in strains 
RM 1221 and 81116 was the same (as shown by the 1.4 kb predicted PCR product below on a 
1 % (w/v) agarose gel). Both genes were absent in strain NCTCI 1168. (b) The gene 
arrangement of the putative arsenic genes in strains RM1221 and 81116. There is a short 7 bp 
DR (5’- aaa tga a -3’) flanking arsBC. Arrows denote direction of transcription.
(a)
1.4 kb
(b)
44i
Tsr
DR DR
0.5 kbp
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arsBC in strain RM1221, whilst in strain NCTCI 1168, the intergenic region between 
CJ1562 and Cjl563 contained one copy of this 7 bp DR.
Comparison of the genome for strains 81116 (or RM1221) and NCTCI 1168 has 
identified the arsenic regulator (arsR) gene to be located in a similar genomic region. 
It therefore seems likely that the arsBC genes were lost from strain NCTCI 1168 
rather than a random insertion event occurring in strains 81116. In addition, the 
presence of a 7 bp DR sequence flanking the ends of arsBC in strain 81116 (Figure
4.1) has been used to hypothesise that a spontaneous deletion may have occurred in 
strain NCTCI 1168 by recombination between the DRs. As a consequence arsBC was 
lost from the genome of strain NCTCI 1168, leaving behind a single copy of the 7 bp 
DR between CJ1562 and CJ1563. The role of this putative arsenic operon in C. jejuni 
is debatable and awaits further characterisation. However, some idea of its function 
may be gained by examining other bacteria. This has already been discussed earlier in 
Section 3.2.16. Nevertheless, without a selective pressure the arsenic operon may no 
longer be required by C. jejuni and as a consequence was deleted from the genome.
4.2.2 Di- and tri-peptide transporter
The di- and tri-peptide transporter protein (DtpT) from strains 81116 and RM 1221 
both had 34 % amino acid identity to DtpT in Bacillus subtilis. This particular gene 
was absent from strain NCTCI 1168. The DNA sequence obtained from strain 81116 
by chromosomal walking using primer If43 (see Section 5.2.1 for more details), 
identified the full gene sequence and adjacent genes. This organisation was found to 
be the same in strain RM1221. The dtpT gene in both cases was predicted to have a 
ribosomal binding site and a promotor sequence. The average G+C ratio of 30.6 % 
was typical for C. jejuni DNA. Interestingly, the 3’ end 200 bp sequence of dtpT was 
identical to that of Cj0654c, a pseudogene resembling a transmembrane transporter in 
strain NCTCI 1168. However, in strains 81116 and RM1221, this 200 bp of sequence 
was not present in Cj0654c but instead was only present in the 3’ end of dtpT (Figure
4.2). Moreover, a 33 bp DR flanked the dtpT sequence in strains 81116 and RM1221. 
Strain NCTCI 1168 only contained one copy of the 33 bp DR in Cj0654c.
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Figure 4.2
Gene location of dtpT in the genome of strains 81116 and RM 1221. The dashed lines show 
the position of dtpT in comparison with strain NCTC 11168. Homologous recombination 
mediated through terminal direct repeat (DR) sequences (5’gca ctt get aca aac caa agt ccc atg 
act tga 3’) has possibly led to a deletion mutation in strain NCTCI 1168 whilst leaving behind 
one copy o f the DR sequence. Arrows denote direction o f transcription.
DR
o f
NCTC 11168
A
81116
RM1221
DR DR
1.0 kbp
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It is also tempting to speculate that strain NCTCI 1168 has lost dtpA by 
recombination, mediated by the 33 bp DR’s (Figure 4.2). Such events are well 
recognised in other bacteria (Mollet and Delly, 1990; Groenen et al, 1993; Sumegi et 
al, 1997). Interestingly, there are a large number of putative transporters in strain 
NCTCI 1168, a high proportion of which have similarities to proteins in other 
organisms, whilst the remainder appear to have conserved ATP-binding cassette 
(ABC) component protein motifs (Parkhill et al, 2000) The ABC-type peptide 
transporters are the most thoroughly characterised peptide-transport systems (Higgins,
2001). They are composed of multiple proteins, typically consisting two integral 
membrane proteins (permeases) each having six transmembrane segments, two 
peripheral membrane proteins that bind and hydrolyse ATP and a periplasmic (or 
lipoprotein) substrate-binding protein (Tomii and Kanehisa, 1998). However, DtpT 
from C. jejuni did not share any distinguishing characteristics with the ABC-type 
family of transporters. Instead, it has a high degree of similarity to the geptide 
transport (PTR) family. The PTR family is composed of a single protein containing 
multiple transmembrane segments that forms a channel across the cytoplasmic 
membrane. In Lactococcus lactis, the product of the dtpT gene has been shown to 
catalyze the proton motive force-driven peptide uptake and appears to be specific for 
di- and tripeptides (Hagting et al, 1994; Fang et al, 2000). The principal function of 
DtpT is thought to be utilisation of peptides, as an amino acid source, in environments 
that contain a low concentration of free amino acids. Such environments include meat 
products (VerheuI et al, 1998).
4.2.3 Cj0033 intra-specific gene variation
The putative integral membrane protein with an unknown function (CJ0033B) from 
strain RM1221 had 32 % amino acid identity to Cj0033 in C. jejuni strain 
NCTCI 1168. Even though the amino acid identity between Cj0033B and Cj0033 was 
low, no other protein similarity was identified in the public databases. The G+C ratio 
of Cj0033B was 23 %, which was relatively low for the species average (30.6 %). 
Surprisingly, there was little similarity between Cj0033 and Cj0033B sequences at the 
DNA level, except for the fact that the G+C ratio was similar (24 % for Cj0033). 
Furthermore, DNA equivalent to that found for insert 188 (Cj0033B) was located 
between Cj0032 and Cj0034c in strain RM 1221. However, in strain 81116 the DNA
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between Cj0032 and Cj0034c was identified as Cj0033 and did not contain the DNA 
identified for Cj0033B. This suggested that in strain 81116, Cj0033B was located 
elsewhere on the genome. Chromosomal walking using strain 81116 genomic DNA 
with primers derived from Cj0033B in strain RM 1221, is required to identify the 
genomic location of the DNA for insert 188.
The low amino acid identity between Cj0033B and Cj0033 suggests that these 
proteins may belong to a family of C. jejuni-specific membranal proteins that contain 
a conserved amino acid motif. The sequence variability observed in these genes may 
be due to either different functional roles, or antigenic variation for immune evasion. 
It can be speculated that in strain RM 1221, Cj0033 has been replaced with Cj0033B 
by some, as yet unknown, mechanism. However, strain 81116 does appear to contain 
both Cj0033 and Cj0033B. Cj0033 is located between Cj0032 and Cj0034c (as in 
NCTCI 1168) and Cj0033B is located elsewhere in the genome of strain 81116. 
Interestingly, the upstream gene, Cj0032, contained a polymorphic tract, which may 
make the product of Cj0033 and Cj0033B susceptible to phase variation. In strain 
NCTCI 1168 these homopolymorphic tracts were grouped mainly in three regions; the 
LOS/LPS, flagellar and capsular biosynthesis clusters, all of which are recognised 
regions of genetic instability possibly associated with antigenic variation. Such 
clustering has also been reported in the genomes of Neisseria meningitidis (Saunders 
et al, 2000), Chlamydia pneumonia (Viratyosin et al, 2002), N. gonorrhoeae (Shafer 
et a l, 2002; Jonsson et al, 1991) and Helicobacter pylori (Tomb et al, 1997). The 
role of Cj0033B in colonisation by C. Jejuni is, therefore, worth further investigation.
4.2.4 The 50 kb island
Finally, the transfer protein (TraG) from strain RM 1221 had 21 % amino acid identity 
to TraG from N  gonorrhoeae. Primer If47 derived firom insert 183 and primer Ifl23 
derived from the RM 1221 traG region were used to amplify and sequence a 
homologous 1.5 kbp region in strain 81116 (data not shown). A comparison between 
the two strains revealed numerous point mutations within the sequences. The identity 
of this region between strains 81116 and RM 1221, at the DNA and amino acid levels 
was 95% and 74 %, respectively. Interestingly, the traG gene was found within a 
50,791 bp island in strain RM1221 (Figure 4.3). This island was absent from strain 
NCTCI 1168. The island is flanked by a 18 bp DR (5’-TCCTCTTGAGCGCACCAT-
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Figure 4.3
The traG gene was found to belong to a 50, 791 bp island in strain RM 1221. The island is 
flanked by a 18bp DR (5’-TCCTCTTGAGCGCACCAT-3’) and one copy of the 18 bp DR is 
part of the arginine tRNA molecule located between genes CjlOl 1 and CJ1012. There are 44 
ORFs predicted for the region of which the majority have unknown functions. Nevertheless, 
the ORFs with predicted functions, xerC, traG traC and vgrG are shown. The arrows denote 
the direction o f transcription.
6#
10 bp 
G/C tract
. /
DR
CDS- CDS +
10.0 kbp
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3’), which may have facilitated the initial integration of the island into the bacterial 
chromosome. In strain RM 1221, one copy of the 18 bp DR is part of the arginine 
tRNA molecule located between genes CjlOll and Cjl012. Furthermore, there was 
an ORF predicted to code for an integrase/recombinase (xerC) located within the 
island adjacent to the integration site in strain RM1221 (Table 4.1b). However, there 
was no evidence for the presence of an exeisionase gene. Interestingly, xerC was also 
potentially subject to phase variation due to a 10 bp polymorphic tract. There was also 
an ORF coding for a vgrG gene (Table 4.1b), also called a ‘recombination hot spot’ 
(Rhs) accessory genetie element. The product of this gene had 26 % amino acid 
identity to VgrG from P. aeruginosa. In E. coli such elements were located on the 
PAIs of strains J96 and 536 (Blum et al, 1994; Blum et al, 1995; Swenson et al,
1996).
Annotation of the island in strain RM 1221 has predicted that it is composed of 44 
ORFs, the majority of which have unknown functions (Figure 4.4). The genes within 
this island appear to be roughly organised in two regions, divergently transcribed 
from near the centre of the island (-24 kbp in Figure 4.4), which might imply that this 
50 kb length of DNA was once a plasmid. However, no origin of replication was 
identified. Indeed, a number of ORFs in the island have similarity to transfer (tra) 
genes from other bacteria, which encode the transfer machinery on conjugative 
plasmids or are involved in Type IV secretion systems (Winans et al, 1996). TraG is 
necessary for mating-pair stability and was hypothesised to be part of the conjugative 
channel (Frost et al, 1994). The other transfer protein, TraC (Table 4.1b), was 
predicted to have a role in assembly of conjugative pili (Schmidt-Eisenlohr et al, 
1999). A variable genetic island specific to N. gonorrhoeae was also found to encode 
traG and absence of this gene in strains was indicative of the absence of the island 
(Dillard and Seifert, 2001). Thus it would be interesting to see if the presence of traG 
in C. jejuni strains could be used as a predictive indicator of the C. jejuni island. To 
date, traG DNA has been found in 8 out of 12 C. jejuni strains screened (Chapter 3), 
including strain RM 1221, suggesting that this island might be relatively common in 
the C. jejuni species. Further investigation of the role of this island in C. jejuni is 
required.
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Figure 4.4
A GenomeAtlas plot o f the putative genomic island found in C. jejuni strain RM1221, kindly 
provided by David W. Ussery, Centre for Biological Sequence Analysis, Technical University 
o f Denmark, Lyngby, Denmark . The first three rows (A-C) are DNA structural features; row 
D is the location o f predicted genes (blue genes are transcribed on the same strand, red genes 
are on the other DNA strand); rows E and F are o f global Direct and Inverted repeats, 
respectively; lane G is the GC skew, and lane H is the AT content.
The structural features are related to unwinding o f the DNA double helix. The intrinsic 
curvature predicts promoter sequences since greater DNA curvature is found in promoter 
sequences than ORFs. In addition, the higher DNA curvature also predicts terminator sites. 
Position preference and DNAase I sensitivity are both measures o f DNA flexibility and such 
periodic flexibility is thought to enhance curvature o f DNA. The less negative stacking energy 
indicates a less stable DNA sequence i.e. DNA meltability. Therefore AT-rich DNA 
sequences which have a lower negative stacking energy are more readily denatured. Thus the 
trend for promoter DNA is greater intrinsic curvature, less stacking energy and less flexibility.
The GC skew looks at the bias towards GC bases in the synonomous position (third base 
position) o f codons. Anomalies in GC skew and the presence o f  large repetitive DNA (direct 
or inverted) sequences indicates high genetic plasticity.
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The association of genomic islands (gene clusters of potential horizontal origin in a 
prokaryotic genome) with tRNA genes, has also been seen for pathogenic islands 
(PAIs) in E. coli, Y  enterolitica and S. Typhimurium (Blum et al, 1994; McDaniel et 
al, 1995; Camiel et al, 1996; Shea et al, 1996). PAIs comprise of large DNA 
regions (often greater than 30 kbp of DNA) and often carry more than one virulence 
gene, the G+C content of which often differ from those of the remaining bacterial 
genome (Hacker et al, 1997). Generally, PAIs are present in pathogenic strains, and 
absence or sporadic distribution in less-pathogenic strains of one species or a related 
species. PAIs represent compact, distinct genetic units, often flanked by DRs. They 
are frequently associated with tRNA genes and/or insertion sequences (ISs) at their 
boundaries, and also contain ‘mobility’ genes (integrases, ISs, transposases, and/or 
origins of plasmid replication). The presence of these ‘mobility’ genes often leads to 
their instability within the genome, resulting in rearrangements, sequential deletions 
or even loss of the PAL However, the high number of mutations that can occur in 
these ‘mobility’ genes, often leading to stop codons, may consequently result in their 
stability within the genome.
In E. coli, it has been speculated that the PAI-I, PAI-II and ‘locus of enterocyte 
effacing island’ (LEE or PAI-III) were inserted into such tRNA loci where prophages 
were known to integrate (Blum et al, 1994). The presence of an ORF, predicted to 
code for an integrase/recombinase (xerC), located within the 50 kbp genomic island 
and adjacent to this putative integration site in strain RM1221 (Figure 4.3) supports 
the suggestion that this region is PAI-like. In such a location the flanking DRs may 
act as targets for specific recombinases, thereby facilitating rearrangements. The 
recombinases in E. coli {xerC) and in P. aeruginosa {sss) encode proteins that belong 
to the lambda integrase family of site-specific recombinases, which play a role in 
phase variation caused by DNA rearrangements (Blakely et al, 1993; Dekkers et al, 
1998). In C. jejuni, the polymorphic tract upstream of xerC may have a similar role.
In strain NOTCH 168, there was a single copy of the 18 bp DR in the same tRNA 
locus as in strain RM 1221, but no island was detected. This observation suggested 
that strain NCTCl 1168 may have lost the island during its evolution. The island has a 
G+C ratio of 26 % which is less than the average predicted for C. jejuni species, once 
again suggesting horizontal transfer. Unfortunately, PCR amplification of a similar
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potential island from strain 81116 was hampered by the presence of a large number of 
inverted repeats throughout the 50 kb region. Such repeats may render the 50kb island 
unstable and sensitive to multiple rearrangements by homologous recombination, 
deletions and duplications. Furthermore, the presence of the terminal DRs may cause 
additional instability. The E. coli PAI-I and PAI-II are flanked by a 16 bp and 18 bp 
DR, respectively. These PAIs may be deleted from the chromosome to subsequently 
leave one copy of the DR in the PAI-negative strains (Hacker et al, 1990). 
Conversely, the enteropathogenic E. coli LEE island and the S. Typhimurium 40 kb 
PAI have no obvious terminal DRs or insertion sequence (IS) elements and lack of 
such elements may account for their relative stability within their bacterial genomes 
(McDaniel a/., 1995; Mills 1995).
4.2.5 Conclusions
Genes no longer beneficial to an organism may become superfluous and will be 
eventually lost by the accumulation of mutations and deletions. In the genome of C. 
jejuni strain NCTCl 1168, at least 20 of the 1, 654 predicted coding sequences (CDS) 
probably represent pseudogenes (Parkhill et al, 2000), which may once have been 
functional genes that, over time, have accumulated mutations due to lack of selection 
pressure. Such changes may have occurred as a result of variations in environmental 
exposure. In contrast, such deleterious effects may be balanced by genomic gains 
made through horizontal transfer. The acquisition of new genes following horizontal 
gene transfer can result in the generation of variants of pathogens. For example the 
acquisition of LEE in enteropathogenic E. coli has been found to induce ‘attaching 
and effacing’ (AE) lesions (McDaniel et al, 1995), whilst the presence of PAI-I or 
PAI-II in uropathogenic E.coli causes hemolysis (Blum et al, 1994). Similarly, the 
Salmonella pathogenicity islands (SPIs) are necessary for invasion of Salmonella into 
epithelial cells (SPI-I) or essential for survival within macrophages (SPI-II) (Shea et 
al, 1996; Mills et al, 1995). The identification of a 50kb insert into the C. jejuni 
genome, with at least some of the properties of a putative pathogenicity island is, 
therefore, an interesting observation. Work on this C  jejuni genetic island will 
continue to be investigated to establish whether it has a role in pathogenesis or some 
other function in C. jejuni. In other bacteria, non-pathogenic genomic islands have 
encoded metabolic pathways for the degradation of chlorobenzene, catabolism of
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aromatic compounds, antibiotic resistance or genes involved in natural transformation 
(Dillard and Seifert, 2001; Ito et al, 2003; Muller et al, 2003; Sentchilo et al, 2003).
Clearly, the results presented here and elsewhere (Dorrell et al, 2001) demonstrate 
the extensive genetic diversity within the C. jejuni species. The observations suggest 
that the tRNA loci and the occurrence of direct repeats in C. jejuni play key roles in 
the generation of this genetic diversity and therefore the evolution of this species. 
Gene acquisition and deletion, as well as DNA rearrangements, may all contribute to 
this. The generation of new genetic variants may play a role in the adaptation of the 
bacteria to different environments or colonisation of new hosts. Further work is 
needed to investigate this hypothesis.
Previous studies have demonstrated that the integration of DNA into the 
Campylobacter genome can occur by homologous recombination, following the 
introduction of DNA with as little as 202 bp of homologous sequence by 
transformation (Wassenaar et al, 1993; Bâillon et al, 1999; Richardson and Park,
1997). However the frequency of recombination was found to increase with longer 
homologous DNA sequence stretches. Furthermore, previous work on C. coli has 
showed that some strains can take up non-replicating plasmids and splice them 
directly into the chromosome with little or no DNA homology and was, therefore, 
described as illegitimate (Richardson and Park, 1997). Although the mechanism has 
not been fully elucidated, it may be associated with efficient DNA repair mechanisms 
and with ligation of linear DNA fragments into the genome.
Recently, chromosomal plasticity regions have been identified for C. jejuni Such 
regions, where the variable genes were often presented as large clusters in the 
genome, appear to be acquired or lost from the genome in groups during evolution 
(Pearson et al, 2003). Unlike the variable gene clusters (genomic and pathogenicity 
islands) found in the genomes of E. coli and Salmonella, the plasticity regions 
identified for C. jejuni do not have a markedly different G+C content to the bulk of 
the genome. In addition, they are not associated with mobile elements (insertion 
sequences or transposons) important in horizontal DNA transfer. Transposons or 
transposable elements are another major cause of genetic variations in bacteria, which 
to date have not been identified in Campylobacters. Nevertheless, transposons encode
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not only the function necessary for transposition, but also, functions unrelated to 
transposition; for example antibiotic resistance genes, toxin production genes, 
metabolic genes (Blot, 1994). Such transposition does not require extensive DNA 
homology between the transposable element and its target site in the prokaryotic 
genome. Moreover, the transposition event itself can promote rearrangements of the 
genome. Finally, horizontal transfer by plasmids or phages may also play a role in the 
creation new genetic variants (Finlay and Falkow, 1997). Genetic determinants can be 
disseminated to other bacteria by bacterial conjugation (transfer of DNA from donor 
to recipient while the cells are in physical contact), transformation (take up of 
exogenous DNA) and transduction (virus-mediated transfer of DNA).
In this study, analysis of C. jejuni genes, identified by subtractive hybridisation as not 
present in the original genome sequenced strain, NCTCl I I 68 (Parkhill et al, 2000; 
Chapter 3) has provided significant insight into understanding the evolution of this 
bacterial species. In this way subtractive hybridisation has clearly contributed to the 
extension of the ‘species’ genome. Obviously, sequencing entire genomes from other 
strains is the optimal method of achieving this but is still constrained by cost and time 
resources
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CHAPTER FIVE
Characterisation of a strain-specific gene from 
C. jejuni encoding a member of the PTR family 
of peptide transporters
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5.1 Introduction
Of the six C  jejuni inserts identified by subtractive hybridisation (Chapter 3) as 
having no similarities to any genes in the database, insert 50 was the most intriguing, 
not only because it encoded a putative membrane protein but also because it was 
found to hybridise to a random selection of C. jejuni strains, but not strain 
NCTCl 1168 (Figure 3.9b). Furthermore, for one strain (94/194), isolated from 
chicken caeca, it was the only insert that hybridised to total genomic DNA (Table 
3.2). Interestingly, strain 94/194 colonises the chick model to the same extent as 
freshly isolated strains (K. J. Clow, personal communication) and therefore insert 50 
may be especially important in chicken colonisation.
The work described in this chapter was to obtain the remaining gene sequence for 
insert 50 in C. jejuni strain 81116 and to identify the gene. In addition, to clarify the 
role of this gene, a mutant was created in strain 81116 and the mutant was 
characterised.
5.2 Results and Discussion
5.2.1 Identification of the gene sequence for insert 50 by chromosomal walking
One of the limitations of PCR to analyse a region of interest is that it requires 
knowledge of flanking sequences in order to design primers. To overcome this, an 
adaptation of PCR using a single primer to a known DNA sequence has been used to 
successfully amplify adjacent unknown DNA sequence from genomic DNA (Screaton 
et al, 1993).
Initially, primer 1143 was designed to the DNA sequence from insert 50 (Fig 5.1). If43 
and genomic DNA from strain 81116 were used in three parallel PCR reactions at 
different annealing temperatures for 60 cycles. The products were then pooled and 
cleaned as described in section 2.6.5. A 1.2 kbp PCR product was observed on a 1% 
(w/v) agarose gel (Figure 5.1). This PCR product was DNA sequenced using primer 
1171. Searches against the NCTCl 1168 genome sequence (Parkhill et al, 2000), 
revealed the translated 1.2 kbp DNA from positions 950 to 1200 bp had 95% amino 
acid identity to Cj0654c. The remaining sequence was not present in the genome of
160
C hapter 5. C haracterisation  o f  a strain  specific gene from  C  jejim i encoding  a m em ber o f  the PTR
fam ily o f  transporters
Figure 5.1
(a) Genomic DNA from strain 81116 was used for chromosomal walking with a single primer, 
If43 and the PCR product was visualised on a 1% (w/v) agarose gel. Lane 1, 1.2 kbp PCR 
product; lane 2, 1 kbp DNA ladder (Gibco). (b) Sequencing with If71 identified the sequence 
flanking the 3’ end of insert 50. The product o f the 1.2 kbp DNA sequence from position 1 to 
619 has amino acid identity to a di- and tri-peptide transporter, and from position 950 to 1200 
has 98% identity to Cj0654c. Arrows denote direction of transcription.
(a)
-  0.5
(b)
lf43 lf71 
► ►
Insert 50 Unknown DNA sequence
<■ Di- and tri-peptide transporter CJ0654C
0.1 kb
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Strain NCTCl 1168. Similarity searches in the NCBI database identified the translated 
DNA between positions 1 to 619 had 43% amino acid identity to a di- and tri-peptide 
transporter (DtpT) from Listeria innocua (Blast score of 4e-32). To identify the 
remaining dtpT sequence and confirm the gene position between Cj0653c and 
Cj0654c, primers Ifl02 and Ifl03 were designed and used to amplify DNA from 
strain 81116. A 2 kbp PCR product was observed (Figure 5.2) from strain 81116. 
Incidentally, strain NCTCl 1168 produced the expected 0.3 kbp PCR product and an 
additional 0.5 kbp band with the same primers. The 0.5 kbp band was artefact and 
increasing the PCR annealing temperature may have prevented this band. DNA 
sequencing of the 2 kbp PCR product confirmed dtpT to be present between Cj0653c 
and Cj0654c in strain 81116.
The DNA sequence (Figure 5.3) obtained from chromosomal walking using strain 
81116 genomic DNA, revealed that insert 50 encoded part of a putative di- and tri­
peptide transporter (DtpT). The majority of peptide transporters that have been cloned 
and characterised to date have been found to be proteins of the ATP-binding cassette 
(ABC) family (Detmers et al, 2001). However, DtpT identified in C. jejuni had 
significant amino acid similarity to a relatively new family of peptide fransporters 
called the PTR family (Steiner et al, 1995). This group of proteins was uncovered by 
sequence analyses of a number of ABC and other various membrane transport 
proteins, and was found to comprise a distinct, separate group of proteins. ABC 
peptide transporters are multicomponent systems that consist of two transmembrane 
domains and two ATP binding domains (Detmers et al, 2001). They are encoded by 
an operon containing 3-5 genes. In addition to these proteins, the systems involved in 
peptide uptake into the cell employ a specific ligand binding protein or receptor to 
capture the peptide. In contrast, the PTR carriers comprise of a single polypeptide 
(Hagting et al, 1997; Nakajima et al, 1997). Some members of the PTR family have 
been identified on the basis of a protein database search and called are the POT family 
(for proton-dependent oligonucleotide transport) (Paulsen and Skurray, 1994). 
However, it is unknown whether all of the members of this family are proton- 
dependent or if they mediate transport of oligonucleotides and, therefore, the more 
generic designation PTR is often used.
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Figure 5.2
Genomic DNA from strain 81116 or NCTCl 1168 was used to amplify the DNA between 
Cj0653c and Cj0654c using primers ID02 and Ifl03. The PCR products were visualised on a 
1% (w/v) agarose gel. Lane 1, 3.5 kbp band was observed for strain 81116; lane 2, 0.3 kbp and 
0.5 kbp bands for strain NCTCl 1168, where the 0.5 kbp band was PCR artefact; lane 3, 1 kbp 
DNA ladder (Gibco). The results confirmed the presence o f additional DNA {dtpT gene) 
between Cj0653c and Cj0654c in strain 81116.
-  4.0
composite photograph
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Figure 5.3
The 1551 bp sequence of the C. jejuni dtpT gene. The amino acid sequence o f DtpT is shown 
beneath the nucleotide sequence. The predicted -10 and -35 region of the predicted 
promoter element and ribosomal binding sites (rbs) are shown in bold. The start codon of the 
next putative gene sequence, Cj0653c is shown. There does not appear to be a putative 
transcriptional terminator for dtpT.
CAAAATCACCAAAGTTGAAAATTGATCTAATATTTCTTTTTTTATATTTGCAAAAAAGTAACATTATGATATA?U^TCATT 8 0  
TAAAAATATTACAAAGTTATA CA TA TTTTTTA A TTTCTTG TCTATAATTTATAAATAAAAATACCCAAAGGATATAATTG 1 6 0
-35 -10 rbs M
AGTAAAAATGTAAAAAATTTAGATACTTCATTTTTTGGACATCCAAAACCACTTTTATCTCTTTCACTCACTGAGCTTTG 2 4 0  
S K N V K N L D T S F F G H P K P L L S L S L T E L W  
GGAAAGATTTTCTTTTTACGGAATTCGTCCCTTGCTTTACCTTTTTATGATAGCAAGTTTTGAAAAAAGTGGAATGAACT 3 2 0  
E R F S F Y G I R P L L Y L F M I A S F E K S G M N  
TAAAACCTGAAGAAGCAAGTGCAATTATGGGAATTTTTGCAAGTTGTTTATATCTTGCTGCTTTGCCAGGTGGATGGCTT 4 0 0  
L K P E E A S A I M G I F A S C L Y L A A L P G G W L  
GCGGATAATTACTTAGGACAAAAAAGAGCAATTTTACTAGGTGCTTTAACTATAGCATTTGGACATTTGTGCATAGCCTT 4 8 0  
A D N Y L G Q K R A I L L G ' A L T I A F G H L C I A F  
TTCTTATTTTAACAATAAAATAATTTTTGTTGGTATGGTTTTTTTGGTTATAGGTACAGGACTTTTTAAAACTTGTGCTT 5 6 0  
S Y F N N K M I F V G M V F L V I G T G L F K T C A  
CTGTAATGGTTGGAATGCTTTATAAAAAAAATGATGCAAGGCGTGACTCTGGTTTTACTCTTTTTTATATGTGCTTTAAT 6 4 0  
S V M V G M L Y K K N D A R R D S G F T L F Y M C F N  
TTTGGTGCTTTTGTAGCTCCTTTAATTTGCGGCTTTTTACAAAAAGAATACGGATGGCATTTTGGTTTTGGTGCAGGTGG 7 2 0  
F G A F V A P L I C G F L Q K E Y G W H F G F G A G G  
GATTGGTATGCTTTTAGCGGTAATTATTTTCTACCTAAAAACTATGCCTGATTTAAAAGAATTTGATGAAAAAGTTGGCA 8 0 0  
I G M L L A V I I F Y L K T M P D L K E F D E K V G  
TAGACTCTACTTGGGATAGACCAAGCAAAAAAAGCAAAAACGCATTTTACATCATCATTGTATCAGGTATTGTTTTGCTT 8 8 0  
I D S T W D R P S K K S K N A F Y I I I V S G I V L L  
GGAGCAATATTTTTAATCCTTGGTGGTTTTATAAAATTAGATGCACAAGTTATTAATAAAAATATTATTCTAACTATCTT 9 6 0  
G A I F L I L G G F I K L D A Q V I N K N I I L T I L  
AGCTTGTGCTGGAATTTATTTTTTATATCTTTTCGCTTTTACTTCTTTAAAAATAGAAGAAAAAAGAAATTTAATTATTT 1 0 4 0  
A C A G I Y F L Y L F A F T S L K I E E K R N L I  I  
TTATTGTTTTATTTTTAGCGGCTGCGGTATTTTGGTCAGTATATGAGCAACAATACACTTCTTTTAATTTTTTTGCAGAA 1 1 2  0 
F I V L F L A A A V F W S V Y E Q Q Y T S F N F F A E  
AAATTAACGGATAAAACCATATTAAATTATGAAATTCCTACAATATGGTTTCAATCTCTTGGAGGTTTATTTGTTATACT 1 2 0 0  
K L T D K T I L N Y E I P T I W F Q S L G G L F V I L  
TTTTGCACCTTTTAGTGCTTTTATATGGACTATATGTGCCAAAAATAATAAAGAAATTTCATCTATTATTAAATTTGCAT 1 2 8 0  
F A P F S A F I W T I C A K N N K E I S S I  I  K F A 
TAGGACTTTTGGGTGCAGCTTTGGCATTTTTAATAATGGCTTTAGCTTCAAATCATGCAATTAGTTTAAATGGCGATGCT 1 3 6 0  
L G L L G A A L A F L I M A L A S N H A I S L N G D A  
AATACATTAAGAGAAAATTTAGAAAATTCATCACAAATTATTTTAGTTTCACCTTGGTGGCTTGTCAGTAGCTTTTTGCT 1 4 4 0  
N T L R E N L E N S S Q I I L V S P W W L V S S F L L  
TATGGTTTTAGGAGAGCTTTGCCTTTCCCCTGTGGGACTTTCTATAATGACAAAAATTGCACCTAATTTAATTAAATCTC 1 5 2 0  
M V L G E L C L S P V G L S I M T K I A P N L I K S  
AAGTCATGGGACCTTGGTTTGTAGCAAGTGCATTAGGCAATGCTTTAGCTGGATTCATAGGTGGTAAAGCAAGTGAAGAA 1 6 0 0  
Q V M G P W F V A S A L G N A L A G F I G G K A S E E  
AATATAGCTTATTTGCCAAATTTATTTTACCAATGTATGTGGATATTACTTGGTGGGGTTATAATTTGGCTTATAGTCAA 1 6 8 0  
N I A Y L P N L F Y Q C M W I L L G G V I I W L I V K  
AAAACCTATCAATAAAATACTAAAAAATTAATATTAAGGAGAAAATATGAGTATTTACAAACAAAGAGTATTAGAACTTA 1 7 6 0  
K P I N K I L K N *  r b s  M
GAAGATTAATGAAAGAAAATAATATTGACGCCTATCTCATCTTAAGCGCGGATCCGCATTTGAGCGAATATTTACCAGAA 1 8 4 0  
TATTACAAAAACAGAGTCTTTATCAGTGGCTTTAAGGGTTCTGTTGGAACAGTTCTTATCACACAAGAAGAGGGCTTTTT 1 9 2 0  
GTGGGTAGATGGAAGATATTGGCTTCAAGCACAAAAG 1 9 5 7
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The PTR proteins appear primarily in eukaryotic organisms including Saccharomyces 
cerevisiae (Perry et al, 1994), Candida albicans (Basrai et al, 1995), Arabidopsis 
thaliana (Steiner et a l, 1994), rabbit intestine (Fei et al, 1994) and human intestine 
(Liang et al, 1995). The transport of peptides in mammals, plants and yeast is I n ­
dependent and Na"^-independent. In contrast, most peptide transport systems in 
bacteria require phosphate energy for transport. Nevertheless, non-ABC-type peptide 
transporters have also been identified for prokaryotes (Hagting et al, 1984; Verheul et 
al, 1995; Nakajima et al, 1997). Despite the similarity in substrate between the ABC 
peptide transporter subfamily and the PTR subfamily, these two groups are essentially 
structurally unrelated. To date, the most fundamental difference appears to lie in the 
energetics. In addition, the ABC peptide transporters handle only a narrow range of 
peptides whilst the PTR family members have a broad spectrum of peptide-substrate 
specificity. The first bacterial non-ABC transporter was discovered in Lactococcus 
lactis, in which a di- and tripeptide transport protein (DtpT) was found to utilise a 
proton-motive force to drive peptide uptake. On the whole, bacterial peptide-transport 
systems have the ability to transport peptides up to six residues long while in 
eukaryotic organisms, except C. albicans, only peptides of chain length three or less 
are transported optimally. Furthermore, most eukaryotic cells appear to have a single 
peptide-transport system while in bacteria, multiple systems are often present.
The primary function of peptide transport, for most species of bacteria, fungi, plants 
and animals, is thought to be utilisation of peptides as amino acid and nitrogen 
sources, (Payne, 1980). The peptide transport system in mammalian intestinal 
epithelial cells is responsible for the absorption of the digestion end products of 
dietary proteins, mainly di- renal homeostasis and tripeptides (Mathews, 1987). Along 
with this, the transporters from mammalian renal epithelial cells uptake di- and 
tripeptides, which contributes to renal homeostasis (Daniel and Herget, 1997). In 
addition to being a nutrient source, bacterial peptide transporters can also serve other 
functions. Examples involve, recycling of cell wall peptides released fi*om the 
peptidoglycan during bacterial growth and reused for the synthesis of new cell wall 
material (Goodell and Higgins, 1987), involvement in bacterial chemotaxis (Higgins, 
1986; Kelly-Wintenberg and Montie, 1994) a bacterial accumulation of high levels of 
peptides at high osmolarity, such that they contribute to osmoregulation (Amezaga et 
al, 1995). Finally, microbial acquisition of nutrients is a central feature of host-
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parasite relationships, and bacterial pathogenicity is, in part, dependent on the 
availability and acquisition of nutrients. Investigation of the intracytoplasmic growth 
and virulence of L. monocytogenes auxotrophic mutants revealed that this food 
pathogen utilises intracellular peptides as a source for amino acids (Marquis et al, 
1993).
With all this evidence in mind, the putative DtpT protein of C. jejuni may play a role 
in establishing and maintaining colonisation in vivo through acquisition of intestinal 
di- and tripeptides, and thus contribute to the survival of the organism. The generation 
and characterisation of a dtp! mutant in C. jejuni strain 81116 will clarify whether the 
gene for insert 50 has a role in chicken colonisation, as previously predicted by the 
subtractive hybridisation work.
5.2.2 Bioinformatic characterisation of dtpT gene of C. jejuni
The DNA and predicted amino acid sequence for dtpT from strain 81116 is shown in 
Figure 5.3. Transcription of the 1551 bp dtpT gene is predicted to be initiated by a 
or rpoD promoter element and the typical -10 and -35 region is shown in Figure 5.3 
according to the proposed definition of a C. jejuni promotor (Wosten et al, 1998). 
Based on the presence of three conserved regions, the locations are approximately 10, 
16 and 35 bp upstream of the transcription start point in various strains. However, a 
more recent analysis of C. jejuni promotors, which used the whole genome sequence, 
suggests that C. jejuni contains a -35 region completely different from other known 
bacterial rpoD promotors and instead exhibits a strong periodic signal instead of a 
standard -35 box (Petersen et al, 2003). The predicted ribosomal binding site (rbs) 
for dtpT is at position -6. The start codon, TTG, rather than ATG is used to encode 
formylmethionine. However, no possible transcriptional terminator sequence was 
identified for the dtpT mRNA transcript, thus indicating that the downstream gene, 
Cj0653c was also transcribed from the dtpT promotor. As CJ0653 appears to have its 
own ribosomal binding site at position -6, and is predicted to be a putative 
aminopeptidase, most likely catalysing the removal of Xaa-Pro dipeptides (where Xaa 
denotes any amino acid residue) from the N-terminus of polypeptides and proteins 
(Rigolet et al, 2003), it seems likely that these genes may have evolved to be co­
regulated. Thus in strain 81116, DtpT may import both di- and tri-peptides into the
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cell and once internalised the aminopeptidase may hydrolyse the tripeptide, Xaa-Xaa- 
Pro to release Xaa and Xaa-Pro for C. jejuni to utilise.
The overall G+C content of dtpT is 30.63 %, which matches well with that of the 
genome of C. jejuni strain NCTCl 1168 (Parkhill et al, 2000). From the C. jejuni 
dtpT gene a primary amino acid sequence of the DtpT protein was deduced to be a 
517 amino acid protein with a molecular mass of 57470 Da and pi of 8.92, as 
calculated by the Protean program (DNAStar, Lasergene). Predict Protein has 
suggested the DtpT to contain a conserved domain that belongs to an integral 
membrane protein of the PTR2 family of transporters. Membrane topology profiling 
using Predict Protein has proposed ten hydrophobic (alpha helices) stretches in this 
protein. These are long enough to span the membrane in a zig-zag fashion with the 
amino- and carboxyl-termini located on the inside (Hagting et al, 1997). The putative 
DtpT transmembrane segments are shown by the amino acid positions in Figure 
5.4(a). However, the number of proposed hydrophobic stretches depends on the 
programme used to predict the topology of the protein and consequently the C. jejuni 
DtpT protein could be predicted to comprise of 10, 12 or 14 transmembranal regions 
(data not shown). More detailed studies are required to substantiate the topological 
model presented in Figure 5.4(b). Nevertheless, hydropathy analysis has indicated that 
each protein within the PTR family has numerous hydrophobic segments possibly 
divided into two clusters of five to seven domains similar to the uniporters 
(facilitative diffusion), symporters (ion cotransport), and antiporters (counter 
transport) (Steiner et al, 1995). Therefore, the ten a-helices predicted for C. jejuni 
DtpT may somehow associate to form a transmembrane channel (Figure 5.5). In 
prokaryotes, membrane spanning transporters typically contain a multiple of a - 
helices (generally 12) that align with each other in a circle to form a channel through 
the membrane (Tolner et al, 1995). The actual transport event involves a 
conformational change in the protein following binding of its substrate, the proton 
motive force drives the transporter and these events shuttle the compound across the 
membrane.
Comparison of the C. jejuni DtpT sequence with other bacterial orthologues, have 
shown most of the conservation at the N-terminal 200 amino acids (Figure 5.6).
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Figure 5.4
(a) Prediction of the membrane topology (http://cubic.bioc.columbia.edu/predictprotein) for the 
C. jejuni DtpT protein. The putative transmembrane-spanning segments (Ml to MIO), as well as 
the regions inside (i) and outside (o) of the membrane, are indicated by the amino acid positions 
of DtpT. (b) A diagrammatic secondary structure for DtpT.
Positions Segments Explanation
1-63 il inside region 1
64-81 Ml membrane helix 1
82- 93 ol outside region 1
94-118 M2 membrane helix 2
119-156 12 inside region 2
157-174 M3 membrane helix 3
175-182 o2 outside region 2
183-200 M4 membrane helix 4
201-294 13 inside region 3
295-312 M5 membrane helix 5
313-337 o3 outside region 3
338- 355 M6 membrane helix 6
356-380 14 inside region 4
381-398 M7 membrane helix 7
399-418 o4 outside region 4
419- 436 M8 membrane helix 8
437-458 15 inside region 5
459-476 M9 membrane helix 9
477- 486 o5 outside region 5
487-506 MIO membrane helix 10
507- 517 16 inside region 6
(a)
(b) OUT
COOHIN
Cytoplasmic
membrane
168
C h ap ter  5. C haracterisa tion  o f  a strain  specific gene from  C. jejuni encod ing  a  m em ber o f  the PT R
fam ily  o f  transporters
Figure 5.5
(a) Operational model predicted for the di- and tri-peptide transporter (DtpT) from C. jejuni. 
The ten a-helical domains (blue shading) are proposed to form a transmembrane pathway for 
peptide passage through the cytoplasmic membrane. The membrane exists in an energetically 
‘charged’ form in which a separation of protons from hydroxyl ions occurs across its surface. 
This energised state o f the membrane is known as the proton motive force and drives the energy 
requiring peptide transporter. The transmembrane electrochemical proton gradient is constantly 
being re-established through energy-yielding reactions, such as the activities o f the cytochrome 
complex (grey shading).
0—0
Cytoplasmic
membrane
Key:
Dipeptide
Tripeptide
A
Proton
H+and H+
Hydroxyl ion
OH-
A
H+ H
Î 1 i I
OH- OH- OH OH- OH OH- OH
Cytoplasm
A  IN H- H+
H* H. H
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Figure 5.6
Comparison of the predicted DtpT sequence from C jejuni with other bacterial orthologues
1 M S K N V K N L D T - - - - - - - - - S F F G H P K P L L S  C .je ju n i
1 M Q S S I N N T K T - - - - - - - - R T F F G H P Y P L S S  P. lu m in escem
1  M S - - - D K E Q L E K L - - - - D K S F L G Q P K G L A T  E nterococcus fa e c a lis
1 M S - - - T E K - - - - - - - - - E K T F F G H P R G L A T  L isteria  innocua
1 M A S S L T K D S V T P G T P G S E K T F F G H P R G L A T  S trep tom yces averm itilis
1 M A - - - S I D N E S I I K S V P Q K G F F G H P R G L F T  B acilis  sub tilis
H  — — — — — — — — — — — — — — — — — — — 'S' — Q — P — — jj — — Consensus
22 L S L T E L W E R F S F Y G I R P L L Y L F M I A S F E K S C. je ju n i
23 L F F T E M W E R F S Y Y G I R P L L I L F M A A T I Y D G P. lum inescens
24 L F F T E M W E R F S Y Y G M R A I L M Y Y I Y D T V A N G E nterococcus fa e c a lis
19 L F N T E F w E R F s Y Y G M R A I L I Y Y M Y Y S V S K G L isteria  innocua
31 L F M T E M w E R F s Y Y G M R A L L P L Y L - - - V A P G S trep tom yces averm itilis
28 L F F T E F w E R F s Y Y G M R A I L L Y Y L Y T E T V N G B acilis  sub tilis
L - - T E - w E R F s - Y G - R - - L - - - - - - - - - - - Consensus
52 G M N L K P E E A S A I M G I F A S C L Y L A A L P G G W L C .je ju n i
53 G M G I P R E Q A A A I V G I F A G S V Y L T A L P G G W L P. lum inescens
54 G L G L P K A T A L A I M S I Y G S M V F M S S I I G G W V E nterococcus fa e c a lis
49 G L G F S Q S T A T A I M S I Y G S L V F M S G V I G G w F L is ter ia  innocua
58 G L H L S A A T A T A I Y S V Y V S L V Y L L A L P G G w F S trep tom yces averm itilis
58 G L G F D K G T A V A I M S T Y G S L V Y M S T I I G G w L B acilis  sub tilis
G - - - - - - - A - A I - - - - - - - - - - - - - - G G w - Consensus
82 A D N Y L G Q K R A I L L G A L T I A F G H L C I A F S - Y C .je ju n i
83 A D N W L G Q R Q A V W Y G S I I I A L G H L S I A L S A F P. lum inescens
84 S D R V L G S R K T V F I G G L L I I A G H I V L A T P - F E nterococcus fa e c a lis
79 A D R V L G P R Q T I F Y G G V L I M V G H L V L A I P - S L is ter ia  innocua
88 A D R V L G P R K T V A V A G L I I M L G H L T L A L P - T S trep tom yces averm itilis
88 A D R V F G T A N T V F Y G G I F I M F G H I A L A Y P - - B acilis  sub tilis
- D - - - G - - - - - - - - - - - I - - G H - - - A - - - - Consensus
1 1 1 F N N K M I F V G M V F L V I G T G L F K T C A S V M V G M C .je ju n i
1 1 3 F S H Y L F F I G L L L I V L G T G L F K T C V T V M V G T P. lum inescens
1 13 G - V P A L F V S I M L I V F G T G M L K P N V S G M V G H E nterococcus fa e c a lis
108 G G A A A L F V S M A F I I L G T G L L K P N V S S V V G D L ister ia  innocua
117 S G T - - F F A G L G L V A I G S G L L K A N I S T M V G H S trep tom yces averm itilis
1 1 6 G S S I A F Y I S M V L I I V G T G L L K P N V s S V V G D B acilis  sub tilis
- - - - - - - - - - - - - - - G - G - - K - - - - - - V G - Consensus
1 4 1 L Y K - K N D A R R D S G F T L F Y M C F N F G A F V A P L C. je ju n i
143 L Y K - K D D P R R D G G F S L F Y M G I N I G S F I A P L P. lum inescens
1 42 L Y S - K T D L R R D A G F S I F Y M G I N I G A L I A P L E nterococcus fa e c a lis
138 L Y P - A G D N R R D A G F S I F Y M G I N L G A F I A P P L is ter ia  innocua
145 L Y D G P D D P R R D G G F T L F Y I G I N L G A F A A P L S trep tom yces averm itilis
146 L Y T - K E D P R R D S G F S I F Y M G I N L G G L L A P L B ac ilis  sub tilis
L Y - - - - D - R R D - G F - - F Y - - - N - G - - - A P - Consensus
PTR signature motif
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1 70 I C G F L Q K E Y G - W H F G F G A G G I G M L L A V I I F C .je ju n i
172 T T G L L V R D Y G - W H W G F G I G G L G M L V A L L I F P. lum inescens
1 71 V V G T L G Q E Y - N Y H L G F S V A A V G M F F G L L Q Y E nterococcus fa e c a lis
167 I V S N V S D H A G S F H A G F G V A A V G M A I A L V V Y L is ter ia  innocua
175 I I G T V G E N V - N W H L G F A L A A L G M A L G L A Q Y S trep tom yces averm itilis
175 I V G T L G Q K Y - N Y H L G F G A A A V G M L L G L I V F B acilis  sub tilis
H - G F - - - - - G M - - - - - - - Consensus
199 Y L K T M P D L K E F D E K V G I D S T W D R P S K K S K N C .je ju n i
201 R F Y T I P L M R Q Y D K E G G L D S S w D H P T V K R E N P. lum inescens
200 Y F Q G R K S L A G I G Q A P T - - N P M S K E E Q K K F A E nterococcus fa e c a lis
197 V T G K R Y L K E A G K K A P - - N P L Q K S E A K I L T L is ter ia  innocua
204 L L - G S R H L S A R S S D V P - - T P L S - A E E K A A T Strep tom yces averm itilis
204 P L T R K K N T G L A G S N V P - - N P L s K K S A - - I G B acilis  sub tilis
Consensus
229 A F Y I I I V S G I V L L G A I F L I L G G F I K L D A Q V C .je ju n i
231 V G K W V F T T V I A I I A I I A L L I L G V I P F N P V A P. lum inescens
228 K A F M - L A I V V A L L I F G G A Y V T G H L T I D F F I E nterococcus fa e ca lis
225 M K I I G I I L A I G L L I A V L T L I T G S L T I N T I I L is ter ia  innocua
230 L R K S A M W A A V A V V F Y A I V G F S G H Y T L N W L L S trep tom yces averm itilis
230 T G I G V I I V A A V I I S V Q - - - T G V L T I K R F I B acilis  sub tilis
G Consensus
2 5 9 I N K N I I L T I L A C A G I Y F L Y L F A F T S L K I E E C .je ju n i
2 6 1 V A S A M V Y V I S S C V T L Y F A Y L F L F A G L S S S D P. lum inescens
25 7 N T I S V L G I L L P - - V Y Y F S K M L T S K D V T A E E E nterococcus fa e c a lis
2 5 5 L A V T V M G V G V P - - L A Y F I M M M T S K K T E A D E L ister ia  innocua
2 6 0 V P I T V A G L I I P - - V M V I A R I K R D K A L D R V E S trep tom yces averm itilis
2 5 7 D L V S I L G I L I P - - V I Y F I I M F T S K K A D K T E B acilis  sub tilis
Consensus
2 8 9 K R N L I I F I V L F L A A A V F W s V Y E Q Q Y T S F N F C .je ju n i
2 9 1 R S R L L V C F I L L V S A A F F W s A Y E Q T P T S F N L P. lum inescens
2 8 5 K P K V L A Y L p L F L A A I V F W s L E E Q G S S I L A L E nterococcus fa e c a lis
2 8 3 R S R L T A Y I p L F L I A V L F w M I E E Q G S T T L A L L is ter ia  innocua
28 8 Q S K M S A Y I w F F V A A A V F w M I Y D Q G G S T L S I S trep tom yces averm itilis
28 5 K s R L A A Y V p L F I G A V M F w A I Q E Q G A T I L A V B acilis  subtilis
- - - - - - - - - - - - - A - - F w - - - - Q - - - - - - - Consensus
3 1 9 F A E K L T D K T I L N Y E I P T I W F Q S L G G L F V I L C .je ju n i
3 2 1 F A N D Y T N R I V M G F E I P T V W F Q s I N A L F I I L P. lum inescens
3 15 F A N E R T Q T S L F G F P 1 A A s w F Q s L N P V F V V I E nterococcus  fa e c a lis
3 1 3 F A A E R T D L S I W G F N L N P A N F Q s L N P V F V I T L is ter ia  innocua
318 F A D S S A E N T I F D W H F P V S W Y Q s V N P V L I M A S trep tom yces averm itilis
3 15 Y A D E R I R L S L G G F E L Q S S W F Q s L N P L F V V I B acilis  subtilis
- A Q s Consensus
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3 4 9 F A P F s A F I W T I C A K N N K E I S s I I K F A L G L L
3 5 1 L A P V F S W F W P R L A K N N I N P S s I S K F I I G I L
3 4 5 L T P I F V T L W T K L G K R - - Q P S T V V K F S L G L V
3 4 3 L S P I F A W I w T K L G D R - - Q P s T p R K F A L G L F
3 48 L A P V F A W L w L A L N R R G K E P s T A T K F A S G L L
3 4 5 F A P I F A W L w M K L G K R - - Q P s T P V K F S I G I I
- - P - - - - - w - - - - - - - - - - s - - - K F - - G - -
C. je ju n i  
P. lum inescens  
E nterococcus fa e ca lis  
L isteria  innocua  
S trep tom yces averm itilis  
B acilis  sub tilis  
C o n sen su s
379 G A A L A F L I M A L A S N H A I S L N G D A N T L R E N L C .je ju n i
381 F A A G G F G V M I L A A Q N V L A - T G E T P. lum inescens
373 F A G L S F V L L M L p G L - - - - L Y G - T E G R -  -  -  - E nterococcus fa e c a lis
3 7 1 F A G L S F V V M M L P G I - - - - L H G N T T T L -  -  -  - L is ter ia  innocua
378 L I G A S F F L F L A P - L - - - - A I A D G G H K -  -  -  - S trep tom yces averm itilis
373 L A G L S F I I M V F P A M Q G K E A L — — — — B acilis  sub tilis
F Consensus
4 0 9  E N S S Q I I L V S P W W L V S S F L L M V L G E L C L S P  C .je ju n i
4 03 -  - -  - -  - -  - V S P F W L I S S S L F L T L G E L C L S P  P. lum inescens
3 9 4  -  - -  - -  - -  - V S P L W L F F S F F I M I V G E M C L S P  E nterococcus fa e c a lis
3 9 3  -  - -  - -  - -  - V S P L W L V L S F F I C I F G E M F I S P  L is ter ia  innocua
3 9 9  -  - -  - -  - -  - A A A M W L V A I Y F V Q T V G E L T V S P  S trep tom yces averm itilis
3 9 3  -  - -  - -  - -  - V S P L W L V L S F L L V V L G E L C L S P  B acilis  sub tilis
Consensus
4 3 9  V G L S I M T K I A P N L I K S Q V M G P W F V A S A L G N  C .je ju n i
4 2 5  I G L A T M T I L A P S R M R G Q V M G L W F C A S A L G N  P. lum inescens
4 1 6  V G L S  I  T T K L A P K A F E A Q T V A I W L L A D A A S Q  E nterococcus fa e c a lis
4 1 5  V G L S A T T K L A P K A F A S Q T M S L W F L S D A M G Q  L is ter ia  innocua
4 2 1  V G L S V T T K M A P A K Y A S Q M M G V W F L A V T A G D  S trep tom yces averm itilis
4 1 5  V G L S V T T K L A P A A F S A Q T M S M W F L T N A A A Q  B acilis  su b tilis
— G L ~  — — ~ — Q “ “ — — — Consensus
4 69 A L A G F I G G K A S E E N I A Y L P N L F Y Q C M W I L L  C .je ju n i
45 5  L A A G L I G G H V R A D Q L D N L P D L F S R V S L A L V  P. lum inescens
4 4 6  A I N A Q I A R F Y T P G T E S - - - A Y F G I V G L V A V  E nterococcus fa e c a lis
4 45 A F N A Q V T Q F F N A D T E I - - - A Y F G I T G F V A I  L is ter ia  innocua
4 5 1  A T T G L L S I A G V D L N K T - - - G I V A L Q A T L A A  S trep tom yces averm itilis
4 4 5  A I N A Q V A G L F D K I P E T - - - M Y F G T I G L I S I  B acilis  sub tilis
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -  -  Consensus
4 99 G G V I I W L I V K K P I N K I L K N  C .je ju n i
4 8 5  I C A A V L M V L I V P I R R L L N S A D K S E A K A Q  P- lum inescens
4 7 3  V A G I L L F I V K K P I Q N L M G D V - - - - - - - R  E nterococcus  fa e c a lis
4 7 2  G F A I A L F I F A P F L K K Y M K G V - - - - - - - H  L is ter ia  innocua
47 8 V A G V A V W M Y R K K V K E L M G D V - - - - - - - H  S trep tom yces averm itilis
4 72 V L G G I L L L L S P V I K R A M K G V - - - - - - - L  B acilis  sub tilis
- - - - - - - - - - - - - - - - - - - - - - - - - - - -  Consensus
Multiple sequence alignment has been performed using MegAlign program (DNAStar, LaserGene). 
Designations on the right hand side refer to the origin of the sequences ; Photorhabdus luminescens, 
Accession number CAE 14106; Enterococcus faecalis,  NP_814225; Listeria innocua,  NP_469907; 
Streptomyces avermitilis,  NP 824659; Bacilis subtilis,  CAB 12175. Numbers on the left hand side 
indicate amino acid positions. Amino acids in red are identical to the one present at the same position 
in the C. je ju n i  DtpT. In the consensus, the amino acid highlighted in blue, is the potential residue 
essential for uptake function.
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Significant amino acid identities of the bacterial orthologues varied from 43% to 31% 
(Figure 5.7). Without mutational studies on the amino acid residues conserved in the 
consensus, it was difficult to determine the exact residue(s) required for substrate 
specificity. Nevertheless, in the protein sequence of mammalian peptide transporters, 
PepTl and PepT2, it has been reported that the His-57 and His-87 respectively, were 
the most critical histidyl residues that were necessary for uptake function and 
probably represented some critical binding sites. Comparison of the C. jejuni DtpT 
protein sequence with other bacterial residues also identified a conserved histidyl 
residue (Figure 5.6) at His-103.
Comparison with conserved regions of the PTR family has also identified a unique 
bacterial PTR signature motif, F Y (M, 1) G 1, F) N (F, 1, L) G (A, S, G) (F, L) 
(Figure 5.6) (Paulsen and Skurray, 1994; Steiner et al, 1995). Interestingly, the motif 
occurs in the third (Figure 5.4), fourth or fifth (depending on the topology prediction 
program used) hydrophobic segment of each of the PTR sequences (Steiner et al, 
1995). The retention of this motif suggests that it may play an important role in the 
transport process.
5.2.3 Generation of a dtpT suicide vector, pIAH-<AjpT
To study the role of the dtpT gene in the physiology and colonisation potential of 
C. jejuni, a mutant was created via inactivation of the dtpT gene in strain 81116. 
Initially, a 0.8 kbp dtpT DNA fragment was amplified using primers lf43 and lf89 
from C. jejuni strain 81116 with HotStarTaq (Qiagen). The dtpT PCR product with A 
overhangs was ligated to linearised pCR®2.1-T0P0® (3.9 kbp) with T overhangs 
covalently bound to Topoisomerase 1 firom Vaccinia virus using the TOPO TA 
cloning® kit (Invitrogen). The cloned DNA was introduced into competent TOPOF’ 
E. coli cells and transformants selected on the basis of ampicillin (100 pg ml'^) 
resistance. Twenty randomly selected colonies were grown overnight in LB 
containing ampicillin and the plasmid was extracted from each culture by Mini DNA 
plasmid preparation. Each plasmid (2pi) was digested with E c o ^  and visualised on a 
1 % (w/v) agarose gel. The plasmids that gave a 3.9, 0.5 and 0.3 kbp band profile 
(data not shown) were the correct constructs and named pCR®2.1- dtpT (Figure 5.8). 
However, the pCR®2.1 -TOPO® vector also contained a kanamycin resistance gene.
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Figure 5.7
Comparison o f C. jejuni DtpT protein sequence with bacterial orthologues.
Conservation with the C. jejuni DtpT 
517 amino acid (aa) polypeptide sequence
DtpT Polypeptide Identity Blast P
orthologues Length (aa) (similarity) value
P. luminescens 512 43% (61%) le-112
Enterococcus faecalis 493 32% (48%) le-60
Listeria innocua 492 32% (48%) 8e-58
Streptomyces avermitilis 498 31% (48%) 2e-56
Bacilis subtilis 492 34% (50%) le-55
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Figure 5.8
The initial cloning step for constructing the dtpT suicide vector. The 0.8 kbp dtpT PCR product 
was amplified using primers If43 and If89 from C. jejuni strain 81116. The dtpT PCR product 
with A overhangs, was ligated to linearised pCR®2.1-TOPO® with T overhangs and transformed 
into E. coli competent cells. The plasmid was named pCR®2.1-J/pT.
0.8 kbp 
dtpT PCR product
lacZ^pUC origin
11 origi
pCR®2.1-TOPO
3908 bp
Ampicillin
Kanamycim^
1. TA cloning to pCR®2.1-TOPO®
2. Transform into E. coli
E c o R I
EcoR\
TOPO®
'pCR®2.1-^^T' 
(4.7 kbp)
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This was a problem because kanamycin was the only available antibiotic at the time to 
disrupt dtpT in order to generate a suicide vector. Therefore the vector had to be 
replaced with one without a kanamycin gene. Additionally, there was no suitable 
restriction site in the vector multiple cloning site that would not cut the dtpT DNA. 
Consequently, PCR amplification of the dtpT DNA and TA cloning into a more 
suitable vector, was required.
The M l3 forward and reverse primers were used to amplify the dtpT DNA insert 
flanked by 0.1 kbp of multiple cloning site DNA from pCR®2.1- dtpT. The 1 kbp 
dtpY PCR product with A overhangs was cleaned by DNA agarose extraction and 
then subcloned into pGEM®T-Easy (Promega) with T overhangs using T4 DNA 
ligase, as recommended by the manufacturer. The cloned DNA was introduced into 
competent TOPOF’ E. coli cells and colonies selected on LB agar plates containing 
ampicillin (100 pg mT^). Twenty randomly selected colonies were grown overnight in 
LB containing ampicillin and each culture was put through colony PCR with M l3 
forward and reverse primers using HotStarTaq. The PCR products were visualised on 
a 1 % (w/v) agarose gel. The 1.2 kbp PCR products were correct (data not shown) and 
the corresponding plasmid named pGEM-dtpT (Figure 5.9).
Previously, the development of the plasmid-based inverse PCR technique has aided 
the construction of insertional mutants when no suitable restriction site was present 
within the gene sequence for insertion of a antibiotic cassette (Wren et al, 1994). The 
length of the flanking sequences on either side of the insertion site is of prime 
importance for recombination of the mutant gene with its wild-type chromosomal 
counterpart (Wassenaar et al, 1993). Recombination integration events have been 
possible with as little as 202 bp of homologous DNA sequence, however, the 
frequency of recombination increased with longer homologous stretches (Wassenaar 
et al, 1993). For that reason, a Bglll restriction site was introduced 0.1 kbp from the 
start codon of the dtpT gene, using primers If87 and If88. As a direct result of the 
inverse PCR, a 4 kbp PCR product flanked by BgBl sites was produced. This was run 
on a 1 % (w/v) agarose gel and the band was purified by DNA agarose gel extraction. 
Following digestion with BgRl and ethanol precipitation, the DNA was recircularised 
by ligating the Bglil ends together with T4 DNA ligase. The recircularised plasmid
176
C h ap ter  5. C haracterisa tion  o f  a  strain  specific gene from  C. jejuni encoding  a m em ber o f  the  P T R
fam ily  o f  transporters
Figure 5.9
The second cloning step for constructing the dtpT suicide vector. The d tp l  DNA was amplified 
from pCR®2.1-6%)T using M13F and M13R primers. The dtpT PGR product with A overhangs, 
was ligated to linearised pGEM® T-Easy with T overhangs and transformed into E. coli 
competent cells. The pGEM® T-Easy vector did not contain a kanamycin resistance gene, which 
was the antibiotic to be used to disrupt the dtpT gene. The plasmid was named pGEM-<%?T.
5acII
Ampicillin
pGEM®T-EasyiacZ,x T
3015 bp
EcoRI
/i'cvRI
M lSPlL
dtpT 
0.8 kbp \— HcoRl
pCR®2.1-TOPO® M13R
1. PGR amplification o f dtpT DNA 
using M13 F and M13R primers
2. TA cloning to pGEM®T-Easy
3. Transform into E. coli
E coRl
dtpT
pGEM
‘pGEM-rfrpT’ 
(4.2 kbp)
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was introduced into competent TOPOlOF’ E. coli cells and colonies were selected on 
LB agar containing ampicillin. Twenty colonies were grown overnight in LB 
containing ampicillin and the plasmid was extracted from each culture by Mini DNA 
plasmid preparation. Each plasmid was digested with Bglil and visualised on a 1 % 
(w/v) agarose gel. The plasmids that gave a single 4.2 kbp band profile (data not 
shown) had the introduced Bgïïi site and named pGEM-dtpT-Bglll (Figure 5.10).
The final cloning step involved BgBl digestion of pGEM-dtpT-Bglll plasmid, 
dephosphorylation and ethanol precipitation. A Campylobacter kanamycin resistance 
gene (1.5 kbp) (kindly provided by Prof. Julian. M. Ketley, Leicester University) with 
BamEl ends was ligated to linearised pGEM-dtpT-Bglll with T4 DNA ligase and 
transformed into competent TOPOlOF’ E. coli cells. Colonies were selected on LB 
agar plates containing ampicillin and kanamycin. Twenty colonies were grown 
overnight in LB containing ampicillin and kanamycin, and the plasmid was extracted 
from each culture by Mini DNA plasmid preparation. The correct construction of the 
5.7 kbp suicide vector was confirmed by restriction analysis with EcoBl, Hinàlll, 
BamEil and EcoBl-Hinàlll digests and was named pIAH-^/ZpT (Figure 5.11 and 5.12). 
The kanamycin resistance gene in the pIAH-^//pT was flanked by 0.4 and 0.4 kbp of 
dtp! sequence.
The kanamycin cassette inserted into dtpT has a promotor but no transcriptional 
terminator. Generally it is not considered to give rise to polar affects in gene 
expression when it is orientated with the same transcriptional polarity as the mutated 
gene. In the pIAH-<%)T suicide plasmid, the kanamycin cassette was placed in the 
same transcriptional orientation as the target gene. Consequently, when a dtpT mutant 
was generated in strain 81116, the downstream gene, Cj0653c was potentially not 
effected when the chromosomal copy of dtpT was disrupted with the kanamycin 
cassette.
5.2.4 Inactivation of dtpT in strain 81116
Strain 81116 has been previously used for obtaining transformants by electroporation 
with suicide vectors (Wassenaar et al, 1993; Bâillon et al, 1999). Therefore, the 
pIAH-i/ZpT suicide vector was introduced into strain 81116 by electroporation in 
order to disrupt the wild-type dtpT gene, 0.1 kbp from the start codon.
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Figure 5.10
The third cloning step for constructing the dtpT suicide vector. Inverse PGR primers If67 and 
If68 were used to amplify a 4.3 kbp product from the pCR-Script-<7^T plasmid template. 
Following Bglil digestion, the DNA was re-circularised by self-ligation and transformed into E. 
coli competent cells. The plasmid was named pCR-Script-a^^T- BgEl.
1187 If 88
pGEM
%/n /.c»Ri
EcoRl
EcoRl
I.IPCR
pGEM
£coR l 
EcoRI %/II
0.4 kbp 0.4 kbp
1. BgRl digestion
2. Self ligation
3. Transform into E. coli
EcoRl
.EcdRl
pGEM
‘pGEM-û?//jT- BgaV  
(4.2 kbp)
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Figure 5.11
The final cloning step for constructing the dtpT suicide vector. The pGEM-dtpT-BglU plasmid 
was linearised with BgBl and ligated to kanamycin gene with BamUl compatible ends before 
transforming into E. coli competent cells. The suicide vector was named ^lAYl-dtpT.
BamHl Bam El
I Kanamycin |
1.5 kbp
pGEM
1. BgBl digestion
2. Ligation to kanamycin cassette
3. Transform into E. coli
h:4,kbp 1.5 kbp O.^-kfip
EcdBJ
Sail
Sncl
pGEM
(5.7 kbp)
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Figure 5.12
Ethidium bromide stained 1 % (w/v) agarose gel o f digested \ilAW-dtpT. Lane 1, undigested 
pIAH-i/tpT; lane 2, EcoBJ digested pIAH-c//pT; lane 3, HindlW digested plAH-dtpT', lane 4, 
BamHI digested pIAH-<i/pT; lane 5, EcoBA and Hindlll digested pIAH-<i/pT; lane 6, 1 kbp DNA 
ladder (Gibco).
IÈM
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Electroporations were carried out using 0 pg, 0.5 pg and 1.0 pg of plasmid pIAH- 
dtpT mixed with 50 pi of strain 81116 (10^ c.f.u.) in electrobuffer. After a 5 hour 
recovery on BA plates, the transformants were selected by plating onto BA plates 
supplemented kanamycin (50 pg ml'^). After 48 hours, there were no colonies 
observed on the 0 pg plates, however, the 0.5 and 1.0 pg plates gave approximately 
1000 transformants each. Incidentally, standard E. coli vectors, such as pGEM®T- 
Easy in this case, have been frequently used as suicide vectors in Campylobacter 
because they are unable to replicate. Normally a double crossover event occurs 
leading to the elimination of vector sequence and replacement of the wild-type gene 
with the disrupted copy. Single crossovers do occur but due to their instability in 
Campylobacters tends to ultimately lead to a double crossover or resolves back to the 
wild-type. Thus, the emergence of kanamycin resistant transformants suggested that 
the chromosomal copy of dtpT had been replaced by the kanamycin disrupted copy.
During this experiment, it was noticed that the time taken for the kanamycin resistant 
transformants to appear as colonies on the BA plates supplemented with kanamycin 
was much longer than expected for the wild-type. Furthermore, the colonies appeared 
much smaller in size that the wild-type suggesting an impairment in motility. To 
establish whether this motility impairment was directly due to gene disruption rather 
than a spontaneous mutation, two further separate electroporations were performed to 
generate more kanamycin-resistant transformants. Simultaneously, a pebS suicide 
vector (pIAH-pg65) was also used to generate mutants in strain 81116. Peb3 was 
identified as an outer membrane protein in C. jejuni (Pei et al, 1991). Previously, the 
generation of pebS mutants in strain 81116 resulted in colonies indistinguishable to 
the parental strain (1. H. Ahmed, unpublished) and therefore was a useful control for 
spontaneous mutations in motility. The pebS kanamycin-resistant transformants were 
all fully motile. However, on each occasion the resulting dtpT kanamycin-resistant 
colonies appeared smaller in size than the wild-type. Overall, this suggested that the 
observed phenotype was due to chromosomal disruption of dtpY in strain 81116 rather 
than a spontaneous mutation. On the other hand, if  by chance, the dtpT promotor was 
non-functional and not expressed in strain 81116, insertion of the kanamycin cassette 
in the same orientation as dtpY would have led to a polar effect. This would have 
reflected the predicted lack of transcriptional terminator in dtpT (Figure 5.3) and as a
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consequence, the kanamycin promotor could have switched on the downstream gene, 
Cj0653c. Thus, the phenotype observed for the dtpT mutant could have been due to 
the expression of Cj0653c.
5.2.5 Analysis of dtpT mutants
Analysis of the kanamycin-resistant transformants for disruption of dtpT in strain 
81116 was carried out using PGR and Southern blot analysis.
5.2.5.1 PCR
To confirm the successful generation of a dtpT mutant, PCR amplification of the dtpT 
gene using primers Ifl02 and Ifl03 (each designed to the genes, Cj053c and Cj0654c, 
respectively, which flank dtpT) from the parental strain and kanamycin-resistant 
transformants, were compared (Figure 5.13). The parental strain gave the expected 
PCR product of 2 kbp. The mutant strains gave a single PCR product of 3.5 kbp. This 
indicated that the chromosomal copy of dtpT had been replaced by the kanamycin 
disrupted copy from the suicide vector. The observation of a second band of 2 kbp, 
would have suggested a single homologous recombination event and insertion of the 
entire suicide vector without disruption of the chromosomal dtpT gene, but this was 
not seen.
5.2.5.2 Southern blot analysis
Further analysis by Southern blot analysis was used to confirm that dtpT had been 
insertionally inactivated by the kanamycin gene in strain 81116. Genomic DNA from 
the kanamycin-resistant transformants and the parental strain were extracted and 10 
pg was digested with Hindlll restriction enzyme at 37°C for 36 hours. The suicide 
vector, pIAH-<i(pT was digested with EcoRI and 500 ng was used as a positive 
control. The resulting DNA fragments from each sample were separated by 
electrophoresis through a 1% (w/v) agarose gel at 25 V overnight. Then the DNA was 
transferred from the agarose gel to a nylon membrane as described in Section 2.9.1
The membrane was hybridised with, respectively, an alkaline phosphatase-labelled 
probe specific for pGEM®T-Easy vector, dtpT gene and the kanamycin resistance
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Figure 5.13
Ethidium bromide stained 1% (w/v) agarose gel o f PCR products obtained from amplification of 
dtpT gene with primers Ifl02 and Ifl03. Lane 1, using wild-type strain 81116 genomic DNA; 
lane 2, using wild-type strain NCTC11168 genomic DNA; lane 3, using kanamycin resistant 
dtpT mutant genomic DNA; lane 4, no DNA; lane 5, 1 kbp DNA ladder (Gibco).
184
C h ap ter  5. C haracterisation  o f  a strain  specific  gene from  C. jejuni encod ing  a m em ber o f  the P T R
fam ily  o f  transporters
gene, as described in Section 2.9.3. Only the suicide vector, pIAH-<7/pT (positive 
control) hybridised with each of the probes. Neither the transformants nor the parental 
strain contained pGEM®T-Easy vector (data not shown). All transformants hybridised 
two bands at 3 and 2.5 kbp with the dtp! gene probe whilst the parental strain 
hybridised with one band at 4.0 kbp (Figure 5.14(a)). All the transformants, but not 
the parental strain, hybridised to the kanamycin resistance gene at 1.5 kbp (Figure 
5.14(b)). Collectively, this suggested that double homologous recombination rather 
than a single homologous recombination event had occurred and as a consequence, 
the pGEM®T-Easy vector DNA from the suicide vector had been lost. In other words 
the chromosomal dtpT gene had been successfully replaced with the kanamycin 
disrupted copy from the suicide vector.
5.2.5.3 Examination of dtpT mutant by transmission electron microscopy
The mutant and parental strain were negatively stained according to the method 
described in section 2.10.1 and examined by transmission electron microscopy. The 
mutant had normal looking flagella (Figure 5.15), however, although this is not a 
quantitative method, there appeared to be less flagella than the parental strain.
5.2.5.4 Determination of cell growth
The dtpT mutant and parental strain were grown under microaerobic conditions at 
42°C for a total of 50 hours (see Section 2.10.2). During this time, viable counts were 
taken at 0, 4, 7, 22, 30 and 50 hours. The resulting growth curves for the dtpT mutant 
and parental strain were similar (Figure 5.16). This suggested that mutant was able to 
grow as well as the parental strain under these conditions in vitro.
5.2.5.5 Prevalence of dtpT in C jejuni strains from various sources
One hundred and thirty four C. jejuni strains from various sources (31 isolates from 
poultry, 31 isolates from bovine, 29 isolates from humans, 18 from ovine, 15 isolates 
from porcine and 10 isolates from various other sources) were tested for the presence 
of the dtpT gene. All strains were grown overnight on BASA plates at 42°C under 
microaerobic conditions. Each strain was put through a colony PCR reaction using 
HotStarTaq with primers If43 and If89. Agarose gel electrophoresis was used to 
confirm the presence of a 0.8 kbp dtpT PCR product. The prevalence of strains with 
the dtpT gene is shown in Table 5.1. Fisher’s exact statistical analysis was used to
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Figure 5.14
Autoradiographs o f Southern blots hybridised with (a) dtpT gene (b) kanamycin gene. Lane 1, 
kanamycin resistant dtpT mutant genomic DNA digested with Hind[\\\ 2, wild-type strain 81116 
genomic DNA digested with HindWV, ; 3, ^lAH-dtpT suicide vector digested with HindWl
(a) (b)
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Figure 5.15
Transmission EM of the dtpT mutant.
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Figure 5.16
Growth curves o f  the dtpT  mutant strain and the parental strain 81116. One hundred microliters 
o f bacterial suspension in 0.1 M PBS pH 7.2 (approximately 10  ^ to 10  ^ c.f.u. mT )^ was 
inoculated into a pre-warmed (37°C) large BHI/YE biphasic broth and left to grow at 42°C 
under microaerobic conditions. A viable count o f the bacterial culture was taken in triplicate, 
after 0, 4, 7, 22, 30 and 50 hours o f growth.
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Table 5.1
Presence of di- and tri-peptide transporter gene in C. jejuni from various sources. Values are 
numbers (percentage) o f isolates carrying dtpT gene from a particular source. Fisher’s Exact 
statistical analysis was used to compare the dtpT proportions among the sources. The P value o f 
0.1102 was not statistically different and suggested there were equal proportions among the 
sources.
C. jejuni Source Numbers (percentage) positive
Poultry 21/31 (67.74%)
Bovine 12/31 (38.71%)
Human 16/29 (55.17%)
Ovine 8/18 (44.44%)
Porcine 11/15 (73.33%)
Other 7/10 (70.00%)
Total 75/134 (55.97%)
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compare the overall observed numbers for each source tested against the expected 
value. The expected value was determined by the number of isolates carrying dtpY in 
the total number of C. jejuni isolates tested. The P value was determined to be 0.1102. 
Therefore, the hypothesis of equal proportions among the sources was accepted since 
there were no statistical differences at this P-level. Nevertheless, as the negative 
results could have resulted from small base changes in the gene, greater accuracy of 
prevalence would require Southern hybridisation analysis.
5.2.5.6 Motility assay
The mutant and wild-type strains were stabbed into semisolid MH motility agar plates 
to determine their ability to swarm. Each plate was stabbed four times with one strain 
and performed in duplicate, to give a total of eight colonies. The diameter of the wild- 
type colony increased at a much faster rate than that of the mutant strain (Figure 
5.17). After 19, 26 and 33 hours the mutant had a motility of only 32.34, 51.13 and 
48.31% of the wild-type strain (Table 5.2). Overall, the mutant had approximately 
half the swarming ability of the parental strain.
Previously, during the generation of random transposon mutagenesis library of C. 
jejuni strain 480, mutants with 0-70% motility of the wild-type strain, were 
characterised (Golden et al, 2000; Golden et al, 2002). Four of these mutations were 
found to be in Cj0256, Cj0399, CjlOll and Cjl564. All had a 51-71% of the wild- 
type motility, but with normal expression of FlaA. However, in these mutants the 
ability to invade INT407 cells in vitro was reduced. The first three of these four genes 
were predicted to be probable integral membrane proteins. The fourth gene, Cjl564 
was a probable methyl-accepting chemotaxis gene. Even though DtpT has also been 
predicted to be an integral membrane protein, it may have a different mode of action 
from the aforementioned genes since in Section 5.2.5.7 the DtpT-deficient mutant was 
shown to have the same invasion efficiency as the wild-type. Given that little, or no 
motility, and a significantly reduced invasion efficiency, was observed with each dtpT 
mutant clone, effects on the flagellum structural, biosynthesis and motor genes were 
unlikely to have been effected in the dtpT mutant.
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Figure 5.17
The colony produced by the dtp!  mutant strain on semisolid MH motility agar plates compared 
to parental strain 81116. The bacterial colonies after 19 hours of growth by the (a) mutant strain 
and (b) parental strain, and after 33 hours of growth by the (c) mutant strain and (d) parental 
strain.
(d)
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Table 5.2
The mean diameter o f eight colonies o f the dtpT mutant, on semisolid MH motility agar plates 
after 19, 26 and 33 hours, compared to the wild-type strain.
Mean diameter o f colony (cm) and Standard Deviation
Time in hours Wild-type dtpT mutant
19 1.237 ±0.092 0.400 ± 0.027
26 1.688 ±0.113 0.863 ± 0.032
33 2.950 ± 0.267 1.425 ±0.053
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5.2.5.7 Invasion assay using INT407 cells
Previous studies (C. Feamley, PhD thesis) have demonstrated the capacity of strain 
81116 to invade INT407 cells. Investigation of the kinetics of Campylobacter 
invasion in INT407 monolayers, has indicated that invasion efficiency varies with the 
inoculum (Hu and Kopecko, 1999), such that the total number of internalised bacteria 
increases with greater bacterial concentrations, from a MOI of 0.02 steadily to a broad 
maximum peak at a MOI of 200, and decreased thereafter.
To overcome variations in inoculum levels due the crude method of estimating 
bacterial cell concentration, a range of MOIs (number of bacteria added per epithelial 
cell) were used to compare the invasiveness of strains. INT407 cells were infected 
with different starting MOIs of log-phase (20 hours of growth) C. jejuni strain 81116 
or the DtpT-deficient mutant and then incubated for three hours (the invasion period) 
and then for a further two hours in the presence of gentamicin (to kill all extracellular 
bacteria) prior to enumeration of internalised bacteria. The numbers of internalised 
bacteria at each MOI tested was used to compare the ability of mutant and parental 
strain to invade. Figure 5.18 shows the mutant and parental strain internalised INT407 
cells to a similar extent. As the invasion efficiencies were determined according to the 
percentage number of bacteria internalised per inoculum, any variations in inoculum 
between strains were accounted for by standardising the MOI to 200. At a MOI of 
200, the invasion efficiency of the dtpT mutant was 0.0022% and the wild-type strain 
was 0.0023%. The similar invasion efficiencies suggested DtpT was not required for 
internalisation of INT407 cells in vitro.
5.2.5.8 Chick colonisation model
The value of the one-day-old chick model to assess the role of Campylobacter 
colonisation factors in vivo has been well established (Wassenaar et al., 1993). Such 
studies have shown that C  jejuni strain 81116 colonised chicks in a dose dependent 
manner and that a dose of 10  ^ c.f.u. is required for maximum colonisation (10^ c.f.u. 
g'  ^of caecal contents) in 100% of birds.
A preliminary study in the one-day old chick model showed a reduced colonisation 
level by the DtpT-deficient strain as compared the wild-type (data not shown). The 
procedure was repeated to ascertain reproducibility of the results. In addition, a
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Figure 5.18
Comparison of the capacity of the dtpT mutant to invade INT407 cells compared to the parental 
strain 81116.
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mutant strain (R2) of 81116, which did not express both flaA  and flaB  and which 
lacked flagella (Wassenaar et al, 1991), was also tested in the chick model and 
compared to the dtpT mutant. Previous colonisation studies on R2 have also shown a 
reduced colonisation efficiency compared to the parental strain (Wassenaar et al, 
1993). Five days post-oral-challenge with the dtpT mutant at doses of 10"^  c.f.u. and 
10  ^ c.f.u resulted in 40% and 80%, respectively, of chicks colonised (Figure 5.19). 
For the wild-type strain, a dose of 10  ^ c.f.u resulted in 90% of chicks colonised 
(Figure 5.19). The R2 mutant was dosed at 10"^  c.f.u. and 40% of the chicks were 
colonised five days post-oral challenge (data not shown).
The geometric mean level of colonisation for the dtpT mutant at a dose of 10"^  c.f.u. 
and 10  ^c.f.u was 2.49 and 4.71 log^ ® c.f.u., respectively. Both levels were lower than 
the parental strain level (dosed at 10  ^ c.f.u.) of 9.22 log^ ® c.f.u. The parental strain 
chick colonisation levels were compared to the low (10"^  c.f.u.) and high (10^ c.f.u.) 
dose mutant colonisation levels by Mann-Whitney test; P values of <0.0001 and 
0.0005, respectively, were obtained. Thus, the difference observed between the chick 
colonisation values was statistically significant, even when the mutant dose was a log 
higher than the parental dose. This suggests that DtpT was required by strain 81116 to 
achieve normal wild-type colonisation levels in chicks. In addition, the Mann- 
Whitney test was also used to compare the mutant and R2 (each dosed at 10"^  c.f.u) 
chick colonisation levels. The geometric mean level of colonisation for R2 was 1.59 
log^  ^ c.f.u., as compared to 2.49 log^ ® c.f.u. for the dtpT mutant. Even though there 
was reduced bacterial colonisation by R2, a P value of 0.9705 suggested similar levels 
of potential for chick colonisation in the DtpT and flagella-deficient strains.
5.2.5.9 Chemotaxis assay
Because reduced swarming may reflect defective chemotactic responses, the dtpT 
mutant and parental strain 81116 were next tested for a chemotactic response to a 
number of readily available chemicals (L-malate, oxgall, porcine and bovine bile, 
lysine, L-serine, N-acetylneuraminic acid, N-acetyl-D-glucosamine, a-ketoglutarate, 
D(+) galactose and D(+) Glucose and N-acetyl-D-galactosamine) as described in
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Figure 5.19
Chick caecal colonisation at five days post-challenge by the dtpT mutant compared to the 
parental strain 81116. The geometric mean level of colonisation for each group is shown by a +. 
The dotted line represents the limit of detection of 100 c.f.u.
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Section 2.10.13. This assay was performed with the assistance of Julie M. Turner, 
Leicester University, UK.
Both the dtp!  mutant and parental strain gave a positive chemoattractant response 
(dense bacterial accumulation around the chemical HAP) in the presence of L-malate, 
porcine and bovine bile and a-ketoglutarate, but no response was observed in the 
presence of oxgall, lysine, L-serine, N-acetylneuraminic N-acetyl-D-glucosamine, 
D(+) galactose, D(+) Glucose and N-acetyl-D-galactosamine. The chemotactic results 
are summarised in Table 5.3. Examples of a very positive chemoattractant response 
(++) and non-chemotactic response (0) to various chemicals by C. jejuni strain 81116 
are shown in Figure 5.20 The chemotactic results are summarised in Table 5.3.
Strains NCTC11168 (Julie M. Turner, unpublished data), and 74C and 108C 
(Hugdahl et al, 1988) have been previously tested against a number of the test 
chemicals. Therefore, strain NCTC11168 was used as a known control for the 
chemotactic responses to the various chemicals, for the dtpT mutant and parental 
strain. However, it must be noted that Hugdahl and colleagues used different chemical 
concentrations to test C  jejuni strains 74C and 108C, as well as only one value to 
define all positive chemotactic responses, regardless of strength (Hugdahl et al, 
1988). These results are also included in Table 5.3.
Glucose was the only carbohydrate tested in the assay, and as previously shown with 
strain 74C, was not a chemoattractant for this strain, and this is not surprising since 
Campylobacters are unable to utilise carbohydrates. Interestingly, L-serine was not a 
chemoattractant for strain 81116, but was a chemoattractant for strains 74C, 108C and 
NCTC11168. Conversely, the bile constituent, oxgall, was not a chemoattractant for 
strain 81116 but was a chemoattractant for strains 74C, 108C and NCTCl 1168.
Previous evidence indicates that mutations in the E. coli peptide transport genes 
results in the inhibition of peptide taxis (Manson et a l, 1986). An ABC transporter 
from Erwinia chrysanthemi was found to act as a specific receptor for chemotaxis as 
well as mediate uptake for pectic oligomers (Hugouvieux-Cotte-Pattat et al, 2001). 
An aromatic acid transporter (proton symporter) from Pseudomonas putida with 12
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Table 5.3
Chemoattractants for C. jejuni strain 81116, dtpT mutant and NCTCl 1168 determined by the HAP 
procedure, and this assay was performed with the assistance of Julie M. Turner, Leicester 
University, UK. Previous data* for strains 74C and 108C have also been included (Hugdahl et al, 
1988).
C hem ical 1 Concn 8 1 1 1 6 dtpT 111168 1 Concn 74C 108C
L-malate 1 M ++ ++ 1 -f-f 0.1 M 4- +
0.6 M ++ + 4 - 1  4-4- 0.01 M -f +
0.5 M + + ++ ! ++
0.4 M ++ -I-+ I 4-4- j
Oxgall 5  % 0 0 1 + 25% 4- 4-
3.75 % 0 0 ! + 10% 0 0
Bile from porcine 1 % + + 1 ND N/A 1
0.75 % 0 0 1 ND
0.5 % 0 0 1 ND
0.25 % 0 0 ! ND
Bile from bovine 1 % + + 1 ND 100% 4- 4-
0.75 % 0 0 ! ND 10% + +
0.5 % 0 0 i ND 1% 0 0
0.25 % 0 0 1 ND
Lysine 1 M 0 0 ! ND 0.1 M 0 0
0.6 M 0 0 1 ND 0.01 M 0 0
0.5 M 0 0 i ND
0.4 M 0 0 i ND
L-serine 1 M 0 0 1 + + 0.1 M 4- 4-
0.6 M 0 0 1 4-4- 0.01 M + +
0.5 M 0 i 0 ! + + 0.0001 M 0 0
0.4 M 0 1 0 i 4-4-
N-acetylneuraminic acid 2 mg 0 1 0 I ND 2 mg/ml 0 0
---------------------------------- 1.5 mg____ _
1 mg
0 I 
0 I
0
'  -Q '
! ND  
I '  ND
0.5 mg/ml 0
■ 1
0
0.5 mg 0 i 0 1 ND i
N -acetyl-D-glucosam ine 0.375 M 0 ! 0 1 ND 0.5 M 0 0
0.25 M 0 1 0 1 ND 0.1 M 0 0
0.2 M 0 i 0 i ND 0.01 M 0 0
0.15 M 0 1 0 ND
□ -ketoglutarate 1 M ++ 1 + 4- i ND 0.1 M + 1
0.6 M ++ ! 4-4- ND 0.01 M +  i +
0.5 M + +  i 4-4- ND 1
0.4 M + 4- 1 4-4- ND i
D(+) galactose 0.25 M 0 I 0 ND 1 M 0 ! ND
0.2 M 0 ! 0 ND j
0.15 M 0 j 0 ND i
0.1 M 0 i 0 ND
D(+) g lu cose 1 M 0 i 0 ND 1 M 0 ! ND
0.6 M 0 1 0 ND 0.5 M 0 1 ND
0.5 M 0 i 0 ND 0.1 M 0 i ND
0.4 M 0 ! 0 ND 0.0001 M 0 i ND
N -acetyl-D-galactosamine 0.1 M 0 ! 0 ND 0.5 M 0 ! 0
0.05 M 0 1 0 ND 0.1 M 0 1 0
0.01 M 0 1 0 ND 0.01 M 0 1 0
0.005 M 0 Î 0 ND i
Il
Iiii
!i
II
II
O cs
II
I t
S I  
f ?
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Figure 5.20
Examples of a very positive chemoattractant response (++) and a non-chemotactic response (-) 
to various chemicals by C. jejuni strain 81116. The lower HAP on each plate is the PBS control. 
The upper chemical HAP from the left to right plate (a) IM and 0.6 M a-ketoglutaric acid, and 
(b) 0.25 M and 0.2 M D(+) galactose
(a)
(b)
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membrane-spanning regions called PcaK, also acts as a chemoreceptor for this 
compound (Ditty and Harwood, 1999). The E. coli dipeptide permease, Dpp, is yet 
another example of a transporter identified as both a chemoreceptor and transporter 
for peptides (Higgins, 1986; Abouhamad.ef al, 1991). Therefore, one explanation for 
the reduced motility of the dtpT mutant could be that DtpT may act as, or interact 
with, a chemoreceptor for peptides, subsequently affecting flagellar motor direction, 
along with the transportation of di- and tripeptides. In the presence of a chemical 
attractant gradient, the cell’s movement becomes less random and runs become longer 
(flagella anti-clockwise rotation dominates) and tumbles (clockwise rotation) less 
frequent. When the bacterial colony uses up nutrients such as peptides and grows 
larger, a chemical gradient is formed firom the centre of the colony to the outside of 
the colony. If, the DtpT-deficient mutant cannot sense this gradient, cellular 
movement would be more random than for the parental strain, resulting in reduced 
swarming.
Comparison of the chemotactic responses of strains 81116, NCTCl 1168, 74C and 
108C to various chemicals revealed a number of interesting differences. Such 
variations may only represent a small fraction of the different responses observable 
within C. jejuni strains, and may be a reflection of the large genetic diversity observed 
within the species (Dorell et al, 2001; Dingle et al, 2001; Duim et a l, 2001). In H. 
pylori, a fully functional chemotaxis system, along with motility, appears to be 
necessary for colonisation thereby presumably maintaining the bacterium in the 
mucosa layer close to the epithelial cell surface, thus reducing removal of bacteria 
from the stomach by gastric mucosal flow (Foynes et al, 2000). Therefore, it would 
be interesting in the future to determine whether the differences observed in C. jejuni 
chemotaxis may effect bacterial colonisation at mucosal surfaces.
5.2.6 Conclusions
In conclusion, a gene containing the DNA sequence for insert 50 has been identified 
and that gene characterised. This DNA fi*agment was conserved in 11/12 C. jejuni 
strains, suggesting it was part of a putative gene, potentially involved in colonisation 
of the intestinal tracts of chickens. Identification of the DNA sequence for insert 50 
revealed a gene encoding a protein sequence with significant similarity to di- and tri­
peptide transporters (PTR) from other bacteria. Therefore, to characterise this gene, a
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dtpT mutant was generated in C. jejuni strain 81116. The expression of the DtpT- 
encoding gene was shown not to be essential for C. jejuni growth in vitro. In addition, 
the rate of cell growth for the DtpT-deficient strain in vitro was similar to that of the 
wild-type and further suggested that DtpT was dispensable for normal C. jejuni 
growth under these conditions. This was not too surprising since approximately only 
half of the randomly selected C. jejuni strains contained dtpT, and if  there had been a 
detrimental effect on growth by the mutation, a majority of the isolates would have 
been expected to be positive for the gene. C. jejuni strains (134 isolates from a variety 
of sources) that were tested for the presence of dtpT were positive at different 
frequencies amongst the host sources, and no source was found to be colonised with 
strains consistently containing dtpT. This suggested that DtpT does not provide 
advantage for C. jejuni colonisation in any particular host. Although many strains, 
including, NCTCl 1168 do not contain dtpT, there may be an alternative gene present 
with similar functional properties to dtpT, especially when considering that the 
genome of strain NCTCl 1168 contains numerous uncharacterised putative transport 
genes. For strain 81116, it could be hypothesised that DtpT provides a colonisation 
advantage because it transports a wide variety of di- and tripeptides, whilst the 
putative transporters in strain NCTCl 1168 may be more specific and thus the range of 
peptides imported would be limited.
Interestingly, the kanamycin-resistant transformants generated for the dtpT gene were 
all less motile than the parental strain. Electron microscopy (EM) showed that the 
dtpT mutant cells expressed normal flagella. However, by eye there appeared to be 
fewer present on the mutant strain EM grids. To confirm this, the fiagellin from the 
mutant and parental strains would need to be quantitatively compared by methods 
such as quantitative western blotting analysis. An alternative explanation of the 
observations was reduced motility. Indeed, the mutant was found to have 
approximately half the swarming ability of parental strain.
To date it is unknown whether PTR proteins contribute to the bacterial invasion of 
eukaryotic cells. Since the in vitro invasion assay has been well established for 
C. jejuni, the invasion ability of the DtpT-deficient mutant was compared to the 
parental strain. The indistinguishable invasion efficiencies of the strains suggested 
that the dtpT gene did not have a role in bacterial invasion of INT407 host cells. In
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Spite of this, it can not be ruled out that DtpT could provide C. jejuni with some 
advantage for intracellular survival by scavenging di- and tripeptides from within the 
host cell. Investigation of the intracytoplasmic growth and virulence of L. 
monocytogenes auxotrophic mutants revealed that this food pathogen may utilise 
intracellular peptide as a source of amino acids (Marquis et al, 1993). Therefore, 
future DtpT characterisation studies on C  jejuni involving intracellular survival 
studies need to be undertaken since bacterial pathogenicity is, in part, dependent on 
the availability and acquisition of nutrients.
In the chick colonisation model, the DtpT-negative mutant colonised the chicks at 27- 
51% of the wild-type levels after five days post-challenge. Whilst the flagella- 
deficient mutant colonised at 64% of the DtpT-deficient mutant levels, this was not a 
statistically significant difference. This suggested that while DtpT was not essential 
for establishing colonisation, it was required for optimal bacterial colonisation of 
chicken caeca, as observed for the flagella-deficient mutant. It has previously been 
shown that the FlaA protein of flagella is essential for optimal bacterial colonisation 
of chicken caeca (Wassenaar et al, 1993). In contrast, a 81116 strain variant (SF-1) 
with flagella composed of FlaA, but with poor motility, is a better coloniser than the 
wild-type. In the dtpT mutant the flagella looked normal, which suggested FlaA had 
not been effected (Wassenaar et al, 1991). This indicated that the absence of DtpT, 
rather than defective flagella, was effecting the chicken colonisation levels. In 
addition, FlaA and motility are two important flagella properties required for efficient 
bacterial invasion of eukaryotic cells (Wassenaar et al, 1991). Although, a defined 
pflA mutant, which had paralysed flagella, was still able to adhere, it was incapable of 
invasion in vitro (Yao et al, 1994). As the invasion phenotype for the DtpT-deficient 
mutant was indistinguishable from the parental strain, this suggested that, even though 
motility had been reduced for the dtpT mutant, neither the motility nor FlaA had been 
significantly effected to alter the invasion efficiency of the strain.
One explanation for both the reduced motility and chicken colonisation levels, 
concomitant with a normal wild-type invasion efficiency, may be that DtpT is 
involved in a series of complex interactions important for chemotaxis. However, 
preliminary results suggested no differences in taxis between the dtpT mutant and 
parental strain. Nevertheless, other potential chemoattracttants like alanine-alanine
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(Hagting et al, 1993) need to be tested before this effect can be definitely be 
discarded, however whether alanine-alanine is an chemoattractant for this bacterium 
is unknown.
One obvious function of DtpT is the uptake of small peptides, which play an 
important role in satisfying the nutritional requirements of some microorganisms 
(Payne, 1980). A broad range specificity of such uptake has been found in eukaryotic 
peptide transporters of the PTR family. This family appears to be distantly related 
(39% divergent) to their prokaryotic counterparts (Steiner et al, 1995). The presence 
of these peptide transporters in both eukaryotic and prokaryotic organisms attests to 
the importance of peptide transport as a fundamental biological process retained 
throughout evolution. Intestinal epithelial cells rapidly uptake di- and tri-peptides by a 
specific apical peptide transporter encoded by the PEPTl gene (Doring et al, 1998). 
The physiological role of PEPTl lies in the absorption of peptide bound amino acids 
from the intestinal tract after their release by enzymatic breakdown of dietary or 
endogenous proteins. Thus, the evolutionarily-related DtpT protein from C. jejuni 
and other bacteria (Steiner et al, 1995) may provide an advantage for providing the 
organism with essential amino acids for survival and possibly adaptation to 
colonisation of the intestinal tract.
The occurrence of C  jejuni in the food chain may be unavoidable because of the 
pathogen’s ubiquity. Meat products, such as poultry, that have been implicated as a 
sporadic cause of campylobacteriosis, contain low concentrations of free amino acids 
but are rich in peptides (Amezaga et al, 1995; Amezaga and Booth, 1999). Another 
common bacterial contaminant of raw and minimally processed foods, mainly dairy 
products, meat and raw vegetables, is Listeria monocytogenes, which is unable to 
synthesis all the amino acids essential for growth (Farber and Peterkin, 1991). 
However, both di- and tripeptides have nutritional value in providing essential amino 
acids, and peptides are translocated prior to hydrolysis by internally located 
peptidases (Verheul et al, 1998). In C jejuni, the identification of a putative 
cytoplasmic aminopeptidase, Cj0653c (Parkhill et al, 2000), downstream of the dtpT 
gene, suggests that hydrolysis may occur soon after peptide internalisation, especially 
considering that Cj0653c is the only other gene transcribed from the dtpT promotor. 
In summary, the DtpT transporter and associated aminopeptidase proteins may
203
C h a p te r  5. C haracterisa tion  o f  a stra in  specific  gene from  C. jejuni encod ing  a m em ber o f  the  P T R
fam ily  o f  transporters
provide C  jejuni with a mechanism for the translocation of small peptides, which 
would that may provide the organism with essential amino acids. This may allow the 
organism to subsist in foods that have amino acids in the forms of peptides available 
as a result of being liberated from proteins by proteases of other microorganisms 
present in foods.
Overall, the physiological importance of peptide importation into C. jejuni cells 
should not be underestimated as a bacterial factor contributing to pathogenicity. The 
most obvious role of the transporter may be to provide C  jejuni with a range of 
essential amino acids for cellular metabolism, enabling the organism to survive and 
grow in the host intestinal tract. Other functions may include chemotaxis, 
intracytoplasmic host cell survival, osmoregulation and recycling of cell wall peptides 
(Goodell and Higgins, 1987; Higgins, 1986; Amezaga et al, 1990; Marquis et a l, 
1993; Kelly-Wintenberg and Montie, 1994).
Future work could the role of DtpT in intracellular survival by counting the number of 
internalised bacteria following an extended gentamicin step. To establish whether 
DtpT contributes to bacterial growth in the caecum, equal numbers of the mutant and 
wild-type strains could be inoculated in vitro into caecal contents obtained from a 
chicken and incubated microaerobically. Viable counts over a period of time would 
establish the importance of DtpT in the growth of C  jejuni in the caecum. The C. 
jejuni DtpT identified in this chapter has not been experimentally proven to be a 
peptide transporter. One way to investigate this might be to use a toxic peptide to 
characterise peptide uptake in the dtptT mutant. The growth of the wild-type strain 
would be inhibited whilst the mutant would be expected to be resistant to the toxicity. 
The dtpT mutant was inactivated 100 bp from base pair position 1 of the dtpT gene 
which would have produced a truncated (33aa) DtpT protein. The production of only 
6.6% of the DtpT protein suggests that the truncated DtpT is unlikely to have any 
residual activity. Finally, complementation of the dtpT mutant through insertion of the 
wild-type gene on a plasmid into the mutant and resulting in reversion to the wild- 
type phenotype (such as complete motility) would verify the characterisation of DtpT 
in C. jejuni
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CHAPTER SIX
Characterisation of the C. jejuni y-glutamyl 
transpeptidase gene
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6.1 Introduction
To identify bacterial properties that allow C. jejuni to colonise the intestines of 
chickens, genomic subtractive hybridisation between a good (strain 81116) and a poor 
(strain NCTC11168) chicken colonising strain was performed (Chapter 3). One 
particular 369 bp DNA fragment (insert 236), unique to strain 81116, was identified 
and predicted to be part of a C  jejuni y-glutamyl transpeptidase {ggt) gene. Due to its 
presence in the chicken colonising strain and absence in the poorer colonising strain, 
it was hypothesised that this gene could be a potential C. jejuni colonisation factor.
The enzyme y-glutamyl transpeptidase (GGT) has been extensively studied in 
mammalian tissues and its activity is thought to be clinically significant because 
elevation of GGT activity in serum is an efficient marker for hepatic and biliary tract- 
associated diseases.
GGT is a membrane-bound enzyme that plays a major role in glutathione metabolism 
(Figure 6.1) catalysing the hydrolysis of y-glutamyl compounds, such as the 
ubiquitous tripeptide glutathione (L-y-glutamyl-L-cysteineglycine), and the transfer of 
the y-glutamyl moiety to amino acids, peptides or even glutathione (Tate and Meister, 
1981). The y-glutamyl amino acids are taken up by cells and cyclised to 5-oxoproline 
and the transported amino acid is released. Finally the 5-oxoproline is hydrolysed and 
glutamate is regenerated. The glutamate can then be used to synthesise glutathione. 
Thus GGT plays a role in the degradation and synthesis of glutathione and 
collectively, these reactions give rise to a y-glutamyl cycle.
The thiol, glutathione is an antioxidant molecule and plays an important part for 
providing vital cellular protection against reactive oxygen species (ROS) generated by 
aerobic respiration, particularly hydrogen peroxide and certain organic 
hydroperoxides (O’Donovan and Fernandes, 2000). ROS with superoxide, hydroxyl 
radical, hypochalous acid and nitric acid, exhibit a broad spectrum of biotoxicity and 
are crucial to host defence for the antimicrobial activity of neutrophils and other 
phagocytes. More specifically, the enzyme glutathione peroxidase, in its selenolate 
form, reduces the peroxide substrate to an alcohol (Figure 6.2). Glutathione, in its 
reduced form (GSH), now comes into action by forming a selenosulphide adduct (E-
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Figure 6.1
The membrane bound enzyme, y-glutamyl transpeptidase forms part o f the y-glutamyl cycle and 
catalyses the transfer o f the y-glutamyl moiety o f glutathione to a number o f amino acids and 
peptides (Orlowski and Meister, 1970). The y-glutamyl cycle is a mechanism for the transport o f  
amino acids across cell membranes, as well as for degrading and generating glutathione. All 
enzymatic reactions o f the cycle occur in the cytosol o f cells except for the formation o f the y- 
glutamyl amino acid, which takes place on the extracellular face o f the membrane. 1, y-glutamyl 
transpeptidase; 2, y-glutamyl cyclotransferase; 3, cysteineglycine dipeptidase; 4, 5-oxoprolinase; 
5, y-glutamylcysteine synthase; 6, glutathione synthase.
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Figure 6.2
Glutathione plays a key role in detoxification by reacting with hydrogen peroxide and organic 
peroxides (Epp et al., 1983). The selenolate form of glutathione peroxidase reduces the peroxide 
substrate to an alcohol and in turn is oxidised to selenenic acid. The enzyme contains a selenium 
analogue of a cysteine active site and in contact with glutathione forms a selenosulphide adduct. 
A second glutathione then regenerates the active form of the enzyme by attacking the 
seleneosulphide to form oxidised glutathione.
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Se-S-G). A second glutathione is required to regenerate the active form of the enzyme 
by attacking the seleneosulphide bond. As a consequence, glutathione is converted to 
an ‘oxidised’ form (GSSG) in which the two tripeptides are linked by a disulphide 
bond. Overall, glutathione cycles between the GSH and GSSG forms in response to 
peroxide detoxification by glutathione peroxidase.
Evidence indicates that the eukaryotic GGT-dependent breakdown of extracellular 
glutathione, for subsequent intracellular resynthesis, aids maintenance of cellular 
glutathione levels and increased cellular resistance to hydrogen peroxide-induced 
injury (Shi et al, 1993; Sweiry et al, 1995; Potdar et al, 1997; Chikhi et al, 1999). 
Furthermore, eukaryotic cells once depleted of GSH, have an increased susceptibility 
to oxidant-mediated killing (Meister, 1992). Similar observations have been reported 
in yeast (Izawa et al, 1995). Hydrogen peroxide causes damage by inducing single- 
and double-stranded breaks in DNA and oxidises biological membranes and proteins. 
Therefore GGT appears to have an important role in combating oxidative stress. 
Interestingly, mice with a genetic y-glutamyl transpeptidase deficiency, exhibit 
glutathionuria (high glutathione concentration levels in the urine and blood), severe 
growth failure, reduced life span and infertility (Harding et al, 1997). In humans 
increased serum GGT is observed in conjunction with obstructive liver disease, high 
alcohol consumption and the use of enzyme-inducing drugs (Seist et al, 1989). These 
conditions appear to increase production of free radical, which can rapidly be reduced 
to hydrogen peroxide. As a consequence, serum GGT is raised in response to the 
stress of glutathione depletion. Otherwise, interaction of hydrogen peroxide with 
myeloperoxidase (an enzyme that scavenges nitric oxide), reduced iron, or products of 
nitric synthase may lead to formation of more toxic intermediates, such as 
hypochlorous acid anion, hydroxyl radicals, hydroxide anions and hydroxide anions, 
nitrogen dioxide, peroxynitrite (Fang 1997). Inactivation of hydrogen peroxide may, 
however, interrupt the production of these toxic species and aid persistence and 
survival within host cells and tissues.
GGT-encoding genes from both mammalian and bacterial species have been 
sequenced. There are two obvious differences between bacterial and mammalian 
GGTs. Firstly, the 5’-end of the open reading frames for bacterial GGTs are signal
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peptides, and consequently the enzyme is normally localised in the periplasmic space 
(Suzuki et al, 1986; Xu and Strauch, 1996; Mineyama and Saito, 1997 Chevalier et 
al, 1999). In contrast, the N-termini of mammalian GGTs are anchor domains, which 
interact with the plasma membranes (Tate and Meister, 1981; Ikeda et al, 1995). In 
other words, bacterial GGTs tend to be soluble periplasmic enzymes, whereas 
mammalian GGTs are membrane-bound enzymes. Secondly, only GGT from 
mammals are glycosylated (Tate and Meister, 1981). On the other hand, bacterial and 
mammalian GGTs share extensive amino acid homology and both are first translated 
as precursor proteins before being processed to form two GGT polypeptide subunits. 
Mammalian GGT precursors are glycosylated before undergoing a proteolytic 
cleavage to form the large and small subunits of the mature enzyme. Whilst bacterial 
GGTs undergo two proteolytic cleavages, the first results in cleavage of the signal 
peptide and the second processes the GGT to form the two subunits of the enzyme.
Although the importance of y-glutamyl transpeptidase in glutathione metabolism and 
amino acid transport in mammalian tissues has been recognised for many years (Tate 
and Meister, 1981), little data is currently available about the role of this enzyme in 
bacteria. To date, several microorganisms, including E. coli, P. aeruginosa, B. 
subtilis, H  pylori, and T. denticola, exhibit GGT activity (Suzuki et al, 1989, Ishye et 
al, 1993, Xu and Strauch, 1996, Chevalier et al, 1999, Chu et al, 2003). 
Surprisingly, few bacterial GGTs have been characterised at the biochemical and 
molecular levels (Suzuki et al, 1989; Ishiye et a l, 1993; Xu and Strauch, 1996; 
Chevalier et a l, 1999). For instance, only some Neisseria isolates, such as N. 
meningitidis but not A. gonorrhoeae species express GGT activity (Riou et al, 1982). 
Whether the gene is present in all strains of these species is unknown, nevertheless, a 
GGT-negative N. meningitidis strain has been identified. This negative strain was the 
result of an insertion sequence (IS) in the ggt gene. Characterisation of ggt mutants 
indicates that GGT is not required for bacterial growth under normal in vitro 
conditions, but in E. coli, the utilisation of exogenous y-glutamyl peptides by cells is 
dependent upon the production of a catalytically active GGT. In conclusion the 
physiological role of GGT in bacteria remains controversial.
An essential role for GGT in glutathione metabolism has been reported in the
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periodontal bacterial pathogen, T. denticola (Chu et al, 2002; Chu et al, 2003). In 
such studies, a competitive inhibitor of GGT suppressed glutathione metabolism and 
of hydrogen sulphide (H2S) production. The highly toxic H2S molecule has 
hemoxidative and hemolytic activities and induces injury or death of host cells, 
including gingival fibroblasts and epithelial cells. Such studies suggested that GGT- 
mediated hydrolysis of glutathione is the main source for H2S in T. denticola. Like 
eukaryotic cells, aerobic microrganisms are continually exposed to endogenous 
sources of toxic oxygen species as a consequence of aerobic metabolism. 
Interestingly, H. influenzae has been shown to acquire glutathione by importing the 
thiol tripeptide from the growth medium with concomitant increased protection 
against peroxide stress (Vergauwen et al., 2003). The importance of this antioxidant 
activity in prokaryotes, however, has not been clearly established. In H. pylori, GGT 
appears to have a role in the colonisation of the gastric mucosa of mice (Chevalier et 
al, 1999; McGovern et a l, 2001), potentially by participating in the de novo synthesis 
of essential amino acids. Therefore, the reduced colonisation of H. pylori ggt mutants 
observed in animal models may be due to poor survival in vivo. Whether C. jejuni 
GGT has a similar role in the intestinal colonisation of chickens, can utilise 
glutathione for H2S production, or is used for oxidative stress resistance will require 
further investigation.
The aim of this chapter was to obtain the remaining gene sequence for insert 236 in 
C. jejuni strain 81116 and to confirm its designation as ggt. In addition, to clarify the 
role of C. jejuni GGT, a mutant was created in strain 81116 and the GGT activity of 
the mutant and parental strain were compared. Finally, the ability of the C. jejuni ggt 
mutant were also tested to colonise chickens and survive oxidative stresses.
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6.2 Results and discussion
6.2.1 Identification of the gene sequence containing insert 236
6.2.1.1 Degenerate PCR
Insert 236 encoded a putative polypeptide with 72 % amino acid identity to the H. 
pylori y-glutamyl transpeptidase (GGT) polypeptide. There was also a significant 
degree of similarity with GGT from E. coli and S. enterica (Figure 6.3). The full GGT 
sequences from E. coli, H  pylori and S. enterica were aligned with the known C. 
jejuni amino acid sequence obtained for insert 236 (Figure 6.4). A degenerate primer 
(If66) was designed to a conserved amino acid region, as near as possible to the N 
terminus of the protein sequence alignment (boxed in Figure 6.4). The degenerate 
primer was used with a primer designed to the known C. jejuni ggt DNA sequence 
(If50) which coincidentally, aligned to the amino acids at the C terminus of the C. 
jejuni GGT sequence. A PCR product of approximately 1.5 kbp was predicted from 
this bacterial protein alignment. Degenerate PCR was performed using genomic DNA 
from strain 81116 with the aforementioned primers. A 1.5 kbp PCR product was 
observed on a 1 % (w/v) agarose gel (Figure 6.5). Sequencing of the PCR product 
identified a 1521 bp DNA sequence, which encoded a putative polypeptide with 
significant amino acid similarity to GGT from H. pylori.
6.2.1.2 Chromosomal walking
Chromosomal walks on genomic DNA firom strain 81116, using a primer (IfZl or 
If72) designed from the known ggt sequence successfully identified flanking DNA 
sequence around this region. An additional 728 bp of DNA flanking the 3’ end of ggt 
was also identified. The product of this flanking DNA had no similarity to any 
sequence in strain NCTCl 1168, but had 54 % amino acid identity and 67 % similarity 
(Blast P value 2e-62) to a cytochrome c-type biogenesis protein (YCF5) from 
Wolinella succinogens (Accession number: NP 908253.1). The DNA sequence of ggt 
and flanking DNA obtained from strain 81116 was compared to the ggt genetic region 
(30 kbp) identified and kindly provided by Emily Kay, Cambridge, from strain 81- 
176. Comparison of the ggt sequences fi*om strains 81-176 and 81116 revealed 99.5 % 
similarity at the DNA level (data not shown). In addition, the cytochrome c biogenesis 
DNA sequence obtained so far for strain 81116 was 99 % identical to 81-176 (data
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Figure 6.3
The predicted protein sequence for insert 236 has significant amino acid similarity with gamma- 
glutamyl transpeptidase from H. pylori (red), S. enterica (green) and E. coli (blue). The amino 
acid consensus is is shown in grey in between the protein sequences and conservative 
substitutions are indicated by a +.
Score = 162 bits (410), Expect = 5e-40, Helicobacter pylori GGT 
Identities = 84/116 (72%), Positives = 96/116 (82%), Gaps = 2/116 (1%)
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C .  jejuni  : 184
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Figure 6.4
The full GGT sequences from E.coli (blue), H. pylori (red) and S. enterica (green) were aligned 
with the known C. jejuni amino acid sequence (black). A degenerate primer (If66) was designed 
to a conserved amino acid region, shown in the box below. The degenerate primer and a primer 
designed to the known C. jejuni ggt DNA sequence (If50) were used in a PCR to identify the 
majority o f the C.jejuni sequence.
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S. enterica
1 2 4  E. coli 
H. pylori 
S. enterica
RDMFLDDQGNPDSKKSLTSHLASGTPGTVAGFSLALDKYGTMPLNKVVQPAFKLARDGFIVN
KNMFLDKQGNVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAIS
RDMFLDDQGNADAKKSLTSHLASGTPGTVAGFSLALEKYGTMPLNKVVRPAMKLAEEGFVVN
186 E. coli 
H. pylori 
S. enterica
DALADDLKTYGSEVLPNHENSKAIFWKEGE-PLKKGDTLVQANLAKSLEMIAENGPDEFYKG
QRQAETLKE-ARERFLKYSSSKKYFFKKGHLDYQEGDLFVQKDLAKTLNQIKTLGAKGFYQG
DALANDLKTYGSEVILNHENSKAIFWKDGE-PLKKGDKLVQKNLAKSLEMIAENGPDAFYKG
248 E. coli 
H. pylori 
S. enterica
TI AEQI AQEMQKNGGLI TKEDLAAYKAVERTPI SGDYRGYQVYSMPPPSSGGI HI VQI LNI L  
QVADLIEKDMQKNGGIITKEDLASYNVKWRKPVIGSYRGYK1 ISMSPPSSGGTHLI QI LNVM 
AIADQIAGEMQKNGGLMTKEDLANYKAVERTPI SGDYRGYQVFSMPPPSSGGI HI VQI LNI L
3 1 0 E. coli 
H. pylori 
S. enterica
ENFDMKKYGFGSADAMQIMAEAEKYAYADRSEYLGDPDFVKVPWQALTNKAYAKSIADQIDI  
ENADLSTLGYGASKNIHIAAEAMRQAYADRSVYMGDADFVSVPVDKLINKAYAKKI FDAIQP  
ENFDMKKYGFGSADAMGIMAEAEKYAYADRSEYLGDPDFVKVPWGALTHKAYAKTLADQIDI
372 E. coli 
H. pylori 
S. enterica
NKAKPSSEIRPGKLAPYESNQTTHYSVVDKDGNAVAVTYTLNTTFGTGIVAGESGILLNNQM
DTVTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM
NKAKPSSQIKPGKLAPYESNQTTHFSVVDKDGNAVAVTYTLNTTFGTGIVAGNTGILLNNQM
4 3 4 E. coli 
H. pylori 
S. enterica
DDFSAKPGVPNVYGLVGGDANAVGPNKRPLSSMSPTIVVKDGKTWLVTGSPGGSRI ITTVLQ 
DDFSIKPGNPNLYGLVGGDANAI EANKRPLSSMSPTI VLKNNKVFLVVGSPGGSRI I TTVLG 
DDFSAKPGVPNVYGLVGGDANAVGPKKRPLSSMSPTI VVKEGKTWLVTGSPGGSRI ITTVLQ
S M S P T I I L K D G K V F M V V G S P G G S R I I T T V L G
496 E. coli 
H. pylori 
S. enterica 
Clone 236
MVVNSIDYGLNVAEATNAPRFHHQWLPDELRVEK-GFSPDTLKLLEAKGQKVALKEAMGSTQ 
VISNVIDYNMNISEAVSAPRFHMQWLPDELRIEKFGMPADVKDNLTKMGYQIVTKPVMGDVN 
MVVNSIDFGMNVAEATNAPRFHHQWLPDELRVEK-GFSPDTLKLLEQKGGKVALKEAMGSTQ 
V I S N V I D H K M D I S T A V E S P R F H M Q W L P D E I R T E P F G I I K D V Q N N L E K M G Y K I T K E P Y M G D V N
558 E. coli 
H. pylori 
S. Enterica 
Clone 236
S I M V G P - D G E L Y - - G A S D P R S V D D L T A G Y  5 8 7  E.coli
AI QVLPKTKGSVFYGATDPRK------------- EF H. pylori
S I M V G P - D G E L Y - - G A S D P R S V D D L T A G Y  5,  enterica
A I M V D P K T G K I I - - G S M D T R K - ■EF Clone 236
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Figure 6.5
Ethidium bromide stained 1 % (w/v) agarose gel o f  ggt PCR products using the degenerate PCR 
parameters. Lanes: 1, 1.5 kbp band representing the degenerate PCR product, using 81116 
genomic DNA and primers If66 and If 50; (2) Positive control, 262 bp band corresponding to 
the subtractive hybridisation insert 236, using 81116 genomic DNA and primers If49 and IfSO
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not shown). This indicated the genomic location of ggt in strain 81116 was similar to 
strain 81-176. The similarity of ggt genetic region was further confirmed by designing 
a primer to a region in CjOOSl, which was conserved between strains 81-176 and 
NCTCl 1168 (Figure 6 .6). In strain 81-176, primers If 50 and If 146 were predicted to 
amplify a 2.8 kbp PCR product. These primers were used to amplify the 
corresponding region in strain 81116 and the expected 2.8 kbp PCR product was 
amplified (Figure 6 .6) and confirmed by DNA sequencing (data not shown).
6.2.1.3 The ggt gene sequence for C jejuni strain 81116
The DNA and predicted amino acid sequence for ggt from strain 81116 is shown in 
Figure 6.7. Transcription of the 1671 bp ggt gene was predicted to be initiated by a 
promoter element and the -10 and -35 consensus sequence was determined 
according to the definition of a C. jejuni promotor proposed by Wosten et ah, 1998. 
However, as already mentioned in Chapter 5, the -35 region for C. jejuni is 
completely different from other known bacterial rpoD promotors and instead exhibits 
a strong periodic signal rather than a standard -35 box (Petersen et al, 2003). The 
proposed ribosomal binding site (rbs) for ggt is at position -5. A transcriptional 
terminator was also predicted for the ggt mRNA transcript and the DNA region 
corresponding to the mRNA terminator transcript is shown. The ggt terminator on the 
mRNA strand contained a palindromic sequence that could form a hairpin loop 
structure and allow the RNA polymerase to dissociate from the DNA template. This 
seems a likely Rho-dependent terminator since it does not contain a poly-uracil tract 
after the hairpin loop structure.
Comparison of the 81116 sequence with that of 81-176 confirmed the high degree of 
conservation of GGT within C. jejuni. Only 3 of the 556 amino acids of the whole 
GGT molecule were different in these two strains. All of these were located in the 
large subunit of the GGT (data not shown). The ggt gene for strain 81116 codes for a 
protein with a molecular mass of 60300 Da, as calculated by the Protean Program 
(DNAStar, Lasergene). The first 17 amino acids at the N-terminus of GGT (Figure 
6.7) was proposed to be a typical signal sequence (cleavage site between Ala-17 and 
Ala-18), as predicted by the Signal P program at www.cbs.dtu.dk/services/signalP/.
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Figure 6.6
Primer Ifl46 was designed to CjOOSl from strain 81-176 and used with If50 to amplify the 
corresponding region in strain 81116. (a) The arrangement of ggt and adjacent genes in strain 
81-176. (b) Ethidium bromide stained 1 % (w/v) agarose gel of lanes. Showing in lane 1, 2.8 
kbp PCR product using the mentioned primers from strain 81116; lane 2, XIHindWl ladder.
(a)
Ifl46
< Strain
81-176
1.0 kb
(b)
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Figure 6.7
The 1671 bp sequence of the C. jejuni ggt gene. The amino acid sequence of GGT is shown 
beneath the nucleotide sequence. The predicted -10 and -35 region of the presumed promoter 
element, ribosomal binding site (rbs) and transcription terminator (t) are shown in bold. The 
signal peptide is in blue, large GGT subunit in red and small GGT subunit in green.
TCA A TA A A TTTTA A A TA TTTTA G CA A A A A A A TCTCA A G TTTG G TA TA A A A TTTA A A A G TTA CTTTTTG TA A TTTTA TA A A  8 0 
AAAATAAT TATATAAAAT GAGAATAT TT  GATACAAAAT T T TAAAAT T T TAAATAT T T T TATA A AA A TA TATCAT TT T T TA  1 6 0  
AA TTT A T C A A TA C C C C TA G TTT TG TTA C A A T A A TTC T A TA TA TCATTAAAAAGGA.GTA A A A TG C G TTA TTTA G C TA TA TT 2 4 0
-35 -10 rbs M R Y L A I  F
TG CG A TTTCA A TCA CGCTAA G TTTTGG TG CA GCTAA TCCA CCTATA CA A GA TA GA A CAG G CAC AG G ACTTGTTTTATCAA  3 2  0 
A I S I T L S F G A A N P P I Q D R T G T G L V L S  
GTCATGAACTAGCCAATAAAATAGGCAAAGAAGTTCTTGATAAAGGCGGAAATGCCATAGATGCAGCTGTAGCAGTAGGT 4 0 0  
S H E L A N K I G K E V L D K G G N A I D A A V A V G  
TA TG CTTTG G CTG TA G TG CATCCTG CA GCA G GA A ACA TA GG TG G TG GTGG CTTTG CAG TCA TTCATCTA GCCA A TG GA G A  4 8  0 
Y A L A V V H P A A G N I G G G G F A V I H L A N G E  
A A A TA CCA GG CTTGA TTT TAGAGAAATGGCACCTT TAAAAGCAAGCAGAAATATGTATCTTGATAGOAAAGGAGAAGTTA 5 6 0  
N T T L D F R E M A P L K A S R N M Y L D S K G E V  
TAAAAGATGCTTCA ACTATAG G TTA TCTA G CTG CTG GA G TA CCAG G AA CG GTTA AA G GTATGA G TG CTA TGCTTG ATCGC 6 4  0 
I K D A S T I G Y L A A G V P G T V K G M S A M L D R  
TACGGCACTATGAAACTAAAAG ACTTG ATGG CTCCTGCTATAA A ACTAG CTG AA A AA G GTTA TCTCA TCA A CGA TA G ACA  7 2 0  
Y G T M K L K D L M A P A I K L A E K G Y L I N D R Q  
AGAACAAACCATGCTAG A AG CTA A AG A TA TG TTTA A AG A ATTTCCTAG TTCAA G CAA A TA TTTCCTTA A AA A AG ATGG CA  8 0 0  
E Q T M L E A K D M F K E F P S S S K Y F L K K D G  
GCACTTATAAAAGCGG GG A TTTGTTTG TCCA AA A AG A TCTA G CAA A AA CTTTA AA A CTTA TCG CA AA G GA A GG TCCTGA T 8 8 0  
S T Y K S G D L F V Q K D L A K T L K L I A K E G P D  
GCTTTTTA TA AG G GA A AA A TCG CTG ATTTAATAGCAGCGGATATGGCTAAAAACAAAGGCATTATCACTAAAGAAGATCT 9 6 0  
A F Y K G K I A D L I A A D M A K N K G I  I T K E D L  
A G CA CA A TA CCA A G CTATTTG G AG A AA A CCTG TA GA A GG CA CTTA TA G GG GTTA TG ATATCATTTCCA TG TCG CCA CCTA  1 0 4 0  
A Q Y Q A I W R K P V E G T Y R G Y D I I S M S P P  
G CA G TG G GG G TG CTCA TA TCA TCG AA A TTTTAA A TA TCA TG GA A AA TG CCA ATATAG A AA A TTTA G GCTTTG CA AG CTCT 1 1 2 0  
S S G G A H I I E I L N I M E N A N I E N L G F A S S  
A A A A CTTTA CA CA TA ATGG CTG A AG CTA TG CG TCA AG CTTA TG CG GA TA G ATCAG A ATACA TG G GCG A TCCTG A TTTTG T 1 2 0 0  
K T L H I M A E A M R Q A Y A D R S E Y M G D P D F V  
AAAAATCCCAC T T GATAAACTTACAAGCAAAGAATACGCTAAAGAAAT TTATGCA A AA A TTCCA A AA G ATAA GG CTTTA C 1 2 8 0  
K I P L D K L T S K E Y A K E I Y A K I P K D K A L  
CAAGCTCAAAAGTAAA A CCTG GTTTA G GA CA AA TTCACG A AG G ACA TA A TACCACTCATTA TTCTG TA CTA G ATAG CA AA  1 3  6 0  
P S S K V K P G L G Q I H E G H N T T H Y S V L D S K  
G G CA A TG CTG TA A G CA TTA CCTA TA CG ATCAA TG CG AG TTA TG G TTCA G GTGCTACG G TTG A AG G GG CA GG G TTTTTA CT 1 4 4 0  
G N A V S I T Y T I N A S Y G S G A T V E G A G F L L  
CAATGATGAAATGGATGATTTTTCA A TCA AA CCA GG CG TG CCAA A TTTATACG G ACTTG TA GG CG GA G AA G CTA ATGCTA  1 5 2 0  
N D E M D D F S  I K P G V P N L Y G L V G G E A N A  
TAGAACCTAAAAAAA G ACCTTTA A GCTCTA TG AG TCCA A CTA TCA TA CTA AA AG A TG GA A AA G TA TTTATGG TA GTAG G T 1 6 0 0  
l E P K K R P L S S M S P T l  T L K D G K V F M V V G  
A GTCCAG G TG GTTCTA G GA TCA TCA CG ACA G TTTTACAA GTGA TTTCA AA TG TG A TCG ATCATAA A ATGG ATATATCAA C 1 6 8 0  
S P G G S R I I T T V L Q V I S N V I D H K M D I S T  
AGCGGTAGAATCTCCA A GA TTTCA CATGCA G TG GCTACCTGA TG A AA TCA G AA CA GA G CCTTTTGG A ATCATCAA A GA TG  1 7  6 0  
A V E S P R F H M Q W L P D E I R T E P F G I  I K D  
TG CA AA A CAA TCTTG AA A AA A TG GG CTATAAAATCACAAAAGAACCTTATATGGGTGATGTAAATGCTATCATGGTCGAT 1 8 4 0  
V Q N N L E K M G Y K I T K E P Y M G D V N A I M V D  
CCAAAAACTGGAAA A ATCATAG G CTCTA TG G ATACA A GA j\AA G AA TTCTAA CTTCTTA TTT A C C C T TG A A A TTTC A A G G G  1 9 2  0 
P K T G K I I G S M D T R K E F .  t
TA A ATTTATGCA G G A CTTTTA A G TTTTCTTTTA A A A A A TG C TCCTA A A A TTA A A A TCA CTG TA A A A G CA A TG A A A A A A TA  2 0 0 0  
TA A AA A TTTAG GCACA G GCACAGGATCTCCTGTTGCATAAGAATGCAATCCTGAAAGATAGAAATTTACCCCAAAATAAG 2 0 8 0  
TCA TCA A A  2 0 8  8
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The position of a second C  jejuni post-translational cleavage site was predicted 
between Asn-370 and Thr-371 (Figure 6 .8). This site would process the GGT 
polypeptide precursor into the large and small subunits of the mature enzyme, with 
calculated molecular masses of 38204 and 20256 Da, respectively. The cleavage site 
was predicted by comparison of the C. jejuni GGT protein with bacterial and 
mammalian orthologues (Figure 6 .8), which illustrated a conserved structure to the 
enzyme. C. jejuni GGT shares 65%, 50%, 50% 49% 37%, 33%, , 32% and 32% 
identity with the amino acid sequences of H. pylori, E. coli, P aeruginosa, 
S. typhimiurium, B. subtilis, rat, pig and human, respectively (Table 6.1). Not 
surprisingly, the GGTs from evolutionarily related organisms, (C. jejuni and K  
pylori', E. coli and S. typhimurium', rat, pig and human) had the best similarities (not 
shown). Each group contained GGT protein sequences with the least protein sequence 
divergence. In E. coli, the mechanism for processing GGT to the subunits of the 
mature enzyme may be an intramolecular autocatalytic event rather than undertaken 
by a protease (Suzuki and Kumagai, 2002) and the oxygen atom of the side chain of 
Thr-391 (also the N-terminal residue of the small subunit) appears essential for this 
process. In addition, the Thr-391 residue in E. coli also acts as the catalytic 
nucleophile for GGT hydrolase activity (Inoue et al, 2000).
Notably, the threonine residue at the N-terminus of the small subunit was conserved 
in all the GGTs (Figure 6 .8). A number of additional residues (highlighted blue in the 
consensus), appear to have important roles in the catalytic function of mammalian 
GGTs (Ikeda., et al, 1993; 1995; 1996). For example, replacement of the B. subtilis 
GGT Asp-445 residue (conserved in all the GGTs and highlighted green in the 
consensus) with Ala abolishes its transpeptidation activity but not its hydrolytic 
activity (Minami et al, 2003). Not surprisingly, the small subunit, which contains the 
catalytic site of the enzyme is more conserved than the large subunit in all the 
mammalian and bacterial GGTs (Table 6.1).
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Table 6.1
Comparison of the C.jejuni GGT protein sequence with bacterial and mammalian orthologues.
Conservation with C. jejuni GGT protein sequence
(370 and 186 amino acids (aa), large and small subunits, respectively)
GGT
orthologues
Overall % 
Identity 
(similarity)
Blast P 
value
Size & % Identity (% similarity) of subunits 
Large Small
H. pylori 64% (76%) 0 379 aa; 58% (72%) 188 aa; 75% (85%)
E. coli, 48% (64%) le-152 390 aa; 45% (60%) 190 aa; 56% (73%)
B. subtilis, 37% (54%) 2e-91 402 aa;37% (56%) 185 aa; 41% (57%)
Human 32% (48%) 4e-53 380 aa; 27% (44%) 189 aa; 47% (62%)
P.aeruginosa 50% (64%) le-140 375 aa; 48% (63%) 200 aa; 53% (66%)
Pig 32% (49%) 7e-57 379 aa; 28 %(48%) 189 aa; 42% (56%)
Rat 32% (50%) le-58 379 aa; 27% (47%) 189 aa; 48% (61%)
B. Typhimiurium 51% (68%) le-162 390 aa; 46% (62%) 190 aa; 56% (73%)
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Figure 6.8
Comparison of the predicted GGT amino acid sequence from C. jejuni with bacterial and 
eukaryotic orthologues. ^
1 M - R - - Y - L A I F A I S I T L S F G A A c .  j e j u n i
1 M - R R S F - L K T I G L G V I A L F L G L L N P L S A A S H .  p y l o r i
1 M I K P T F - L R R V A I A A L L S G S C F S A A A A P P - E . c o l i
1 M K R T W N - V C L T A L L S V L L V A G S V P F H A E A K B . s u b t i l i s
1 M K K K L V V L G L L A V V L V L V I V G L C L W L P S A S H u m a n
1 M K N Q T F - S K A L L A T A L P . a e r u g i n o s a
1 M K K R Y L L L A L A A V A L V L L I L G L c L W L P S N S P i g
1 M K N R F L V L G L V A V V L V F V I I G L c I W L P T T S R a t
1 M - K P T F - M R W V A I A A L L A G G T F s A V A N P P V S . t y p h i m u r i u m
M C o n s e n s u s
1 9 N P P
29 Y P P
29 A P P
3 0 K P P
3 1 K E P
1 6 - S C
3 1 K - P
3 1 G K P
29 A P P
I Q - - - - - - - - - - D R T
V S Y G V E E D V F H P V R A
K S Y D E Y K Q V - - - D V G
- - - - - D N H V Y - - - - -
A L F N V H A A S Q A P V G A
- - - - - H N H V Y - - - - -
- - - - - D - H V Y - - - - -
V S Y G V E E D V F H P V R A
G T G L V L S S H E L A C .  j e j u n i
K V G L A L S S H P L A H. p y l o r i
K Q G M V A S V D A T A E . c o l i
K D G M V A T A H P L A B . s u b t i l i s
T R A A V A A D A K Q C H u m a n
E N G M V V T A Q H I A P . a e r u g i n o s a
P R A A V A A D A L R C P i g
S K A A V A T D A K R C R a t
T Q G M V A S V D A M A S . t y p h i m u r i u m
C o n s e n s u s
3 9 N K I G K E V L D K G G N A I D A A V A V G Y A L A V V H P C .  j e j u n i
4 8 S E I G Q K V L E E G G N A I D A A V A I G F A L A V V H P H. p y l o r i
5 9 T Q V G V D I L K E G G N A V D A A V A V G Y A L A V T H P E . c o l i
5 7 S E I G A D V L K K G G N A I D A A V A I Q F A L N V T E P B . s u b t i l i s
5 1 S K I G R D A L R D G G S A V D A A I A A L L C V G L M N A H u m a n
4 5 S K V G V E V L K S G G N A I D A A V A V G Y A L A V V Y P P .  a e r u g i n o s a
5 0 s E I G R D T L R D G G S A V D A A I A A L L C V G L M N A P i g
5 0 s E I G R D M L Q E G G S V V D A A I A S L L C M G L I N A R a t
5 9 T Q V G V D I L K Q G G N A V D A A V A V G Y A L A V T H P 5 . t y p h im u r i u m
- - - G - - - L - - G G - - - D A A - A C o n s e n s u s
69 A A G N I G G G G F A V I - H L A N G E N T T L D F R E M A C .  j e j u n i
7 8 A A G N I G G G G F A V I - H L A N G E N V A L D F R E K A H. p y l o r i
89 Q A G N L G G G G F M L I - R S K N G N T T A I D F R E M A E . c o l i
8 7 M M S G I G G G G F M M V Y D G K T K D T T I I D S R E R A B . s u b t i l i s
8 1 H S M G I G G G L F L T I Y N S T T R K A E V I N A R E V A H u m a n
7 5 A A G N I G G G G F M T I - Q L A D G R K T F L D F R E K A P. a e r u g i n o s a
80 H S M G I G G G L F L T I Y N S T T R K A E I I N A R E V A P i g
8 0 H S M G I G G G L F F T I Y N S T T R K A E V I N A R E M A R a t
89 Q A G N L G G G G F M L L - R T K D G A T T A I D F R E M A S . t y p h im u r iu m
G G G - F R E - A C o n s e n s u s
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9 8 P L K A S R N M Y L D S K G E V I K  -  D A S T I G Y L A A G C. j e j u n i
1 0 7 P L K A T K N M F L D K Q G N V V P  -  K L S E D G Y L A A G H. p y l o r i
1 1 8 P A K A T R D M F L D D Q G N P D S  -  K K S L T S H L A S G E . c o l i
1 1 7 P A G A T P D M F L D E N G K A I P  F  S E R V T K G T A V G B . s u b t i l i s
1 1 1 P R L A F A T M F N S S E Q S Q K G G L S V A H u m a n
1 0 4 P L A A T A N M Y L D K D G N V I K -  G A S T T G Y L A V G P. a e r u g i n o s a
1 1 0 P R L A S A S M F N S S E Q S E E G G L S V A P i g
1 1 0 P R L A N T S M F N N S K D S E E G G L S V A R a t
1 1 8 P A G A T R D M F L D D Q G N A D A  -  K K s L T S H L A S G S . t y p h im u r iu m
P - - A - - - M - - - - - - - - - — — — - - - - - - - - - - C o n s e n s u s
1 2 7 V P G T V K G M S A M L D R Y G T M K L K D L M A P A I K L C .  j e j u n i
1 3 6 V P G T V A G M E A M L K K Y G T K K L S Q L I D P A I K L H. p y l o r i
1 4 7 T P G T V A G F S L A L D K Y G T M P L N K V V Q P A F K L E . c o l i
1 4 7 V P G T L K G L E E A L D K W G T R S M K Q L I T P S I K L B . s u b t i l i s
1 3 4 V P G E I R G Y E L A H Q R H G R L P W A R L F Q P S I Q L H u m a n
1 3 3 V P G T V S G M E Y A R E K Y G T K T R Q Q L I S P A I T L P .  a e r u g i n o s a
1 3 3 V P G E I R G Y E L A H Q R H G R L P W A R L F Q P S I E L P i g
1 3 3 V P G E I R G Y E L A H Q R H G R L P W A R L F Q P S I Q L R a t
1 4 7 T P G T V A G F S L A L E K Y G T M P L N K V V R P A M K L S . t y p h i m u r i u m
- P G - - - G - - - - - - - - G - - - - - - - - - P - - - L C o n s e n s u s
157 A E K G Y L I N D R Q E Q T M L E A K D M F K E F P S S S K C. j e j u n i
1 6 6 A E N G Y A I S Q R Q A E T L K E A R E R F L K Y S S S K K H. p y l o r i
177 A R D G F I V N D A L A D D L K T Y G S E V L P N H E N S K E . c o l i
177 A E K G F P I D S V L A E A I S D Y Q E K L - - S R T A A K B . s u b t i l i s
1 6 4 A R Q G F P V G K G L A A A L E N K R T V I E Q Q P V L C E H u m a n
1 6 3 A D K G F V L E Q G D V D M L W T S T K D F E K D R A N S G P .  a e r u g i n o s a
1 6 3 A S Q G F P V G K G L A A A L E R S Q D A I K R H P A L C E P i g
1 6 3 A R H G F P V G K G L A R A L D K K R D I I E K T P A L C E R a t
177 A E E G F V V N D A L A N D L K T Y G S E V I L N H E N S K S . t y p h i m u r i u m
A G C o n s e n s u s
1 8 7 Y F L K K D G S T Y K S G D L F V Q K D L A K T L K L I A K C  . j e j u n i
1 9 6 Y F F K K G H L D Y Q E G D L F V Q K D L A K T L N Q I K T H. p y l o r i
2 0 7 A I F W K E G E P L K K G D T L V Q A N L A K S L E M I A E E . c o l i
2 0 5 D V F L P N G E P L K E G D T L I Q K D L A K T F K L I R S B . s u b t i l i s
1 9 4 - V F C R D R K V L R E G E R L T L P Q L A D T Y E T L A I H u m a n
1 9 3 A I F M N K G Q P F Q P G E R L V Q K D L A R T L R L I S A P .  a e r u g i n o s a
1 9 3 - V F C R N G N V L R E G D L V T M P R L A K T Y E T L A V P i g
1 9 3 - V F C R Q G K V L Q E G E T V T M P K L A D T L Q I L A Q R a t
2 0 7 A I F W K D G E P L K K G D K L V Q K N L A K S L E M I A E S . t y p h i m u r i u m
G L A C o n s e n s u s
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2 1 7 E G P D A F Y K G K I A D L I A A D M A K N K G I I T K E D C .  j e j u n i
2 2 6 L G A K G F Y Q G Q V A E L I E K D M K K N G G I I T K E D H. p y l o r i
2 3 7 N G P D E F Y K G T I A E Q I A Q E M Q K N G G L I T K E D E . c o l i
2 3 5 K G T D A F Y K G K F A K T L S D T V Q D F G G S M T E K D B . s u b t i l i s
2 2 3 E G A Q A F Y N G S L T A Q I V K D I Q A A G G I V T A E D H u m a n
2 2 3 K G T D G F Y K G E V A D K L V A S M K A G G G I I T Q A D P. a e r u g i n o s a
2 2 2 E G A Q A F Y N G S L T A Q I V K D I Q E A G G I V T A E D P i g
2 2 2 E G A R A F Y N G S L T A Q I V K D I Q E A G G I M T V E D R a t
2 3 7 N G P D A F Y K G A I A D Q I A G E M Q K N G G L M T K E D S.  t y p h im u r i u m
- G G G D C o n s e n s u s
247 L A Q Y Q A I W R K P V E G T Y R G Y D I I S M S P P S s G C. j e j u n i
256 L A S Y N V K W R K P V V G S Y R G Y K I I S M S P P S s G H .  p y l o r i
267 L A A Y K A V E R T P I S G D Y R G Y Q V Y S M P P P S s G E . c o l i
265 L E N Y D I T I D E P I W G D Y Q G Y Q I A T T P P P s s G B . s u b t i l i s
253 L N N Y R A E L I E H p L N I S L G D A V L Y M P S A p L S Human
253 L D Q Y K T R E L A P V E C D Y R G Y H V V S A P P P s S G P . a e r u g i n o s a
252 L N N Y R A E L I E Q p L R I S L G D A Q L Y A P N A p L S P i g
252 L N N Y R A E V I E H p M S I G L G D S T L Y V P S A p L S R a t
267 L A N Y K A V E R T P I S G D Y R G Y Q V F S M P P P s S G S . t y p h i m u r i u m
L C o n s e n s u s
2 7 7 G A H I I E I L N I M E N A N I E N L G F A S S K - - - - T C. j e j u n i
2 8 6 G T H L I Q I L N V M E N A D L S A L G Y G A S K - - - - N H. p y l o r i
2 9 7 G I H I V Q I L N I L E N F D M K K Y G F G S A D - - - - A E . c o l i
2 9 5 G I F L L Q M L K I L D H F N L S Q Y D V R S W E - - - - K B . s u b t i l i s
2 8 3 G P V L A L I L N I L K G Y N F S R E S V E S P E Q K G L T H u m a n
2 8 3 G V V I C E I M N I L E G Y P M K E L G Y H S A Q - - - - G P . a e r u g i n o s a
2 8 2 G P V L A L I L N I L K G Y N F S R A S V E T P E Q K G L T P i g
2 8 2 G P V L I L I L N I L K G Y N F S P K S V A T P E Q K A L T R a t
2 9 7 G I H I V Q I L N I L E N F D M K K Y G F G S A D - - - - A S . t y p h i m u r i u m
G C o n s e n s u s
3 0 3 L H I M A E A M R Q A Y A D R S E Y M G D P D F V K I P - - c .  j e j u n i
3 1 2 I H I A A E A M R Q A Y A D R S V Y M G D A D F V S V P - - H. p y l o r i
3 2 3 M Q I M A E A E K Y A Y A D R S E Y L G D P D F V K V P - - E . c o l i
3 2 1 Y Q L L A E T M H L S Y A D R A S Y A G D P E F V N V P - - B . s u b t i l i s
3 1 3 Y H R I V E A F R F A Y A K R T L - L G D P K F V D V T E V Human
3 0 9 V H Y T I E A M R H A Y V D R N S Y L G D P D F V K N P - - P .  a e r u g i n o s a
3 1 2 Y H R I V E A F R F A Y A K R T L - L G D P K F V N V T E V P i g
3 1 2 Y H R I V E A F R F A Y A K R T M - L G D P K F V D V S Q V R a t
3 2 3 M Q I M A E A E K y A Y A D R S E Y L G D P D F V K V P - - S . t y p h i m u r i u m
C o n s e n s u s
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3 3 1 L D K L T S K E Y A K E I Y A K I P K D K A L P S S K V - - C. j e j u n i
3 4 0 V D K L I N K A Y A K K I F D T I Q P D T V T P S S Q I - - H. p y l o r i
3 5 1 W Q A L T N K A Y A K S I A D Q I D I N K A K P S S E I - - E . c o l i
3 4 9 L K G L L H P D Y I K E R Q Q L I N L D Q V N K K P K A G D B . s u b t i l i s
3 4 2 V R N M T S E F F A A Q L R A Q I S D D T T H P I S - - - - H u m a n
3 3 7 L A H L L D K D Y A A K I R A A I N P Q K A G I S Q E I - - P .  a e r u g i n o s a
3 4 1 V R N M S S E F F A D Q L R A R I S D T T T H P D S - - - - P i g
3 4 1 I R N M S S E F Y A T Q L R A R I T D E T T H P T A - - - - R a t
351 W Q A L T H K A Y A K T L A D Q I D I N K A K P S S Q I - - S . t y p h i m u r i u m
I C o n s e n s u s
359
368
379
379
368
365
367
367
379
P W K Y Q E G S
Y  Y
i
K P G L G Q I H E G H N T T H Y S V c .  j e j u n i
K P G M G Q L H E G S N T T H Y S V H. p y l o r i
R P G K L A P Y E S N Q T T H Y S V E . c o l i
Q V E Q P K D K V E G Q T T H F T V B . s u b t i l i s
K P E F Y T P D D G G - T A H L S V H u m a n
K P G - V P P H E G S N T T H Y s I P . a e r u g i n o s a
E P E F Y T P D D A G - T A H L s V P i g
E A E F Y L P D D G G - T A H L s V R a t
K P G K L A P Y E S N Q T T H F s V 5 . t y p h im u r i u m
- - - - - - - - - - - - T - H - - - C o n s e n s u s
3 7 7 L D S K G N A V s I T Y T I N A S Y G S G A T V E G A G F L C ,  j e j u n i
3 8 6 A D R W G N A V s V T Y T I N A S Y G S A A S I D G A G F L H. p y l o r i
3 9 7 V D K D G N A V A V T Y T L N T T F G T G I V A G E S G I L E . c o l i
4 0 9 A D R W G N V V S Y T T T I E Q L F G T G I M V P D Y G V I B . s u b t i l i s
3 8 7 V A E D G S A V s A T S T I N L Y F G S K V R S P V S G I L H u m a n
3 8 2 V D K D G N A V s V T Y T L N D W F G A K V M A N G T G V L P .  a e r u g i n o s a
3 8 6 V S D D G S A V s A T S T I N L Y F G S K V R S R I S G I L P i g
3 8 6 V S E D G S A V A A T S T I N L Y F G S K V L S R V S G I L R a t
3 9 7 V D K D G N A V A V T Y T L N T T F G T G I V A G N T G I L 5 . t y p h im u r iu m
- - - - G - - V - - T - T - - - - - G - - - - - - - - G - - C o n s e n s u s
4 0 7 L N D E M D D F S I K P G V P N L Y G L V G G E A N A I E P C . j e j u n i
4 1 6 L N N E M D D F S I K P G N P N L Y G L V G G D A N A I E A H. p y l o r i
4 2 7 L N N Q M D D F S A K P G V P N V Y G L V G G D A N A V G P E . c o l i
4 3 9 L N N E L T D F D A I P G G A N E V Q P B . s u b t i l i s
4 1 7 F N N E M D D F S S - P S I T N E F G V p P S P A N F I Q P H u m a n
4 1 2 L N D E M D D F T S K V G V P N M Y G L I Q G E A N A I G P P . a e r u g i n o s a
4 1 6 F N D E M D D F S S - P N I T N Q F G V R P S P A N F I T P P i g
4 1 6 F N D E M D D F S S - P N F T N Q F G V A P S P A N F I K P R a t
4 2 7 L N N Q M D D F s A K P G V P N V Y G L V G G D A N A V G P S . t y p h i m u r i u m
- N - - - - D F - - - - - - - - - - - - - - - - A N - - - - C o n s e n s u s
224
C hap ter 6. C haracterisa tion  o f  the  C .jejuni y -g lu tam yl transpepetidase  gene
4 3 7 K K R P L S s M S p T I I L - K D G K V F M V V G S P G G S C. j e j u n i
4 4 6 N K R P L S s M S p T I V L - K N N K V F L V V G S P G G S H .  p y l o r i
4 5 7 N K R P L S s M S p T I V V - K D G K T W L V T G S P G G S E . c o l i
4 5 9 N K R P L s s M T p T I L F - K D D K P V L T V G s P G G A B . s u b t i l i s
4 4 6 G K Q P L s s M C p T I M V G Q D G Q V R M V V G A A G G T Human
4 4 2 G R R P L s s M s p T I V T - K D G K T V M V V G T P G G S P. a e r u g i n o s a
4 4 5 G K Q P L s s M c p V I I V G E D G Q V R M V V G A S G G T P i g
4 4 5 G K Q P L s s M c p S I I V D K D G K V R M V V G A S G G T R a t
4 5 7 K K R P L s s M s p T I V V - K E G K T W L V T G S P G G S S. t y p h im u r iu m
- - - P L s s M - p - I - - - - - - - - - - - - G - - G G - C o n s e n s u s
4 6 6 R I I T T V L Q V I S N V I D H K M D I s T A V E S P R F H C .  j e j u n i
4 7 5 R I I T T V L Q V I S N V I D Y N M N I s E A V S A P R F H H. p y l o r i
4 8 6 R I I T T V L Q M V V N S I D Y G L N V A E A T N A P R F H E . c o l i
4 8 8 T I I S S V L Q T I L Y H I E Y G M E L K A A V E E P R I Y B . s u b t i l i s
4 7 6 Q I T T A T A L A I I Y N L W F G Y D V K R A V E E P R L H H u m a n
4 7 1 R I I T A T L L T M L N M I D Y G M N L Q E A V D A P R F H P .  a e r u g i n o s a
4 7 5 Q I T T S T A L A I I H S L W F G Y D V K R A V E E P R L H P i g
4 7 5 Q I T T S V A L A I I N S L W F G Y D V K R A V E E P R L H R a t
4 8 6 R I I T T V L Q M V V N S I D F G M N V A E A T N A P R F H S . t y p h i m u r i u m
- I A P R - - C o n s e n s u s
4 9 6 M Q W L P D E I R T E P F G I I K D V Q N N L E K M G Y K I C .  j e j u n i
5 0 5 M Q W L P D E L R I E K F G M P A D V K D N L T K M G Y Q I H. p y l o r i
5 1 6 H Q W L P D E L R V E K - G F S P D T L K L L E A K G Q K V E . c o l i
5 1 8 T N S M S - S Y R Y E D - G V P K D V L S K L N G M G H K F B . s u b t i l i s
5 0 6 N Q L L P N V T T V E R - N I D Q A V T A A L E T R H H H T H u m a n
5 0 1 Q Q W M P E S T N I E A F A L S P D T Q K I L E S W G Q K F P .  a e r u g i n o s a
5 0 5 N Q L L P N T T T L E K - G I D Q A V A A A L K T R H H Y I P i g
505 N Q L L P N T T T V E K - N I D Q V V T A G L K T R H H H T R a t
5 1 6 H Q W L P D E L R V E K - G F S P D T L K L L E Q K G Q K V S . t y p h i m u r i u m
C o n s e n s u s
5 2 6 T K E P Y - M G D V N A I M V D P K T
5 3 5 V T K P V - M G D V N A I Q V L P K T
5 4 5 A L K E A - M G S T Q S I M V G P D G
5 4 6 G T S P V D I G N V Q S I S I D H E N
5 3 5 Q I A S T F I A V V Q A I V R T A G G
5 3 1 A G P Q P - A N H I A A I L V G A P S
5 3 4 Q D A S T F I G V V Q A I V R T P S G
5 3 4 E V T P D F I A V V Q A V V R T S G G
5 4 5 A L K E A - M G S T Q S I M V G P D G
- G - - - - - - K I I  C .  j e j u n i
G - - - - - - S V F  H. p y l o r i
- - - - - - - - - L  E . c o l i
T F K G V A D S S R  B . s u b t i l i s  
- - - - - - - - - W  H u m a n
G G K P I G K N R F  P . a e r u g i n o s a  
- - - - - - - - - W  P i g
R a t
- - - - - - - - - L  S . t y p h i m u r i u m
- - - - - - - - - -  C o n s e n s u s
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5 4 8 - G S M D T R K E F C. j e j u n i
5 5 8 Y G S T D P R K E F H. p y l o r i
5 6 5 Y G A S D P R S V D D L T A G Y E . c o l i
5 7 6 N G A A I G I N L K R K B . s u b t i l i s
5 5 5 A A A S D S R K G G E - P A G Y H um an
5 6 0 Y G A N D P R R N T G L A L G Y P. a e r u g i n o s a
5 5 4 A A A S D S R K G G E - P A G Y P i g
5 5 4 A A A S D s R K G G E - P A G Y R a t
5 6 5 Y G A S D p R S V D D L T A G Y S . t y p h i m u r i u m
C o n s e n s u s
A multiple sequence alignment was performed using the MegAlign program (DNAStar, 
LaserGene). Designations on the right hand side refer to the origin of the sequences : C. jejuni 
strain 81116, this study; H. pylori of GeneBank AE000511 (HP-1118); E. coli, PI8956; B. 
subtilis, P54422; human, PI9440; P.aeruginosa, P36267; pig, P20735; rat, P07314; S. 
typhimiurium, NP462452. Numbers on the left hand side indicate amino acid positions. Amino 
acids in red are identical to the one present at the same position in the C. jejuni GGT. Vertical 
arrows show the putative cleavage sites for C. jejuni. In the consensus, the amino acids 
highlighted blue, indicate the residues assigned to the catalytic site of the mammalian enzyme; 
and in green, indicates the residue essential for transpeptidation activity in B. subtilis.
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6.2.3 Generation of a ggt suicide vector, pIAH-ggt
To study the role of the C. jejuni ggt gene, a suicide vector was generated to inactivate 
the gene in strain 81116. The Campylobacter kanamycin resistance gene, kindly 
provided by Prof. Julian M. Ketley, and used to make the suicide vector, has a 
promoter but no transcriptional terminator. Thus, this is polar in either direction but 
potentially less so if it is placed in the same transcriptional orientation as the target 
gene. However, in strain 81116, the genes flanking ggt (Figure 6 .6) are in a different 
transcriptional orientation and ggt was predicted to have a transcriptional terminator. 
Therefore, kanamycin cassette insertion into ggt and subsequent disruption was not 
expected to effect the expression of any other gene in strain 81116.
Initially, 1521 bp of the ggt gene (basepair positions 145 to 1665) was amplified using 
primers If66 and If50 from C. jejuni strain 81116 using HotStarTaq (Qiagen). The ggt 
PCR product, with A overhangs, was ligated to linearised pCR®2.1-T0P0® (3.9 kbp) 
with T overhangs covalently bound to Topoisomerase I, using the TOPO TA cloning® 
kit (Invitrogen) (Figure 6.9). The cloned DNA was transformed into competent 
TOPOF’ E. coli cells and selected for colonies on LB agar plates containing 
kanamycin (50 pg ml'^). Twenty random colonies were grown overnight in LB 
containing kanamycin and the plasmid was extracted from each culture by Mini DNA 
plasmid preparation. Each plasmid (2pl) was digested with Æ^ coRI and visualised on a 
1 % (w/v) agarose gel. The plasmids that gave a 3.9 and 1.5 kbp band profile were the 
correct constructs and named pCR®2.1-gg^f. The ggt DNA was now flanked by EcoKL 
sites in pCR®2.1-ggf, making the next step of cloning possible.
Even though the kanamycin gene in pCR®2.1 -TOPO® was from E. coli and unlikely 
to function in C. jejuni, ggt was next subcloned into a vector without this antibiotic 
resistance gene, because the C. coli kanamycin cassette used to generate the suicide 
vector could also function normally in E. coli. Absence of the E. coli kanamycin gene 
would then allow kanamycin selection of E. coli transformants containing the suicide 
vector with the C. coli kanamycin cassette. Therefore, pCR®2.1ggt (5 pg) was 
digested with F^coRI (Figure 6.10) and visualised on a 1 % (w/v) agarose gel and the
1.5 kbp ggt DNA fragment with E^coRI ends was purified by DNA agarose gel
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Figure 6.9
The initial cloning step for constructing the ggt suicide vector. The 1521 bp ggt PCR product 
was amplified using primers If66 and IfSO from C. jejuni strain 81116. The ggt PCR product 
with A overhangs, was ligated to linearised pCR®2.1-TOPO® with T overhangs and transformed 
into E. coli competent cells. This method was used due to the ease of cloning. The plasmid was 
named pCR®2.1-ggt. nto E. coli competent cells.
1.5 kbp 
ggt PCR product
/iCoRI
pUC origin
fl oriRU
pCR®2.1-TOPO®
3908 bp
Ampicillin
Kan am y d  I
1. TA cloning to pCR®2.1-TOPO®
2. Transform into E. coli
AwRI
1.5 kbp
‘pCR®2.1-^^’ 
(4.4 kbp)
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Figure 6.10
The second cloning step for constructing the ggt suicide vector. The pCR®2.1-ggr plasmid was 
digested with EcoRi and the 1.4 kbp fragment was purified. The fragment was ligated to 
linearised pCR-Script™SK(+) with EcoRI compatible ends and transformed into E. coli 
competent cells. The pCR-Script™SK(+) vector did not contain a kanamycin resistance gene, 
which was the antibiotic resistance gene casstte going to be used to disrupt the ggt gene. The 
plasmid was named pCR-Script-gg/.
i ’coRl
1.5 kbp BcoRl
n (+r
Ampicillin
pCR-Script™
SK(+)
1 2961 bp
Hinàlll
lacZ
EcoKl digestion 
Ligation to Æ'coRI ends in
hTM^lEl ori^ pCR-Scripf 
Transform into E. coli
Script™
E'coRl
EcoRI
‘pCR-Script-g§^^’ 
(4.4 kbp)
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extraction. The purified ggt DNA fragment was then cloned into pCR-Script™ SK(+) 
vector (2.9 kbp) obtained from Stratagene, digested with EcoRi, dephosphorylated 
and cleaned by ethanol precipitation. The linearised vector was ligated to the purified
1.5 kbp ggt fragment using T4 DNA ligase and then transformed into competent 
TOPOF’ E. coli cells (Figure 6.10). Twenty random colonies were grown overnight in 
LB containing ampicillin (100 pg ml'^) and the plasmid was extracted from each 
culture by Mini DNA plasmid preparation. Each plasmid (2pl) was digested with 
EcoRt and visualised on a 1 % (w/v) agarose gel. The plasmid that gave a 2.9 and 1.5 
kpb band profile was chosen for the next stage and named pCR-Script-gg/^.
Plasmid-based inverse PCR technique was used again (see Section 5.2.2) to inactivate 
the ggt gene with an antibiotic resistance gene cassette. Initially, a unique restriction 
site was introduced 532 bp from base pair position 1 of the ggt gene. PCR 
amplification of pCR-Script-ggf with primers Jf67 and Jf68 (designed to hybridise in 
opposite orientations and included a BgK\ at their 5’ ends) was performed (Figure 
6.11). As a direct result of inverse PCR, a 4.3 kbp PCR product flanked by Bglll sites 
was produced. This was run on a 1 % (w/v) agarose gel and the band was purified by 
DNA agarose gel extraction. The amplified product was then digested with Bglil, and 
re-circularised by self-ligation with T4 DNA ligase. The re-circularised plasmid was 
transformed into competent TOPO 1 OF’ E. coli cells and colonies were selected on LB 
agar containing ampicillin. Twenty colonies were grown overnight in LB containing 
ampicillin and the plasmid was extracted from each culture by Mini DNA plasmid 
preparation. Each plasmid was digested with BgRl and visualised on a 1 % (w/v) 
agarose gel. The plasmids that gave a single 4.3 kbp band profile had the introduced 
BgRl site and named pCR-ggf-Bg/II.
The final cloning step (Figure 6.12) involved BgRl digestion of pCR-gg^-Rg/II 
plasmid, followed by dephosphorylation and ethanol precipitation. A Campylobacter 
kanamycin resistant gene (1.5 kbp) with BamlRl ends was ligated to linearised pCR- 
ggt-BgRl using T4 DNA ligase and transformed into competent TOPO 1 OF’ E. coli 
cells. Colonies were selected on LB agar plates containing both ampicillin and 
kanamycin. Twenty colonies were grown overnight in LB containing ampicillin and 
kanamycin, and the plasmid was extracted from each culture by Mini DNA plasmid
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Figure 6.11
The third cloning step for constructing the ggt suicide vector. Inverse PCR primers If67 and 
If68 were used to amplify a 4.3 kbp product from the pCR-Script-gg? plasmid template. 
Following BgW digestion, the DNA was re-circularised by self-ligation and transformed into 
E. coli competent cells. The plasmid was named pCR-Script-ggt- BglW.
IÎ61 If 68
g g /ii gg/n
g g r  1.5 kbp
pCR-ScriptTM 
SK )^
B glll / ico R l
l.IPCR
pCR-Script™ SK(+)
0.4 kbp 1.0 kbp
1. BgRl digestion
2. Self ligation
^  3. Transform into E. coli
gg/n
ggt 1.4 kbp
pCR-Script™
SK(+)
‘pCR-Script-ggt- BglVY 
(4.3 kbp)
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Figure 6.12
The final cloning step for constructing the ggt suicide vector.The pCR-Script-ggt- Bglll plasmid 
was linearised with Bglll and ligated to kanamycin gene with BamHl compatible ends before 
transforming into E. coli competent cells. The suicide vector was named pIAH-ggt.
Bglll
Bam H l Bam H l
I Kanamycin |
1.5 kbp
ggt 1.4 kbp
1. BgBl digestion
2. Ligation to kanamycin cassette
3. Transform into E. coli
H in àlll
.5 kbp
E coR l
H in d lll
Kpn l
‘pIAH-ggt’ 
(5.8 kbp)
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preparation. The plasmids that gave a 1.0, 1.9 and 2.9 kbp band profile following 
EcoRi digestion were correct. Further digestion with other enzymes {BamHl, Notl or 
Kpnl) confirmed the correct construction of the 5.9 kbp suicide vector (Figure 6.13) 
and was named pIAH-ggt. The ggt gene was disrupted from base pair position 532 by 
the kanamycin gene in pIAH-ggt, and the kanamycin cassette was in the opposite 
orientation to ggt.
6.2.4 Inactivation of ggt in C. jejuni strain 81116
Strain 81116 has been previously used for obtaining transformants by electroporation 
with suicide vectors (Wassenaar et al, 1993; Bâillon et al, 1999). Therefore, the 
pIAH-ggt suicide vector was directly introduced into strain 81116 by electroporation 
in order to disrupt the wild-type ggt gene from position 532 bp with the kanamycin 
gene. Electroporations were carried out on 0 pg, 0.5 pg and 1.0 pg of plasmid pIAH- 
ggt mixed with 50 pi of strain 81116 (10^ c.f.u.) in electrobuffer. After 5 hours of 
recovery on BA plates, the transformants were selected by plating onto BA plates 
supplemented kanamycin (50 pg ml"^). After 48 hours, there were no colonies 
observed on the 0 pg plates, however, the 0.5 and 1.0 pg plates gave 6 and 1 
transformant(s), respectively. Since standard E. coli vectors are unable to replicate in 
Campylobacters, a double crossover event leads to the elimination of vector sequence 
and replacement of the wild-type gene with the disrupted copy. Thus, the emergence 
of kanamycin resistant transformants suggests that the chromosomal copy of ggt had 
been replaced by the kanamycin-disrupted copy.
6.2.5 Analysis of mutants
6.2.5.1 PCR
To confirm the successful generation of a ggt mutant, PCR amplification of the ggt 
gene using primers IfZO and IflOO from the parental strain and kanamycin-resistant 
transformants were compared (Figure 6.14). The parental strain gave the expected 
PCR product of 1.5 kbp. The mutants gave a single PCR product of 3.0 kbp. This 
indicated that the chromosomal copy of ggt had been replaced by the kanamycin 
disrupted copy from the suicide vector. The presence of an additional band (see
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Figure 6.13
Ethidium bromide stained 1 % (w/v) agarose gel of digested pIAH-ggf recovered from 
transformants. Lane 1, undigested pIAH-gg?; lane 2, BamHl digested pIAH-ggf; lane 3, EcoKl 
digested pIAH-ggf; lane 4, Notl digested pIAH-g^/; lane 5, Kpnl digested pIAH-ggr. Ikbp 
ladder (Gibco) positions are given on right-hand side.
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Figure 6.14
Ethidium bromide stained 1 % (w/v) agarose gel of PCR products obtained from amplification 
of ggt gene with primers If70 and Ifl 00, lane 1, using wild-type strain 81116 genomic DNA ( 1.5 
kbp); lane 2, using kanamycin-resistant ggt mutant genomic DNA (3.0 kbp).
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Section 5.2.4.1) of 1.5 kbp would have suggested that the chromosomal ggt gene had 
not been disrupted, but this was not seen.
6.2.S.2 Southern blot analysis
Further analysis by Southern blotting was used to confirm the insertional inactivation 
of ggt by the kanamycin gene in strain 81116 (Figure 6.15). Therefore genomic DNA 
from the kanamycin resistant transformants and the parental strain were extracted and 
10 pg was digested with Hindlll restriction enzyme at 37°C for 36 hours. The suicide 
vector, pIAH-ggt was digested with EcoRl and 500 ng was used as a positive control. 
The resulting DNA fragments for each sample were separated by electrophoresis 
through a 1% (w/v) agarose gel at 25 V overnight. Then the DNA was transferred 
from the agarose gel to a nylon membrane as described in Section 2.9.1
The membrane was hybridised with, respectively, an alkaline phosphatase-labelled 
probe specific for pCR-Script vector, ggt gene and the kanamycin-resistance gene, as 
described in Section 2.9.3. Only the suicide vector, pIAH-ggt (positive control) 
hybridised with each of the probes. None of the transformants or parental strain 
contained pCRScript vector. All transformants hybridised with three bands at 2.0, 1.6 
and 1.5 kbp with the ggt gene probe whilst the parental strain hybridised with two 
bands at 1.9 and 1.7 kbp. All the transformants, but not the parental strain, hybridised 
to the kanamycin-resistance gene at 1.5 kbp.
The ggt gene contains one Hindlll site and the wild-type pattern was predicted to give 
two bands at 1.9 and 1.7 kbp, as observed. For the mutant, the correct construction 
was predicted to give the three band sizes observed, since the kanamycin cassette 
contained an additional HindUR site. Collectively, this suggested that double 
homologous recombination had occurred (see Section 5.2.4.2), and consequently, the 
chromosomal ggt gene had been successfully replaced with the kanamycin disrupted 
copy from the suicide vector.
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Figure 6.15
Autoradiographs o f Southern blots hybridised with (a) ggt gene (b) kanamycin gene. Lane 1, 
kanamycin-resistant ggt mutant genomic DNA digested with Hindi\\\ 2, wild-type strain 81116 
genomic DNA digested with HindlW, ; 3, pIAH-ggt suicide vector digested with ///«dill
(a) (b)
1 2  3 1 2  3
- t
-3 .0  # - 3 . 0
-2 .0  ^ k - 2 . 0
- 1.6  - 1.6
-1.0 ^ - 1 . 0
-0 .5  % -0 .5
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6.2.5.3 Examination mutant by transmission electron microscopy
The mutant and wild-type strains were examined by EM, as already described in 
Section 5.2.5, No difference in the physical appearance of the ggt mutants was 
observed compared to the parent strain (Figure 6.16).
6.2.5.4 Determination of cell growth
The ggt mutant and parental strain were grown under microaerobic conditions, as 
already described in Section 5.2.6. The resulting growth curves for the ggt mutant and 
parental strain were similar (Figure 6.17) and suggested that both strains were able to 
grow similarly under these conditions in vitro.
6.2.5.5 GGT activity assay
6.2.5.5.1 Quantitative determination of GGT activity forg^/ mutant and parental 
strain
The GGT activity for the ggt mutant and the parental strain were assessed using the 
ThermoTrace GGT assay (Alpha Laboratories) at exponential and stationary phases of 
growth (20 and 40 hours from the predetermined growth curves (Section 6.2.5.4), 
respectively). The GGT activity at 32, 37, 42 or 47°C, was also determined for both 
strains. The results are summarised in Table 6.2. No specific activity was observed for 
the ggt mutant, verifying successful gene disruption and gene replacement had 
occurred. At both exponent!^ and stationary phases, the GGT specific activity for the 
parental strain was most active at 42°C. This suggests that the enzyme may have
evolved to work best in hosts, such as chickens with a body temperature of 42°C. On
1
average, a 1.9-fold higher specific activity was observed in the exponential phase than 
in the stationary phase. Thig suggests that GGT is required by C. jejuni more during 
the exponential phase of growth but that it may also be required albeit to a lesser 
extent, during the stationary phase. Alternatively, degradation of the enzyme occurred 
to a greater extent during the stationary phase.
The wild-type strain 81116 and the ggt mutant were assayed for the production of 
GGT activity by the rate of formation of 5-amino-2-nitrobenzoate, using the 
Thermotrace method. The wild-type strain produced GGT activity at both exponential 
and stationary phases, with higher activity observed in the former phase. This
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Figure 6.16
Transmission Electron Micrograph of the C. jejuni ggt mutant.
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Figure 6.17
Growth curves of the ggt mutant strain compared to the parental strain 81116. One hundred 
microliters of bacterial suspension in 0.1 M PBS pH 7.2 (approximately 10^  to 10^  c.f.u. ml' )^ 
was inoculated into a pre-warmed (37°C) large BHI/YE biphasic broth and left to grow at 42°C 
under microaerobic conditions. A viable count of the bacterial culture was taken, in triplicate, 
after 0, 4, 7, 22, 30 and 50 hours of growth.
parental strain
ggt mutant
0 5 10 15 20 25 30 35 40 45 50 55
Time (Hours)
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Table 6.2
Quantitative determination o f y-glutamyltranspeptidase activity expressed as Units per ml per 
mg o f whole protein. The specific activity o f the ggt mutant compared to the parental strain 
81116, at different temperatures and at, (a) exponential phase, (b) stationary phase.
Exponential Phase of Growth (20 hours)
81116wt ggt mutant
32 »C 21.40 U/mL/mg 0* U/ml/mg
37 «C 22.95 U/ml/mg 0* U/ml/mg
42 «C 25.63 U/ml/mg 0* U/ml/mg
47 "C 22.25 U/ml/mg 0* U/ml/mg
(a)
(b) Stationary Phase of Growth (40 hours)
81116wt ggt mutant
32 “C 12.49 U/ml/mg 0* U/ml/mg
37 "C 12.12 U/ml/mg 0* U/ml/mg
42 "C 13.76U/ml/mg 0* U/ml/mg
47 "C 12.01 U/ml/mg 0* U/ml/mg
o
* The sensitivity o f the assay is 0.001 AAbs/min per U/L
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disagrees with previous studies, in which GGT activity in B. suhtilis and E. coli was 
shown to be primarily expressed post-exponentially (Hashimoto et al, 1995; Xu and 
Strauch, 1996). The higher GGT activity during the exponential phase of growth, 
rather than stationary phase, suggests that the presence of the active enzyme in 
C. jejuni during the early stages of host colonisation may provide some selective 
advantage over strains negative for GGT. The ggt mutant did not produce any GGT 
activity, which confirmed the successful inactivation of the GGT enzyme in C  jejuni 
and that this gene alone was responsible for the activity observed.
The wild-type cells grown at 42°C were found to have GGT activity at a reaction 
temperature of 32, 35, 42 and 47°C., For both the exponential and stationary fractions 
the maximal activity was observed at 42°C. The lower average activity observed in 
the stationary phase fraction may be due to the degradation of the enzyme after a 
prolonged period of time. This was in contrast to E. coli where GGT expression was 
maximal at 20°C and in which the activity was greatly affected by the growth 
temperature. Maximal activity in E. coli was observed when cells were grown at 20°C 
and little or none was observed when grown at 37, 40 or 43°C (Suzuki et al, 1986). 
However, when cells grown at 20°C were incubated at 45°C, 55% of the activity was 
stably maintained. This was due to a low-temperature dependent ggt promoter as well 
as the stability of the ggt mRNA at lower temperatures, rather than synthesised GGT 
being degraded at higher temperatures (Hashimoti et al, 1997). Nevertheless, GGT 
was expressed during logarithmic growth in E. coli and primarily post-exponentially 
in B. subtilis (Xu and Stanch, 1996) The latter may be due to an unidentified ggt 
regulatory factor. On the contrary, no temperature effect was observed on H. pylori 
GGT gene expression and there was no temporal induction of GGT expression with 
the growth phase of cells Thus, as observed for H. pylori, the C. jejuni ggt gene 
appears to be constitutively expressed (Chevalier et al, 1999). This is quite likely, 
considering that the predicted ggt promoter element in C. jejuni has similarity to the 
cj^^-like promotor consensus sequence.
6.2.5.S.2 Colourmetric test for GGT activity in C  jejuni strains
Since the specific activity for GGT appeared to be solely potentially attributable to the 
ggt gene in strain 81116, this activity could be used to rapidly determine ggt
2 4 2
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prevalence in C  j'ej'uni strains. Therefore, the C. jej’uni strains screened for the 
presence of ggt by Southern blot analysis (Chapter 3), were grown to stationary phase 
(20 hours) and resuspended in IM Tris pH 8.0 (10^ '^ ® c.f.u. ml'^). The cells were then 
mixed with the appropriate amount of the ThermoTrace GGT assay reagent and 
incubated at 37 °C for 30 min. GGT presence was detected as a yellow colour 
development. This colour change was only detected in strains positive for ggt (Figure 
6.18). Thus the presence of the DNA sequence of the gene correlated directly with the 
expression of the GGT activity.
6.2.5.6 Presence of ggt in C jejuni from various sources
One hundred and thirty four C. jejuni strains from various sources (31 isolates from 
poultry, 31 isolates from bovine, 29 isolates from humans, 18 from ovine, 15 isolates 
from porcine and 10 isolates from various other sources) were tested. The strains were 
grown overnight on BASA plates at 42°C under microaerobic conditions. Each strain 
was put through a colony PCR reaction using HotStarTaq with primers If50 and 
IflOO. A positive control using strain 81116 was simultaneously used to amplify ggt 
and absence of a PCR product would indicate PCR failure. In addition, a negative 
control using strain NCTC11168 genomic DNA was used to account for any DNA 
contamination. However, as already discussed in Section 5.2.7, a negative result could 
have been due to small DNA sequence differences in the gene. Agarose gel 
electrophoresis was used to confirm the presence of a 1.5 kbp ggt PCR product. The 
numbers, as well as percentages, of isolates from each source carrying the ggt gene is 
shown in Table 6.3(a). Fisher’s exact statistical analysis was used to compare the 
overall observed numbers for each source tested against the expected value. The 
expected value was determined by the number of isolates carrying ggt in the total 
number of C. jejuni isolates tested. The P value was determined to be 0.042 and this 
indicated that ggt was not equally distributed in each source. As a consequence, the 
Fisher’s exact statistical analysis was used again to identify the source(s) that was 
causing the difference. This time the observed numbers for one source was compared 
with each of the other sources. The results are shown in Table 6.3(b). The significant 
P values (P < 0.05) are highlighted in red and this indicated that there was a higher 
proportion containing ggt in humans than in cows and pigs. None of the other 
differences were statistically different.
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Figure 6.18
(a) Colourmetric test for GGT activity in C jejuni strains and, (b) the presence o f the ggt 
fragment (insert 236), identified by Southern blot analysis o f genomic DNA digested with 
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Table 6.3
Presence o f y-glutamyl transpeptidase gene in C. jejuni from various sources
(a) Values are numbers (percentage) o f isolates carrying ggt gene from a particular source.
(b) The individual proportions from each source was compared to another using the Fisher’s 
Exact statistical analysis. The significant P values (P < 0.05) are marked in red.
C. jejuni Source Numbers (percentage) positive
Poultry 7/31 (22.58%)
Bovine 2/31 (6.45%)
Human 11/29 (37.93%)
Ovine 3/18 (16.67%)
Porcine 1/15 (6.67%)
Other 2/10 (20.00%)
Total 26/134 (19.40%)
(a)
Bovine Human Ovine Porcine Other
Poultry 0.147 0.262 0.726 0.243 1.000
Bovine 0.004 0.342 1.000 0.245
Human 0.191 0.035 0.445
Ovine 0.607 1.000
Porcine 0.544
(b)
245
Chapter 6. Characterisation of the C.jejimi y-glutamyl transpepetidase gene 
6.2.S.7 Invasion assay using INT407 cells
Based on previous studies (C. Feamley, PhD thesis), INT407 cells were infected with 
different starting MOIs (number of bacteria added per epithelial cell) of log-phase (20 
hours of growth) C. jejuni strain 81116 or the GGT-deficient mutant. The mixture was 
incubated for three hours (the invasion period) and then gentamicin added and 
incubated for a further two hours (to kill all extracellular bacteria) prior to 
enumeration of internalised bacteria. The numbers of internalised bacteria at each 
MOI tested was used to compare the ability of mutant and parental strain to invade 
INT407 cells (Figure 6.19). The invasion efficiency at a MOI of 200 was 5.4-fold 
higher for the ggt mutant (0.0092%) when compared to the parental strain (0.0017%). 
Although, for both strains the total numbers of internalised bacteria increased with 
greater bacterial concentrations, the invasion efficiency between the ggt mutant and 
parental strain, steadily decreased from 5.9, 5.3, 4.5 to 3.5-fold at MOIs of 50, 100, 
200 and 400, respectively. This was not surprising since only a limited number of 
bacteria can invade eukaryotic cells at one time and thus, increasing bacterial numbers 
results in saturation.
6.2.5.S Aerobic survival
Cell survival was assessed under aerobic conditions in Mueller Hinton broth at 42°C. 
The number of wild-type cells recovered over the course of 7 hours was comparable 
to those of the initial number of cells tested (0 hours). The ggt mutant possessed 
survival characteristics similar to those of the wild-type (Figure 6.20). This suggested 
the survival rates under atmospheric oxygen conditions at 42°C, was similar for the 
parental strain and the GGT deficient mutant. For both strains, after seven hours, the 
bacterial numbers progressively reduced and by 24 hours the numbers were 
undetectable (data not shown)
6.2.S.9 Methy viologen susceptibility assay
To assess the contribution of GGT to the oxidative stress resistance of C. jejuni, the 
sensitivities of the wild-type strain and the GGT-deficient mutant to methyl viologen, 
an effective superoxide-generating agent, was determined by the appearance of a 
growth inhibition zone around the disc containing methyl viologen. The diameters of 
the clear zones next to the discs were similar at each concentration of methyl viologen 
used (Figure 6.21), indicating that the susceptibility of the mutant to methyl viologen
24 6
C hapter 6. C haracterisa tion  o f  the  C. jejuni y -g lu tam yl transpepetidase  gene
Figure 6.19
Comparison of the capacity o f the ggt mutant to invade INT407 cells compared to the parental 
strain 81116
20000 1
17500-
ggt mutant
3
15000-u
I  12500-
I parental strain
7500-
2500-
0 400 1200200 600 800 1000 1400
Multiplicity of Infection (MOI)
24 7
C hapter 6. C haracterisa tion  o f  the C  jejuni y-g lu tam yl transpepetidase  gene
Figure 6.20
Survival of the ggt mutant under atmospheric oxygen conditions compared to the parental strain 
81116 .
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Figure 6.21
Susceptibility of the ggt mutant to the superoxide-generating agent, methyl viologen compared 
to the parental strain 81116.
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was similar to the wild-type parental strain and that GGT did not have a role in 
protecting the bacterium from superoxide radicals.
6.2.5.10 Hydrogen peroxide susceptibility assay
To further test the contribution of GGT to the oxidative stress resistance of C. jejuni, 
the sensitivities of the wild-type strain and the GGT-deficient mutant were tested 
against hydrogen peroxide. Hydrogen peroxide (final concentration of 0.5 mM) was 
added to bacterial cells grown in Mueller Hinton broth (10^ c.f.u. ml'^), and the 
surviving numbers of bacteria were determined over a period of 120 mins (Figure 
6.22). Both the ggt mutant and parental strain were sensitive to hydrogen peroxide 
stress, however to different degrees. After 20 mins, levels of viable mutant cells were 
consistently 1.7 logs higher than those of the wild-type parental strain. Therefore, the 
loss of GGT appears to have increased the bacterium’s resistance to hydrogen 
peroxide stress.
6.2.5.11 Chick colonisation model
Five days post-oral-challenge with a dose of 10"^  c.f.u. resulted in 88% of chicks 
colonised by both the wild-type and ggt mutant (Figure 6.23). The geometric mean 
level of colonisation by the ggt mutant was 4.74 log^ ® c.f.u., and lower than the 
parental strain at 6.11 log^ ® c.f.u. However, the Mann-Whitney test gave a P value of 
0.1049, suggesting that the difference observed between the mean values was not 
statistically different. In other words, even though the ggt mutant had a mean 
colonisation level less than the parental strain, the actual level of colonisation was not 
statistically different and, therefore, would not make a physiological difference. After 
three weeks post-oral challenge, the parental strain resulted in 100% colonisation of 
chicks to maximum levels of 10  ^to 10  ^ c.f.u. g'  ^ of caecal contents (Figure 6.24). In 
contrast, colonisation levels in all birds by the ggt mutant were undetectable, and a P 
value of 0.0002 by Mann-Whitney test confirmed the results were statistically 
different.
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Figure 6.22
Susceptibility of the ggt mutant to hydrogen peroxide compared to the parental strain 81116.
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Figure 6.23
Chick caecal colonisation at five days post-challenge by the ggt mutant compared to the 
parental strain 81116. The geometric mean level of colonisation for each group is shown by a +. 
The dotted line represents the limit of detection of 100 c.f.u.
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Figure 6.24
Chick caecal colonisation at three weeks post-challenge by the ggt mutant compared to the 
parental strain 81116. The geometric mean level o f colonisation for each group is shown by a +. 
The dotted line represents the limit of detection o f 100 c.f.u.
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6.2.6 Conclusions
The identification of a gene ggt containing the DNA sequence for insert 236 has been 
described. This gene has, as originally described, a significant similarity to y-glutamyl 
transpeptidases from other microorganisms. A ggt mutant was generated in C. jejuni 
strain 81116 and the expression of the GGT-encoding gene was shown not to be 
essential for C. jejuni in vitro growth. In addition, the rate of cell growth for the GGT- 
deficient strain in vitro was similar to that of the wild-type and further suggested that 
GGT was dispensable for normal C. jejuni growth in vitro. This was not surprising 
since only 19.4% of randomly selected C. jejuni strains contained ggt and one might 
suppose that if there had been a detrimental effect on growth by the mutation, a higher 
frequency of isolates positive for the gene would have been expected. In contrast, all 
H. pylori clinical isolates synthesise a catalytically active GGT (Chevalier et al, 
1999). Furthermore, similar levels of GGT activity were observed amongst various 
Helicobacter species. These included H. felis, H  mustelae and H. canis, bacteria that 
naturally colonise the gastric mucosa of cats, ferrets and dogs, respectively. In 
addition to these, H. hilus and H. hepaticus, which colonise both the intestine and 
liver of mice, exhibited GGT activity. The Helicobacter GGT protein was also highly 
conserved within the genus. Nevertheless, of these C. jejuni strains (134 isolates from 
a variety of sources) that were positive for the presence of ggt there was variability in 
the prevalence amongst isolates from different host sources, and no source was found 
to consistently contain ggf-positive isolates. A statistically higher proportion of 
isolates from humans (37.93%) contained the gene than from cows (6.45%) and pigs 
(6.67%). This might suggest that GGT may provide some advantage to C. jejuni 
colonisation of humans, compared to cows and pigs. Suitable animal model for human 
colonisation would be required to test this hypothesis.
In C. jejuni strain NCTC11168, Cj0779 was identified as a probable thiol peroxidase 
(Parkhill et a/., 2000). Characterisation of a mutant in Cj0779 would be required to 
establish whether this putative enzyme has the ability to use glutathione as a substrate 
for protection against oxidative stress. However, strain NCTCl 1168 does not possess 
ggt (Chapter 3) and so perhaps this strain has numerous uncharacterised transport 
systems that allow it to import glutathione, rather that generating it, as has been 
observed in Streptococcus mutans (Sherrill and Fahey, 1998).
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The GGT activity in the C. jejuni strains tested was dependent on the presence of the 
ggt gene. Strain NCTCl 1168 which does not contain any gene with a predicted amino 
acid sequence similar to GGT, as expected, did not produce any GGT activity. Six 
(including strain 81116) of the seven strains (Figure 3.9g) that tested positive for ggt 
by Southern analysis suggested the gene was located predominately in the same 
genomic position as strain 81116. This implied that these strains have retained ggt due 
to a strong selection pressure, such as survival in a limiting environment, where the 
presence of the enzyme may allow the cells to utilise glutathione to fulfil either 
cysteine or glycine auxotrophic requirements.
Interestingly, contrary to expectations there was a higher rate of internalisation into 
INT407 cells by the ggt mutant, compared to the wild-type strain. This could be 
explained from the results obtained for GGT inhibition in other microorganisms. 
Initially, a rise in intracellular glutathione levels is observed before leakage starts 
from the bacterial cells. Eventually levels decrease during which time glutathione 
increases in the media (Nakayama et al, 1984). Similar results were observed with 
mammalian GGT, where inhibition of the enzyme was accompanied by extensive 
glutathionuria (Griffith and Meister, 1979). Elevated glutathione levels may enhance 
the organism’s resistance to oxidative stress.
The ability to survive under atmospheric oxygen conditions was the same for both the 
ggt mutant and wild-type strains at least for up to seven hours. This indicated that 
GGT was not involved in the adaptation of C. jejuni to these conditions, but instead 
GGT may have a role in intracellular survival, as implicated by the enhanced 
resistance to hydrogen peroxide stress by the ggt mutants. One hypothesis is that 
similar numbers of bacteria, for both the ggt mutant and wild-type, initially invaded 
the INT407 cells but the elevated intracellular glutathione levels of the ggt mutants 
may have enhanced their ability to survive inside eukaryotic cells for longer than the 
wild-type. Furthermore, since the mutants tested were in exponential phase when 
added to the monolayer, the ggt mutant cells most likely contained glutathione levels 
higher than the wild-type, as has been observed for E. coli (Nakayama et al, 1984). 
Therefore the increased numbers of internalised bacteria for the ggt mutant may have 
been due to the increased levels of intracellular glutathione. Thus, the differential
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between mutant and wild-type reflects intracellular survival rather than efficiency of 
invasion. Interestingly, the ggt gene was predominantly present in C  jejuni strains 
that were low invaders in the gentamicin protection assay (Mary Bagnall, personal 
communication). This fits with the higher invasion ability of the GGT negative 
mutants as compared to the wild-type strain, that has GGT activity. However, the 
actual mechanism for intracellular survival by C. jejuni strains is most likely to be 
complicated and involve various other mechanisms. A number of studies in vivo have 
established that C. jejuni is a facultatively intracellular bacterium (Black et al, 1988; 
Babakhani et al., 1993; Konkel et al, 1992). This intracellular existence provides this 
fastidious, asaccharolytic, slow growing organism an unoccupied niche, where 
microbial competition is relaxed or non-existent. Once inside, C. jejuni may be 
exposed to a variety of host killing mechanisms, including hydrogen peroxide, as the 
bacteria remains bound within an endosome (De Melo et al, 1989). Therefore 
resisting hydrogen peroxide stress and subsequently interrupting the formation of the 
more toxic intermediate products may allow improved persistence and survival of C. 
jejuni within the eukaryotic cells. However, it is difficult to assess how extensively 
these in vitro observations can be applied to the situation in vivo, such as in the 
intestinal epithelium.
Five days post oral-challenge in the chick colonisation model, the GGT-negative 
mutants colonised the chicks to 77.5% of the wild-type levels. Moreover, by three 
weeks post oral-challenge, the colonisation levels by the mutant in all the chicks 
tested were undetectable, whilst the wild-type strain colonised all chicks to maximum 
levels. This suggested that GGT was not essential for establishment of the infection, 
instead was required for prolonged chicken colonisation. Given that the ggt gene is 
not part of a polycistronic operon, as it is transcribed on the opposite strand to the 
flanking genes, and has a predicted transcriptional terminator element, the difference 
in the ability to colonise chickens can be attributed to the creation of a mutant 
deficient in GGT activity.
The first GGT-negative mutant tested in an animal model was generated in a mouse- 
adapted H. pylori strain, SSI (Chevalier et al, 1999). From days 3- to 60-post 
inoculation of outbred Swiss mice, no GGT-negative mutants were detected in the 
stomachs of any of the animals, suggesting an essential role for GGT in colonisation.
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Two years later, the work was repeated by another research group, but this time a 
GGT-negative mutant was generated in H. pylori strain HpM5 and tested in inbred 
C57BL/6 mice and gnotobiotic-piglets (McGovern et al, 2001). In these two animal 
models, the GGT-negative mutants did maintain colonisation of the gastric mucosa 
but at significantly lower levels than the wild-type, suggesting that GGT activity at 
least offers some advantage to strains in colonisation. Most recently, another GGT- 
negative mutant was generated but this time in H. pylori strain 26695, and tested in, 
yet another different model (Guo andMekalanos, 2002). This mutant was not 
attenuated in the outbred CD-I suckling (5- to 6- day old) mice, most likely due to the 
short infection time (24 hours), the different resident microflora, and/or the limited 
immune system of infant mice.
C. jejuni may have evolved numerous strategies, including the presence of GGT 
activity, to maintain intracellular glutathione levels to defend themselves against the 
deleterious consequences of oxidant exposure. Additionally, it has been suggested that 
the high intracellular glutathione concentrations of enteric bacteria may explain the 
lack of phagocytic antimicrobial activity normally exerted by nitric oxide (NO ) 
against these pathogens (Fang et al, 1997). NO* is associated with membrane 
damage, where it is required for the production of peroxynitrite (bactericidal) and S- 
nitrosoglutathione (bacteriostatic). Interestingly, Staphylococcus contains low 
concentrations of glutathione and appears to be susceptible to NO* related microbial 
activity. Thus a sub-set of C. jejuni strains may therefore have evolved to be 
predominately dependent on GGT activity to import and utilise glutathione. Thus, 
inactivating GGT in these organisms may have caused an initial elevation followed by 
a reduction in intracellular glutathione over a period of time, and once the levels had 
significantly reduced, the mutants may become sensitive to the in vivo inflammatory 
responses. However, one possible suggestion why the inactivation of GGT did not 
cause any deleterious effects on growth in vitro, may be due to the large number of 
putative transport systems in C. jejuni for importation of essential amino acids. Thus, 
the lower colonisation ability of the GGT-negative mutants in vivo may not reflect the 
observations in vitro. Hence, the reduction in colonisation in vivo may have been due 
to the depleted glutathione levels, which is a potential amino acid source for essential 
glycine and cysteine. Alternatively, it could be that 5-days post infection with the 
GGT-negative mutant, the difference in colonisation levels were due to a partial
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reduction in intracellular glutathione. However, by week three, the glutathione level 
may have critically reduced leaving the bacteria more sensitive to the host’s oxidative 
response. Alternatively, the ggt mutation may reflect recovery of ggt mutants still 
present but non culturable on the selective media used (which would induce stress).
With all the C. jejuni and H. pylori evidence in mind, it appears that GGT in these 
closely related organisms may provide some, and in some cases a huge advantage in 
bacterial colonisation. However this does depend on the bacterial strain, animal model 
and duration of infection. Thus, the evidence regarding the importance of GGT as a 
virulence factor in C. jejuni may be strengthened through the use of multiple models, 
which unfortunately are lacking for this organism. Although the exact physiological 
relevance of GGT is still not firmly established, the occurrence and relatively high 
degree of amino acid homology of the enzymes present in mammals. Gram-negative 
and Gram-positive bacteria indicates an important evolutionary role in cellular 
metabolism.
Future work could involve the complementation of the ggt through insertion of the 
wild-type gene on a plasmid into the mutant strain and reversion to the wild-type 
phenotype (such as GGT activity) would confirm the characterisation of GGT in C. 
jejuni. Finally, the ggt mutant was inactivated 532 bp from base pair position 1 of the 
ggt gene which would have produced a truncated (177aa) GGT protein. However, 
only 50% of the large GGT subunit and no small GGT subunit is likely to be 
produced in the mutant. A truncated large GGT subunit is unlikely to have any 
residual activity in the mutant strain as the catalytic site of the enzyme is in the small 
GGT subunit.
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CHAPTER 7
General discussion
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This research project aimed to investigate aspects of the potential for the molecular 
basis for poultry colonisation by C. jejuni. Poultry strains are generally considered to 
be a major source of human infection (Nielsen et al., 1997; Hanninen et al., 2000) 
Nielsen et al., 1997). In this study, genomic subtractive hybridisation has been used to 
identify the genetic differences between C. jejuni strains with different chicken 
colonisation potentials. The laboratory subculture of strain NCTCl 1168 is the first C. 
jejuni strain to be completely genome sequenced (Parkhill et al, 2000). In addition to 
the availability of the genome sequence, the poor colonisation phenotype of strain 
NCTCl 1168 in comparison to other C. jejuni strains, made it an ideal candidate for 
genomic subtractive hybridisation. Therefore, it was hypothesised that using 
NCTCl 1168 as a representative poor colonising strain in genomic subtractive 
hybridisation with a good colonising strain, strain 81116, would identify genetic 
material encoding chicken colonisation-associated genes. To some degree this 
hypothesis has been proven in that several genes putatively associated with 
colonisation were identified. However, the original NCTCl 1168 isolate (111680), 
which was isolated from the faeces of a diarrheic patient in 1977 by Martin Skirrow 
and frozen ever since, has recently been discovered in a strain collection and when 
tested in the chick colonisation model (Gaynor et al, 2004), in stark contrast to 
NCTCl 1168, was an excellent coloniser of chickens. The explanation for this is 
thought to be that NCTCl 1168 has been cultured and stored in the laboratory for 
many years, which may have affected the organism’s normal biological processes 
(Gaynor et al, 2004), and this was reflected in observed differences between the 
microarray-based transcriptional profiles of these two 11168. Such differences may be 
due to small but accumulative vertical evolutionary events, without having incurred 
more readily identifiable changes such as gene loss, gene gain, or horizontal gene 
transfer.
By total coincidence, the genomes of two 11168 variants were screened for each of 
the 23 81116-specific DNA fragments identified by subtractive hybridisation in 
Chapter 3 (Table 3.2). Neither variant contained any of the 81116-specific DNA 
fragments, which implicated that the different colonisation phenotypes of strains 
111680 and NCTCl 1168 was not due to any of the 81116-specific DNA and the 
putative genes they represented. This does not necessarily mean that the putative 
81116-specific genes may not increase the colonisation potential for strain
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NCTCl 1168, even though NCTCl 1168 appears to contain all the genes necessary for 
colonisation.
Gaynor et al, (2004) showed that the expression profiles for the two 11168 variants, 
under microaerobic and severely oxygen-limited conditions, differed (Gaynor et al, 
2004). Many of the differences were in respiration and metabolism genes and 
opérons. The cause for the expression differences was not established but single­
nucleotide polymophisms (SNPs) in genes involved in colonisation or regulation 
could be factors (Fleischmann et al, 2002). Simultaneously, Carillo et al, (2004) 
have also examined the expression for two different variants of the 11168 strain, one 
was also the NCTCl 1168 genome sequenced strain (Parkhill et al, 2000) and the 
other a virulent NCTCl 1168-VI, which was claimed to represent the original clinical 
isolate. The authors identified that the different virulence properties for the variants 
was largely due changes in the expression of both 6^ -^ and regulated genes. 
Greater differences in expression were observed for the 0^^-controlled genes. 
However, inactivation of flhA  (an important component of the flagella export 
apparatus) and not (fliA) in NCTCl 1168-VI resulted in expression patterns similar 
to that of NCTCl 1168. Thus, an intact flhA  appears to be important for the 
transcription of and regulated genes. These findings indicated that the 
flagella regulatory system plays a key role in C. jejuni pathogenesis, and that flhA  is a 
key element involved in the coordinate regulation of the late flagella genes and of 
unknown genes. These unknown genes, which are expressed with the late flagella 
proteins, are thought to be involved in virulence.
Interestingly, the colonisation potential of strain 81116 can be increased further by a 
single passage through chicks (Cawthraw et al, 1996). In comparison, strain 
NCTCl 1168 can also increase its colonisation on passage, but to a much lower extent 
and the passaged isolate is still regarded as having a poor colonisation potential. This 
suggests that the colonisation process in C. jejuni is complex and that SNPs may be 
one of a number of factors influencing chicken colonisation. Indeed, the differences in 
gene expression and phenotypic characteristics between the 11168 variants suggests 
that C. jejuni has the ability to shift its metabolism and respiration strategies to
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accommodate the lower-oxygen microaerobic and largely anaerobic environments 
encountered in the gut by an, as yet, undetermined mechanism (Gaynor et al, 2004).
Genomic subtractive hybridisation between strains 81116 and NCTCl 1168 has, 
nevertheless, identified DNA fragments predicted to belong to genes which may lead 
to the successful colonisation of C. jejuni in chickens and subsequently human 
colonisation. The identification of genes predicted to be involved in arsenic resistance 
(insert 31 and 186) may contribute to the survival of this organism in chickens which 
have been give phenylarsonic compounds for controlling caecal coccidiosis and to 
promote growth (Pergantis et a l, 1997). Furthermore, the putative glycosyltransferase 
(yvlaNB) and dTDP-glucose 4,6-dehydratase (rmlB) genes (inserts 141 and 205, 
respectively) are involved in the modification of LOS and may play a role in immune 
evasion resulting in prolonged C. jejuni colonisation. The motility accessory factors 
{maf) (inserts 149 and 209) are located in the flagella biosynthesis and modification 
genomic region, and variation of the Maf proteins in C. jejuni may increase the 
organism’s antigenic diversity for immune evasion. In addition, when the flagella are 
no longer advantageous to the organism, flagella expression can be switched off 
through phase variation of m af genes. Moreover, the advantage for reversible 
expression means that Maf can enable fiagellum formation and allow C. jejuni to 
move to a new colonisation site when the nutrients at the infection site become 
limiting.
The large number of putative restriction modification (R-M) genes (inserts 60, 68, 
202, 246, 135 and 136) and the putative abortive phage resistance (rloA and rloB) 
genes (inserts 243 and 246) identified in C. jejuni strain 81116 may be an efficient 
mechanism to limit the acquisition of novel genes by horizontal transfer systems, 
(plasmids, bacteriophages, transposons or gene cassettes) (Brunder and Karch, 2000). 
These genes may collectively prevent C. jejuni cells up taking foreign bacterial DNAs 
from the large numbers of bacteria present in the intestinal tract of the host. Genetic 
changes in the genome may lead to phenotypic changes, which may affect essential 
properties like survival or colonisation, and therefore genetic uptake needs to be 
suppressed. Indeed, the genotypic profiles of the laboratory adapted strain, 81116, 
which has undergone numerous laboratory passages, is identical to the original 81116 
strain isolated almost 20 years previously (Palmer et al, 1983; Manning et al, 2001).
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Altogether, the data suggests that strain 81116 contains chicken colonisation 
determinants that are much more stable than the ones present in strains NCTCl 1168 
or 111680. Further work is required to establish whether any of the R-M and abortive 
phage resistance genes contribute to the stability of strain 81116.
Initially, the DNA for insert 188 encoded a protein with some amino acid similarity to 
cytochrome c oxidase III from the protozoan Trypanosoma brucei. However, insert 
188 was later identified as part of a gene encoding a protein with similarity to Cj0033 
(a putative integral membrane protein with an unknown function) from C. jejuni strain 
NCTCl 1168 (CJ0033B). Interestingly, even though Cj0033B and Cj0033 had no 
DNA similarity whatsoever, each had a similar low G+C ratio (23 and 24 %, 
respectively). Although the amino acid identity between Cj0033B and Cj0033 is low 
(32 %), the amino acid similarity is much higher (50 %) suggesting that they both 
contain a conserved protein motif and possibly some fimctional conservation. 
Furthermore, both Cj0033 and Cj0033B may be surface exposed in C. jejuni, and 
therefore, may have immunogenic properties. Immunogenic proteins are important as 
antibodies induced against such proteins may have a host protective effect preventing 
colonisation and disease presentation. Antigenic variation between different strains 
may allow re-colonisation of a host with C. jejuni but this time with an organism with 
different antigenic properties.
Recently, the availability of a second genome sequence (strain RM 1221, TIGR) for 
C. jejuni, although still preliminary, has allowed further comparisons and analysis of 
these 81116-specific DNA fragments. Five of these DNA fragments, inserts 31, 50, 
183, 186 and 188 were identified as a putative arsenite export gene (arsE), di- and tri­
peptide transporter gene {dtpT), transfer gene (traG), arsenate reductase gene (arsC) 
and a gene encoding a putative integral membrane protein with an unknown function 
(Cj0033B), respectively. The information from strain RM 1221 was used to compare 
the genomic locations of these inserts in strain 81116, as well as generate potential 
mechanisms for their absence in strain NCTCl 1168. The observations suggested that 
the tRNA loci and the occurrence of direct repeats in C. jejuni play key roles in the 
generation of genetic diversity and therefore towards the evolution of this species. 
Furthermore, the DNA from pseudogenes (such as Cj0654c which resembles a 
transmembrane transporter) in strain NCTCl 1168 may have originally belonged to
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functional genes such as dtpT identified in strain 81116. Over time, such functional 
genes may have accumulated mutations or deleted. In this case, Cj0654c may have 
resulted into a pseudogene due to lack of a selection pressure. Consequently, such 
changes may have occurred as a result of variations in environmental exposure.
Clearly genes that for some reason become deleterious or are no longer beneficial to a 
bacterial clone, may be lost by the accumulation of mutations and deletions. Segment- 
wise rearrangement of genomic DNA sequences by recombinational shuffling and 
horizontal gene transfer, which results in the acquisition of foreign DNA, may also 
contribute to the adaptation to new habitats. The identification of a 50 kbp island, 
which contains insert 183, in the genome of C. jejuni strain RM1221 appears to 
represent a large DNA insertion event, as indicated by the direct repeat (DR) 
sequences flanking the island. In addition, the 50 kbp island is positioned within a 
tRNA molecule and a putative ORF within the island is predicted to code for an 
integrase/recombinase {xerC). Such events are some of the properties of a putative 
pathogenicity island. However, in the absence of any virulence gene(s), this 50 kbp 
insertion may represent a non-pathogenic genomic island, as reported in other bacteria 
(Dillard and Seifert, 2001; Ito et al, 2003; Muller et al, 2003; Sentchilo et al, 2003). 
Therefore, it would be interesting to investigate whether the 50 kbp genomic C. jejuni 
island also encodes for genes involved in metabolism of certain compounds or 
antibiotic resistance genes, which could contribute to the survival of the organism.
The DNA fragment for insert 50, encoding an unknown membranal protein, was 
characterised further. This fragment was initially found to be conserved in 11/12 
C. jejuni strains, suggesting it may be important in colonisation. Identification of the 
DNA sequence for insert 50 revealed a gene encoding a protein sequence with 
significant similarity to di- and tri-peptide transporters (DtpT) belonging to the 
peptide fransporter (PTR) family. A DtpT-deficient mutant was generated in strain 
81116. Investigations with this mutant indicated that DtpT was not required for in 
vitro growth or invasion of INT407 cells. However, DtpT may use intracellular 
peptides as a source of amino acids which would contribute to intracytoplasmic 
growth and virulence of the organism (Marquis et al, 1993). Even though the DtpT- 
deficient mutant was motile, it had half the swarming ability of the parental strain. 
One possible reason for this was that DtpT may act as, or interact with, a
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chemoreceptor for peptides, which might subsequently affect flagella motor direction. 
Thus, further work is required to determine whether DtpT may be involved in a series 
of complex interactions that eventually affect the chemotaxis of the organism. To 
efficiently assess any role of DtpT in chemotaxis, peptides imported by DtpT would 
first need to be determined. Finally, in the chick colonisation model, the DtpT- 
deficient mutant colonised at 27-51% of the wild-type levels after five days post­
challenge. This result is consistent with previous work, which has shown that a C. 
jejuni strain deficient in the chemotaxis protein, CheY, had reduced colonisation 
levels in mice and failed to induce disease in ferrets (Yao et al, 1997).
The other DNA fragment characterised further was Insert 236. Both the DNA insert 
and appropriate gene, encoded a protein with significant similarity to y-glutamyl 
transpeptidase (GGT). In H. pylori, GGT appears to have a role in the colonisation of 
the gastric mucosa of mice (Chevalier et a l, 1999; McGovern et a l, 2001). Therefore 
a GGT-deficient mutant was generated in C. jejuni strain 81116 and characterised. 
GGT was not required for in vitro growth of strain 81116, however, it was essential 
for the hydrolysis and transfer of the y-glutamyl moiety to peptides and bacterial 
resistance to hydrogen peroxide. It was postulated that GGT was necessary for 
maintaining bacterial intracellular glutathione levels in strain 81116, which was 
required for bacterial resistance to the in vivo inflammatory responses from chickens.
The results presented here and elsewhere (Dorrell et al, 2001) demonstrate the 
extensive genetic diversity within the C. jejuni species. These studies suggest that the 
genetic difference between C. jejuni strains may contribute to the overall phenotypic 
differences observed. Gene acquisition and deletion, as well as DNA rearrangements 
in C. jejuni, may all contribute to the generation of new genetic variants and may play 
a role in the adaptation of the bacteria to different environments or colonisation of 
new hosts. However, adaptation of C. jejuni to a particular niche is actually more 
complicated, since one strain (NCTCl 1168 and 111680) appears able to shift its 
metabolism and respiration strategies, by an unknown mechanism (Gaynor et al, 
2004; Carillo et al, 2004).
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Clearly, subtractive hybridisation between just two strains has increased the known 
numbers of genes that can exist in C  jejuni. Unquestionably, there are genes present 
within the C. jejuni species, which have yet to be identified. All the possible genes 
that can exist in this species need to be identified before the extent of intraspecies 
variation can be determined. DNA microarray studies used to investigate genomic 
diversity in 18 C. jejuni strains identified seven hypervariable plasticity regions (PRl 
to PR7) (Pearson et al., 2003). Interestingly, PR5 contains genes for LOS 
biosynthesis, flagellin and post-translational modification of flagellin. This is 
consistent with the identification of the m af genes (Inserts 149 and 209) from strain 
81116. PR4 contains NANA synthase genes, which correlates with the identification 
of dTDP-glucose 4,6-dehydratase (rmlB) (Insert 205) and glycosyltransferase 
(wlaNB) (Insert 141) genes. Therefore, both DNA arrays and genomic subtractive 
hybridisation can identify genes with partial DNA similarity. However, the current 
microarray consists of primarily NCTCl 1168 genes. This approach is therefore 
limited, since novel genes will not be detected. Consequently, genomic subtractive 
hybridisation provides a significant advantage in the identification of novel genes in 
C. jejuni. Subsequently, all new genes identified by genomic subtractive hybridisation 
should be added to the existing microarray to provide a more complete picture for the 
genomic diversity that exists within the C. jejuni species.
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ABSTRACT: Comparative genomics for Campylobacter jejuni has to date only been possible with I q
experimental techniques such as subtractive hybridisation. However, a second genome sequence for f ^
C. jejuni (strain RM1221) is currently being annotated at TIGR. Preliminary sequence data for strain 
RM1221 was used to screen a number of DNA sequences identified by genomic subtractive hybridisation 
between strains 81116 and NCTC 11168 (the first genome sequenced strain). Five 81116-specific DNA 
fragments were present in the genome of strain RM1221. These included two genes involved in arsenic 
resistance, a gene with similarity to a di-tripeptide transporter, the product of a gene with 32% amino 
acid identity to CjOOSS, and a gene with similarity to a conjugal transfer gene. The genome organisation 
of these genes in strain RM1221 was compared to strain NCTC 11168 and the results extrapolated 
to strain 81116. Direct repeat sequences were found to be associated with genes absent from NCTC 
11168. Interestingly, traG was located within a previously unidentified 50,791 bp island. Furthermore, the
0. jejuni island was inserted into the tRNA locus where prophages are known to integrate. The majority 
of the ORFs for the island did not have similarities in the database. Nevertheless, a number of genes 
were predicted to encode the transfer machinery usually found on either conjugative plasmids or Type IV 
secretion systems, a site-specific recombinase, and a ‘recombination hot spot’ (Rhs) accessory element.
The sequencing of a second genome in 0. jejuni has accelerated our research and understanding into 
the mechanisms of genomic diversity.
Keywords: Campylobacter jejuni, Genome Sequence, Direct Repeat Sequences, Genomic Instability.
1. INTRODUCTION of different strains. Strain NCTC 11168 genome microarray
Campylobacter jejuni is a microaerophiUc, Gram-negaüve wilh other C jejuni strains have revealed that
bacteria that colonizes the intestines of most mammals substantial amount of the genome (-80% ) contains the
anti birds. In humans, colonization may initially induce core set of essential genes that determine the characteristics
fever, followed by severe abdominal pain and profuse diar- members of the species [7]. However, the remaining
rhoea [1]. Moreover, this organism is considered as a major 20% of genes were either different or absent. Along with
cause of human acute bacterial enteritis worldwide [2]. sequence variations, genes or entire gene clusters can be
Despite intensive study there have been few advances absent from different strains of C. jejuni [7—9]. Hence it is
in developing effective control strategies. Epidemiological likely that the genome sequenced strain of C. jejuni, NCTC
studies on large numbers of C. jejuni isolates have shown 11168 [10], may only partially reflect the genetic diversity
a high degree of phenotypic and genotypic diversity [3-6]. found within the C. jejuni species.
It is likely that such diversity is reflected in phenotypic An earlier subtractive hybridisation study between strains
variation in the colonization and disease-causing potentials NCTC 11168 and 81116 not only revealed sequence diver-
__________  gence between these 2 strains but also identified poten-
* Author to whom correspondence should be addressed. tial genes present in 81116 which are not present in
J. Genome Sci. Tech. 2005, Vol. 3, No. 2 1551-7551/2005/3/001/007/$17.00+.25 doi;10.1166/gl.2005.002
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NCTC 11168 [11]. Recently the availability of a sec­
ond C. jejuni genome sequence (strain RM1221, TIGR), 
although not complete, has allowed further comparisons 
and analysis of these 81116-specific DNA fragments. Five 
of the 81116-specific DNA fragments had very similar 
DNA identities in strain RM1221. The information from 
strain RM1221 was used to further characterise each of the 
clones, their possible location in the genome and possible 
mechanisms for their absence in strain NCTC 11168.
2. METHODS
2.1. Media and Growth Conditions
C. jejuni strains were routinely grown for 24 h at 
42 °C under microaerobic conditions (85% Nj, 7.5% COg, 
7.5% O2) on blood agar plates supplemented with 10% 
sheep blood, 50 jxg Actidione ml“  ^ and selective antibiotics 
(Oxoid) [12]. Escherichia coli was maintained on Luria- 
Bertani (LB) agar or in Luria-Bertani broth (Difco) at 
37 °C in atmospheric conditions. When required the media 
was supplemented with 100 pg  ampicillin ml“  ^ or 50 pg  
kanamycin ml"\ C. jejuni and E. coli were stored as frozen 
cultures at —80 °C in 1% (w/v) proteose peptone water 
(Difco) containing 10% (v/v) glycerol or in Luria broth 
(LB) containing 50% glycerol [13], respectively.
2.2. PGR
The bacterial strains and primer sequences used in this 
study are shown in Table I. Genomic DNA for PCR ampli­
fication was prepared from C. jejuni cultures using the 
CTAB method for DNA isolation [13]. PCR amplification 
was used with 10 ng of genomic DNA together with 
50 pmol of each forward and reverse primer
using the HotStarTa  ^ mastermix (Qiagen) according the 
manufacturer’s guidelines.
2.3. Chromosomal Walking
A rapid technique was adopted to achieve chromosomal 
walks [14]. Three separate 50 p i PCR reactions with Hot- 
StarTaq master (kit) using one primer (50 pmol) were 
applied to the genomic DNA template (100 ng). Each PCR 
reaction was identical with exception of the annealing tem­
peratures. The parameters were 95 °C for 15 min; followed 
by either 45,55 or 60 °C for 30 s; 72 °C for 2 min; followed 
by 60 cycles of 95 °C for 30 s; 45/55/60 °C for 30 s and 
72 °C for 2 min. The three PCR samples were combined, 
concentrated by ethanol precipitation and the end pellet was 
dissolved in 10 /a1 water. Following confirmation of a PCR 
product on an agarose gel, the product was sequenced.
2.4. Cloning and Sequencing
PCR products were ligated into pCR2.1-TOPO vector 
using the TOPO TA Cloning kit (Invitrogen). The ligated 
products were transformed into TOPOlOF' competent 
E. coli cells, as recommended, and transformants were 
selected for kanamycin resistance. PCR amplication was 
performed directly on transformants resuspended in water 
using 50 pmol jx\~^  of M l3 forward and reverse primers 
together with HotStarTa  ^ master mix (Qiagen). PCR 
parameters are as follows; 95 °C for 15 min followed by 
25 cycles of 94 °C for 45 s, 60 °C for 45 s and 72 °C 
for 1 min 45 s, with a final incubation at 72 °C for 
10 min. Agarose gel electrophoresis confirmed the presence 
of DNA inserts.
Transformants were cultured in 1 ml of LB broth 
with kanamycin selection, purified using a QIAprep spin 
miniprep kit (Qiagen) and sequenced (with 3.2 pmol /rl“  ^
M13 primer) on a ABI system. The DNA sequences were 
edited using the SeqMan and EditSeq programs (DNAstar, 
Lasergene).
Table I. Summary of the bacterial strains, plasmids and primers used in this study.
Bacterial strains
81116 C. jejuni cUnical isolate [46]
NCTC 11168 C. jejuni cUnical isolate [10]
RM1221 C. jejuni poultry isolate (http://www.tigr.org.)
TOPOlOF E. coli
F (lacFTn/0 (Tet' )^}mcrA A(mrr-IbsdlRMS-mcrBC) 
^ i0 l\acZ A M \5  ALACxlreck\deoRaraD{ara-leu)
7697 gal\JgalKrpsh{Sti^)endAlnupG
Cloning vector
PCR2.1-T0P0 Plasmid map shown at http://www.invitrogen.com
Primer Sequence 5' to 3' Brief description
M13F cgc cag ggt ttt ccc agt cac ga Primer for pCR2.1-TOPO vector
M13 R tea cac agg aaa cag eta tga c Primer for pCR2.1-TOPO vector
If 43 ggt aaa tea ggc ata gtt ttt ag Chromosomal walking primer for insert 50
If 71 cca aaa cca aaa tgc cqat ccg Sequencing primer for insert 50 chromosomal walking product
If 47 gca ggt ctg ctt ttc cac c Reverse traG primer derived from strain 81116 insert 183
If 123 gaa gaa gag aag ctt agt taa aag Forward traG primer derived from strain RM 1221 genome
If 106 cac aat age tgc cgt tct c Reverse arsB primer
If 107 gcc taa tgc cca ttt tac aag Forward arsC  primer
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2.5. Sequence Analysis
Homology searches were performed using the BLAST 
suite of programmes [15] and also against the com­
plete C. jejuni genome sequences. The complete genome 
sequence of C. jejuni NCTC 11168 was downloaded from 
GenBank [10]. Open reading frames (ORFs) were eval­
uated by using the EasyGene genefinding software from 
CBS (http://www.cbs.dtu.dk/services/EasyGene/). Prelimi­
nary sequence data for strain RM 1221 was obtained from 
The Institute for Genomic Research (TIGR), with per­
mission, through their website at http://www.tigr.org. The 
GenomeAtlas plots were made using GeneWiz visualisation 
software, as previously described [16, 17].
3. RESULTS AND DISCUSSION
Previously, subtractive hybridisation between C. jejuni 
strains NCTC 11168 and 81116 revealed 23 DNA frag­
ments which were 81116-specific and not present in NCTC 
11168 [11]. Sequence comparisons revealed five of the 
81116-specific DNA fragments, clone 31 (232 bp), clone 50 
(124 bp), clone 183 (195 bp), clone 186 (196 bp) and clone 
188 (163 bp) to also be present in strain RM1221. Clone 31 
was found to be part of a heavy metal efflux gene predicted 
to be involved in arsenite export (arsB) (1050 bp); clone 
186 was part of an arsenate reductase gene (arsC) (420 bp); 
clone 50 had similarity to a di-tripeptide transporter gene 
(dtpT) (1551 bp); clone 188 was part of a gene with sim­
ilarity to CJ0033 (2454 bp); and clone 183 was part of a 
transfer gene (traG) (1602 bp). The findings are summa­
rized in Table II. The genome organisation of these genes 
in strain RM 1221 was compared to that in the genome 
of strain NCTC 11168 and the results were extrapolated 
to the genome of strain 81116. This has provided insight 
into a potential mechanism that C. jejuni may exploit for 
generating genomic diversity.
3.1. Arsenic Operon
The heavy metal efflux protein predicted to be involved in 
arsenite export (ArsB) from strain RM 1221 had 47% amino 
acid identity to ArsB from Listeria innocua. The arsenate
( A )
- 1 . 4  kb
( B )
CV
DR DR
0.5 kb
Figure 1 . (A) PCR primers derived from strain RM1221 confirmed the 
arsB and arsC  arrangement in strain 81116 was the same (as shown by the 
1.4 kb predicted PCR product below), and absent in strain NCTC 11168. 
(B) Gene arrangement o f  the putative arsenic genes in strains RM 1221 
and 81116. There is a short 7 bp DR (5'-aaa tga a-3') flanking arsBC. 
Arrows denote direction o f transcription.
reductase (ArsC) from RM 1221 had 46% amino acid iden­
tity to ArsC from Clostridium acetobutylicum. PCR using 
primers derived from the RM 1221 genome confirmed the 
same sizes of products and arrangement in strain 81116 
(Figure 1). The arsB and arsC genes had a 13 bp over­
lap, were in different reading frames and had an average 
G-t-C ratio of 32%. The putative arsRBC operon in the 
genome of strain RM 1221 contained an additional hypo­
thetical 50 amino acid peptide, CJ1562, but its role in 
arsenic resistance has yet to be established. Strain NCTC 
11168 contains arsR and Cj 1562 in the same genomic 
location as in strain RM 1221. However arsBC were absent
Oo
o
Table II. Summary o f  the genes identified in this study.
Clone
number Locus*
Size
(hp)
Amino acid identity 
(similarity)
Closest hom ology 
in database blast score
31 800621-801670 1050 47% (65%) arsB L. innocua N P _569192.1 le-78
186 801658-802077 420 46% (67%) OMC C. acetobutylicum NP_149268.1 2e-26
50 1606471-1608021 1551 34% (50%) dtpT B. subtilis NP_388249.1 8e-69
188 604529-606982 2454 32% (50%) Cj0033 C. jejuni N P _281255.1 le-27
183 1271251-1272852 1602 21% (41%) traG N. gonorrhoeae A F 374415_2 3e-14
1277018-1277716 699 31% (51%) jrerC(Cj0863c) C. jejuni NP_282024.1 3e-20
1257443-1258594 1152 29% (48%) fmC S. typhimurium BAA77998.1 le-37
1239217-1240470 1254 26% (49%) vgrC P. aeruginosa NP_248785.1 3e-14
‘ Note that the RM1221 genome sequence data (received May 2003) may contain errors or be incomplete and therefore should be regarded as 
preliminary.
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from the genome of strain NCTC 11168. It seems likely, 
therefore, that the arsBC genes were lost from strain 
NCTC 11168 rather than a random insertion event occur­
ring in strains RM1221 and 81116. Furthermore, there was 
a 7 bp direct repeat sequence (DR) (5'-aaa tga a-3') flanking 
arsBC in strain RM1221. In strain NCTC 11168, the inter- 
genic region between CJ1562 and Cjl563 contained one 
copy of this 7 bp DR. Therefore, it could be hypothesised 
that a spontaneous deletion had occurred by recombination 
between the DRs, consequently losing arsBC and leaving 
a single copy of the short direct repeat.
The role of this putative arsenic operon in C. jejuni is 
debatable. Staphylococcus aureus also contains an arsRBC 
operon [18] where ArsB is an integral membrane subunit 
that forms a translocation channel and intracellular arse­
nate (As (V)) is enzymatically reduced to the more toxic 
arsenite (As (IE)) by ArsC in the cytosol. Arsenite is sub­
sequently extruded from the cell by an energy dependent 
efflux process and appears to be driven by the membrane 
potential [19]. In the past, phenylarsonic compounds have 
been used in poultry feed and subsequently contaminated 
agricultural lands [20, 21]. Without a selective pressure 
the arsenic operon may no longer be required and as a 
consequence deleted from the genome.
3.2. Di-Tripeptide Transporter
The di-tripeptide transporter protein (DtpT) from strains 
81116 and RM1221, both had 34% amino acid identity to 
DtpT in Bacillus subtilis. This particular gene was absent 
from strain NCTC 11168, however there are a large num­
ber of putative ABC transporters in this strain, a high 
proportion of which have similarities to proteins in other 
organisms, whilst the remainder appear to have conserved 
ABC-component protein motifs [10]. The product of the 
dtpT gene in Lactococcus lactis has been shown to catalyze 
the proton motive force-driven peptide uptake and appears 
to be specific for di- and tripeptides [22, 23].
The DNA sequence obtained from strain 81116 by chro­
mosomal walking identified the full gene sequence and 
adjacent genes. This organisation was found to be the same 
in strain RM1221. The dtpT gene in both cases was pre­
dicted to have a ribosomal binding site and a promotor 
sequence. Interestingly, the 3' end 200 bp sequence of dtpT 
was identical to that of Cj0654c, a pseudogene resembling 
a transmembrane transporter in strain NCTC 11168. How­
ever, in strains 81116 and RM 1221, this 200 bp of sequence 
was not present in Cj0654c but instead was only present 
in the 3' end of dtpT (Figure 2). Moreover, a 33 bp DR 
flanked the dtpT sequence in strains 81116 and RM1221. 
Strain NCTC 11168 contained one copy of the 33 bp DR 
in Cj0654c. It is tempting to speculate that strain NCTC 
11168 has lost this gene by recombination, mediated by 
direct repeats. Such events are well recognised in other 
bacteria [24-26].
DR
NCTC 11168
81116
RM1221
DR DR
1.0 kb
Figure 2. Gene location of dtpT  in the genome of strains 81116 and 
RM1221. The dashed lines show the position of dtpT  in comparison with 
strain NCTC 11168. Homologous recombination mediated through termi­
nal direct repeat (DR) sequences (5'gca ctt get aca aac caa agt ccc atg 
act tga 3') has possibly led to a deletion mutation in strain NCTC 11168 
whilst leaving behind one copy of the DR sequence. Arrows denote direc­
tion of transcription.
3.3. Cj0033 Intra-Specific Gene Variation
The putative integral membrane protein with an unknown 
function (Cj0033) from strain RM1221 had 32% amino 
acid identity to Cj0033 in strain NCTC 11168. The G-t-C 
ratio of this putative gene was 23%, which was relatively 
low for the species average (30.6%). Surprisingly, there 
was little similarity between both Cj0033 sequences at the 
DNA level. Furthermore, clone 188 was found to be located 
between Cj0032 and Cj0034c in strain RM1221. Interest­
ingly, Cj0032 contained a polymorphic tract, which may 
make the product of Cj0033 susceptible to phase variation. 
In strain NCTC 11168 these homopolymorphic tracts were 
grouped mainly in three regions; the LOS/LPS, flagellar 
and capsular biosynthesis clusters, all of which are recog­
nised regions of genetie instability possibly associated with 
antigenic variation. Such clustering has also been reported 
in the genomes of Neisseria meningitidis [27], Chlamydia 
pneumonia [28], N. gonorrhoeae [29, 30] and Helicobacter 
pylori [31]. Homopolymorphic tracts enable rapid varia­
tion in surface properties, which may allow immune avoid­
ance and successful host colonisation. The role of Cj0033 
in colonisation by C. jejuni is, therefore, worth further 
investigation.
3.4. The 50 kb Island
Finally, the transfer protein (TraG) from strain RM 1221 
had 21% amino acid identity to TraG from N. gonorrhoeae. 
Primers derived from the RM1221 traG region were used 
to amplify and sequence the homologous region in strain 
81116. A comparison between the two strains revealed 
numerous point mutations within the sequences. The iden­
tity of this region between strains 81116 and RM1221, 
at the DNA and amino acid levels was 95% and 74%, 
respectively. Interestingly, the traG gene was found within 
a 50,791 bp island in strain RM1221 (Figure 3). This island 
was absent from strain NCTC 11168. The island is flanked
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Figure 3. A GenomeAtlas plot of the putative pathogenicity island found in C. jejuni strain RM1221. The first three rows (A-C) are DNA structural 
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by a 18 bp DR (5'-TCCTCTTGAGCGCACCAT-3'), which 
may have facilitated the initial integration of the island into 
the bacterial chromosome. In strain RM 1221, one copy of 
the 18 bp DR is part of the arginine tRNA molecule located 
between genes CjlOll and Cjl012. The flanking DRs may 
act as targets for specific recombinases, thereby facilitating 
rearrangements. This association with tRNA genes has also 
been seen for other pathogenic islands (PAIs) in E. coli, 
Y. enterolitica  and S. typhimurium  [32-35]. In E. coli,  it 
has been speculated that the PAI-I, PAI-II and ‘locus of 
enterocyte effacing island’ (LEE or PAI-III) were inserted 
into the tRNA loci where prophages are known to inte­
grate. Furthermore, there was an ORF predicted to code for 
an integrase/recombinase (xerC)  located within the island 
adjacent to the integration site in strain RM 1221 (Table 2). 
However, there was no evidence for the presence of an 
excisionase gene. Interestingly, xerC  was also potentially 
subject to phase variation due to a 10 bp polymorphic tract. 
xerC  in E. coli  and sss  in P. aeruginosa  encode proteins 
that belong to the lambda integrase family of site-specific 
recombinases, which play a role in phase variation caused 
by DNA rearrangements [36, 37]. There was also an ORF 
coding for a vgrG  gene (Table 2), also called a ‘recombina­
tion hot spot’ (Rhs) accessory genetic element. The product
of this gene had 26% amino acid identity to VgrG from 
P. aeruginosa.  In E. coli such elements are located on the 
PAIs of strains J96 and 536 [32, 38, 39].
Although in strain NCTC 11168, there was a single copy 
of the C. je jun i  island DR in the same tRNA locus as 
in strain RM122I, no island was detected. This observa­
tion suggests that strain NCTC 11168 may have lost the 
island during its evolution. The island has a G-t-C ratio of 
26%, which is less than the average predicted for C. je jun i 
species. Unfortunately, PCR amplification of the island in 
strain 81116 was hampered by the presence of a large num­
ber of inverted repeats throughout the 50 kb island. Such 
repeats may render the 50 kb island unstable and sensitive 
to sequential rearrangements by homologous recombina­
tion, deletions and duplications. Furthermore, the presence 
of the terminal DRs may cause additional instability. The 
E. coli  PAI-I and PAI-II are flanked by a 16 bp and 18 bp 
DR, respectively. These PAIs may be deleted from the chro­
mosome and subsequently leaving one copy of the DR in 
the PAI-negative strains [40]. The enteropathogenic E. coli 
LEE island and the S. typhimurium  40 kb PAI have no 
obvious terminal DRs or insertion sequence (IS) elements 
and lack of such elements may account for their relative 
stability within the bacterial genome [33, 41].
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Annotation of the island in strain RM1221 has predicted 
that it is composed of 44 ORFs, the majority of which have 
unknown functions. The genes within this island appear 
to be roughly organised in two regions, divergently tran­
scribed from near the centre of the island (~24 kbp in 
Figure 3), which might imply that this 50 kb length of DNA 
was once a plasmid. However, no origin of replication was 
identified. Indeed, a number of ORFs in the island have 
similarity to transfer {ira) genes from other bacteria, which 
encode the transfer machinery on conjugative plasmids or 
are involved in Type IV secretion systems [42]. TraG is 
necessary for mating-pair stability and is hypothesized to 
be part of the conjugative channel [43]. The other trans­
fer protein, TraC (Table 2), is predicted to have a role in 
assembly of conjugative pili [44]. A variable genetic island 
specific to N. gonorrhoeae was also found to encode traG 
and absence of this gene in strains was indicative of the 
absence of the island [45]. Thus it would be interesting 
to see if the presence of traG in C. jejuni strains could 
be used as a predictive indicator of the C. jejuni island. 
To date, traG DNA has been found in 8 out of 12 C. jejuni 
strains screened [11], including strain RM 1221, suggesting 
that this island might be relatively common in the C. jejuni 
species. Further investigation of the role of this island in 
C. jejuni is obviously required.
4. CONCLUSIONS
Genes no longer beneficial to an organism may become 
superfluous and will be eventually lost by the accumula­
tion of mutations and deletions. In the genome of C. jejuni 
strain NCTC 11168, at least 20 of the 1,654 predicted 
coding sequences (CDS) probably represent pseudogenes 
[10], which may once have been functional genes that, 
over time, have accumulated mutations due to lack of 
selection pressure. Such changes may have occurred as 
a result of variations in environmental exposure. In con­
trast, such deleterious effects may be balanced by genomic 
gains made through horizontal transfer. The acquisition of 
new genes following horizontal gene transfer can result in 
the generation of variants of pathogens. For example the 
acquisition of LEE in enteropathogenic E. coli has been 
found to induce ‘attaching and effacing’ (AE) lesions [33], 
whilst the presence of PAI-I or PAI-II in uropathogenic 
E.coli causes hemolysis [32]. Similarly, the Salmonella 
pathogenicity islands (SPIs) are necessary for invasion of 
Salmonella into epithelial cells (SPI-I) or essential for sur­
vival within macrophages (SPI-II) [35, 41]. The identifica­
tion of a 50 kb insert into the C. jejuni genome with at least 
some of the properties of a putative pathogenicity island is 
therefore an interesting observation. Work on this putative 
C. jejuni pathogenicity island will continue to be investi­
gated to establish whether it has a role in pathogenesis.
Clearly, the results presented here and elsewhere [7] 
demonstrate the extensive genetic diversity within the 
C. jejuni species. Our observations suggest that the tRNA
loci and the occurrence of direct repeats in C. jejuni play 
key roles in the generation of this genetic diversity and 
therefore the evolution of this species. Gene acquisition 
and deletion, as well as DNA rearrangements, may all con­
tribute to this. The generation of new genetic variants may 
play a role in the adaptation of the bacteria to different 
environments or colonisation of new hosts. Our work will 
continue to investigate this hypothesis.
In our study, analysis of C. jejuni genes, identified by 
subtractive hybridisation as not present in the original 
genome sequenced strain, NCTC 11168 [10, 11], albeit 
only five genes, has provided significant insight into our 
understanding of the evolution of this bacterial species. 
Thus subtractive hybridisation has clearly contributed to the 
extension of the ‘species’ genome. Obviously, sequencing 
entire genomes from other strains is the optimal method of 
achieving this but this is still constrained by cost and time 
resources.
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The consumption o f poultry m eat contam inated w ith Campylobacter je juni is 
considered to  be a risk factor for human campylobacteriosis. The developm ent 
o f targeted strategies to  control Campylobacters in broilers w ould benefit 
from know ledge o f those bacterial factors important in colonization o f the  
avian gut. During preliminary studies it w as noted that C je juni NCTC 11168 
w as a poorer colonizer o f chickens than strain 81116. This poor colonization  
could not be fully restored by in vivo passage, suggesting that it w as a 
genetically endow ed property o f strain 11168. As the genom e sequence is 
available for this strain, the technique o f subtractive hybridization w as used to  
identify gene fragm ents o f strain 81116 not present in strain 11168. After tw o  
screening cycles, 24 out o f 42 clones w ere identified as having DNA inserts 
specific for strain 81116. Six o f th ese 24 clones contained gen e fragm ent 
inserts w ith similarities to  restriction-m odification enzym es found in other 
bacteria. Two inserts had similarity to  arsenic-resistance genes, w hereas four 
others had similarities to  cytochrome c oxidase III, dTDP-glucose 4,6- 
dehydratase, y-glutamyl transpeptidase and an abortive phage-resistance 
protein. At least som e of th ese genes may be involved w ith colonization. A 
further six inserts had weak similarities to  hypothetical proteins or to  proteins 
with assigned functions from strain 11168. The remaining six clones had gene- 
fragm ent inserts w ith no database matches. Southern-blot analysis confirmed  
that strain-dependent variation existed for each of th ese  DNA inserts. These 
results indicate that subtractive hybridization can successfully identify genes  
that are absent from the only C. je juni strain for which the genom e sequence is 
currently available.
K eyw ords : subtractive hybrid ization
INTRODUCTION
Campylobacter jejuni is a major cause of human acute 
bacterial enteritis worldwide (Tauxe, 1992). The sources 
and routes of infection are debatable, but the con­
sumption of contaminated poultry meat is considered to 
be a significant risk factor. Surveys have shown that 
broilers frequently carry large numbers of these 
organisms in their intestinal contents (Newell &
Abbreviations: AP, alkaline phosphatase; R-M, restriction-modification.
The GenBank accession numbers for the  sequences reported in this paper 
can be found in Table 2.
Wagenaar, 2000). This carriage is both chronic and 
asymptomatic. The spillage of gut contents during 
processing can contaminate the retail poultry product 
and the abattoir environment (Newell et al., 2001). 
Currently, the reduction or elimination of Campylo­
bacters in the food chain is largely focussed at the 
poultry farm level. Unfortunately, enhanced biosecurity 
has largely failed to prevent Campylobacter entering the 
broiler house from the environment. In part, this failure 
is a reflection of the low infectious dose, rapid bacterial 
growth within the avian gut and subsequent rapid 
transmission to adjacent animals. All of the evidence 
suggests that C. jejuni has evolved to efficiently colonize 
the avian gut as a commensal. Therefore, a better
0002-5210 © 2002 SGM 1203
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understanding of the colonization determinants in­
volved in this process may ultimately lead to more 
targeted and effective control strategies, such as pro­
biotic administration or vaccination.
To date, only a few potential colonization factors, 
specific for the avian host, have been identified using 
defined mutants in experimental oral models of chick 
colonization. A role for the flagellin genes in chicken 
colonization has been demonstrated (Wassenaar et al., 
1993; Nachamkin et al., 1993); however, non-motile 
and a flagellate bacteria are still able to colonize 
(Wassenaar et al., 1993). Other genes apparently im­
portant in avian-gut colonization identified so far 
include sod  (Purdy et al., 1999), racR (Bras et al., 1999), 
pg/// (A. Karlyshev, unpublished data) and cadF (Ziprin 
tV 1999).
Kpidcmiological studies on large numbers of C. jejuni 
isolates have shown a high degree of phenotypic and 
genotypic diversity (Owen et al., 1 9 9 7 ; Lindstedt et al., 
2()0(); Dingle et al., 2001; Wassenaar & Blaser, 1999). It 
seems likely that such diversity is reflected in phenotypic 
variation in the colonization and disease-causing 
potentials of strains. Certainly strain variation in viru­
lence properties has been observed in both in vitro 
(Corelov et al., 1990) and in vivo  models, though such 
models may poorly reflect the spectrum of disease seen 
in humans (Pang et al., 1987; Black et al., 1988; 
Wassenaar & Blaser, 1999). Understanding the mol­
ecular basis and biological consequences of genetic 
diversity among strains is important for disease control. 
To this end the recent genome sequencing of C. jejuni 
NCTC 11168 (Parkhill et al., 2000) now enables, by 
DNA array technology (Lan & Reeves, 2000), the 
absence of genes in other C. jejuni strains to be detected. 
However, the identification of the presence of additional 
genes in other strains is not feasible using this approach.
Ch jejuni NCTC 11168 was derived from a case of 
human campylobacteriosis in 1977 (M.B. Skirrow, 
personal communication). Preliminary studies indicated 
that this strain displayed a relatively poor colonization 
potential in chickens compared to that previously 
reported for the well-characterized strain 81116 
(Cawthraw et al., 1996). The inability of chicken passage 
of strain 11168 to fully restore its colonization potential 
indicated that this phenotype had a genetic basis. 
Therefore, the method of subtractive hybridization was 
used to identify genetic material, potentially associated 
with colonization, present in C. jeju7^ i strain 81116 but 
not present in the genome sequence of strain 11168.
METHODS
Bacterial strains. C./e/w ni N C T C  11168 and strains 81116 and 
81-176, w ere all derived from  hum an cases of cam pylo­
bacteriosis (Parkhill e t  a l .,  2000; Palm er e t  a l . ,  1983; K orlath 
e t  a l . ,  1985, respectively) and are all routinely used in 
labora to ry  investigations. O ther isolates included in this 
investigation w ere random ly selected from  the collection of C. 
je ju n i  strains held at the V eterinary L aboratories Agency: 
strains 99/189, 99/322 and 99/388 were from  the faeces of
C  JEJUNt 
TESTER STRAIN
GENERATION OF 
TESTER DNA
G enom ic DNA 
ex trac ted  
from  stra in  81116
A/ul and  Oral d igestion
ADAPTER
LIGATION
TO
TESTER DNA
HYBRIDIZATION 
ONE
HYBRIDIZATION
TWO
0-1-2 kb ran g e  of 
81116 DNA frag m en ts
A d a p te r  1 A d a p te r  2R
Alui-  a n d  Dral- 
d lg ested  driver DNA 
NCTC-11168
Afu\- a n d  Oral 
d ig ested  driver DNA 
NCTC 11168
PRIMARY
PCR
PRODUCTS
1. Fill In recessed end  o f a d a p te r  
-A 2. PCR w ith  PCR prim er 1
(a, d, e) No am plification
(b) PCR suppressed  by th e  fo rm a tio n  o f  a loop  e.g.
(c) Linear am plification  e .g . g ] ------
(f) Exponential am plification
SECONDARY
PCR
PRODUCTS
3. PCR using n ested  prim er 1 
 ^f  an d  n ested  p rim er 2R
Enrichm ent o f f 
(81116-speclflc DNA sequences)
KEY
A d a p te r  1 3  Solid box, Identical sequence to  primer 1 
. , Open box, Identical sequence to  nested primer 1
A d a p te r  2K J  Diamond, identical sequence to  nested primer 2R
■ DNA strand
Fig. 1. The  s t r a t e g y  a d o p t e d  fo r  s u b t rac t iv e  h y b r id iz a t ion .  
D iges ted  t e s t e r  DNA (81116) is s u b d iv id ed  in to  t w o  p o r t io n s  
a n d  t h e  5' e n d s  a r e  l ig a ted  t o  a n  a d a p t e r .  Each a l i q u o t  is 
d e n a t u r e d  a n d  h y br id iz ed  t o  excess d e n a t u r e d  d r iver  DNA 
(11168). In t h e  se c o n d  hybrid iz a t io n ,  t h e  a l iq u o ts  a r e  c o m b in e d  
a n d  excess d e n a t u r e d  d r iver  is a g a in  a d d e d .  A m plif ica t ion  w i th  
PCR p r im e r  1 e x p o n e n t ia l ly  c o n c e n t r a t e s  t h e  t y p e  f  m olecules ,  
w h ich  r e p r e s e n t  DNA p r e s e n t  in t h e  t e s t e r  b u t  w h ich  is a b s e n t  
f ro m  t h e  driver.  A se c o n d  PCR w i th  n e s te d  p r im ers  1 a n d  2R 
f u r t h e r  en r ich es  t es te r- spec if ic  DNA.
patients w ith d ia rrhoea ; strains 94/194, 99/346 and 99/385 
were from  the caeca of broilers in unrelated  poultry  flocks; 
strain  EX114 was an environm ental strain  from  a poultry  
farm ; and strain  99/312 was from the faeces of a cow.
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Table 1. Summary of the  bacterial strains, plasmids and primers used in subtractive hybridization, cloning and 
sequencing
Reagent Description"'
Adapter 1 5'-CTAATACGACTCACTATAGGGCTCGAGCGGCCGCCCGGGCAGGT-3' 3'-GGCCCGTCCA-5'
Adapter 2R 5 -C T A A T A C G A C T C A C T A T A G G G C A G C G T G G T C G C G G C C G A G G r-3 ' 3 '-GCCGGCTCCA-5'
PCR primer 1 5'-CTAATACGACTCACTATAGGGC-3'
Nested primer 1 5'-TCGAGCGGCCGCCCGGGCAGGT-3'
Nested primer 2 5 -A G C G T G G T C G C G G C C G A G G T -3 '
M13 (forward) 5'-CGCCAG GG TTTTCCCA GTCACGA -3'
M13 (reverse) 5'-TCACACAGGAAACAGCTATGAC-3'
Tester C. jejuni 81116; colonizes the chicken gut
Driver C. jejuni N C T C  11168; poorly colonizes the chicken gut
E. coli TOPlOF' F' [lacF TnlO (Tet^)]wcrA A{mrr-lhsdlRMS-mcrBC) ^80lacZAM15 AlacX7 recAl deoR araD{ara-leu)7697 
galU galK rpsL (Str^) endAl nupG 
pCR2.1-TOPO Plasmid map shown at h ttp ://w w w .invitrogen.com
" Adapter 1 and 2R homology to PCR primer 1 (shown in bold). Adapter 1 homology to nested primer 1 (shown in italic) and adapter 
2R homology to nested primer 2 (shown in bold italic).
Media and grow th conditions. C. jejuni strains w ere routinely  
grow n for 24 h at 42 °C under m icroaerobic conditions (85 % 
Ng, 7-5% COg, 7-5% Og) on  b lood agar plates supplem ented 
w ith 10%  sheep blood, 50 gg A ctidione m k^ and selective 
antibiotics (O xoid) (Skirrow , 1977). Escherichia coli w as 
m aintained on L uria-B ertan i (LB) agar o r in L uria-B ertan i 
bro th  (Difco) at 37 °C in a tm ospheric conditions. W hen 
required the media w ere supplem ented w ith  100 gg am picillin 
ml"^ o r 50 gg kanam ycin ml"^. C. jejuni and E. coli w ere stored  
as frozen cultures a t —80 °C in 1%  (w /v) p roteose peptone 
w ater (Difco) contain ing 10%  (v/v) glycerol or in Luria b ro th  
(LB) contain ing 50%  glycerol (Ausubel et al., 1994), re­
spectively.
Chicken-colonizatlon m odel. A quantita tive oral chick- 
colonization assay w as perform ed as previously described 
(W assenaar et al., 1993). Briefly, g roups of 10 specific 
pathogen-free chickens (SPAFAS, C harles River), housed in 
isolators, w ere dosed a t day 1 o f age by oral gavage. Doses 
ranged from  10^ to  10® c.f.u. (100 gl OT M  PBS, pH  7-2)“  ^ of 
C. jejuni N C T C  11168, adm inistered  in 100 gl OT M  PBS 
(0-0234 M  disodium  hydrogen phospha te ; 0 0066 M  po tass­
ium  dihydrogen o rth ophospha te ; 0-07 M  N aC l; pH  7-2). 
Doses w ere p repared  by harvesting bacteria, g row n overnight 
on blood agar plates a t 42 °C, in to  sterile PBS. A t 5 days p o st­
challenge, the levels of colonization  w ere determ ined by 
plating  o u t d ilu tions of caecal contents. C hick-colonization 
levels w ere given as c.f.u. (g caecal contents)"^ fo r individual 
birds. T he lim it o f detection o f colonization w as 100 c.f.u. 
(g caecal contents)"^. T he dose response for the colonization 
po ten tial of C. jejuni 81116 has been previously described 
(W assenaar et al., 1993) and has been consistent in over 20 
experim ents.
Subtractive hybridization. A schem atic d iagram  of the sub- 
tractive-hybrid ization  technique is show n in Fig. 1. T he D N A  
sequences o f adapters and prim ers used in this study are 
show n in T able 1. Initially, genom ic D N A  prepara tions from  
C. jejuni 81116 (tester) and strain  11168 (driver) w ere isolated 
using the CTAB m ethod for D N A  isolation (Ausubel et al., 
1994). Lach p repara tion  w as digested w ith  Alu\ and D ral, 
according to  the m ethods described in the PCR-Select Bacterial 
Subtraction  k it (C lonetech), to  give a range of b lunt-ended 
fragm ents of betw een 0 1  and 2-0 kbp , as determ ined by gel
electrophoresis. T he blunt-ended D N A  fragm ents from  C. 
jejuni 81116 w ere subdivided in to  tw o  aliquots and  each 
aliquo t w as ligated to  a different adap te r (1 o r 2R). T his 
resulted in double-stranded  D N A  fragm ents w ith  an extended, 
single-stranded adap te r sequence on the 5' end of each 
com plem entary  strand . Both aliquots w ere denatu red  and 
com bined w ith  an excess o f denatu red  driver D N A  and the 
m ix ture  w as incubated  a t 63 °C for 1-5 h (Fig. 1, hybrid ization  
one). In the second hybrid ization  (Fig. 1, hybrid ization  two) 
the tw o aliquots were com bined and incubated  a t 63 °C 
overnight w ith m ore fresh denatu red  driver D N A . D uring  this 
stage tester-specific D N A  (ligated to  adap te r 1) annealed  to 
tester-specific D N A  (ligated to  adap te r 2R). T he recessed ends 
of the adap ters w ere filled and the  p rim ary  PC R  w as carried  
ou t to exponentially  am plify tester-specific D N A  (type f 
molecules). In the secondary PC R , nested prim ers to  adapters 
1 and 2R w ere used to  fu rther enrich the tester-specific D N A  
(type f  molecules). T he first genom ic sub trac tion  w as carried  
o u t w ith  a hybrid ization  tem pera tu re  o f 63 °C, as recom ­
m ended by the m anufacturer. A second ro u n d  o f subtractive 
hybrid ization  w as perform ed w ith  10 gl of the secondary  PC R  
products, bu t this tim e a hybrid ization  tem pera tu re  o f 61 °C 
w as used.
Preparation o f the subtractive-hybridization library. T he
secondary PC R  products w ere ligated in to  pC R 2.1 -T O P O  
vector using the T O P O  TA  C loning k it (Invitrogen). T he 
ligated products w ere transfo rm ed  in to  T O P lO F ' com peten t 
E. coli cells, as recom m ended, and tran sfo rm an ts w ere se­
lected for kanam ycin and am picillin resistance. PC R  am pli­
fication w as perform ed directly on the tran sfo rm an ts  using 
50 pm ol gL^ o f M13 fo rw ard  and  reverse prim ers together 
w ith  H otStarTaq  m aster m ix (Q iagen). PC R  p aram eters w ere 
as follow s : 95 °C for 15 min follow ed by 25 cycles o f 94 °C for 
45 s, 60 °C for 45 s and 72 °C for 1 min 45 s, w ith  a final 
incubation  a t 72 °C fo r 10 min. Agarose-gel e lectrophoresis 
confirm ed the presence of D N A  inserts (data n o t show n).
Dot-blot and Southern-blot hybridizations. For the d o t blots, 
50 ng o f each PC R  product w as denatu red  by incubating  in a 
boiling w ater ba th  for 5 min and spo tted  on to  a H ybond-N  +  
m em brane (A m ersham ). D N A  w as cross-linked to  the  m em ­
brane by UV light. For p robe labelling, 200 ng o f genom ic 
D N A  digested w ith  A lul and D ral w as labelled using alkaline
1205
I. H . A hm ed  an d  o thers
phosphatase (AP) according to A lkPhosD irect labelling kit 
guidelines (A m ersham ). T he blots were prehybrid ized in 
A lkPhos D irect H ybe buffer for l b  a t 60 °C and then 
hybridized overnight at 60 °C w ith 200 ng of the AP probe. For 
Southern-b lo t analysis, 10 gg of each C. jejuni genom ic D N A  
was digested w ith  either H ind lll or HinÛ, electrophoresed 
th rough  a 1%  (w /v) agarose gel and transferred  on to  a 
H ybond-N  +  m em brane. Each D N A  insert (50 ng) o f in terest 
was labelled w ith A P; hybrid izations and stringency w ashes 
w ere carried o u t at 60 °C as before.
Sequencing and analysis. Strain-81116-specific clones w ere 
cu ltured  in 1 ml LB bro th  w ith kanam ycin selection, purified 
using a Q IA prep spin m iniprep k it (Qiagen) and sequenced by 
using the CEQ  D TCS sequencing system (with 3 2 pm ol M 13 
prim er gT^) on a CEQ 2000 D N A  sequencer (Beckman 
C oulter). T he D N A  sequences w ere edited using the e d i t s e q  
program  (D N A star, Lasergene) and hom ology searches were 
perform ed using the b l a s t  suite of p rogram s (Altschul et al., 
1997).
lb )
*  »
#
RESULTS
C. jejuni 81116 colonizes the chick model in a dose- 
dependent manner, with a dose of 10® c.f.u. maximally 
colonizing 100% of the birds (Wassenaar et al., 1993). 
This differs from other freshly isolated strains tested, 
which display all-or-nothing-type colonization patterns 
and maximally colonize all the birds with doses of 
10“-10 ’^ c.f.u. (Cawthraw et al., 1996). However, this 
apparent lower colonization potential of strain 81116 
can be overcome by a single passage through chicks, so 
that the passaged strain (81116?) maximally colonizes 
birds with a dose as low as 35 c.f.u. (Cawthraw et al.,
1996). In comparison with strain 81116, strain 11168 
was a poor colonizer (Fig. 2). A dose of 10*^  c.f.u. gave a 
detectable colonization level in only two out of 10 birds. 
A dose of 10® c.f.u. was required to colonize 100% of
3  10® -
Dose [c.f.u. (100 gl 0 1 M PBS, pH 1-2)-^]
Fig. 2. Caeca!  c o lo n iz a t io n  levels o f  chicks g iven  a r a n g e  of  
d o se s  o f  C. je ju n i  s t ra ins  81116  ( □ ) ,  11168 (V )  a n d  chick- 
p a s s a g e d  11168 (11168P) ( ♦ ) .  T he  b r o k e n  line r e p re s e n t s  t h e  
d e t e c t i o n  limit o f  t h e  e x p e r im e n t .
Fig. 3. R e p re s e n ta t iv e  d o t - b lo t  hyb r id iz a t io n  o f  p ro d u c t s  f ro m  
t h e  s u b t rac t iv e  hybrid iz a t io n .  The  s u b t ra c t iv e -h y b r id iz a t io n  
p ro d u c t s  w e r e  c lo n e d  a n d  PCR, using  t h e  M13 f o rw a r d  a n d  
reverse  p r imers ,  w a s  u se d  t o  am plify  t h e  inserts. Each PCR 
p r o d u c t  w a s  s p o t t e d  o n t o  a H ybond-N -t- m e m b r a n e  a n d  
p r o b e d  w i th  (a) A P-labelled  s t ra in  81116  g e n o m ic  DNA 
f r a g m e n t s  a n d  (b) A P-label led  s t ra in  11168 g e n o m ic  DNA 
f r a g m e n t s .  PCR p ro d u c t s  t h a t  h y b r id iz ed  s t ro n g ly  t o  s t ra in  
81116  DNA a n d  w e a k ly  o r  n o t  a t  all w i th  s tra in  11168 DNA 
w e r e  ch o s e n  f o r  se q u e n c in g .  An e x a m p le  o f  a s t r a in -8 1 116- 
specific inse rt  has b e e n  circled.
birds challenged, and even then colonization was at a 
mean level below the maximum level seen with freshly 
isolated Campylobacter strains. Chick-passaged strain 
11168 (11168?) did show some increased ability to 
colonize, but this was still lower than that of the 
unpassaged strain 81116 (Fig. 2).
Genomic subtractive hybridization was applied to 
identify DNA sequences present in strain 81116 and 
absent in strain 11168 (Fig. 1). The initial round of 
subtractive hybridization at 63 °C indicated that sub­
traction had occurred at only a low efficiency, given that 
relatively few transformants were recovered and that 
many of the clones contained DNA inserts with se­
quences present in 11168. Consequently, the second 
round of subtraction was performed at a lower hybridi­
zation temperature (61 °C), which greatly enhanced the 
annealing of homologous driver and tester DNA, and 
the subsequent amplification of tester-specific DNA. 
Cloning of these ?CR products into pCR2.1-T0?0 
resulted in 255 colonies, of which 167 contained inserts. 
Dot-blot hybridization was performed to test the 
specificity of the DNA fragments using the genomic 
DNA (labelled with A?) of strains 81116 and 11168 as 
probes (Fig. 3). Forty-two of the 167 inserts were found
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Table 2. Summary of th e  sequence analysis of clone inserts specific for C. jejuni 81116 and absent from C je juni NCTC 
11168
Insert Size
(bp)
Predicted protein similarity/species Predicted amino 
acid identity (%)
Blast
score
Accession no.
30 259 N o similarity"' - - A J315005
31 232 Arsenite export protein {arsB)'"-, Sinorhizobium  sp. As4 64 2 X  10^ 1 AJ315006
46 384 Putative oxidoreductase chain; Campylobacter jejuni 61 1 X  10»® AJ315007
50 124 N o similarity"' - - AJ315008
60 170 Type I R -M  protein (S subunit) ; Haemophilus influenzae Rd 51 2 X 10 °^ AJ315009
65 147 N o similarity"' - - AJ315010
68 443 Type I R -M  protein (M subunit) ; Salmonella enterica 32 1x10= AJ315011
117 280 N o similarity - - AJ315012
121 321 N o similarity - - AJ315013
135 644 Sty SPl type I R -M  (M subunit)"'; Salmonella enterica 32 2x10= AJ315014
136 308 Putative type I R -M  protein (S subunit) ; Streptococcus 
thermophilus
39 2 X 10^ = AJ315015
141 301 Putative glycosyltransferase ; C. jejuni 40 1 X 10" AJ131360.1
(CAC01393)
149 208 Hypothetical protein (Cjl337) ; C. jejuni 47 2x10= AJ315016
183 195 Hypothetical protein (Rv0235c)"'; Mycobacterium  
tuberculosis
35 0-033 AJ315017
186 196 Arsenate reductase {arsC) ; Aquifex aeolicus 35 8x10= AJ315018
188 163 Cytochrome c oxidase 111" ; Trypanosoma brucei 38 3-4 AJ315019
202 309 Type II R -M  protein; Helicobacter pylori J99 68 5 X  10=» AJ315020
205 313 dTDP-glucose 4,6-debydratase (rmlB) ; Legionella ' 
pneumophila
51 7 X  10»= AJ131360.1
(CAC01395)
209 248 Hypothetical protein (Cjl333); C. jejuni 48 2 X 10" AJ315021
212 194 Probable membrane protein (Cjl560)"'; C. jejuni 56 5 X  10" AJ315022
236 369 y-Glutamyl transpeptidase ; Helicobacter pylori 26695 72 5 X 10^ = AJ315023
243 150 N o similarity''' - - AJ315024
246 297 Abortive phage-resistance protein ; Lactococcus lactis 34 0-033 AJ315025
■ Predicted membrane-spanning domain.
to strongly hybridize to strain 81116 and either weakly 
or not at all to strain 11168. DNA sequencing revealed 
that 24 of these 42 clones contained inserts that were 
absent in strain 11168 (Table 2), of which one DNA 
sequence was represented twice (inserts 126 and 136, 
only the latter has been included in the remaining 
analysis). The remaining 18 DNA inserts (43%) were 
false positives, i.e. analysis using the b l a s t  suite of 
programs revealed high sequence similarities in strain 
11168 and also predicted similarities of 75-100% at the 
amino acid level when each DNA sequence was trans­
lated in all six reading frames. Most of these false- 
positive inserts were present in the cloning plasmid as 
chimeras (13 inserts), in which two different inserts had 
ligated into one vector joined by adapter sequences. Five 
inserts (46, 141, 149, 209 and 212) had weaker, but 
significant, similarities (40-61 % identity at the amino 
acid level) with genes present in strain 11168. Twelve 
sequences had no similarity to any gene in the strain 
11168 genome sequence, but they did have significant 
similarity to genes of other organisms. The remaining 
six sequences (inserts 30, 50, 65, 117, 121 and 243) had 
no significant similarity with any sequence present in the
NCBI databases searched. The 23 strain-81116-unique 
DNA fragments (mean size of 272 bp ; range 124-644 bp) 
were further analysed for the presence of potential 
surface structures and conserved motifs in protein 
families by p r e d i c t  p r o t e i n  (http://dodo.cpmc. 
columbia.edu/predictprotein/submit_def.html). The 
prevalence of these unique sequences, among a diverse 
range of other C. jejuni strains, was determined by 
Southern-blot analysis (Table 3). The chromosomal 
DNA of each strain, digested with either Hmdlll or 
HinÛ, was probed with each of the 23 strain-81116- 
specific DNA inserts. The results confirmed the presence 
of all 23 sequences in strain 81116 and their absence 
from strain 11168 DNA (Table 3). Only one of the 23 
inserts (insert 121) was unique to strain 81116 (Fig. 4a). 
In contrast, only insert 50 hybridized to all other strains 
tested, with the exception of strain 11168 (Fig. 4b). The 
remaining 21 sequences gave variable distributions and 
banding patterns, of which two examples are shown 
(Fig. 4c, d, insert 246 and 135, respectively). The results 
are summarized in Table 3. Insert 46 is an example of a 
chimeric insert, in which two DNA fragments (exci- 
nuclease ABC subunit A and putative oxidoreductase)
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Table 3. Southern-blot analysis of each insert against randomly chosen C. Jejuni strains
Insert Hybridization with C . j e ju n i  strain'-' Total
8II16 99/385 99/189 99/388 99/346 EXI14 81176 99/322 99/312 94/194 11168
50 + 4- 4- 4- 4- + 4- + + + — 10
183 + + + + 4- + 4- - - - - 7
68 + + 4- 4- 4- - - 4- 4- - - 7
135 + 4- 4- + 4- - - 4- 4- - - 7
65 4- + 4- + 4- - + — - - - 6
236 + + 4- + 4- - 4- — - - - 6
141 + + 4- + 4- - — — — — - 5
205 4- + + -F 4- — — — — - - 5
246 4- + + + 4- - - - — - - 5
60 4- + + + 4- - - - — - - 5
243 4- + + + 4- - - — — - - 5
30 4- + - 4- 4- 4- - - — - - 5
46 + + - + 4- + — — — - - 5
136 + + - + 4- + - - — - - 5
31 + + + - - + - - — - - 4
186 + 4- + - - 4- - - — - - 4
212 4- + -F - - + - — — - - 4
202 4- - + - - - - + 4- - - 4
188 4- - 4- - + - — — — — 3
149 + - 4- - — 4- — — - — 3
209 + - + - — 4- - — — — 3
117 4- - ■ - - - - - — - - 2
121 4- - - - - - - - - - - 1
Total 23 17 17 16 15 8 6 4 4 1 0
-f , Indicates a positive hybridization; —, indicates a negative reaction (total absence of bands).
were ligated together (Fig. 5a). Removal of the exci- 
nuclease sequence and generation of a new AP-labelled 
probe, containing only the putative oxidoreductase, 
removed those bands that were common to all the 
strains (~ 2 k b p  band for Hmdlll profile. Fig. 5b), 
leaving a IT kbp band in strains 99/385, 81116, 99/388 
and 99/346, and a 2-4 kbp band for strain EX114 (data 
not shown). For the other chimeric inserts, the individual 
strain-81116-specific sequences were also amplified by 
PCR from strain 81116 genomic DNA and then used to 
probe the Southern blots.
DISCUSSION
All freshly isolated C. jejuni strains, i.e. those with 
minimal laboratory passage, tested to date maximally 
colonize [10 -^10^® c.f.u. (g caecal contents)^^] one-day- 
old chicks within 5 days with oral doses of 10^-10^ c.f.u. 
(Cawthraw et al., 1996). Although the laboratory strain 
81116 has a comparatively low colonization potential, 
this can be upregulated by in vivo passage (81116P) to a 
level similar to that of freshly isolated strains. In 
contrast, strain 11168 appears to be a very poor 
colonizer, and even in vivo passage will not upregulate 
its colonization potential to that seen in freshly isolated 
strains. It therefore seems likely that the observed lower 
colonization potential of C. jejuni 11168, compared with
strain 81116, is a reflection of genetic difference(s). In 
this study subtractive hybridization has been success­
fully applied to identify genetic material present in C. 
jejuni 81116 but absent in strain 11168. This approach 
was rendered easier because strain 11168 has recently 
had its genome sequenced.
The low percentage of genuine strain-81116-specific 
sequences, obtained from the initial subtractive- 
hybridization experiment, may have been due to the 
inadequate annealing of homologous DNA sequences 
from strain 11168 to 81116. Decreasing the temperature 
from 63 °C (optimal for bacteria with a CC ratio of 
40-51 mol %) to 61 °C improved this efficiency by 
allowing the preferential amplification of 81116-specific 
sequences. Improved optimization might be achieved by 
decreasing the hybridization temperature further. The 
presence of a number of chimeric clones also confounded 
the overall efficiency, as these were detected as positive 
clones. Nonetheless, a total of 23 DNA sequences 
present in strain 81116 and absent from strain 11168 
have been identified, confirming that intra-species vari­
ation exists between strains of C. jejuni (Dorrell et al., 
2001). Of the 23 strain-81116-specific DNA inserts 
identified six sequences had no significant similarities to 
any entry in the databases searched. In several cases, two 
or more of the strain-81116-specific inserts appeared to
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Fig. 4. The p re se n c e  o f  DNA, f ro m  se lec ted  
inserts , a m o n g  a r a n g e  o f  C. j e ju n i  stra ins , as 
d e m o n s t r a t e d  by  S o u th e r n -b lo t  analysis. 
Tw o r a n d o m  iso lates  o f  s t ra in  11168 w e r e  
t e s te d .  S o u th e rn  h y b r id iz a t io n  o f  H/'ndIll- 
d ig e s te d  g e n o m ic  DNA f ro m  ea c h  s t ra in  w as  
ca r r ied  o u t  w i th  A P- labe l led  su b t rac t iv e -  
hybr id iza t ion -D N A  inse rts  as  p ro b e s ,  (a) 
Insert  121 h y br id iz ed  t o  s t ra in  81116  only, 
(b) Insert  50 hyb r id iz ed  t o  all t h e  s t ra ins  
t e s t e d  e x c e p t  s t ra in  11168. (c) Inser t  246 
hyb r id iz ed  t o  s t ra ins  99/189, 99/385, 81116, 
99/388 a n d  99/346. (d) Inser t  135 hyb r id iz ed  
t o  s t ra ins  99/189, 99/322, 99/312, 99/385, 
81116, 99/388 a n d  99/346.
lave been derived from the same genomic location, as 
ndicated by Southern blotting, suggesting that such 
Train-specific genes may be clustered ; for example, the 
ff/wfl profiles of inserts 60, 243 and 246 were identical.
The appearance of identical banding profiles on 
Southern blots for the two C. je ju n i strains 99/312 and 
Z9/322, when probed with inserts 50, 68, 135 and 202, 
suggests that the genetic arrangement of these strains is 
iimilar. Indeed, PFGE profiles of these two strains are 
tlso identical, indicating that they are clonally related 
A.M. Ridley, personal communication).
Mthough subtractive hybridization was developed to 
icreen for the presence or absence of genes, it can also be 
ised to detect polymorphisms between two strains. This 
vas apparent for inserts 205 and 141. These inserts have 
umilarities to dTDP-glucose 4,6-dehydratase {rmlB) 
rom L eg ion ella  p n eu m o p h ila , an enzyme involved in 
:he glycosylation of the cell wall of pathogenic bacteria 
[Allard e t a l., 2000), and a putative glycosyltransferase 
rom C. je ju n i 11168, respectively. Both inserts had 
dentical H in il  Southern-blot profiles and both were 
fither present or absent in the C. je ju n i strains tested. 
Fhis suggests that the functions of these two genes, 
nvolved in polysaccharide biosynthesis, are co­
ordinated. That inserts were identified that do not
hybridize to strain 11168, despite significant amino acid 
similarity as in the case of insert 141, suggests that (at 
least some) polymorphic genes can be detected by 
subtractive hybridization. These results confirm DNA  
microarray observations indicating that strain 81116 
differs from strain 11168 within this genetic region 
(Dorrell e t a l., 2001). Thus, subtractive hybridization 
not only complements DNA microarray technology but 
provides the additional benefit of detecting novel se­
quences in test strains.
It has been reported that sequences within the flagellar 
modification region and the capsule locus vary between 
strains. In particular, it has been reported that a region 
between Cj 1318 and Gj 1336 of the flagella modification 
locus has been lost from strain 81116 (Dorrell e t a l., 
2001). However, subtractive hybridization identified 
insert 209 to have similarity to Cj 1333. One explanation 
of this anomaly would be a genetic rearrangement in 
strain 81116, so that Gj 1333 was no longer located 
where expected relative to strain 11168. However, the 
identification of a second insert (149) with similarity to 
Gj 1337, and the identical Southern-blot profiles using 
inserts 149 and 209 as probes suggests that these two 
DNA fragments are in close proximity on the 81116 
genome.
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(a) ]  Inser t  46
POS ABC
Putative oxidoreductase subunit (POS)
I n s e r t  46 : 426 SIPYIGNYLSLDPTYKDAYGLPLIRVTYNFTKQDKNLYNFMLPKLKSIMQEM-GAQNIYT 250
consensus S+P+ NYLSLDPTYKDA+G+PL+R+TYNFT QD+ L+ F+ K + + M G ++I
POS : 428 SLPHKNNYLSLDPTYKDAFGMPLLRLTYNFTDQDRALHKFITDKTAEVAKRMQGVKSIKK 487
Insert 46 : 249 SPKLGDYGVVSNGWYTSTHIAGGTIMGTDKSTSVVNPYLQHWDVNNLFVVGAGNFPHNPG 70 
consensus L DY VV Y STH GGT MG D+ TSVVN YLQHWD +NLFVVGAGNF HN G
POS : 488 GAYLKDYSVVP YQSTHNTGGTTMGADRETSVVNTYLQHWDADNLFVVGAGNFQHNSG 54 4
Insert 46 : 69 YNPTLTLNALAYRASEDL 16 
consensus YNPT T+ ALAYR +E +
POS : 545 YNPTDTVGALAYRCAEGI 562
Excinuclease ABC subunit A (ABC)
Insert 46: 595 RSQIDGVLVRLDEEIELAKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLQESSG 431 
consensus R+QIDGVLVRLDEEIELAKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLQES G
ABC : 177 RAQIDGVLVRLDEEIELAKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLQESFG 231
¥ / /
kbp
—  1 0 0
—  5 0
—  40
—  3 0
—  25
—  20
—  10
(b)
Fig. 5. An e x a m p le  o f  a chim eric  clone,  inse rt  46. (a) The DNA 
s e q u e n c e  b e t w e e n  426  a n d  16 has a n  a m in o  acid id en t i ty  o f  
6 1 %  t o  a  p u ta t iv e  o x id o r e d u c ta s e  in C. j e ju n i  11168; t h e  
s e q u e n c e  b e t w e e n  431 a n d  595 has 9 8 %  a m in o  acid id e n t i ty  t o  
ex c inuc lease  ABC s u b u n i t  A f ro m  C. je ju n i  11158. The a m in o  
acid co n s en su s  is s h o w n  in b e t w e e n  t h e  a m in o  acid s e q u e n c e  
f o r  inse rt  46  a n d  t h e  p u ta t iv e  o x id o r e d u c ta s e  o r  exc inuc lease  
ABC s u b u n i t  A; c onse rva tive  su b s t i tu t io n s  a r e  in d ic a te d  by + .  
(b) S o u th e r n -b lo t  h y b r id iz a t io n  us ing  inse rt  46  as a  p ro b e .  The 
o x id o r e d u c ta s e  p a r t  o f  chimeric  inse rt  46  w a s  s h o w n  to  
h ybr id ize  t o  s t ra ins  99/385, 81116, 99/388 a n d  99/346 (1 1 kbp  
b a n d )  a n d  t o  EX114 (2 4 k b p  b a n d )  in a s e p a r a t e  e x p e r im e n t  
( d a ta  n o t  sh o w n ) .  T he  exc inuc lease  p a r t  o f  inse rt  46 w a s  s h o w n  
t o  h ybr id ize  t o  all s trains, inc lud ing  s t ra in  11168, as s h o w n  by 
t h e  b a n d  in all l anes  a t  2 kbp.
A number of DNA inserts were found to have similarities 
to restriction-modification (R-M) genes. Similarities to 
both type I and II R-M  systems were identified in inserts 
60, 68, 135, 136 (all type I from H aem ophilus influenzae 
Rd, Salm onella enterica, S. enterica  and Streptococcus
therm ophilus, respectively) and 202 (type II from 
H elicobacter pylori J99) (Table 2). Southern-blot pro­
files of inserts 68 and 135 were identical with both 
Hmdlll and H inil, suggesting that they are closely 
located in all strains tested. Analysis of these two inserts
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revealed a substantial amount of overlapping DNA  
sequence, suggesting that they might be part of the same 
R-M  gene. There is increasing evidence for the existence 
of multiple R-M  systems in C. jejuni (Miller, 2001). The 
functions of those R-M  genes found in strain 81116 are 
currently under investigation. Interestingly, the chromo­
somal DNA of this strain does not cut with Smal (G. 
Manning, personal communication), even though Smal 
sites have been shown to be present (l.H. Ahmed, 
unpublished data). It is therefore interesting to speculate 
that the R-M  genes detected have a role in this enzyme 
restriction.
Two more inserts (31 and 186), which were absent from 
the strain 11168 genome, have similarities with genes 
involved in arsenic resistance in several bacteria. Insert 
31 has 64% amino acid identity to ArsB from Sino­
rhizobium sp. As4, an integral membrane protein needed 
for the extrusion of arsenite. Insert 186 has 35 % amino 
acid identity to ArsC from Aquifex aeolicus. This gene 
encodes arsenate reductase, which reduces intracellular 
arsenate to arsenite. The Southern-blot profiles of inserts 
31 and 186 were different (data not shown), suggesting 
that these two genes do not form part of an operon. 
However, insert 186 had identical Hmdlll and Hmfl 
profiles (data not shown) to those of insert 212, which 
has similarity to C]T560 ( a putative membrane protein). 
This suggests that ArsB and Cjl560 are co-located in the 
genome of all strains tested. Generally, in Gram-negative 
bacteria the arsenic-effiux pump comprises ArsA, the 
ATPase subunit, ArsB, which anchors the former to the 
membrane, and ArsC in the cytosol (Cervantes et al., 
1994). The observation of arsenite-metabolizing genes 
in strain 81116 and not in strain 11168 is interesting 
especially since phenylarsonic compounds have been 
used, in the past, in poultry feed for controlling caecal 
coccidiosis and to promote growth (Pergantis et al.,
1997). The use of such compounds may have led to the 
contamination of some agricultural lands on which 
poultry litter has been used as manure (Gupta & 
Charles, 1999). The ars operon is widespread among the 
Enterobacteriaceae and arsenic has also been shown to 
induce the synthesis of heat-shock proteins, indicative of 
the stress response triggered due to exposure to this 
toxic chemical (Chang et al., 1989). Thus, the biological 
role of these genes in the colonization of chickens by 
Campylobacters requires further investigation.
Insert 236 has 72% amino acid identity to the H. pylori 
y-glutamyl transpeptidase {ggt) gene. Southern-blot 
analysis of insert 236 revealed an identical Hmfl, but a 
different Hmdlll pattern, to that of insert 65, for which 
no significant protein similarities could be identified. 
This suggests that these inserts are located in close 
proximity in the genome of strain 81116 and that they 
may be linked. As well as functions in the antioxidant 
glutathione pathway (Carmel-Harel & Storz, 2000), 
GGT appears to have a role in the colonization of 
the gastric mucosa by H. pylori (Chevalier et al., 
1999 ; McGovern et al., 2001). Whether this gene product 
has a similar role in colonization of the chicken intestinal 
tract by C. jejuni will require further investigation.
The successful application of subtractive hybridization, 
to genetically compare two strains of C. jejuni with 
differing colonization potentials, has revealed a number 
of strain-specific differences, some of which may be 
potential colonization factors. It should, however, be 
noted that the sequences identified in this study are only 
fragments of much larger genes and that expression of 
the corresponding genes has not yet been proven. 
Moreover, future work involving the mutagenesis of the 
81116-specific sequences in tandem with further chick- 
colonization experiments will be necessary to determine 
the importance of such genes in colonization. Insert 50 is 
particularly interesting since it was universally present 
in the other C. jejuni strains tested (apart from strain 
11168) and for one strain (94/194) was the only insert 
hybridizing. As this strain colonizes the chick model to 
the same extent as freshly isolated strains (K.J. Clow, 
personal communication), insert 50 may be especially 
important in chicken colonization.
In conclusion, the 23 novel DNA segments identified in 
this study represent a selection of genes present in strain 
81116 and absent in strain 11168, and they indicate 
extensive genetic variation even among a small number 
of C. jejuni strains. These results imply that we have, to 
date, found only a portion of the total gene pool existing 
within the C. jejuni species. While C. jejuni genome 
sequence data are limited techniques like subtractive 
hybridization can be used to identify novel genes, which 
can then be used to construct more comprehensive DNA  
arrays to accurately determine genomic diversity.
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